Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	864	"pituitary gland: 334.1;placenta: 293.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025646, HPA043715"	Enhanced				"Secreted to blood"					"CAB025646: , HPA043715: "																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	334.1	293.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PSG1	"CD66f, PBG1, PSBG1, PSGGA"	ENSG00000231924	"Pregnancy specific beta-1-glycoprotein 1"	P11464	19	42866464-42879822	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	362	"placenta: 497.6"	"Cell line enriched"	"Detected in some"	20	"U-2197: 95.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "					"unprognostic (2.02e-1)"	"unprognostic (3.54e-1)"							"unprognostic (2.44e-7)"			"unprognostic (2.28e-2)"		1.3	0.0	0.1	0.0	0.1	0.0	0.6	0.5	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	497.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.3	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0
GH2	"GH-V, GHL, GHV, hGH-V"	ENSG00000136487	"Growth hormone 2"	P01242	17	63880215-63881935	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	309	"pituitary gland: 47.3;placenta: 138.4"	"Cell line enriched"	"Detected in single"	20	"BEWO: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043715	Supported				"Secreted to blood"					"HPA043715: "															"unprognostic (1.02e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	138.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG11	"MGC22484, PSG13, PSG14"	ENSG00000243130	"Pregnancy specific beta-1-glycoprotein 11"	Q9UQ72	19	43007656-43026512	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	220	"placenta: 151.1"	"Cell line enriched"	"Detected in single"	25	"U-2197: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042240, HPA046327"	Enhanced				"Secreted in female reproductive system"					"HPA042240: AB_10797384, HPA046327: "					"unprognostic (2.58e-1)"													0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	151.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"placenta: 299.0"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;BJ hTERT+ SV40 Large T+: 5.4;HBF TERT88: 11.2;T-47d: 5.1;U-2197: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"									HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.2	299.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	6.1	3.4	5.4	2.8	0.1	0.1	0.0	0.2	1.7	0.3	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.7	5.1	0.0	0.3	0.2	2.6	11.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-266/70: 26.0;U-266/84: 8.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	26.0	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	146	"placenta: 495.8"	"Cell line enriched"	"Detected in single"	6	"U-2197: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "																		0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	495.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.7	0.5	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG6		ENSG00000170848	"Pregnancy specific beta-1-glycoprotein 6"	Q00889	19	42902079-42919563	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"placenta: 330.8"	"Cell line enriched"	"Detected in some"	17	"U-2197: 56.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	27	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 2.6"									HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "						"unprognostic (4.23e-1)"												0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	330.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.2	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044738-53051076	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	105	"placenta: 85.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.2;T-47d: 5.7;U-266/84: 3.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.0
PSG2	"CEA, PSBG2, PSG1, PSGGB"	ENSG00000242221	"Pregnancy specific beta-1-glycoprotein 2"	P11465	19	43064211-43083045	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	102	"placenta: 75.3"	"Cell line enhanced"	"Detected in some"		"BJ: 6.4;fHDF/TERT166: 13.7;HBF TERT88: 21.4;U-2197: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"																			"unprognostic (1.02e-2)"				0.4	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	75.3	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	1.1	0.6	2.8	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0
PSG8		ENSG00000124467	"Pregnancy specific beta-1-glycoprotein 8"	Q9UQ74	19	42752686-42855691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	88	"placenta: 142.2"	"Cell line enhanced"	"Detected in some"		"A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;U-2197: 2.6"	"Cancer enriched"	"Detected in single"	17	"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "																"unprognostic (1.85e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	142.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.4	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.0;ASC TERT1: 14.5;HSkMC: 52.2;U-138 MG: 13.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"		41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	8.3	0.0	19.0	14.5	0.0	4.4	7.8	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.6	0.0	0.0	5.9	0.0	0.0	0.9	4.5	0.0	9.2	0.0	0.0	52.2	0.0	6.1	0.7	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	10.5	13.6	0.7	0.3	0.5	0.0	0.0	0.0	9.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5
CGB8		ENSG00000213030	"Chorionic gonadotropin beta subunit 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	85	"pituitary gland: 7.0;placenta: 22.2"	"Group enriched"	"Detected in some"	7	"BEWO: 60.5;U-251 MG: 21.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	7.0	22.2		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	2.5	0.2	21.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PSG5	"FL-NCA-3, PSG"	ENSG00000204941	"Pregnancy specific beta-1-glycoprotein 5"	Q15238	19	43166256-43186536	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	73	"placenta: 171.3"	"Group enriched"	"Detected in some"	8	"BJ: 51.2;fHDF/TERT166: 176.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (1.59e-1)"	"unprognostic (3.38e-2)"				"unprognostic (4.69e-2)"		"unprognostic (1.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (7.92e-2)"	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.1	171.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	2.0	0.5	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	51.2	14.7	0.8	7.1	0.0	0.0	0.0	0.0	176.3	1.9	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.4	0.7	0.4	0.5	0.6	0.5	0.5	0.2	1.0	0.7	0.5	2.0	0.6	0.4	0.5	0.4	0.0	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0
TRIM64	"C11orf28, TRIM64A"	ENSG00000204450	"Tripartite motif containing 64"	A6NGJ6	11	89968502-89975228	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	65	"blood: 8.6;placenta: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	86	"basophil: 8.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.6"									HPA045370	Approved									"HPA045370: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		4.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell line enriched"	"Detected in some"	19	"BEWO: 105.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"					"CAB023350: AB_617281, HPA029698: "	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	105.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
KRTAP26-1		ENSG00000197683	"Keratin associated protein 26-1"	Q6PEX3	21	30319124-30320316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"placenta: 59.4;skin 1: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	50	"placenta: 487.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.4;hTEC/SVTERT24-B: 29.2;U-2197: 28.8;U-251 MG: 25.7;U-87 MG: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"			"Plasma membrane"		"HPA030866: , HPA030867: AB_10602428, HPA030868: "	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	6.0	0.0	0.6	2.1	2.8	0.0	5.9	0.6	0.6	8.0	0.5	0.5	0.4	0.0	2.6	0.5	0.5	0.1	4.6	0.7	0.6	0.7	1.0	0.4	1.1	1.0	0.8	0.5	8.2	0.6	0.0	1.1	487.4	0.8	0.7	0.1	0.9	1.1	0.4	0.5	0.3	0.4	1.5	0.7	0.5	0.1	0.7	0.6	0.5	0.4	0.5	1.2	4.5	0.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	4.9	0.7	2.0	0.0	5.9	12.2	0.0	12.9	1.0	4.4	11.1	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.4	4.8	0.5	0.1	0.0	7.9	0.0	0.9	0.0	10.3	14.9	0.0	29.2	0.9	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.8	0.0	1.5	1.3	0.1	13.3	0.1	8.8	1.5	0.0	0.2	0.0	0.0	0.0	15.9	5.3	28.8	25.7	0.0	0.1	0.0	22.1	0.0	9.8	0.0	0.0	0.0	0.5	0.0	9.8	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	2.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.6
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338610	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"placenta: 440.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HDLM-2: 7.8;HSkMC: 15.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.9"	"Cell type enriched"	"Detected in single"	17	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Approved	Mitochondria				Mitochondria		"CAB000355: , HPA051194: "	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	9.0	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3.0	0.2	0.3	3.0	0.2	0.2	1.2	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.8	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	7.8	0.0	0.3	0.1	3.7	0.2	0.0	0.0	15.0	0.0	0.1	1.8	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.4	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2
INSL4	EPIL	ENSG00000120211	"Insulin like 4"	Q14641	9	5231419-5235304	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"placenta: 88.0"	"Cell line enriched"	"Detected in some"	11	"A549: 23.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"							"unprognostic (9.77e-2)"						"unprognostic (2.02e-1)"		"unprognostic (4.66e-1)"				"unprognostic (7.74e-2)"				0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	88.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	23.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498850	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"placenta: 193.8"	"Cell line enriched"	"Detected in some"	15	"BEWO: 89.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"			Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.7	0.0	0.2	0.2	4.2	0.0	0.1	0.1	0.3	1.1	0.2	0.1	0.3	0.1	2.7	0.9	0.2	0.5	0.1	0.1	0.1	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.5	193.8	0.2	3.2	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.2	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.1	0.3	0.1	0.8	0.1	0.1	0.2	0.2
HBG2	HBG-T1	ENSG00000196565	"Hemoglobin subunit gamma 2"	P69892	11	5253190-5505605	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"placenta: 553.0"	"Group enriched"	"Detected in some"	175	"HEL: 313.8;K-562: 326.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB016143, HPA043234"	Approved									"CAB016143: AB_2295004, HPA043234: "	"unprognostic (4.48e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	2.6	0.3	1.4	0.7	1.2	3.7	0.7	0.9	0.8	0.7	0.7	0.7	0.7	0.4	0.7	0.7	0.7	0.3	0.7	2.3	1.0	1.0	2.3	2.2	5.5	0.7	1.7	0.7	0.7	0.8	0.3	1.0	553.0	0.7	0.7	0.3	0.8	0.7	0.7	1.3	0.3	0.7	0.7	2.3	13.3	0.5	1.1	0.7	0.7	1.7	0.7	0.7	0.7	0.8	0.0	0.1	0.4	0.7	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	9.5	1.4	1.2	0.9	0.8	1.0	1.0	1.7	0.7	0.7	0.7
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"placenta: 246.2"	"Cell line enriched"	"Detected in single"	20	"BEWO: 13.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043715	Supported				"Secreted to blood"					"HPA043715: "		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	246.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 20.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	4.5	2.2	3.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	20.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2
LGALS14	"CLC2, PPL13"	ENSG00000006659	"Galectin 14"	Q8TCE9	19	39704306-39709444	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"placenta: 110.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 5.3;U-266/70: 12.6"	"Cancer enriched"	"Detected in single"	16	"liver cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									HPA065180			Supported	Nucleoplasm				Nucleoplasm		"HPA065180: "										"unprognostic (1.95e-1)"								0.0	0.2	0.1	0.1	0.1	0.2	1.1	0.1	0.3	1.5	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.2	110.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.2	0.0	0.3	0.3	0.1	1.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	3.2	0.6	0.3	0.0	0.4	0.7	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.2	0.5	0.0	5.3	0.1	0.8	0.1	0.0	0.2	1.9	0.2	0.1	1.0	0.4	0.0	0.2	1.2	0.0	0.3	0.3	0.4	0.0	0.1	1.3	0.0	0.5	0.2	0.3	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.2	0.1	0.2	0.0	0.5	0.7	1.0	0.3	12.6	0.7	0.1	0.4	0.3	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.1	3.2	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.0	0.0
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"placenta: 12.1;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"A-431: 61.4;AN3-CA: 38.3;HMC-1: 73.1;U-266/84: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	19.6	0.0	0.3	15.6	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
CSH1	"CSA, CSMT, FLJ75407, hCS-A, PL"	ENSG00000136488	"Chorionic somatomammotropin hormone 1"	P0DML2	17	63894909-63896661	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"placenta: 450.4"	"Cell line enriched"	"Detected in some"	8	"BEWO: 15.9"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB026374, HPA043715"	Enhanced				"Secreted to blood"					"CAB026374: , HPA043715: "															"unprognostic (6.99e-2)"			2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	15.7	450.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.9	0.1	1.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LGALS13	"PLAC8, PP13"	ENSG00000105198	"Galectin 13"	Q9UHV8	19	39602501-39607476	"Predicted intracellular proteins"	Apoptosis	Hemagglutinin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 58.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Group enriched"	"Detected in some"	7	"cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	58.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.0	1.2	2.0	0.0	0.2	0.0
PLAC1	"CT92, OOSP2L"	ENSG00000170965	"Placenta specific 1"	Q9HBJ0	X	134565838-134764322	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 90.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.3;hTCEpi: 14.4;hTERT-HME1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA063425	Enhanced				"Secreted in female reproductive system"					"HPA063425: "	"unprognostic (2.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.89e-4)"	"unprognostic (1.35e-7)"	"unprognostic (3.83e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.33e-16)"	"unprognostic (7.64e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.2	1.0	0.3	0.3	0.9	0.0	0.2	0.1	1.7	0.3	0.4	18.3	0.0	0.1	0.2	2.2	0.0	0.0	0.8	14.4	0.1	5.8	2.1	0.1	1.6	0.1	0.9	0.0	0.2	0.0	2.4	0.0	0.3	3.2	0.0	0.0	2.8	0.0	0.0	3.4	0.6	0.1	0.0	0.0	0.4	0.7	0.2	0.0	0.4	0.0	0.3	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963679-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"placenta: 67.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;U-266/70: 3.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"					"HPA038212: AB_10672739, HPA045455: "	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	67.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	3.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC104389.5		ENSG00000284931			11	5248270-5254783	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	26	"placenta: 321.8"	"Group enriched"	"Detected in some"	1410	"HEL: 421.0;K-562: 155.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043234	Uncertain									"HPA043234: "																		0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	321.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	421.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2										
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42549214-42555213	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 217.6"	"Cell line enriched"	"Detected in many"	8	"BEWO: 87.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA021032, HPA065296"	Enhanced		Supported	Cytosol				Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	2.8	1.5	2.0	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2.0	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6.0	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.7	0.9	4.5	0.6	0.1	87.6	1.2	0.0	0.0	0.0	1.0	0.9	0.0	1.1	0.0	2.6	0.1	0.7	0.0	2.4	2.8	1.2	1.1	1.5	0.2	1.0	1.4	0.2	2.5	0.1	0.5	0.0	1.6	0.3	0.0	1.5	1.3	1.1	0.4	0.8	1.3	1.1	0.7	0.1	1.3	1.2	1.8	0.7	8.9	1.4	10.7	0.8	1.4	1.4	1.7	0.9	0.8	2.5	1.4	0.6	0.5	0.9	1.0	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6.0	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2.0	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.9;RPMI-8226: 25.4;U-266/70: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"											HPA002904	Enhanced									"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.0	1.2	2.7	0.9	19.9	10.3	14.7	8.3	3.0	2.2	2.1	7.2	3.8	7.6	1.6	6.0	1.0	1.6	1.3	2.2	0.6	3.2	0.4	4.6	2.0	1.1	1.1	4.3	3.4	0.2	1.4	0.8	3.4	0.4	7.9	5.9	0.9	0.6	1.0	1.0	1.8	1.0	1.6	25.4	5.6	5.9	2.0	1.7	1.6	3.0	0.9	1.2	0.4	5.9	8.9	0.5	11.4	1.3	42.2	0.0	17.7	2.1	0.9	2.3	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196486	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 267.2"	"Group enriched"	"Detected in some"	22	"BJ: 54.6;U-2 OS: 22.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	8	"basal ganglia: 11.3;hypothalamus: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"			Vesicles		"CAB017775: , HPA035542: "	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.29e-6)"	0.2	0.0	0.2	0.2	11.3	0.0	0.2	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	54.6	0.7	0.9	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	22.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.3	1.0	0.2	0.2	4.2	0.2	0.2	0.2	0.2
TRIM64B		ENSG00000189253	"Tripartite motif containing 64B"	A6NI03	11	89869282-89876017	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	24	"blood: 22.3;placenta: 7.0"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	223	"basophil: 22.3"	"Lineage enriched"	"Detected in single"	223	"granulocytes: 22.3"									HPA045370	Approved									"HPA045370: "															"unprognostic (2.08e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	7.0		0.0	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.6			0.2		0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.4	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
XAGE2	"CT12.2, GAGED3, XAGE-2, XAGE2B"	ENSG00000155622	"X antigen family member 2"	Q96GT9	X	52369030-52375680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"placenta: 106.9"	"Cell line enriched"	"Detected in some"	4	"BEWO: 45.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA052507, HPA060900"	Supported									"HPA052507: , HPA060900: "								"unprognostic (1.21e-1)"		"unprognostic (9.67e-2)"	"unprognostic (1.49e-1)"				"unprognostic (4.47e-2)"			0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	4.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	106.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.7	0.5	9.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"placenta: 175.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 37.3;HSkMC: 26.6;hTERT-HME1: 58.9;HUVEC TERT2: 33.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.6"	"Low region specificity"	"Detected in some"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"		4600000	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (7.41e-5)"	0.3	7.9	0.3	1.0	0.3	1.6	0.1	0.2	0.3	1.5	0.7	0.4	1.0	0.2	2.9	0.6	1.1	0.6	0.2	6.7	0.2	0.5	0.2	0.2	0.2	1.3	0.2	0.4	0.9	0.1	0.0	1.3	175.9	0.4	1.0	0.8	6.2	0.4	0.9	0.2	0.3	0.5	0.8	0.4	0.6	0.5	4.6	0.2	0.3	0.9	0.4	0.7	0.4	1.2	0.0	1.1	0.6	5.0	0.0	0.0	0.4	0.0	4.4	16.1	0.0	2.6	4.6	3.3	17.6	0.0	15.6	11.7	0.0	0.0	0.0	0.0	23.5	2.6	10.4	2.6	14.7	0.0	4.2	0.0	7.4	0.0	37.3	2.3	0.0	26.6	1.4	6.6	58.9	33.1	0.0	0.0	9.6	0.0	0.0	0.8	6.9	5.3	5.1	5.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	4.9	0.0	6.3	12.0	17.9	0.0	0.0	0.0	0.0	1.8	0.0	6.6	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	5.0	0.0	0.0	0.4	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.4	0.4	0.2
GCM1	"GCMA, hGCMa"	ENSG00000137270	"Glial cells missing homolog 1"	Q9NP62	6	53126964-53148829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"placenta: 102.4"	"Cell line enriched"	"Detected in some"	22	"BEWO: 29.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.5"	"Group enriched"	"Detected in many"	8	"B-cells: 1.8;granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011343, HPA073469"	Enhanced		Approved	Vesicles				Vesicles		"HPA011343: , HPA073469: "	"unprognostic (2.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.42e-2)"		"unprognostic (2.96e-2)"	0.3	0.3	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	1.5	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.2	102.4	0.1	0.2	0.0	0.1	0.1	0.1	3.1	0.0	0.4	0.1	0.1	2.2	0.0	2.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.8	0.2	4.5	0.3	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	29.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.6	0.3	2.2	0.2	0.1	0.2	0.7	0.1	0.1	0.2	1.8	0.2	0.2	4.5	0.4	0.3	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Group enriched"	"Detected in some"	8	"Hep G2: 17.6;U-2197: 28.8;U-87 MG: 49.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	28130000	22000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavourable (6.90e-11)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	17.6	0.1	0.3	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1
XAGE3	"CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3"	ENSG00000171402	"X antigen family member 3"	Q8WTP9	X	52862525-52868068	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"placenta: 98.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;U-266/70: 5.7;U-266/84: 5.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.7"									"HPA052507, HPA060900"	Supported									"HPA052507: , HPA060900: "							"unprognostic (6.04e-2)"						"unprognostic (2.30e-1)"		"unprognostic (2.92e-1)"			1.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	1.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.7	5.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Cell line enriched"	"Detected in some"	9	"CACO-2: 37.0"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"				"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: , HPA043264: , HPA044028: "			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favourable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.1	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
PRG2	"BMPG, MBP, proMBP"	ENSG00000186652	"Proteoglycan 2, pro eosinophil major basic protein"	P13727	11	57386794-57390657	"Plasma proteins, Predicted intracellular proteins"	Immunity	"Antibiotic, Antimicrobial, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 322.3"	"Group enriched"	"Detected in some"	63	"HL-60: 140.2;HMC-1: 222.9;NB-4: 443.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"basophil: 9.1"	"Lineage enriched"	"Detected in single"	92	"granulocytes: 9.1"	"Not detected"	"Not detected"							HPA038515	Supported				"Intracellular and membrane"		130000000			"HPA038515: AB_10675800"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.39e-2)"		"unprognostic (3.49e-1)"	"unprognostic (8.62e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.19e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.40e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.32e-1)"	1.5	0.0	0.1	0.1	0.1	16.9	0.9	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.6	0.0	0.2	0.3	0.1	0.0	0.1	2.8	2.2	0.1	0.1	0.1	0.1	0.3	0.0	0.4	322.3	0.1	0.1	0.0	0.1	0.5	0.1	0.3	1.8	0.1	0.1	0.1	6.8	0.1	0.1	0.1	1.6	0.4	0.1	0.2	0.1	0.2	0.0	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	140.2	222.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	443.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
TFPI2	"PP5, REF1, TFPI-2"	ENSG00000105825	"Tissue factor pathway inhibitor 2"	P48307	7	93885397-93890991	"Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"placenta: 1024.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 178.0;hTEC/SVTERT24-B: 88.4;U-138 MG: 85.9;U-2197: 76.5;U-87 MG: 145.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 65.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010142, HPA049158"	Enhanced				"Secreted to extracellular matrix"					"CAB010142: AB_628166, HPA049158: "	"prognostic favourable (8.33e-7)"	"unprognostic (2.20e-2)"	"unprognostic (2.10e-2)"	"prognostic favourable (5.42e-4)"	"unprognostic (5.19e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.86e-2)"	"unprognostic (7.54e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.91e-2)"	21.5	14.6	0.6	5.1	0.7	0.0	4.8	0.6	0.6	1.0	1.0	0.6	0.9	0.0	4.8	1.3	0.7	5.4	2.2	3.3	0.6	1.5	4.7	3.1	3.5	0.6	0.6	0.6	14.9	10.0	0.0	4.4	1024.1	0.9	2.2	0.1	58.2	0.7	0.8	1.0	0.0	0.6	1.2	0.6	0.7	1.5	0.8	0.6	1.5	0.6	0.7	0.6	1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	9.6	3.0	0.0	7.0	1.2	0.0	12.7	2.2	1.3	1.0	0.0	0.0	0.0	178.0	2.9	1.0	0.0	13.6	2.0	0.1	0.0	0.0	0.8	0.0	36.2	0.0	0.0	0.6	0.7	88.4	6.4	30.4	0.0	0.1	16.1	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	3.4	0.3	0.0	8.0	0.0	0.9	0.0	0.0	0.1	43.8	85.9	0.6	76.5	0.1	0.0	0.1	0.3	145.4	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.7	0.6	0.6	0.6	1.5	0.6	0.6	0.9	0.6
AC064853.6		ENSG00000284704			2	227614538-227614840	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	17	"placenta: 1.7"	"Cell line enriched"	"Detected in single"	32	"HeLa: 3.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		1.7		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	6	"HaCaT: 86.1;SiHa: 23.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB026327: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	9.7	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.7	8.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229498-4237531	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"placenta: 411.9"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 15.5;naive B-cell: 8.5"	"Group enriched"	"Detected in many"	15	"B-cells: 15.5;monocytes: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046635	Enhanced				"Secreted to blood"		1200000			"HPA046635: "	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	2.1	2.5	1.9	5.7	1.5	0.4	1.4	0.3	1.0	0.8	1.3	1.1	0.3	1.7	0.6	0.8	0.5	1.7	2.3	0.7	1.7	1.4	2.1	1.9	1.8	18.5	2.5	0.7	0.6	1.0	0.1	1.1	411.9	1.1	1.0	0.7	0.7	1.1	0.6	0.4	0.2	5.1	0.8	3.8	24.6	1.5	0.9	1.3	4.9	0.5	0.3	2.9	2.0	0.5	15.5	0.6	0.1	4.5	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.3	0.2	1.3	0.1	0.0	0.4	0.3	1.3	5.3	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.1	0.0	0.6	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	3.7	0.0	15.5	0.0	0.0	0.6	8.5	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.4	1.9	1.5	0.3	1.0	1.7	1.4	2.5	0.7	1.1	1.3
AL049629.2		ENSG00000284969	"CD59 glycoprotein "		11	33698261-33722467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	16	"placenta: 65.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.0;HUVEC TERT2: 24.4;TIME: 29.9;U-2197: 25.5"									"Group enriched"	"Detected in some"	6	"memory CD8 T-cell: 1.6;T-reg: 2.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"									HPA026494	Uncertain		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA026494: AB_1846321"																		3.2	0.4	0.3	2.8	0.5	1.2	2.2	0.4	2.6	0.7	0.5	0.1	0.9	1.5	1.3	2.3	1.5	0.3	2.6	2.4	1.6		2.0	0.6	1.9	2.0	0.9	1.0	0.4	1.3	0.1	0.2	65.2	0.9	0.4	0.4	0.5	3.1	1.3	3.9	0.0	0.1	1.4	0.7	0.4	3.6	1.0	0.5	0.2	1.0	1.4	1.4	0.8	2.9	0.0	0.3	0.0	0.0	0.0	2.5	0.2	0.5	1.5	0.1	1.0	1.6	3.7	0.0	8.2	3.7	1.1	1.0	0.0	4.2	0.0	0.9	5.6	0.9	0.1	19.0	1.8	0.8	0.1	0.1	3.3	0.3	0.4	0.2	0.5	1.3	1.3	0.4	6.7	24.4	0.2	3.2	7.0	0.4	0.7	0.3	0.2	11.2	0.2	0.7	0.5	2.2	0.9	0.0	0.1	0.9	1.5	2.7	0.4	0.0	29.9	3.1	1.2	25.5	3.2	1.7	1.5	0.1	7.2	0.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2										
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Group enriched"	"Detected in some"	9	"BEWO: 6.8;HSkMC: 2.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010490	Approved				"Secreted to blood"		26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.2	0.4	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.2	0.4	0.1	0.3	0.1	0.0	0.2	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD33	"C12orf7, DKFZp686O1689, PANKY"	ENSG00000167612	"Ankyrin repeat domain 33"	Q7Z3H0	12	51887960-51891664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"placenta: 21.9;retina: 19.5"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058753	Enhanced									"HPA058753: "			"unprognostic (4.42e-2)"	"unprognostic (2.13e-5)"	"unprognostic (8.25e-4)"	"unprognostic (2.37e-1)"	"unprognostic (3.25e-5)"	"unprognostic (2.42e-1)"		"unprognostic (4.07e-1)"	"unprognostic (6.21e-2)"		"unprognostic (5.51e-10)"	"unprognostic (4.41e-3)"	"unprognostic (5.56e-2)"		"unprognostic (2.18e-1)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.8	21.9	0.0	0.0	0.0	19.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"placenta: 29.7;skin 1: 9.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;CACO-2: 3.9;HBF TERT88: 1.3;HUVEC TERT2: 1.4;LHCN-M2: 1.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"															"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	29.7	1.4	0.0	0.0	0.2	0.0	0.0	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.6	0.5	0.1	0.0	3.9	0.0	0.4	0.2	0.3	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	1.4	0.0
GPR78		ENSG00000155269	"G protein-coupled receptor 78"	Q96P69	4	8558725-8619761	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"placenta: 53.3"	"Cell line enriched"	"Detected in single"	202	"BEWO: 21.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA013209	Uncertain									"HPA013209: AB_10601657"	"unprognostic (6.41e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.70e-2)"		"unprognostic (3.82e-4)"	"unprognostic (6.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.88e-15)"	"unprognostic (5.55e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.90e-3)"	"unprognostic (8.15e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974164-38988662	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"placenta: 55.2"	"Cell line enriched"	"Detected in single"	134	"BEWO: 71.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in all"			HPA045402	Enhanced				"Secreted in female reproductive system"					"HPA045402: "	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0.0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0.0	0.2	0.2	4.3	1.0	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1.0	1.0	1.7	0.0	0.1	0.1	0.1	0.1	0.3	0.2	71.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1.0	1.0	2.2	1.4	0.0	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	0.2
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49833973	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 129.2;placenta: 199.4;prostate: 58.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;U-266/70: 8.4;U-266/84: 30.7"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.2	0.7	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.6	0.1	0.2	5.7	0.0	6.6	129.2	0.1	6.8	0.1	0.1	0.4	0.5	0.8	0.1	0.2	0.1	0.1	0.2	0.9	0.1	0.0	0.6	199.4	0.2	58.4	0.0	0.1	0.1	9.8	0.8	0.1	0.1	2.4	0.2	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.2	0.2	0.4	0.5	0.1	0.2	0.2	0.1
RASA1	"CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA"	ENSG00000145715	"RAS p21 protein activator 1"	P20936	5	87267888-87391931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	13	"placenta: 260.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007789, HPA036393, HPA064556"	Enhanced						7900			"CAB007789: AB_598183, HPA036393: , HPA064556: "	"unprognostic (1.57e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-3)"	12.4	8.8	12.3	8.9	12.8	6.4	11.4	17.3	16.3	11.3	8.1	8.6	9.3	6.9	12.4	11.4	10.2	9.5	9.3	7.2	12.0	10.9	8.7	6.5	8.4	9.2	10.1	13.8	15.9	8.2	20.3	12.2	260.6	9.3	8.0	9.8	9.6	10.6	9.6	6.9	9.7	10.0	9.0	9.4	13.7	7.4	14.4	10.0	10.7	14.4	5.7	9.6	11.3	9.8	2.0	1.3	3.1	2.6	8.1	3.5	1.1	11.5	6.5	11.3	7.3	9.6	14.2	8.8	18.5	12.0	11.4	18.9	4.3	30.6	7.5	4.5	20.2	5.4	5.2	15.0	34.7	7.3	4.2	5.6	5.6	4.7	9.7	4.1	6.7	8.0	9.6	32.1	18.2	15.9	3.1	16.2	39.3	7.0	5.0	6.1	5.9	12.1	6.2	25.7	11.1	9.9	10.0	6.9	7.5	6.8	8.8	9.7	7.9	6.4	23.5	14.6	6.4	7.5	23.0	5.7	5.9	7.6	21.3	8.5	10.4	3.1	1.3	1.4	2.0	2.6	3.5	1.4	2.4	1.9	1.1	2.0	2.1	1.9	1.7	8.1	2.4	1.3	3.0	1.1	12.3	12.8	17.3	16.3	12.0	10.9	10.1	13.8	9.3	10.0
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 127.4"	"Cell line enriched"	"Detected in some"	26	"Hep G2: 94.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in female reproductive system"		59000				"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1.0	0.2	0.2	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0.0	0.2	127.4	0.6	0.4	0.0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3.0	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.5	0.6	94.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.9	0.4	1.3	0.0	1.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.2	0.3	1.0	0.5	0.9	0.7	0.4	0.6	0.5
KRTAP5-6	KRTAP5.6	ENSG00000205864	"Keratin associated protein 5-6"	Q6L8G9	11	1697195-1697755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"liver: 6.7;placenta: 2.6;skin 1: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;SK-BR-3: 1.9"	"Cancer enriched"	"Detected in single"	21	"liver cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"prognostic favourable (6.04e-5)"			"unprognostic (3.70e-1)"					"unprognostic (2.93e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0		0.0	0.0	0.0	0.0	2.6		0.0	0.0		0.2	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.1	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.0	1.9	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;HMC-1: 3.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"					"HPA020242: , HPA024247: "	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.2	0.1	0.6	0.5	6.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.5	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"placenta: 8.6;skin 1: 26.1;tongue: 22.2"	"Cell line enriched"	"Detected in single"	5	"hTCEpi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.8	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.4	0.0	0.0	0.4	0.0	0.2	26.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	22.2	1.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 88.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	8.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.5	0.5	0.0	3.9	0.0	1.8	9.8	0.2	0.0	0.2	1.8	0.0	0.7	88.7	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.5	0.7	0.3	0.1	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8
HBG1	HBG-T2	ENSG00000213934	"Hemoglobin subunit gamma 1"	P69891	11	5248079-5249859	"Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"placenta: 74.0"	"Cell line enriched"	"Detected in some"	27	"K-562: 190.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043234	Approved									"HPA043234: "					"unprognostic (3.17e-2)"													1.5	0.1	0.5	0.1	0.6	0.4	0.1	0.5	0.4	0.2	0.1			0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.5	0.4	1.2	0.9	2.6	0.1	0.7		0.2	0.1	0.1	0.4	74.0		0.1	0.1		0.2	0.2	0.9	0.1	0.1	0.1	1.1	7.0	0.5	0.2			0.8		0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.5										
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51519525-51531856	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 87.4"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 100.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	33	"B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3"									"HPA009084, HPA018198"	Enhanced				"Intracellular and membrane"					"HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	1.8	0.0	0.0	5.6	0.0	0.1	0.8	0.0	0.1	1.2	1.7	0.0	0.3	0.9	2.0	1.2	1.5	0.5	8.6	0.4	0.0	0.0	0.4	0.1	4.2	1.5	0.0	0.0	0.1	0.3	0.1	0.1	87.4	0.0	3.7	1.5	0.5	1.4	1.0	0.2	1.3	6.0	3.1	0.0	1.3	1.7	1.0	0.0	0.3	0.2	1.0	2.6	2.2	1.9	6.5	6.8	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.2	100.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555626-64572875	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"epididymis: 22.2;kidney: 47.6;placenta: 64.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 3.7;renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA026076	Enhanced									"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	4.4	0.0	0.1	22.2	0.1	0.1	0.0	0.1	0.1	0.1	47.6	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.1	64.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.3;Hep G2: 11.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"														"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0
DLX3		ENSG00000064195	"Distal-less homeobox 3"	O60479	17	49990005-49995224	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"placenta: 47.6;skin 1: 32.4;tongue: 11.9"	"Group enriched"	"Detected in some"	5	"BEWO: 53.5;SK-BR-3: 17.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.44e-5)"	"unprognostic (3.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	0.5	0.2	0.1	0.0	0.1	0.0	1.5	0.0	0.2	2.2	0.3	0.1	0.0	0.0	0.1	0.6	2.8	0.1	0.2	0.1	0.1	0.1	0.5	0.0	0.4	0.0	0.0	0.0	1.4	0.8	0.0	0.2	47.6	0.3	0.7	0.0	0.5	1.1	1.1	0.1	32.4	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.4	3.6	11.9	3.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	1.0	0.3	0.2	53.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.6	6.6	2.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.2	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.7	5.9	0.0	0.6	17.2	0.0	6.8	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009499	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"		41000	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095"	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.1	8.6	1.9	8.7	14.3	9.2	22.2	17.8	13.6	7.4	5.2	12.6	15.5	0.5	45.9	12.9	25.5	3.9	9.2	1.6	40.7	10.1	24.8	15.5	16.5	7.6	3.4	40.9	10.4	10.4	8.4	3.8	23.6	18.9	2.5	4.9	9.7	1.3	11.2	6.2	2.5	2.2	7.5	3.2	11.5	10.8	3.9	2.6	15.1	8.2	12.6	2.9	9.1	34.7	8.3	17.8	12.7	26.1	4.4	25.1	1.1	15.9	11.2	16.8	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	1.2	0.0	0.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.0	0.0	1.0	51.9	1.2	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	5.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.7	2.1	0.4	0.2	0.5	0.3	0.0	0.9	13.9	2.8	0.0	0.0	71.7	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	6.7	9.9	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.3	0.0	0.0	1.4	1.6	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	1.1	0.0	2.9	0.3	0.0	1.5	0.0	0.0	4.2	5.9	0.0	0.0	0.0	0.0	1.6	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.7	0.1	0.2	2.1	0.2	0.4	0.7	0.2	0.3	1.2	0.8	0.1	1.3	0.9	1.3	0.5	0.8	1.2	0.4
LY6G6C	"C6orf24, G6c, NG24"	ENSG00000204421	"Lymphocyte antigen 6 family member G6C"	O95867	6	31718648-31721845	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HaCaT: 1.9;MCF7: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.35e-1)"		"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.85e-1)"	"unprognostic (8.80e-7)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.38e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	1.9	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.4	0.1	5.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.5	0.0	0.1	0.1	0.0	2.4	0.1	0.2	89.7	0.0	0.1	0.0	0.1	0.1	0.2	0.0	1.8	0.1	56.1	24.8	0.1	4.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.8	0.4	0.1	0.0	0.1	1.9	0.0	0.2	0.1	0.0	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 21.5"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"									"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"					"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavourable (0.00e+0)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.3	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	1.3	0.1	0.0	176.9	0.2	79.9	0.1	0.1	5.0	0.0	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.1	0.0	0.8	0.1	0.0	0.2	105.3	0.0	1.1	0.0	0.0	0.2	13.9	0.1	1.1	0.1	0.0	0.1	0.2	2.0	0.5	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.3	1.3	5.8	0.9	0.8	0.8	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.6	2.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1	3.0	0.5	0.0	0.3	0.0	0.7	0.5	0.0	0.2	0.2	0.4	0.0	0.1	0.4	0.2	0.1	0.2	21.5	0.4	0.2	0.0	0.1	1.1	0.2	0.1	1.0	2.0	0.2	0.3	0.3	0.4	5.8	0.9	0.6	0.6	0.5	0.5	0.6	0.8	0.6	0.3	1.3	0.7	0.8	4.0	0.8	0.8	1.3	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 85.4;placenta: 44.8;retina: 23.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 25.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048582	Approved									"HPA048582: "	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4.0	8.9	1.2	0.3	34.0	0.0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1.0	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0.0	0.3	0.0	1.9	0.3	1.8	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	25.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.4	4.0	8.9	12.3	0.8	1.4	5.4	85.4	0.5
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991119	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 195.7"	"Cell line enriched"	"Detected in many"	4	"U-2197: 103.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054983	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA054983: "	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	22.5	1.0	0.5	3.4	0.5	0.2	8.6	0.2	0.3	6.3	6.2	0.4	3.3	0.6	8.2	7.8	6.1	5.2	6.8	4.3	1.0	0.7	1.8	0.6	16.1	3.6	0.6	0.3	10.6	2.7	0.7	0.4	195.7	0.8	8.0	1.6	2.8	1.9	3.1	7.5	4.0	2.1	11.9	0.8	2.4	2.9	8.0	0.3	0.1	3.4	1.9	1.0	12.2	9.2	1.1	0.6	2.3	0.5	0.8	0.7	0.1	1.5	2.5	13.9	0.0	18.6	23.2	0.2	9.6	6.7	8.2	10.3	2.9	0.6	0.0	0.0	15.0	1.3	0.9	0.9	11.3	5.4	0.0	0.7	0.9	0.0	8.5	0.1	0.0	17.7	1.5	12.0	5.4	1.2	0.0	0.0	10.2	0.0	0.1	0.0	0.2	0.0	0.0	18.4	0.0	0.0	1.6	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.5	18.3	2.7	103.9	0.3	0.0	0.0	0.0	3.4	0.0	0.7	2.3	0.5	0.7	0.4	0.3	0.4	0.5	0.5	0.3	0.2	1.1	0.6	0.7	2.0	0.8	0.4	0.6	0.5	0.1	0.5	0.5	0.2	0.3	1.0	0.7	0.6	0.3	0.8	0.3
AC064853.5		ENSG00000284667			2	227666804-227667061	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	8	"placenta: 1.8"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		1.8		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 12.1;TIME: 3.7;U-87 MG: 7.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4
ADAMTS20	GON-1	ENSG00000173157	"ADAM metallopeptidase with thrombospondin type 1 motif 20"	P59510	12	43353866-43551921	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;U-266/70: 7.5;U-266/84: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027608, HPA027609"	Uncertain				"Secreted to extracellular matrix"					"HPA027608: AB_10600098, HPA027609: AB_10599024"	"unprognostic (3.18e-2)"			"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.04e-1)"		"unprognostic (9.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.26e-1)"		"unprognostic (1.05e-4)"	"unprognostic (7.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.57e-1)"	0.2	0.0	0.7	0.1	1.4	0.1	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.2	0.0	3.6	5.1	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.3	1.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	0.2	0.0	0.0	2.9	5.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	7.5	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.2	0.3	0.7	0.6	0.0	5.1	1.1
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"		2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.3	11.3	6.8	20.3	16.9	10.4	9.6	2.5	3.0	1.1	12.7	18.6	10.2	1.6	5.4	2.0	1.0	2.1	1.7	7.3	2.9	12.5	0.7	3.5	12.9	8.5	8.1	2.6	10.0	2.2	2.1	5.6	1.7	0.5	1.0	0.8	2.6	1.1	3.3	4.9	9.0	0.7	0.8	3.3	14.6	0.8	3.3	0.9	2.0	12.7	2.7	6.0	6.5	6.0	1.0	0.6	0.2	5.3	2.7	7.5	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin beta subunit 5"	P0DN86	19	49043884-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"placenta: 105.2"	"Group enriched"	"Detected in some"	24	"BEWO: 45.8;U-251 MG: 20.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavourable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavourable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	12.7	105.2	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	20.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERVW-1	"envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW"	ENSG00000242950	"Endogenous retrovirus group W member 1, envelope"	Q9UQF0	7	92468380-92477986	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 83.4"	"Cell line enriched"	"Detected in single"	52	"BEWO: 43.5"	"Cancer enriched"	"Detected in single"	143	"testis cancer: 31.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in single"																						"unprognostic (2.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.48e-4)"	"unprognostic (4.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.02e-2)"	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	83.4	0.2	0.2	0.1	0.2	0.4	0.2	0.4	0.4	0.2	0.2	0.3	0.3	0.5	10.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	2.2	0.8	0.1	0.2	0.0	0.1	0.2	0.3	0.2	0.0	0.3	43.5	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.3	0.2	0.1	0.0	0.1	0.2	0.2	0.5	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.2	0.2	0.3	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.8	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.4	2.2	0.2	0.8	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.6	0.0	0.1	0.0	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	875697	54000	"Plasma membrane, Actin filaments"		"CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.0	13.5	6.2	3.6	0.0	0.0	0.0	0.0	2.2	0.0	1.6	0.0	11.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	84.6	0.1	0.0	0.0	0.2	15.3	0.4	0.0	0.0	0.0	1.0	0.8	9.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	30.3	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: , HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favourable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	14.9	0.1	0.4	0.0	112.8	0.0	0.0	1.1	0.0	0.0	0.1	0.9	1.0	0.0	0.0	0.0	0.0	77.4	19.8	0.0	0.0	24.1	0.0	0.1	0.0	0.1	0.0	0.0	44.5	0.2	0.0	0.1	0.1	0.2	0.0	55.3	0.1	0.0	0.1	4.4	67.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	8	"placenta: 78.4;testis: 68.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.7;CAPAN-2: 23.0;EFO-21: 11.3;hTEC/SVTERT24-B: 16.2;hTERT-HME1: 10.9;U-2197: 32.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 9.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 9.0"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA046901: "	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	1.1	1.8	1.6	0.3	2.1	0.3	1.4	2.1	2.3	1.9	1.6	1.8	1.2	0.8	2.6	5.4	2.1	1.9	1.2	2.3	1.4	1.2	1.4	0.3	0.7	0.7	1.4	1.2	3.2	2.3	0.3	1.9	78.4	1.6	1.6	1.0	2.3	2.1	2.7	0.5	2.5	1.0	2.3	1.8	0.7	1.1	68.5	0.6	0.2	2.5	1.1	0.8	1.2	1.1	0.8	1.7	1.2	1.2	9.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	10.7	0.0	0.0	0.0	23.0	0.0	11.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.0	16.2	10.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.3	0.0	32.0	0.0	3.4	1.1	0.0	1.8	0.0	0.6	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.9	0.0	9.0	1.2	1.7	0.5	0.2	1.6	2.1	2.1	2.3	1.4	1.2	1.4	1.2	1.6	0.6
ODAPH	"AI2A4, C4orf26, FLJ23657"	ENSG00000174792	"Odontogenesis associated phosphoprotein"	Q17RF5	4	75556048-75565885	"Disease related genes, Predicted secreted proteins"			"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 10.4;placenta: 34.3"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 30.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"basophil: 10.4"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 10.4"														"Secreted in other tissues"						"unprognostic (1.13e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-2)"		"unprognostic (1.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.17e-7)"	"unprognostic (8.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.40e-4)"	"unprognostic (6.53e-3)"	0.3	0.1	1.5	0.4	1.9	0.6	0.2	1.2	0.9	0.3	0.2	0.2	0.2	0.1	0.3	0.4	0.4	0.1	0.3	0.2	1.9	1.5	0.3	0.4	0.3	0.5	2.4	0.2	0.4	0.2	0.0	1.3	34.3	0.7	0.2	0.5	0.2	0.2	0.3	1.6	0.9	0.3	0.2	2.7	0.4	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.1	10.4	0.2	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	30.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.4	5.5	0.0	0.1	0.3	0.1	0.0	10.4	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	1.5	1.9	1.2	0.9	1.9	1.5	2.4	0.2	0.7	0.4
PSG7		ENSG00000221878	"Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)"		19	42924132-42937178	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	8	"placenta: 23.1"	"Cell line enhanced"	"Detected in some"		"BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.8;U-2197: 4.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.9	0.2	1.3	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365251-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 141.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 50.4;ASC TERT1: 29.3;BJ hTERT+: 20.6;HHSteC: 18.5;HSkMC: 22.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	7	"cerebellum: 31.1"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"		160000000			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	18.8	2.5	1.0	3.9	1.8	0.0	11.9	6.7	0.9	7.1	8.6	0.5	3.6	0.6	6.1	7.8	4.7	4.4	5.4	4.4	1.1	0.7	2.1	1.5	8.6	5.8	1.1	0.5	4.2	2.7	2.2	0.7	141.1	0.7	4.3	3.1	1.5	2.2	1.3	7.4	3.5	3.3	5.7	0.6	3.4	3.6	4.0	0.9	0.0	3.5	2.3	1.3	9.6	7.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	50.4	29.3	0.0	5.3	20.6	0.4	0.6	0.5	0.0	0.0	0.0	1.2	0.0	0.0	4.0	0.3	0.0	0.1	0.0	0.4	0.0	18.5	0.0	1.0	22.9	0.0	4.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.8	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	6.7	0.9	1.1	0.7	1.1	0.5	0.7	0.9
TINCR	"FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2"	ENSG00000223573	"TINCR ubiquitin domain containing"		19	5558167-5578349	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"placenta: 50.0;skin 1: 45.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.5;HaCaT: 18.2;SK-BR-3: 28.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"																		"unprognostic (4.75e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.32e-2)"	0.0	0.4	1.0	0.0	0.7	0.6	1.7	0.0	1.0	1.7	0.4	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.0	0.0	0.0		0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	1.8	50.0	0.6	1.5	0.6	0.1	0.2	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	5.3	3.8	0.3	0.4	2.4	3.0	5.7	1.1	1.6	1.3	0.3	1.0	0.8	0.1	0.2	0.2	0.5	27.5	0.1	0.0	0.0	0.1	0.4	3.2	0.1	0.2	0.1	18.2	0.3	0.2	0.2	0.3	0.6	0.2	1.0	0.2	0.1	0.3	0.2	0.2	6.0	0.1	0.1	0.0	0.1	0.5	0.0	7.3	0.1	0.4	0.5	1.3	0.5	0.2	0.6	0.0	1.9	0.4	0.1	2.0	28.8	2.8	3.5	0.2	0.0	0.3	0.2	0.5	0.0	0.7	0.2	0.5	0.1	0.3	0.6	5.0	1.1	1.2	1.0	0.7	0.7	1.9	0.9	0.9	0.3	2.4	1.0	1.3	5.7	1.6	0.9	3.0	1.0	0.3										
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 157.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.5;BEWO: 62.2;HSkMC: 13.9;K-562: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		47000000	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	14.4	2.4	0.8	8.9	1.4	2.2	13.2	0.7	1.1	11.0	8.2	1.5	3.9	2.2	9.7	8.1	19.7	11.1	6.6	10.7	1.0	0.2	3.4	14.9	13.3	2.3	1.4	0.4	14.5	1.8	0.2	1.3	157.1	3.4	9.4	2.4	19.1	5.7	2.3	21.1	5.4	6.0	17.4	2.2	3.9	8.9	3.3	1.1	0.8	3.8	15.5	4.8	19.1	15.9	0.0	0.5	2.3	3.5	0.0	0.1	0.6	6.5	0.1	0.1	1.2	6.0	29.5	62.2	6.3	5.6	3.8	2.2	0.5	2.5	0.0	1.3	4.3	3.3	0.2	0.9	1.5	0.5	0.1	1.8	0.7	2.6	4.8	0.0	0.9	13.9	0.2	0.9	2.1	0.0	19.9	0.1	0.6	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.2	2.0	4.9	0.0	1.4	3.4	1.1	0.2	1.8	2.6	0.1	0.5	0.1	1.4	0.2	1.2	0.1	0.0	1.6	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	3.5	0.0	0.0	0.6	0.8	1.4	0.7	1.1	1.0	0.2	1.4	0.4	3.4	1.1
C2orf83	DKFZp547H025	ENSG00000042304	"Chromosome 2 open reading frame 83"	Q53S99	2	227610090-227648606	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"placenta: 16.3"	"Cell line enriched"	"Detected in single"	14	"U-2197: 12.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA030319	Approved									"HPA030319: AB_10602112"					"unprognostic (1.12e-2)"									"unprognostic (1.03e-1)"				0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	16.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176382-66178725	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 209.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;SCLC-21H: 2.5"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062111	Uncertain				"Secreted to blood"	10000				"HPA062111: "					"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0.0	6.7	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.1	0.0	6.7	2.7	28.4	0.4	1.1	13.8	0.0
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367740	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 145.3;placenta: 157.2"	"Group enriched"	"Detected in some"	4	"BEWO: 43.1;HEL: 34.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	36	"basal ganglia: 14.8"	"Cell type enriched"	"Detected in single"	37	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 15.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 6.9"	HPA016436	Enhanced									"HPA016436: AB_1847423"	"unprognostic (8.89e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.31e-2)"	"unprognostic (9.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (9.66e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.95e-2)"	0.4	145.3	0.4	0.1	14.8	0.0	0.4	0.3	0.3	0.2	0.2	7.6	0.1	0.0	0.3	0.5	1.5	0.3	0.0	0.3	0.3	0.2	0.1	0.7	0.1	0.0	0.3	0.2	9.2	0.1	0.0	0.4	157.2	0.2	0.2	0.0	0.3	0.1	0.6	0.3	0.1	0.1	0.3	0.3	5.7	0.1	20.4	0.1	0.0	0.1	0.3	0.7	0.2	0.2	0.0	0.0	15.8	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	43.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	34.2	1.0	0.3	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	14.8	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.1
FOXI3		ENSG00000214336	"Forkhead box I3"	A8MTJ6	2	88446787-88452656	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 11.6;retina: 15.7"	"Group enriched"	"Detected in some"	5	"BEWO: 30.7;NTERA-2: 7.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 10.5"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.72e-4)"		"unprognostic (8.11e-3)"		"unprognostic (1.36e-1)"		"unprognostic (6.58e-2)"				"unprognostic (5.29e-2)"	"unprognostic (1.15e-1)"			0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	11.6	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	1.9	0.5	0.9	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.4	0.2	0.3	0.4	0.4	0.3	0.2	0.7	0.4	0.6	1.5	0.9	0.5	0.5	0.2	0.3										
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 463.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 70.7;Hep G2: 36.4;HHSteC: 98.3;TIME: 35.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"pons and medulla: 6.5"	"Cell type enhanced"	"Detected in some"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;monocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	1258667	890000	"Golgi apparatus"		"CAB062554: , HPA011191: AB_1078962, HPA070957: "	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	13.4	2.2	0.4	1.0	0.6	0.0	13.1	0.4	0.5	3.9	13.0	1.0	1.9	1.8	5.9	1.9	2.4	1.1	13.1	1.2	0.5	0.0	64.7	24.1	12.6	0.8	0.4	0.5	2.9	21.9	0.3	2.4	463.0	6.5	25.5	11.0	1.6	2.4	5.1	13.6	1.1	1.8	4.8	1.2	1.4	12.0	2.5	0.4	0.4	5.2	0.5	0.8	47.0	2.7	0.2	0.8	6.3	2.3	0.0	0.0	0.3	0.3	15.8	1.5	0.5	3.8	3.2	70.7	5.5	3.0	0.2	3.2	0.7	4.9	0.0	10.0	0.4	0.1	0.0	2.0	0.8	0.0	0.3	0.2	1.5	36.4	98.3	0.0	6.1	8.4	23.8	15.4	10.0	16.7	24.3	0.1	3.8	3.8	0.0	0.1	0.9	8.9	0.0	0.6	0.0	11.7	15.6	0.1	0.1	0.0	0.9	19.8	0.4	0.0	35.3	0.0	1.3	0.3	0.2	0.2	0.6	0.0	8.9	0.0	4.6	0.0	1.8	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.3	0.4	0.6	0.4	0.5	0.5	0.0	0.4	0.5	6.5	0.4
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"liver: 9.7;placenta: 21.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;U-266/70: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	9.7	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997412-49055650	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 17.6;testis: 17.8"	"Cell line enhanced"	"Detected in many"		"AF22: 35.9;CACO-2: 56.5;Hep G2: 26.5;K-562: 28.6;NTERA-2: 28.7;REH: 32.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA021367, HPA062273"	Enhanced		Supported	Cytosol				Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.1	0.1	0.0	0.9	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.1	0.3	0.5	0.1	0.3	0.1	0.1	0.0	0.1	17.6	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	17.8	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	35.9	0.0	1.3	1.9	25.7	2.0	0.0	2.9	4.9	56.5	0.9	2.9	0.2	0.2	0.0	22.1	0.0	5.2	0.0	13.0	21.4	7.7	26.5	1.7	11.3	5.7	2.6	0.0	0.7	0.0	6.0	28.6	0.0	4.0	0.2	0.0	9.5	28.7	0.0	32.7	11.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	3.1	0.1	0.0	0.3	3.0	0.0	0.0	0.0	19.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0
LVRN	"APQ, AQPEP, FLJ90650, TAQPEP"	ENSG00000172901	Laeverin	Q6Q4G3	5	115962454-116027619	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 75.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;ASC TERT1: 3.8;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053254	Enhanced				"Intracellular and membrane"					"HPA053254: "	"unprognostic (1.47e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-7)"	"unprognostic (1.05e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.31e-2)"	10.6	0.1	0.0	0.5	0.0	0.1	3.9	0.0	0.0	0.3	1.4	0.0	0.4	0.1	0.0	0.0	1.8	0.2	0.4	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.1	75.1	0.0	0.7	0.4	0.0	0.6	1.2	1.3	1.0	1.7	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.3	1.7	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	2.3	3.8	0.8	0.2	0.3	0.1	0.3	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.5	1.1	0.1	0.0	0.9	0.0	0.0	0.2	0.3	1.3	0.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	1.5	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	7	"PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: "		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.1	0.0	9.3	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.0	1.2	6.3	0.0	0.5	0.0	14.9	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
MORN3		ENSG00000139714	"MORN repeat containing 3"	Q6PF18	12	121648742-121672631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 30.1;testis: 51.5"	"Group enriched"	"Detected in some"	9	"BEWO: 12.3;CACO-2: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038709, HPA038710"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA038709: AB_2676164, HPA038710: AB_2676165"	"prognostic favourable (1.16e-4)"	"unprognostic (2.70e-3)"	"unprognostic (5.56e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	0.3	0.2	1.2	0.5	1.4	0.9	0.3	0.3	1.6	0.4	0.3	0.3	0.3	0.2	0.3	1.4	0.3	5.6	0.4	0.3	1.4	1.2	0.4	0.3	1.0	1.4	0.3	0.3	0.3	0.4	3.4	0.7	30.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3	2.5	0.3	0.3	0.3	0.8	0.8	51.5	0.3	0.3	0.5	0.3	0.6	0.3	0.3	1.2	1.2	3.1	0.6	2.2	2.3	0.6	0.1	0.2	0.4	0.2	0.0	0.3	12.3	0.2	0.0	0.1	0.1	6.6	0.3	0.2	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.4	0.3	0.4	0.9	0.1	0.3	0.3	0.0	0.2	0.2	0.3	0.1	0.2	0.8	0.5	0.2	0.1	0.3	0.0	0.1	0.4	0.1	1.0	1.0	0.1	0.2	0.0	0.9	0.1	0.1	0.2	0.2	0.3	0.1	0.2	0.1	0.3	0.9	0.3	0.1	2.3	0.6	0.4	2.1	0.3	2.0	0.8	2.3	1.3	0.2	1.2	2.1	1.4	3.1	2.2	0.5	1.2	2.0	0.6	1.2	1.4	0.3	1.2	1.4	1.2	0.3	0.3	0.3	0.3
NNAT	Peg5	ENSG00000053438	Neuronatin	Q16517	20	37521215-37523693	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 117.2;pituitary gland: 165.1;placenta: 69.1"	"Cell line enriched"	"Detected in some"	22	"SH-SY5Y: 124.5"	"Group enriched"	"Detected in many"	16	"glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 117.2"	"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"														"unprognostic (1.18e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (9.66e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.52e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.90e-2)"	17.0	11.6	35.4	2.6	117.2	2.3	3.5	4.9	68.4	2.3	7.0	11.1	0.0	3.4	4.6	2.5	2.6	2.8	4.2	1.7	35.0	21.4	1.4	1.1	1.7	1.9	4.9	14.0	1.3	1.6	1.0	165.1	69.1	7.9	2.4	3.9	1.5	3.4	1.5	8.0	3.8	3.2	4.4	2.1	1.8	2.1	2.9	3.8	0.2	1.5	0.0	1.1	3.3	0.6	0.7	0.7	0.3	0.3	0.0	1.0	0.0	0.3	0.2	2.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.5	0.1	0.1	0.5	0.0	0.0	0.0	5.5	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.2	0.0	0.6	0.0	0.0	3.1	0.2	124.5	0.1	0.7	0.0	0.2	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.3	0.0	0.0	0.7	0.0	0.0	35.4	117.2	4.9	41.0	35.0	21.4	4.9	14.0	7.9	3.8
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in some"	6	"BEWO: 91.3;HUVEC TERT2: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	12380		Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.2	0.4	0.0	91.3	0.8	0.8	0.4	0.5	2.1	0.1	0.0	2.0	0.6	0.1	0.4	4.1	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.0	1.0	1.6	0.4	43.0	0.0	0.0	12.1	0.1	0.0	0.1	0.4	0.7	0.0	11.3	0.0	0.1	0.2	6.9	3.7	0.0	0.1	1.6	0.0	0.1	8.7	0.0	2.3	0.0	3.6	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0
PHLDA2	"BWR1C, HLDA2, IPL, TSSC3"	ENSG00000181649	"Pleckstrin homology like domain family A member 2"	Q53GA4	11	2928273-2929455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 163.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 82.0;PC-3: 66.6;SK-MEL-30: 52.3;WM-115: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003994			Uncertain	Nucleoli				Nucleoli		"HPA003994: AB_1855311"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.16e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.01e-3)"	"prognostic unfavourable (4.22e-5)"	"unprognostic (1.24e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (2.63e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.59e-1)"	3.8	1.1	0.5	3.6	0.7	1.4	7.7	0.3	1.4	5.6	7.9	0.5	1.7	5.9	2.3	5.5	20.3	2.4	15.6	1.5	0.5	1.9	4.8	3.7	3.9	0.8	1.3	0.5	1.8	4.6	1.2	1.2	163.9	1.9	8.0	1.4	0.8	5.3	2.0	0.8	9.6	7.4	1.9	1.0	1.8	11.1	1.0	0.5	0.2	3.5	24.7	15.1	6.1	8.7	1.5	8.2	0.0	4.9	0.0	3.9	1.5	9.2	8.2	0.3	0.1	0.1	1.7	9.0	20.5	5.2	2.9	2.2	3.3	18.3	0.0	10.0	2.2	11.4	0.0	8.2	0.3	82.0	2.7	0.0	4.4	2.1	6.7	0.0	4.9	2.8	3.7	2.5	2.0	2.4	1.7	0.1	1.2	29.2	0.0	1.4	3.3	66.6	0.0	0.0	5.6	5.9	2.9	0.9	0.0	6.6	4.5	52.3	1.3	0.8	13.6	6.6	3.6	9.2	6.9	0.0	0.1	0.0	5.4	1.4	71.9	0.0	4.9	0.0	0.7	3.0	0.8	1.5	3.9	0.9	8.2	0.0	1.0	0.2	0.0	0.0	0.6	0.0	1.4	1.5	0.5	0.7	0.3	1.4	0.5	1.9	1.3	0.5	1.9	0.5
PSG4		ENSG00000243137	"Pregnancy specific beta-1-glycoprotein 4"	Q00888	19	43192702-43207299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 348.5"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 105.1;U-2197: 28.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (4.29e-2)"	"unprognostic (5.18e-2)"		"unprognostic (9.49e-2)"		"unprognostic (2.52e-2)"		"unprognostic (3.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.57e-1)"	0.6	0.4	0.2	0.5	0.2	0.0	1.4	0.2	0.2	0.2	8.2	0.2	0.2	0.0	0.2	0.2	1.2	0.0	0.2	0.2	0.2	0.0	2.0	0.2	0.2	0.2	0.2	0.2	0.2	2.0	49.1	0.6	348.5	0.2	0.6	5.8	0.2	4.4	0.2	0.2	6.3	0.2	0.2	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.3	105.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	10.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.8	0.4	1.0	28.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 147.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.5;Hep G2: 34.0;SK-BR-3: 17.7;WM-115: 55.3"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	7	"eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030651	Approved				"Secreted in other tissues"		29000			"HPA030651: AB_10602224"	"prognostic favourable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	3.3	18.8	2.5	2.0	7.4	0.0	1.0	0.3	9.2	9.2	6.0	18.6	2.3	13.3	4.4	3.5	2.5	3.4	5.6	3.4	3.6		7.7	0.0	8.1	0.0	12.9	4.9	2.6	5.6	3.5	0.0	147.6	8.2	2.8	2.8	8.5	1.2	6.8	1.5	0.5	19.7	3.9	5.9	0.3	11.9	0.5	9.5	0.0	1.6	0.6	0.0	1.9	0.6	0.0	0.4	3.3	0.0	0.0	0.0	0.0	3.9	2.6	0.2	2.5	0.2	0.3	0.6	5.2	7.1	1.5	2.5	1.9	9.9	0.0	4.8	5.0	0.6	0.1	8.3	0.6	0.0	0.2	0.0	22.5	34.0	5.6	0.0	0.2	1.7	0.1	1.7	1.3	0.0	0.0	0.6	0.2	7.0	0.0	0.2	0.3	1.4	0.1	0.4	0.1	2.4	0.4	0.3	1.2	1.3	17.7	2.6	1.2	0.0	0.1	0.4	5.2	1.4	1.6	1.4	0.0	0.0	2.6	0.0	55.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975112-224039319	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 257.0"	"Cell line enhanced"	"Detected in many"		"BJ: 82.0;fHDF/TERT166: 350.3;SK-MEL-30: 156.2;WM-115: 120.4"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5"	"Group enriched"	"Detected in many"	13	"NK-cells: 16.5;T-cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in female reproductive system"		490000				"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (6.48e-5)"	8.0	5.8	34.7	18.0	30.6	2.2	4.8	14.9	35.2	8.6	6.1	13.0	0.1	7.4	5.1	4.4	9.7	6.0	11.9	24.5	21.9	25.3	10.6	3.3	3.2	7.7	33.0	14.4	38.4	2.9	1.3	2.0	257.0	25.2	6.6	6.2	4.9	3.1	2.8	3.2	3.5	6.0	28.1	23.0	7.8	2.7	14.2	11.9	1.6	6.2	3.2	10.8	18.3	6.9	1.0	0.1	0.3	0.0	16.5	10.5	2.2	0.1	4.4	1.6	1.7	67.4	25.4	0.2	82.0	47.0	6.6	6.4	0.2	0.3	0.0	1.8	350.3	0.2	0.1	5.6	5.7	0.0	1.4	0.8	2.9	1.2	3.3	0.6	0.0	7.3	3.8	19.0	28.6	0.5	0.0	0.0	22.8	0.2	0.1	0.2	3.1	4.9	0.5	1.4	3.3	61.5	5.1	2.3	0.4	15.6	0.0	156.2	0.0	0.3	57.8	39.3	5.4	11.9	3.8	0.3	0.6	0.0	25.1	0.6	120.4	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.4	0.5	0.0	1.0	10.5	5.3	0.3	16.5	0.0	0.1	0.5	2.2	34.7	30.6	14.9	29.8	21.9	25.3	33.0	14.4	25.2	11.9
SH2D5		ENSG00000189410	"SH2 domain containing 5"	Q6ZV89	1	20719732-20732837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 19.5;placenta: 14.8;testis: 9.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.9;hTERT-HME1: 31.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030182			Supported	Cytosol				Cytosol		"HPA030182: AB_10670431"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.80e-6)"	"unprognostic (1.11e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-2)"	0.4	0.9	4.5	1.3	19.5	0.4	0.3	0.5	19.2	0.6	0.5	0.3	0.0	1.2	1.4	0.3	0.5	0.5	0.6	0.3	3.9	4.1	0.4	0.3	0.4	0.3	1.5	7.3	1.7	0.3	0.6	0.1	14.8	2.1	0.5	0.3	0.0	0.4	1.8	0.3	0.6	0.5	1.2	0.3	0.4	0.6	9.4	0.7	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.6	3.8	0.8	0.0	0.0	0.0	0.1	4.6	6.5	4.5	3.0	1.6	1.5	0.0	1.2	1.3	0.4	3.3	24.9	1.8	0.0	1.7	0.0	0.5	1.2	3.7	0.0	0.0	0.2	5.2	8.4	31.9	0.0	0.0	0.0	1.9	0.9	0.5	0.0	1.5	5.0	0.1	0.1	0.2	4.7	0.6	1.4	0.2	0.3	0.1	1.5	0.0	0.0	0.0	5.5	9.7	8.2	2.2	0.0	0.0	0.4	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	19.5	0.5	12.3	3.9	4.1	1.5	7.3	2.1	0.7
SPESP1	SP-ESP	ENSG00000258484	"Sperm equatorial segment protein 1"	Q6UW49	15	68818221-68946811	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"placenta: 14.2;testis: 54.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 11.0;BJ hTERT+ SV40 Large T+ RasG12V: 11.6;HBF TERT88: 13.5;HMC-1: 8.3;RPTEC TERT1: 16.3;SCLC-21H: 12.3;WM-115: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA045936, HPA051040"	Enhanced				"Intracellular and membrane"		13000			"HPA045936: AB_2679504, HPA051040: AB_2681322"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-2)"	2.3	2.7	1.5	0.7	3.3	0.4	2.3	1.1	1.9	1.1	1.5	1.6	4.8	0.9	1.5	4.7	2.0	1.5	2.6	2.8	1.5	1.5	2.2	1.0	1.1	1.9	2.1	0.5	2.7	1.4	0.2	2.9	14.2	3.8	2.7	0.9	1.8	1.7	3.1	1.6	1.0	0.9	2.0	3.2	1.8	1.4	54.3	1.1	0.8	2.2	0.7	0.6	2.9	0.8	1.4	2.6	3.7	4.3	0.7	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	11.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	2.9	0.0	0.0	0.0	0.0	4.0	0.0	8.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	6.4	1.7	0.0	0.0	2.0	0.0	0.0	0.9	0.0	16.3	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	19.2	3.7	4.3	1.3	0.8	3.4	2.0	1.4	1.5	1.1	2.6	1.3	1.3	1.7	1.9	0.7	2.5	1.5	1.4	1.8	1.5	3.3	1.1	1.9	1.5	1.5	2.1	0.5	3.8	1.1
STRA6	FLJ12541	ENSG00000137868	"Stimulated by retinoic acid 6"	Q9BX79	15	74179466-74212267	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix, uterine: 22.7;placenta: 88.6;retina: 42.8"	"Cell line enhanced"	"Detected in some"		"A549: 16.2;CAPAN-2: 46.0;SH-SY5Y: 28.6;WM-115: 69.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040839	Approved									"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.2	1.6	0.2	0.5	0.3	0.0	1.1	0.2	0.5	22.7	0.1	0.3	1.6	0.0	6.9	2.8	1.0	5.0	0.7	0.3	0.4	0.2	7.3	0.0	0.3	1.1	0.1	0.3	0.6	0.2	0.0	5.3	88.6	0.7	5.0	0.0	42.8	0.6	2.6	0.1	0.4	0.2	0.3	1.5	0.3	0.1	2.8	0.1	0.9	0.2	1.4	1.9	1.8	2.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	16.2	0.9	0.0	0.0	0.0	2.7	0.5	0.1	0.0	0.0	5.6	46.0	0.0	11.1	0.0	1.6	0.9	0.0	0.0	0.0	0.0	1.4	0.6	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.2	1.4	0.0	0.2	0.0	0.0	0.0	1.5	8.7	28.6	0.0	1.6	0.0	0.1	0.0	0.0	0.1	3.8	0.3	0.7	0.0	0.1	0.0	0.3	0.0	69.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.4	0.2	0.1	0.3	0.7	0.1
TAC3	"NKB, NKNB, ZNEUROK1"	ENSG00000166863	"Tachykinin 3"	Q9UHF0	12	57010000-57028883	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 133.5"	"Cell line enriched"	"Detected in some"	5	"K-562: 17.2"	"Cancer enriched"	"Detected in many"	7	"urothelial cancer: 40.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045919	Supported	Supported	Approved	Vesicles	"Secreted in female reproductive system"			Vesicles		"HPA045919: AB_10960533"	"unprognostic (4.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.71e-14)"	"unprognostic (1.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	0.5	0.6	3.9	1.5	20.0	0.8	0.5	0.0	11.0	0.5	1.2	0.1	0.0	1.5	0.6	0.5	0.5	0.5	0.6	0.5	4.4	9.5	0.5	0.5	0.5	0.5	0.8	2.1	0.5	0.7	0.5	0.0	133.5	1.5	0.5	1.0	0.3	0.5	0.5	0.5	0.7	3.2	2.0	9.4	0.5	8.1	0.8	0.2	0.0	0.5	0.0	0.6	2.2	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.6	0.0	1.3	0.4	0.0	3.4	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	1.7	2.9	0.8	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.0	0.0	11.0	4.4	9.5	0.8	2.1	1.5	0.2
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532152-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 124.6"	"Cell line enhanced"	"Detected in some"		"A-431: 24.7;BEWO: 38.1;CAPAN-2: 13.9;RT4: 65.4;SK-BR-3: 64.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA042403: , HPA064616: "	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.7	1.4	0.4	0.3	0.1	0.1	0.0	3.7	0.1	0.9	0.1	0.1	0.1	0.2	0.6	0.0	1.3	124.6	0.1	2.8	0.0	0.1	5.0	2.3	0.1	0.1	0.1	0.6	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.7	19.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	3.7	13.9	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.0	64.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Low region specificity"	"Detected in all"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: "	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.4	0.1	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.0	0.2	1.7	0.0	0.1	1.1	0.3	0.3	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	4.4	0.1	0.1	0.7	16.8	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	6.4	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237314	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4"	"Group enriched"	"Detected in some"	19	"AF22: 10.1;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB025842	Approved									"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	8.4	2.1	26.1	3.8	14.2	0.0	3.3	3.8	21.0	1.2	2.3	30.8	0.0	1.8	1.6	0.0	1.8	1.2	5.7	7.2	24.8	9.3	2.5	8.0	3.5	4.0	17.3	10.2	1.2	1.4	1.9	1.5	40.4	32.8	1.2	2.8	0.2	1.7	0.8	5.8	3.0	1.7	4.7	63.8	44.1	1.5	1.2	18.2	0.1	3.1	0.6	1.8	3.8	1.5	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	26.1	14.2	3.8	16.3	24.8	9.3	17.3	10.2	32.8	18.2
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180167-37199385	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 23.7;placenta: 79.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 44.0;RT4: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	354300000		Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	3.3	4.4	1.2	4.2	1.6	0.8	2.5	1.2	1.8	7.8	2.5	1.3	1.6	1.0	23.7	7.2	1.6	5.2	6.2	3.1	1.4	0.7	3.9	7.9	9.2	3.1	1.2	1.3	5.9	2.3	1.4	1.4	79.5	1.7	4.3	2.5	4.4	2.2	3.4	1.5	3.1	3.2	5.7	1.8	4.6	1.8	3.5	1.2	1.6	2.4	1.7	1.8	5.1	2.7	2.4	1.1	1.8	0.5	4.0	3.8	1.0	6.6	8.2	4.3	1.5	0.7	8.7	13.1	1.4	2.7	1.1	0.8	1.5	9.7	0.0	5.6	2.3	13.7	0.1	3.3	0.5	1.9	1.0	1.0	3.1	1.5	3.0	0.0	0.9	12.0	1.9	0.9	0.2	10.3	0.0	3.1	0.4	44.0	0.0	0.2	2.7	0.1	0.1	0.0	1.1	10.0	20.4	0.7	5.6	0.4	7.9	1.1	2.8	0.2	3.5	0.4	2.2	0.1	0.0	6.4	0.1	0.0	0.8	0.8	1.2	1.0	0.5	1.5	0.7	0.5	0.8	0.8	1.3	1.0	0.5	2.4	2.9	2.2	1.8	4.0	0.3	1.1	3.8	1.0	1.2	1.6	1.2	1.8	1.4	0.7	1.2	1.3	1.7	1.2
CXorf67		ENSG00000187690	"Chromosome X open reading frame 67"	Q86X51	X	51406915-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 14.3;testis: 21.4"	"Cell line enriched"	"Detected in single"	46	"U-2 OS: 27.0"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.2"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.1	0.2	0.3	0.2	0.6	0.1	0.1	2.8	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.2	0.2	0.2	0.1	0.7	0.1	0.0	1.5	14.3	0.1	0.4	0.1	0.1	0.9	0.2	0.1	0.2	0.2	0.1	0.4	0.7	0.1	21.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.7	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	2.8	0.4	0.3	0.5	0.2	0.1	0.1	0.1
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319754	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 14.2;placenta: 54.8"	"Cell line enhanced"	"Detected in some"		"A549: 6.4;CACO-2: 5.1;EFO-21: 2.9;Hep G2: 2.9;hTCEpi: 3.5;NTERA-2: 4.6;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA030251, HPA030252"	Approved	Supported								"HPA030251: AB_10611108, HPA030252: AB_10601993"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favourable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	1.0	1.3	0.5	0.4	14.2	0.0	0.4	1.5	1.4	2.3	1.1	1.2	1.0	0.9	3.7	2.2	0.7	2.2	2.9	2.7	0.9	0.5	2.2	2.4	2.0	0.4	1.1	0.9	0.9	1.6	0.0	0.4	54.8	1.7	6.1	0.4	1.6	5.3	0.5	0.4	5.6	0.8	0.8	0.7	0.4	0.5	1.0	0.7	0.9	0.4	0.4	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.2	1.5	1.4	0.9	0.5	1.1	0.9	1.7	0.7
DKK1	"DKK-1, SK"	ENSG00000107984	"Dickkopf WNT signaling pathway inhibitor 1"	O94907	10	52314296-52318042	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 153.6"	"Cell line enhanced"	"Detected in many"		"BJ: 111.1;BJ hTERT+: 61.0;CACO-2: 97.0;fHDF/TERT166: 153.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in female reproductive system"						"unprognostic (5.65e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.35e-8)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (7.80e-6)"	"unprognostic (1.54e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (1.27e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-2)"	15.6	0.1	0.5	0.3	0.4	0.0	4.0	0.4	0.6	26.2	0.3	0.6	1.8	0.1	2.1	0.5	5.3	0.1	2.8	0.6	0.8	1.7	0.5	0.2	0.6	0.3	0.7	0.3	0.9	0.1	0.1	0.2	153.6	15.2	4.2	0.1	0.7	1.6	1.3	0.6	11.7	0.2	1.2	0.2	0.4	0.8	1.6	0.4	0.1	0.2	0.1	0.5	10.6	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	29.7	20.8	0.0	3.1	15.2	3.1	0.0	111.1	61.0	38.2	20.3	97.0	6.2	0.0	0.1	153.6	23.8	0.0	12.7	36.3	0.0	0.0	0.0	0.4	2.4	3.2	0.0	0.0	3.0	1.5	8.2	49.0	3.5	0.0	0.0	25.1	12.8	0.0	0.0	0.0	53.4	0.0	3.4	0.0	14.6	2.4	0.0	34.1	9.9	0.1	1.6	0.1	0.0	7.6	0.0	0.0	33.5	20.2	0.0	0.0	0.0	0.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.8	1.7	0.7	0.3	15.2	0.4
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.9;testis: 9.0"	"Group enriched"	"Detected in some"	5	"BEWO: 7.9;EFO-21: 15.0"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"									HPA036134	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	2.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FCGR2B	"CD32, CD32B, FCG2, FCGR2"	ENSG00000072694	"Fc fragment of IgG receptor IIb"	P31994	1	161663147-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 53.3;placenta: 83.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.2;HMC-1: 23.0;NB-4: 5.1;RPMI-8226: 8.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 53.3;memory B-cell: 42.2"	"Group enriched"	"Detected in many"	18	"B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3"									"CAB007796, HPA014730"	Enhanced									"CAB007796: AB_562288, HPA014730: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.12e-2)"	"unprognostic (6.79e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.37e-1)"	11.3	2.4	0.0	2.0	0.2	0.0	4.1	0.0	0.0	1.9	3.4			0.2	0.9	0.2	2.1	2.1	2.3	3.7	0.0	0.2	2.0	9.5	5.6	2.5	0.5		0.8	0.6	0.0	0.3	83.2		0.3	2.0		3.3	0.2	0.5	2.0	4.6	3.1	4.7	6.7	1.5	0.1			1.7		5.6	3.3	1.2	42.2	14.5	53.3	1.9	0.1	0.3	2.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	53.3	1.8	5.4	0.3	1.9	0.1	42.2	0.1	0.2	14.5	34.3	0.0	0.3	11.2	0.1	1.7	0.0	0.0	2.4										
FHDC1	KIAA1727	ENSG00000137460	"FH2 domain containing 1"	Q9C0D6	4	152936352-152979696	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 86.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 24.1;RT4: 8.0;SK-BR-3: 11.2;WM-115: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008527	Uncertain									"HPA008527: AB_2104099"	"unprognostic (5.42e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.95e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.40e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.30e-1)"	0.7	0.2	0.5	2.0	4.3	11.3	1.9	2.8	4.4	2.4	4.0	0.5	1.4	3.0	1.8	1.6	8.0	1.1	4.9	0.6	0.9	0.8	1.5	0.4	7.7	0.8	0.9	0.8	1.0	1.8	7.4	3.4	86.7	1.5	6.8	4.3	6.9	4.4	1.4	0.4	11.0	6.7	1.0	0.9	4.4	4.2	1.5	0.7	0.8	15.0	4.6	8.7	1.3	3.8	0.5	0.4	2.8	0.3	1.0	0.3	0.0	4.2	0.4	0.7	0.6	0.4	0.2	24.1	0.3	0.9	0.9	0.1	0.3	2.6	0.2	0.1	0.4	0.9	0.2	1.7	0.3	0.5	0.3	0.4	2.5	0.3	0.1	0.1	0.7	0.1	2.2	0.0	0.5	0.0	1.1	0.5	0.3	2.6	0.1	0.1	4.9	0.3	0.0	0.2	0.1	4.4	8.0	4.3	0.2	1.5	11.2	1.6	1.7	0.3	0.1	0.3	0.8	2.0	1.0	0.6	0.4	0.1	0.2	0.1	8.2	0.6	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.3	2.8	1.0	0.2	0.4	0.1	0.0	0.5	4.3	2.8	1.6	0.9	0.8	0.9	0.8	1.5	0.7
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676365-683399	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"placenta: 201.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 35.5;hTCEpi: 39.2;SiHa: 72.5;U-2197: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Approved	Nucleoplasm	"Secreted in other tissues"		6800000	Nucleoplasm		"CAB024899: , HPA045378: "	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavourable (3.01e-4)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavourable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	19.9	29.1	4.0	10.7	6.2	5.6	24.7	1.3	4.2	13.1	14.9	3.8	8.1	3.8	12.8	15.6	12.7	14.1	13.1	27.0	5.0	2.0	13.7	5.1	26.9	8.7	7.3	4.5	16.8	11.7	1.4	5.3	201.0	6.0	14.3	3.1	12.0	4.5	11.0	4.1	6.2	6.5	20.6	10.4	3.9	9.1	34.5	4.9	0.7	7.2	5.5	1.4	16.7	18.3	0.9	2.2	0.1	4.4	0.6	2.6	2.0	1.9	15.6	1.1	0.8	4.9	12.6	35.5	26.5	3.9	6.6	2.4	5.7	3.0	0.8	10.7	17.8	13.7	0.8	22.6	2.2	1.6	1.8	0.7	21.8	4.6	21.2	1.3	2.6	15.7	39.2	7.3	30.7	1.1	1.6	1.1	10.0	6.8	0.5	0.8	1.3	5.4	1.4	0.7	1.7	9.2	0.3	0.7	1.2	72.5	1.4	0.8	1.3	0.7	15.9	6.7	23.1	37.4	9.7	1.8	0.8	0.4	1.0	4.2	3.0	0.0	4.4	0.0	1.0	4.4	0.2	0.3	1.4	1.1	2.2	0.9	2.6	1.6	0.1	0.6	3.2	0.9	0.2	2.0	4.0	6.2	1.3	4.2	5.0	2.0	7.3	4.5	6.0	4.9
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282978-87329278	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;HDLM-2: 10.8;MCF7: 5.9;RT4: 5.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"														"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0			0.0	0.1	0.0	0.0	12.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	10.0	4.5		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3			0.0		0.1	0.5	0.0	0.7	0.1	1.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	5.9	0.0	0.1	1.9	0.0	0.2	0.0	0.0	0.0	5.3	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.6	1.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0										
IGF2BP3	"CT98, IMP-3, IMP3"	ENSG00000136231	"Insulin like growth factor 2 mRNA binding protein 3"	O00425	7	23310209-23470467	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 74.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002037, HPA076951"	Enhanced		Supported	Cytosol				Cytosol		"HPA002037: AB_1851483, HPA076951: "	"unprognostic (5.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.02e-5)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.43e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.87e-4)"	"unprognostic (7.51e-3)"	0.4	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.3	0.4	0.3	0.4	0.1	0.0	0.2	1.3	4.8	0.7	0.1	0.5	0.3	0.2	0.2	0.3	1.2	3.4	0.2	0.0	0.2	1.5	0.0	0.2	74.0	0.7	0.2	0.0	0.3	0.7	0.1	0.2	0.2	0.3	0.0	1.2	1.0	0.2	6.5	0.0	11.4	0.6	0.2	6.0	0.2	0.6	1.2	0.4	1.5	1.5	0.0	0.2	3.0	14.5	4.3	32.7	9.7	5.2	13.8	20.0	2.4	11.0	6.1	7.6	13.8	11.6	11.0	13.2	6.5	9.6	14.1	10.8	10.8	1.7	5.6	5.8	11.7	11.5	16.1	10.5	4.1	14.1	7.6	4.7	2.0	52.3	26.4	0.0	14.8	0.0	6.4	7.1	26.1	13.4	9.9	10.9	14.1	12.1	1.3	8.6	18.8	1.4	0.1	12.2	0.0	2.0	21.0	5.9	0.3	12.8	6.3	0.0	4.6	17.3	23.5	11.8	22.6	0.0	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.0	0.4	0.9	0.2	0.0	1.5	0.0	0.0	0.0	0.0	3.0	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.0	0.7	0.0
INHBA		ENSG00000122641	"Inhibin beta A subunit"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 148.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.5;hTEC/SVTERT24-B: 59.6;hTERT-HME1: 24.7;TIME: 30.7;U-138 MG: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"		290000				"unprognostic (4.11e-3)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	1.7	1.0	1.2	3.6	3.7	6.6	1.3	0.7	3.5	1.7	1.5	0.8	1.3	0.3	13.6	4.2	3.8	1.6	17.3	9.3	1.9	1.6	2.0	7.9	26.4	0.6	1.2	0.7	5.2	1.2	0.0	0.8	148.2	4.8	2.4	0.2	1.4	4.3	3.8	1.2	2.9	0.8	3.8	8.7	0.4	1.5	3.9	1.3	0.4	1.5	2.6	0.7	4.8	1.8	0.2	0.7	1.8	1.3	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.8	1.9	0.0	4.7	0.5	2.6	0.8	0.0	0.1	0.0	0.3	1.7	3.9	0.0	19.5	2.5	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.8	1.1	59.6	24.7	2.1	0.1	0.0	5.9	0.0	0.0	0.1	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.1	0.0	0.0	0.0	30.7	46.4	13.4	4.9	4.8	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	1.8	0.0	1.3	0.0	0.0	0.3	1.2	3.7	0.7	1.3	1.9	1.6	1.2	0.7	4.8	1.3
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Low region specificity"	"Detected in all"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.9;BJ hTERT+: 5.1;REH: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"					"CAB002593: , HPA068864: "	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.9	2.9	4.2	0.0	0.2	5.1	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	3.0	0.3	0.0	0.7	0.1	0.0	0.0	0.7	0.1	7.9	0.0	0.2	0.3	0.0	3.0	5.1	1.9	0.3	0.0	1.8	0.0	1.3	0.3	0.0	0.8	0.0	0.1	0.1	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2
NFE4	NF-E4	ENSG00000230257	"Nuclear factor, erythroid 4"		7	102973437-102988856	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"blood: 20.8;placenta: 15.7"	"Group enriched"	"Detected in some"	4	"BEWO: 23.0;HUVEC TERT2: 28.3"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	48	"eosinophil: 9.1;neutrophil: 20.8"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 20.8"																				"unprognostic (6.56e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.40e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.47e-2)"		"unprognostic (4.97e-2)"		"unprognostic (2.19e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.36e-9)"	"unprognostic (1.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.71e-3)"	0.2	1.9	0.2	0.4	0.2	2.6	0.2	0.2	2.2	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.5	0.0	0.4	0.6	0.2		0.2	0.2	1.2	0.6	0.2	0.2	1.1	0.6	0.0	0.2	15.7	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.7	0.2	0.2	0.2	2.5	0.1	1.5	0.2	0.2	1.5	2.9	0.2	0.2	0.2	0.1	0.1	20.8	0.1	0.0	0.3	0.0	0.2	0.2	0.7	0.2	0.0	0.0	23.0	0.2	0.0	0.0	0.0	1.1	0.6	0.6	0.3	0.0	0.3	0.0	0.0	0.1	0.1	1.4	5.6	4.1	0.1	0.3	2.0	0.3	0.2	0.0	0.8	0.0	28.3	2.5	0.3	0.6	0.3	1.0	1.7	0.2	0.3	0.9	0.5	0.2	0.0	0.5	0.9	0.3	0.2	0.4	0.0	0.5	0.6	0.3	1.0	2.8	1.4	0.2	0.7	5.8	0.3	1.8	6.0	0.6	0.0	0.1	9.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	20.8	0.0	0.1	0.1	0.0	0.0										
NPW	PPL8	ENSG00000183971	"Neuropeptide W"	Q8N729	16	2009926-2020755	"Predicted intracellular proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 49.0;placenta: 17.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 16.7;PC-3: 9.3;RPMI-8226: 29.2;SCLC-21H: 50.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA064874	Approved				"Secreted to blood"					"HPA064874: "	"unprognostic (7.54e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.20e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.81e-5)"	"unprognostic (6.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.41e-1)"	"unprognostic (3.43e-2)"	0.9	0.6	0.6	1.3	0.8	2.3	0.4	0.6	1.6	1.6	1.3	0.0	3.1	1.4	5.9	3.0	0.9	1.1	0.7	0.3	0.5	0.9	1.0	49.0	0.4	1.3	0.4	0.7	1.0	2.0	0.3	5.9	17.7	1.2	1.5	0.7	1.1	0.5	3.4	0.3	2.3	0.7	0.6	0.5	2.8	6.0	4.3	0.4	3.7	0.8	0.9	1.0	0.6	1.3	1.6	2.0	4.7	2.1	1.6	1.8	0.6	0.1	0.8	0.1	1.0	0.1	0.0	0.2	0.3	0.1	0.2	0.3	1.8	0.6	0.1	0.0	0.3	0.3	0.5	0.2	0.2	0.6	1.0	0.0	1.1	0.5	0.8	0.1	0.0	0.5	0.5	0.3	0.8	0.0	2.8	0.6	0.0	0.5	0.1	16.7	0.7	9.3	3.3	0.0	29.2	0.1	0.0	50.8	4.1	0.3	0.8	0.1	2.2	1.3	0.6	0.1	0.2	0.1	0.0	1.3	0.4	0.3	0.2	0.3	0.1	3.6	2.1	1.9	0.6	1.3	1.8	1.4	0.3	0.2	2.0	1.6	0.9	0.3	4.7	1.6	0.6	1.1	1.1	0.6	0.6	0.8	0.6	1.6	0.5	0.9	0.4	0.7	1.2	0.4
P2RY6	P2Y6	ENSG00000171631	"Pyrimidinergic receptor P2Y6"	Q15077	11	73264505-73298617	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 36.4;lymphoid tissue: 31.1;placenta: 38.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 32.9;EFO-21: 10.4;MCF7: 15.3;SK-BR-3: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 10.9;plasmacytoid DC: 36.4"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022740, HPA074751"	Enhanced									"CAB022740: , HPA074751: "	"unprognostic (2.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.93e-3)"	"unprognostic (4.00e-3)"	"unprognostic (1.86e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (2.50e-7)"	"unprognostic (1.48e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.05e-1)"	2.5	1.8	2.7	8.3	3.5	0.8	1.5	0.5	3.2	2.5	2.1	3.1	0.0	3.0	1.2	2.6	2.9	1.6	2.4	2.7	1.8	1.0	6.2	3.7	3.0	4.8	2.3	1.7	2.1	1.7	0.5	2.7	38.0	2.8	2.1	2.2	5.9	2.0	0.9	2.9	0.9	4.9	3.4	3.8	31.1	1.9	0.8	3.5	3.3	5.0	1.8	3.1	4.1	1.6	0.0	36.4	0.1	1.8	1.5	0.1	1.0	0.7	7.8	0.0	32.9	0.0	0.0	6.8	0.1	0.0	0.1	0.1	7.1	0.1	0.0	10.4	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.1	15.3	0.1	1.3	0.1	0.0	0.0	0.0	0.9	5.4	0.0	0.1	0.5	1.4	26.6	0.0	6.3	1.4	0.1	1.3	0.1	1.0	0.1	0.3	0.0	0.0	1.3	2.1	0.0	0.0	1.1	0.0	0.0	1.8	0.1	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.1	1.5	0.6	36.4	0.0	1.0	2.7	3.5	0.5	3.2	1.8	1.0	2.3	1.7	2.8	3.5
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.1;placenta: 22.7;testis: 14.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.1;RT4: 9.7;SK-MEL-30: 8.7;WM-115: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037683: , HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	1.3	0.8	3.3	0.8	15.4	1.2	1.4	0.9	8.6	2.2	1.0	32.1	0.0	0.6	1.0	1.7	2.0	1.3	1.3	3.7	6.0	3.0	0.6	0.7	1.0	0.7	22.7	4.6	0.6	0.5	0.8	0.5	22.7	12.0	0.9	1.8	0.0	1.4	1.4	1.5	1.1	0.7	1.3	12.9	1.0	0.7	14.4	15.6	0.0	0.8	0.0	1.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.2	0.0	0.0	0.0	0.1	0.1	2.9	1.2	0.5	0.2	6.1	5.0	0.0	5.5	0.3	4.2	0.0	4.1	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	2.0	1.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	5.5	0.0	3.8	0.0	2.0	9.7	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.3	0.2	1.1	0.2	3.5	0.0	0.0	0.0	0.2	1.2	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	15.4	0.9	8.6	6.0	3.0	22.7	4.6	12.0	15.6
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008979-13169103	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 154.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.0;RPTEC TERT1: 21.4;U-2197: 14.9;U-87 MG: 28.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 10.5"	"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.0;NK-cell: 4.1"	"Group enriched"	"Detected in many"	13	"NK-cells: 4.1;T-cells: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules				Microtubules		"HPA044247: , HPA048079: "	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favourable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	3.2	4.5	1.3	1.6	2.2	0.0	4.3	1.7	1.7	4.3	5.0	2.2	4.4	8.3	4.8	9.6	5.6	3.4	5.8	4.8	2.0	1.5	15.6	11.9	5.7	0.7	2.5	2.2	4.3	3.8	10.2	4.2	154.0	10.5	4.5	3.8	3.8	7.8	5.8	1.0	25.1	9.0	3.0	6.9	1.9	2.2	4.2	1.4	5.7	24.3	3.6	1.9	4.8	6.0	0.0	0.2	0.1	0.0	4.1	3.0	0.2	0.6	1.1	0.8	0.0	7.0	10.1	5.4	0.0	1.5	1.0	4.1	8.7	4.4	0.0	0.5	0.2	12.0	0.0	3.3	1.4	0.0	0.0	0.0	2.8	12.3	0.6	0.0	0.1	5.7	10.4	4.0	1.3	0.6	0.0	16.0	11.3	0.2	0.0	0.0	0.0	1.4	1.1	2.0	7.0	21.4	8.6	0.0	0.1	0.1	1.1	0.0	8.9	0.2	1.5	4.5	1.5	14.9	1.0	0.1	0.0	0.0	28.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.4	0.1	0.0	0.0	0.7	0.1	0.1	4.1	0.0	0.2	0.0	0.2	1.3	2.2	1.7	1.7	2.0	1.5	2.5	2.2	10.5	1.4
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136108-30148735	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 13.5;placenta: 39.4"	"Cell line enriched"	"Detected in single"	50	"HEL: 5.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 3.4"	"Low region specificity"	"Detected in all"			HPA043818	Uncertain									"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"A549: 21.1;BEWO: 11.7;hTCEpi: 13.7;NTERA-2: 21.7"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	21.1	0.0	0.0	0.0	0.1	11.7	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	4.0	0.1	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1
ZNF777	KIAA1285	ENSG00000196453	"Zinc finger protein 777"	Q9ULD5	7	149431363-149461123	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"placenta: 65.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003252	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA003252: AB_1080755"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.72e-2)"	5.0	4.3	5.5	4.1	8.8	6.9	4.9	7.1	9.3	5.2	5.2	5.4	3.5	4.5	7.3	3.5	4.1	6.5	3.5	4.7	5.3	5.1	3.8	4.4	4.4	4.7	4.3	5.3	9.1	6.6	6.6	5.9	65.7	6.6	5.8	3.3	5.0	7.3	5.8	10.6	7.3	4.4	5.4	6.2	6.0	4.9	4.2	3.5	3.5	5.2	4.8	3.9	6.2	5.0	0.4	0.2	0.6	0.3	0.1	1.5	0.1	10.1	12.6	8.6	12.3	6.3	5.2	11.0	6.6	7.0	9.0	7.8	7.8	6.5	6.5	13.4	7.4	6.8	8.3	10.0	4.9	10.5	12.6	6.4	3.6	7.8	10.9	8.9	9.3	6.1	11.5	7.3	10.6	4.8	20.4	0.0	5.1	13.1	18.9	12.3	10.3	7.4	15.6	4.3	13.6	5.5	8.0	9.3	13.1	11.4	11.7	11.0	5.5	15.0	7.5	7.6	3.0	14.9	10.7	6.2	5.4	3.0	5.7	6.2	9.6	0.0	0.3	0.0	0.5	0.3	0.1	0.3	0.4	0.4	0.0	0.4	0.1	1.5	0.6	0.1	0.1	0.2	0.0	0.1	5.5	8.8	7.1	9.3	5.3	5.1	4.3	5.3	6.6	3.5
AC007846.2		ENSG00000285471			17	5772926-6080792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"placenta: 3.0;testis: 3.6"	"Cell line enriched"	"Detected in some"	9	"RH-30: 29.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.5		0.0		0.0	0.0		0.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		3.0		0.1	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.3	0.0	3.6			0.0		0.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	29.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADAMTS6	ADAM-TS6	ENSG00000049192	"ADAM metallopeptidase with thrombospondin type 1 motif 6"	Q9UKP5	5	65148736-65481920	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 32.4"	"Cell line enhanced"	"Detected in many"		"BJ: 9.8;HBF TERT88: 10.8;hTEC/SVTERT24-B: 10.0;hTERT-HME1: 11.9;TIME: 11.2;U-2197: 12.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.8;naive B-cell: 3.6"	"Group enriched"	"Detected in many"	13	"B-cells: 4.8;T-cells: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043441	Enhanced				"Secreted to extracellular matrix"					"HPA043441: "	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-6)"	"unprognostic (3.23e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.02e-4)"	"unprognostic (4.18e-3)"	2.2	0.7	0.9	2.0	0.8	0.3	1.8	0.2	1.8	2.9	1.4	0.8	1.6	0.6	5.1	3.0	1.0	2.7	6.3	2.3	0.8	0.9	1.5	0.5	2.3	1.7	0.8	1.4	1.8	0.5	0.4	2.0	32.4	2.9	2.3	0.9	1.4	0.6	0.9	0.4	0.8	2.4	5.4	3.2	3.4	1.8	1.9	0.7	3.3	0.9	1.2	1.9	3.6	1.7	4.8	0.2	0.0	0.0	0.0	1.4	0.1	2.0	0.0	0.5	0.5	0.0	1.6	0.0	9.8	5.8	6.1	7.2	0.0	0.2	0.0	0.0	3.7	0.4	0.1	1.9	10.8	1.5	0.0	0.1	3.6	0.2	0.3	0.0	0.5	0.7	0.0	10.0	11.9	5.4	0.0	0.0	3.7	0.0	0.5	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	11.2	2.4	3.6	12.8	7.8	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.0	0.0	1.3	0.0	1.0	4.8	0.3	0.5	0.0	3.6	1.3	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.8	0.2	1.4	0.8	0.9	0.8	1.4	2.9	0.7
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.4;HUVEC TERT2: 8.3;U-2 OS: 22.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: "	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.1	0.0	3.9	0.0	0.0	0.2	1.8	0.0	8.4	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	1.6	0.0	0.8	0.0	0.0	4.0	0.0	1.6	0.0	0.9	0.1	0.1	0.0	0.0	2.0	1.4	0.0	1.1	0.0	0.2	0.0	22.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.0;HaCaT: 4.9;NB-4: 4.8;RPMI-8226: 5.8;THP-1: 20.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"					"Low region specificity"	"Detected in all"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.0	0.0	2.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	4.8	0.2	0.0	0.0	0.0	5.8	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.6	20.9	0.5	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
ARMS2	"ARMD8, LOC387715"	ENSG00000254636	"Age-related maculopathy susceptibility 2"	P0C7Q2	10	122454653-122457352	"Disease related genes, Predicted intracellular proteins"			"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"placenta: 21.2;testis: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HeLa: 1.4;HSkMC: 1.5;SiHa: 1.1;TIME: 1.4;WM-115: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067225	Enhanced									"HPA067225: "	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"		"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.49e-2)"		"unprognostic (1.98e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.60e-2)"	"unprognostic (5.29e-5)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.25e-2)"	0.5	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.7	0.2	0.2	0.2	0.4	1.7	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2	2.3	0.2	0.0	1.0	21.2	0.2	0.2	0.0	0.2	2.7	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.5	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935868-70965431	"Disease related genes, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 37.9;placenta: 29.0;salivary gland: 106.9"	"Group enriched"	"Detected in some"	9	"BEWO: 13.5;HaCaT: 12.4;SK-BR-3: 30.6"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	12	"monocytes: 1.4;T-cells: 1.0"	"Not detected"	"Not detected"							"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: "	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	0.6	0.0	0.1	0.1	0.1	0.0	4.4	0.8	0.2	12.2	0.1	0.1	6.9	0.1	0.5	0.4	0.5	5.0	0.1	0.3	0.1	0.0	37.9	0.1	2.1	0.1	0.1	0.1	2.0	1.1	0.0	1.7	29.0	0.1	0.6	0.0	7.4	106.9	1.1	0.1	11.8	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.3	0.1	1.6	1.1	0.1	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.2	0.2	0.3	0.8	1.6	1.9	13.5	0.2	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.7	12.4	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.3	0.9	0.4	30.6	0.0	0.3	0.0	0.2	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.0	0.1	0.1	0.1	0.1
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.1;RT4: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	Nucleoplasm,Nucleoli			69000000	Nucleoli	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favourable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favourable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.4	5.4	7.2	9.7	8.3	4.9	7.2	13.4	16.2	5.2	7.8	2.1	6.0	5.4	4.0	7.5	3.6	7.6	7.4	9.2	37.1	6.7	3.1	5.0	2.5	5.7	5.9	4.1	4.8	6.7	9.8	5.3	18.9	9.0	6.8	12.3	2.1	9.6	8.2	7.4	5.2	7.3	5.1	3.9	11.8	59.6	6.2	10.4	6.2	7.5	6.7	4.9	3.8	14.3	8.3	2.0	11.1	10.8	11.3	12.9	6.8	14.4	5.7	14.2	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245103-111270523	"Cancer-related genes, Enzymes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 62.9;placenta: 173.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HDLM-2: 11.0;NTERA-2: 17.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.2;plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040259			Approved	Vesicles				Vesicles		"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	1.7	0.0	0.2	1.7	0.2	0.0	6.0	0.3	0.3	3.9	4.2	0.2	23.4	0.2	18.2	62.9	2.4	2.9	2.6	0.4	0.2	0.0	5.1	0.4	0.3	1.1	0.2	0.4	1.9	4.1	0.0	0.2	173.5	0.3	3.6	2.2	2.1	5.6	21.7	1.7	1.0	1.3	2.0	0.3	1.0	7.2	2.8	0.2	0.5	1.7	4.7	2.9	1.4	2.6	0.1	2.0	0.8	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.3	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.4	0.3	0.2
CEACAM8	"CD66b, CGM6"	ENSG00000124469	"Carcinoembryonic antigen related cell adhesion molecule 8"	P31997	19	42580241-42595055	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 71.0;placenta: 35.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.2;monocytes: 3.0"									CAB033676	Approved				"Intracellular and membrane"		15000000			"CAB033676: AB_1125678"		"unprognostic (2.01e-1)"	"unprognostic (4.52e-2)"		"unprognostic (3.31e-1)"			"unprognostic (6.30e-2)"		"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"		"unprognostic (1.71e-2)"	"unprognostic (7.77e-2)"		"unprognostic (9.62e-2)"		0.2	0.0	0.1	0.0	0.1	71.0	0.1	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.1	0.4	4.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	35.6	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.1	10.1	0.0	0.1	0.1	1.9	0.1	0.0	0.0	0.0	0.7	0.5	0.1	4.2	3.0	0.6	0.4	4.1	0.8	0.2	1.1	2.1	0.0	0.5	0.3	1.3	0.0	0.0	0.1	0.2	0.4	1.2	0.3	0.5	0.5	0.0	0.3	0.0	0.2	0.3	0.5	0.7	0.7	0.1	0.8	0.6	0.0	0.1	0.1	0.1	0.0	0.7	1.5	0.0	0.3	0.4	0.9	0.5	0.1	0.5	0.5	1.3	0.4	0.5	0.7	0.8	0.1	0.3	1.2	1.3	0.9	0.8	1.4	0.3	1.5	0.5	1.5	1.3	0.7	0.8	1.3	0.7	0.6	0.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.4	4.2	0.6	3.0	0.1	0.1	4.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49665104	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;placenta: 10.4"	"Cell line enriched"	"Detected in some"	11	"NB-4: 15.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 18.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.7;pons and medulla: 8.1"	"CAB002313, HPA048547, CAB079053"	Supported	Supported								"CAB002313: AB_563661, CAB079053: , HPA048547: "					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.2	0.0	0.2	0.3	5.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	1.6	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.9	0.0	0.2	10.4	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	1.1	0.2	0.4	0.2	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	1.0	0.3	0.2	0.6	1.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	15.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.3	0.4	0.1	0.5	0.3	1.0	0.4	0.1	0.6	0.5	0.3	0.0	0.6	0.1	1.0	0.2	0.0	0.2	5.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9"	"Group enriched"	"Detected in some"	6	"AF22: 22.5;Hep G2: 75.2;SH-SY5Y: 89.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1"	"Group enriched"	"Detected in some"	5	"hypothalamus: 2.6;pons and medulla: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 65.4"	"Region enhanced"	"Detected in many"		"midbrain: 159.6"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"			160000	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: "	"unprognostic (2.16e-2)"			"prognostic unfavourable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			0.3	157.6	0.2	0.7	0.8	0.0	0.9	0.0	0.1	0.5	0.0	1.8	0.2	0.2	0.2	4.4	0.3	0.3	0.8	2.7	0.1	2.6	0.1	0.1	0.1	0.1	0.8	0.0	34.9	4.6	0.0	143.1	244.9	6.0	0.2	0.0	0.2	8.2	0.0	2.0	0.1	0.2	0.2	0.3	0.2	0.2	14.2	0.0	0.5	0.0	10.0	1.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	75.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	6.3	89.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.8	0.0	0.0	0.1	2.6	0.8	0.0	6.0	0.0
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569605-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 137.5"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 9.4;NTERA-2: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"					"HPA001838: "	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favourable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favourable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	16.1	0.1	0.3	0.2	0.2	0.1	2.3	0.0	0.2	0.4	4.1	0.0	0.1	0.2	0.5	0.4	3.3	0.6	1.5	0.6	0.1	0.7	0.2	0.1	18.6	0.2	0.1	0.1	0.2	0.3	0.1	1.7	137.5	0.9	0.6	0.2	27.1	0.2	0.1	0.1	0.4	0.2	2.0	0.6	0.2	0.4	0.2	0.0	0.0	0.2	0.2	0.4	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.7	0.1	0.1	0.9	0.0
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell line enriched"	"Detected in single"	92	"HEL: 42.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol			7500000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 27.6;hTCEpi: 19.9;RPTEC TERT1: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"		5000000	Nucleoplasm	Cytosol	"HPA011423: , HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.4	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	27.6	5.9	0.0	0.6	0.1	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	19.9	0.0	2.9	0.0	1.5	0.0	0.1	0.3	0.0	0.0	1.8	0.8	0.0	0.0	0.0	14.7	0.4	1.2	0.2	1.8	0.8	0.0	2.4	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 19.7"	"Cell line enriched"	"Detected in some"	8	"BEWO: 13.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	19.7		0.8	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505431-108593738	"Disease related genes, Predicted intracellular proteins"			"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.9;placenta: 45.1;skin 1: 23.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.2;hTERT-HME1: 10.4;RT4: 18.2;SK-BR-3: 8.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	14	"cerebellum: 74.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 23.5;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	10	"cerebellum: 64.1"												"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favourable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favourable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.7	0.6	0.8	1.2	2.7	0.1	2.6	74.9	1.1	3.3	3.3	1.4	0.0	0.5	0.9	2.5	9.8	1.5	0.3	0.7	1.1	0.8	3.4	6.7	4.7	0.0	1.6	1.0	0.8	1.4	9.3	2.2	45.1	5.4	1.6	3.8	0.7	6.2	0.1	0.6	23.1	1.1	0.6	2.6	0.6	2.8	1.7	2.4	0.6	1.9	7.1	5.2	1.7	1.9	0.7	0.9	3.0	0.6	3.2	2.2	0.5	3.4	0.4	0.2	0.1	0.0	0.0	2.9	0.2	0.1	0.0	0.6	0.9	5.4	0.0	0.2	0.2	7.2	5.1	1.9	0.2	0.1	1.5	1.5	0.7	0.0	0.5	0.7	0.1	0.1	3.0	0.0	10.4	0.0	2.6	0.0	2.9	0.6	0.9	0.0	0.2	2.2	0.0	0.1	0.0	0.6	18.2	1.3	0.8	0.9	8.9	0.2	5.9	0.1	0.1	0.0	2.2	0.0	1.0	0.1	0.0	0.0	0.1	0.3	0.0	2.0	0.6	0.5	0.7	0.3	0.3	0.7	1.1	0.4	0.5	0.7	2.1	2.2	3.0	3.2	0.4	0.9	0.3	0.5	0.8	2.7	74.9	1.1	1.1	0.8	1.6	1.0	5.4	2.4
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985895	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 262.7"	"Group enriched"	"Detected in some"	8	"HAP1: 53.1;Hep G2: 209.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 269.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7"	"Group enriched"	"Detected in many"	12	"NK-cells: 1.7;T-cells: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006316			Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	30.1	5.9	0.4	3.6	0.7	0.0	50.2	0.6	0.4	3.3	4.5	0.5	2.2	0.5	2.5	11.7	2.0	3.4	9.2	8.0	0.4	1.1	21.2	1.1	37.0	1.9	1.6	0.4	6.0	4.6	0.3	16.9	262.7	1.6	3.6	1.0	6.3	3.8	2.3	4.1	5.5	1.8	3.3	2.1	0.9	4.0	2.1	0.3	2.3	7.2	11.2	3.0	7.6	8.0	0.0	0.2	0.0	0.0	1.7	5.0	0.6	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	2.4	0.0	0.1	209.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	14.5	0.6	1.7	4.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.0	5.0	3.5	0.0	1.7	0.0	0.0	0.0	0.6	0.4	0.7	0.6	0.4	0.4	1.1	1.6	0.4	1.6	0.3
HBM	"HBAP2, HBK"	ENSG00000206177	"Hemoglobin subunit mu"	Q6B0K9	16	153892-166768	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 109.8;placenta: 50.2"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"										400000								"unprognostic (1.30e-1)"										"unprognostic (7.59e-2)"			0.9	0.2	0.4	0.2	0.5	109.8	0.3	0.1	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.6	0.2	0.2	4.4	0.3	0.4	1.7	2.6	16.5	0.2	0.7	0.0	1.6	0.2	0.2	1.1	50.2	1.2	0.5	0.2	1.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	17.5	0.2	0.2	0.0	1.0	2.0	0.1	0.3	2.1	4.9	0.1	0.5	0.5	0.0	0.9	0.4	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.0	10.5	0.4	0.5	0.1	0.2	0.3	0.4	0.7	0.0	1.2	0.0
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5"	"Group enriched"	"Detected in some"	15	"HL-60: 2.8;U-937: 4.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"	40500000				"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.1	0.0	0.1	2.5	0.1	0.0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
INHA		ENSG00000123999	"Inhibin alpha subunit"	P05111	2	219569162-219575713	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;CAPAN-2: 4.3;HEL: 5.6;SK-BR-3: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000047, HPA019141"	Enhanced		Approved	Vesicles	"Secreted to blood"			Vesicles		"CAB000047: AB_322161, HPA019141: AB_1851789"	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	0.5	24.2	0.8	0.5	8.4	0.0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0.0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0.0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	2.5	0.8	0.2	4.6	0.5	0.4	0.7	0.2	0.3	4.3	0.0	0.3	1.0	2.7	0.3	0.7	0.0	0.0	0.8	5.6	2.0	3.0	0.4	0.0	0.0	1.0	1.3	0.0	0.7	0.0	3.4	0.0	0.1	3.1	0.0	0.2	1.7	1.1	0.1	0.2	0.0	0.7	0.3	0.5	1.1	1.6	13.0	0.4	0.8	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Group enriched"	"Detected in some"	5	"HMC-1: 5.0;SK-BR-3: 9.4"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"												"Secreted to blood"	510400					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favourable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3
LGALS16		ENSG00000249861	"Galectin 16"	A8MUM7	19	39655894-39660647	"Predicted intracellular proteins"	Apoptosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 14.2"	"Cell line enriched"	"Detected in single"	95	"BEWO: 9.5"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.6	0.5	0.1	1.3	1.2	0.0	0.0	0.0
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355247-194369743	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 48.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"			1800000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	3.3	0.5	0.5	3.1	0.6	0.0	5.3	0.5	0.5	4.6	2.1	0.2	0.0	0.4	3.5	0.3	1.0	1.3	2.0	1.8	0.5	0.5	0.5	0.5	2.5	0.8	0.5	0.0	3.1	0.8	0.0	0.5	48.1	0.3	0.6	4.2	0.7	1.6	0.0	1.0	9.1	0.8	0.7	0.5	1.3	1.9	0.9	0.0	1.1	1.8	7.7	7.7	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	1.5	1.2	0.0	0.0	0.0	0.0	25.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0
MAGEA8	"CT1.8, MAGE8, MGC2182"	ENSG00000156009	"MAGE family member A8"	P43361	X	149881141-149885835	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 24.6"	"Group enriched"	"Detected in some"	24	"U-2 OS: 19.1;U-266/70: 35.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003998	Enhanced									"HPA003998: AB_10965020"	"unprognostic (6.81e-2)"	"unprognostic (7.56e-2)"		"unprognostic (1.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	24.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	35.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000244	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 94.5"	"Cell line enhanced"	"Detected in all"		"A549: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: "	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	8.7	20.0	3.2	6.0	4.8	5.1	6.2	4.9	3.6	8.0	5.3	4.6	12.7	4.6	8.8	8.5	6.8	7.3	6.7	5.3	4.3	2.8	4.9	9.7	6.0	2.2	4.9	2.2	12.3	9.1	6.0	4.9	94.5	5.8	7.7	4.9	4.2	8.7	8.8	9.4	8.6	4.9	7.4	5.4	2.6	5.6	12.5	5.0	2.3	7.6	7.5	5.2	6.3	15.1	6.0	4.6	10.5	3.8	2.8	4.0	0.7	11.5	46.3	4.6	10.6	14.1	16.3	24.2	11.3	12.0	5.7	7.3	24.5	5.3	1.8	5.9	11.6	9.1	15.4	9.9	6.9	2.7	8.9	2.8	15.7	10.3	10.4	2.0	5.9	8.6	9.6	7.8	11.4	5.1	1.6	17.6	12.7	10.2	4.2	2.8	4.1	17.6	2.0	9.3	2.0	18.5	9.2	4.0	5.1	13.7	13.4	8.9	8.0	2.0	5.3	9.2	9.3	18.2	6.2	5.0	6.5	4.6	9.8	1.8	6.6	10.5	3.8	3.1	3.7	3.0	3.2	3.3	3.6	2.8	1.6	6.0	4.0	3.4	8.2	2.8	3.6	4.6	2.6	0.7	3.2	4.8	4.9	3.6	4.3	2.8	4.9	2.2	5.8	5.0
MYH13	MyHC-eo	ENSG00000006788	"Myosin heavy chain 13"	Q9UKX3	17	10300865-10373130	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 1.9;skeletal muscle: 5.2;stomach 1: 4.8"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"														"unprognostic (8.86e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.81e-2)"	"unprognostic (3.95e-1)"		"unprognostic (8.35e-2)"		"unprognostic (1.42e-2)"	"unprognostic (7.50e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.40e-9)"	"unprognostic (2.44e-2)"	"unprognostic (1.08e-1)"		"unprognostic (2.06e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	5.2	0.0	0.8	0.1	0.1	0.4	4.8	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152240-26187125	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 54.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.4;NTERA-2: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"HPA055889: "	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavourable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (7.58e-12)"	"prognostic favourable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.5	2.5	0.8	7.8	1.2	1.6	4.1	6.2	1.6	1.8	6.7	4.0	2.4	6.2	1.9	1.7	3.1	2.4	7.1	3.6	1.3	1.1	4.2	2.3	5.8	6.9	2.5	0.8	1.7	7.5	0.0	2.1	54.9	2.1	3.7	4.0	2.1	7.7	0.4	3.4	8.2	7.1	0.8	3.7	10.4	5.6	2.5	1.5	11.2	1.6	1.5	8.9	3.1	2.1	1.4	2.8	0.8	1.1	1.1	2.6	0.4	12.5	1.1	0.5	1.3	0.0	0.0	43.4	2.5	4.9	4.9	9.0	8.3	22.0	0.9	16.6	0.2	2.6	1.9	4.2	11.2	8.6	2.7	1.7	1.8	6.1	3.4	1.5	16.8	0.4	0.5	2.0	0.7	11.3	2.6	22.3	0.9	1.7	1.0	2.7	36.4	4.4	1.5	0.1	6.2	6.6	12.4	3.9	4.7	0.0	1.0	0.3	0.6	0.9	23.5	0.4	0.7	0.2	10.1	13.6	21.6	1.0	0.0	5.4	16.8	0.0	1.1	0.0	0.5	1.1	1.6	1.0	2.1	1.0	2.8	1.4	1.2	0.7	0.8	1.1	0.3	0.9	2.6	0.4	0.8	1.2	6.2	1.6	1.3	1.1	2.5	0.8	2.1	1.5
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7959424-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 13.2;skin 1: 10.5"	"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ: 5.3;HBF TERT88: 7.6;LHCN-M2: 3.4"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 2.6"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	0.2	0.0	5.3	2.6	1.2	2.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
NOX5	"NOX5A, NOX5B"	ENSG00000255346	"NADPH oxidase 5"	Q96PH1	15	68930525-69062743	"Predicted membrane proteins, Transporters"	"Angiogenesis, Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 19.1;placenta: 11.1;testis: 43.7"	"Cell line enhanced"	"Detected in some"		"BJ: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.5;EFO-21: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"														"unprognostic (2.33e-1)"	"unprognostic (1.63e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.21e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.71e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	1.5	1.0	0.8	0.4	2.3	0.4	1.5	0.8	1.2	3.0	0.9	0.9	5.3	0.4	1.5	2.5	1.1	1.1	1.1	1.6	0.8	0.9	1.4	0.5	0.6	1.1	1.3	0.1	1.2	0.6	0.5	1.9	11.1	2.7	2.1	0.9	1.1	0.6	2.3	0.9	0.8	1.0	2.3	1.3	19.1	0.9	43.7	0.5	0.2	1.4	0.2	0.6	1.5	1.0	0.4	0.1	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.6	1.9	2.5	1.3	1.5	0.0	3.1	0.4	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.0	0.7	1.5	0.0	0.1	0.3	1.2	0.0	1.6	0.0	0.1	0.6	1.9	0.9	0.3	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	2.3	0.8	1.2	0.8	0.9	1.3	0.1	2.7	0.5
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073852	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 61.3;testis: 24.0"	"Cell line enhanced"	"Detected in some"		"HSkMC: 5.8;hTCEpi: 7.3;LHCN-M2: 5.6;SK-BR-3: 8.8;U-266/70: 4.9"	"Group enriched"	"Detected in some"	7	"testis cancer: 3.6;thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.6"									"HPA037947, HPA037948"	Enhanced									"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.0	1.1	0.2	0.2	0.7	1.2	5.2	0.3	0.7	0.8	0.5	0.3	0.1	0.0	0.2	0.4	2.7	1.4	1.1	0.8	0.2	0.2	0.8	0.4	1.9	4.3	0.9	0.1	0.2	0.1	0.1	1.5	61.3	0.4	0.1	0.0	0.3	3.0	0.1	0.5	0.4	0.3	0.1	0.5	8.0	0.2	24.0	0.3	0.2	1.2	0.1	0.3	0.3	1.1	0.5	1.1	6.6	0.4	1.0	0.6	0.1	0.2	0.6	0.6	0.5	0.3	1.1	2.2	0.4	0.4	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.7	0.4	0.2	0.3	0.4	0.0	0.9	0.0	0.6	5.8	7.3	0.9	0.1	0.7	0.5	0.3	5.6	0.0	0.5	0.7	0.7	0.4	0.7	1.3	1.7	0.0	0.0	0.0	0.4	0.3	8.8	0.1	0.2	0.5	1.0	0.1	2.9	1.3	0.1	4.9	1.6	0.4	2.7	0.5	0.0	1.4	0.4	0.4	0.4	0.2	0.3	0.2	0.6	0.2	0.2	0.5	0.3	0.3	6.6	1.0	0.2	1.1	0.4	0.1	0.2	0.7	0.3	0.3	0.2	0.2	0.9	0.1	0.4	0.3
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell line enriched"	"Detected in single"	18	"HEL: 13.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015095, HPA056839"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;BEWO: 32.9;HaCaT: 43.0;SK-BR-3: 31.6;U-2197: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	19.3	0.0	9.2	31.0	10.7	32.9	1.4	12.7	0.2	0.3	0.9	14.1	0.0	0.5	3.5	43.0	0.1	1.4	0.1	0.0	0.1	0.0	13.7	0.0	0.7	0.0	0.0	6.3	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	1.7	0.0	0.0	0.0	1.0	20.6	0.1	0.7	17.2	31.6	0.1	16.5	0.0	0.1	0.0	0.0	81.7	0.0	0.0	0.0	0.0	16.2	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6
RTL1	"HUR1, Mar1, MART1, PEG11, SIRH2"	ENSG00000254656	"Retrotransposon Gag like 1"	A6NKG5	14	100880655-100884847	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 5.0;brain: 7.6;placenta: 8.3"	"Cell line enriched"	"Detected in some"	31	"SH-SY5Y: 118.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.1"					"HPA066979, HPA077601"	Enhanced		Approved	Cytosol				Cytosol		"HPA066979: , HPA077601: "					"unprognostic (1.61e-1)"					"unprognostic (3.30e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.42e-3)"	"unprognostic (2.10e-1)"			0.0	5.0	0.2	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.6	0.0	0.0	0.0	0.0	1.8		1.3	0.1	0.0	0.3	8.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 25.8;EFO-21: 21.3;HUVEC TERT2: 20.9;TIME: 50.7;U-87 MG: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	27	"B-cells: 3.3"	"Group enriched"	"Detected in many"	6	"amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1"	"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: "	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4.0	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4.0	5.7	2.6	6.2	17.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.1	1.0	0.9	25.8	3.9	5.4	1.3	1.1	6.0	2.8	0.0	21.3	5.6	2.5	0.0	3.8	0.5	0.0	0.0	0.0	10.4	1.3	5.8	0.0	0.2	1.1	6.2	1.5	1.1	20.9	0.0	0.0	1.2	0.4	0.0	0.1	0.8	3.3	0.1	0.2	0.0	1.0	0.5	2.4	11.5	5.6	6.2	0.2	0.4	1.8	50.7	5.1	15.9	0.1	1.0	0.2	0.0	0.3	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.9	1.4	24.9	16.6	4.0	4.5	5.6	3.7	3.9
TBX4		ENSG00000121075	"T-box 4"	P57082	17	61452404-61485110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;Hep G2: 2.1;THP-1: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 1.6"	"CAB032413, HPA044457"	Uncertain		Approved	Vesicles				Vesicles		"CAB032413: AB_2200705, HPA044457: "	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	0.6	15.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	26.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	18.6	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.1	0.0	0.0	5.3	0.5	0.4	0.4	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	2.1	0.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.5	0.0	10.5	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165031953-165041744	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"placenta: 5.0;testis: 6.6"	"Cell line enriched"	"Detected in some"	14	"BEWO: 17.6"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain									"HPA035809: , HPA035810: AB_10601827, HPA061496: "															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	1.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.1	0.2	1.1	0.2	0.3	0.0	0.5	0.3	0.2	1.1	0.1	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AADACL3		ENSG00000188984	"Arylacetamide deacetylase like 3"	Q5VUY0	1	12716115-12728759	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"placenta: 13.4;skin 1: 4.7"	"Cell line enriched"	"Detected in single"	9	"BEWO: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.01e-1)"					"unprognostic (2.54e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC096582.3		ENSG00000283247			7	45859994-45873082	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"breast: 2.8;epididymis: 1.2;placenta: 3.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.1	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	0.1	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	3.3	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.3	0.1	0.3	0.6	0.0	0.1	0.1	0.1	0.7	0.7	0.1	0.8	0.4	0.4	0.5	0.0	0.3	0.4	0.4	0.4	0.1	0.5	0.0	0.1	0.5	0.1	0.1	0.3	1.2	0.6	0.0	0.3	0.2	0.0	0.5	0.2	0.5	0.0	0.4	0.3	0.4	0.1	0.8	1.0	0.3	1.0	0.4	0.2	0.7	0.5	0.0	2.2	0.4	0.2	0.5	0.1	0.1	0.1	0.3	0.1	1.3	1.3	0.2	0.6	1.2	0.2	1.2	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.3	0.2	0.0										
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 51.9;placenta: 104.9"	"Cell line enhanced"	"Detected in many"		"A549: 25.2;Hep G2: 23.5;hTERT-HME1: 23.9;HUVEC TERT2: 46.1;MCF7: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 3.5"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved						70000000			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.6	1.4	1.1	4.1	1.0	0.0	6.1	0.5	1.1	4.1	14.0	1.0	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12.0	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5.0	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0.0	3.5	0.0	0.2	0.0	0.1	0.0	4.7	25.2	0.5	2.6	0.1	0.0	0.0	6.5	1.2	5.0	3.1	20.1	14.6	0.0	5.9	3.7	11.8	0.7	6.3	8.3	0.0	1.9	1.0	4.3	23.5	4.9	4.0	0.0	0.0	10.2	0.1	23.9	46.1	0.1	0.0	2.0	43.2	0.0	0.0	0.2	5.7	0.0	2.2	4.9	2.6	10.7	0.0	0.0	1.9	8.9	4.1	4.8	0.0	1.5	0.0	2.2	2.2	3.2	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55031064	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 130.9;placenta: 53.5"	"Group enriched"	"Detected in some"	87	"HEL: 32.0;K-562: 35.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0.0	0.4	0.3	0.3	2.3	1.0	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1.0	53.5	2.3	2.6	0.3	1.0	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0.0	0.4	3.2	0.0	0.3	7.0	6.5	0.3	2.0	0.3	0.1	0.0	0.3	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.0	0.0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0.0
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 67.1"	"Group enriched"	"Detected in some"	6	"BEWO: 16.6;CAPAN-2: 5.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	0.0	0.2	8.8	0.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.5	1.2	15.4	1.1	0.1	0.0	0.0		0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	6.1	67.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.8	10.5	0.0	0.1	1.6	0.8	0.2	0.1	0.4	11.0	1.9	0.7	0.0	0.9	0.2	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.1	5.4	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.9	0.5	0.7	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	1.3	0.0	1.2	1.1	6.0	1.6	0.0	1.6	11.0	4.1	0.0	0.4	0.1	0.8	5.9	1.9										
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7"	"Group enriched"	"Detected in some"	18	"BEWO: 34.1;NB-4: 9.2;THP-1: 22.4;U-937: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 167.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 167.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"					"CAB017116: , HPA048086: "	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	8.5	1.5	2.9	39.5	3.2	88.9	2.4	0.7	2.9	1.1	1.1	4.2	0.4	0.6	0.7	1.1	1.2	6.9	4.3	5.6	2.6	2.0	1.7	4.5	26.9	27.5	7.2	1.1	1.1	1.3	0.3	1.1	152.7	3.8	1.3	0.5	2.1	1.6	0.5	0.6	0.3	1.6	3.1	7.1	71.4	2.2	1.4	3.3	1.1	1.0	0.4	0.9	4.6	3.9	0.0	8.2	167.3	22.1	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.6	0.0	0.0	22.1	0.6	0.0	4.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	167.3	0.2	1.8	0.2	0.0	10.3	2.9	3.2	0.7	2.9	2.6	2.0	7.2	1.1	3.8	3.3
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111732	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 66.9"	"Cell line enriched"	"Detected in single"	31	"BEWO: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in single"																						"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	1.4	2.0	0.1	0.1	0.1	0.1	0.8	0.2	0.2	0.5	0.8	0.1	0.1	0.3	1.3	0.8	0.7	0.2	0.5	0.5	0.1	0.0	1.5	0.7	1.5	1.0	0.1	0.1	0.1	0.1	15.8	0.1	66.9	0.1	1.2	0.2	0.7	0.9	0.5	0.1	0.9	1.9	0.8	0.1	0.1	1.0	0.3	0.1	0.6	0.2	0.9	0.3	1.5	2.2	0.5	0.0	0.3	0.1	2.1	0.7	0.1	0.0	0.1	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.7	0.4	0.3	2.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1
GJA5	CX40	ENSG00000265107	"Gap junction protein alpha 5"	P36382	1	147756199-147773362	"Disease related genes, Predicted membrane proteins"			"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 60.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 54.3"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013080, HPA071370"	Enhanced									"CAB013080: AB_2533263, HPA071370: "	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.93e-2)"	8.8	0.2	0.6	1.5	1.1	0.0	2.1	0.7	0.7	2.1	2.2	0.8	2.8	0.6	1.2	1.6	1.2	2.6	1.7	15.1	0.9		7.0	0.2	9.3	0.3	0.9	0.0	2.2	0.7	0.8	0.0	60.6	1.2	1.6	0.9	2.0	0.2	3.1	1.7	0.0	1.4	2.5	0.9	1.9	0.0	1.3	0.3	0.0	2.1	0.4	0.5	2.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	2.3	1.7	0.9	0.9	0.2	0.0	0.1	0.0	0.5	0.3	0.1	0.0	3.7	1.4	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7										
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria			570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: "	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.5	7.0	0.0	0.1	65.3	0.0	0.0	0.0	0.0	15.5	0.1	0.1	1.5	0.0	0.1	0.0	0.1	0.0	0.3	3.7	0.0	0.0	10.3	0.0	0.0	14.2	0.0	0.0	0.5	0.0	2.7	0.0	0.1	0.3	0.3	0.2	0.0	7.6	1.2	0.3	0.0	0.1	27.0	0.3	6.2	3.2	0.0	6.0	0.0	1.4	0.0	0.9	0.1	0.2	0.7	0.3	0.3	8.9	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Group enriched"	"Detected in some"	37	"PC-3: 44.7;TIME: 28.2;U-2 OS: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.2	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 66.0"	"Cell line enriched"	"Detected in single"	5	"CAPAN-2: 2.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											CAB016158	Enhanced				"Secreted to blood"	32800000				"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favourable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.2	0.1	0.0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0.0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0.0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66.0	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.0	2.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell line enhanced"	"Detected in many"		"AF22: 15.2;BEWO: 10.9;Hep G2: 13.2;HSkMC: 15.1;U-251 MG: 13.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"									HPA064126			Approved	Vesicles				Vesicles		"HPA064126: "	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.2	0.0	4.6	5.2	10.9	4.3	6.3	3.9	4.1	0.0	0.1	0.0	0.0	5.9	0.0	0.4	2.4	2.0	1.2	3.1	0.3	2.0	13.2	6.0	0.5	2.3	15.1	0.8	1.3	3.6	0.0	4.5	0.0	3.1	0.8	0.7	0.6	0.5	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	3.8	0.0	0.0	13.9	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0
IFIT1B	"bA149I23.6, IFIT1L"	ENSG00000204010	"Interferon induced protein with tetratricopeptide repeats 1B"	Q5T764	10	89378056-89385205	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 23.2;placenta: 14.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062924	Approved									"HPA062924: "	"unprognostic (2.59e-1)"	"unprognostic (3.13e-1)"			"unprognostic (6.62e-3)"	"unprognostic (4.55e-2)"			"unprognostic (4.11e-2)"	"unprognostic (9.34e-2)"			"unprognostic (1.76e-1)"	"unprognostic (6.86e-2)"				0.4	0.0	0.2	0.0	0.2	23.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.3	0.1	0.2	0.5	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	14.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.6	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.9	0.2	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	1.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	0.0	2.4	0.2	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.8	1.0	1.6	0.2	2.8	2.3	3.0	1.7	3.5	4.0	3.9	1.6	8.6	0.6	17.9	4.7	10.0	0.8	16.7	5.6	0.7	1.0	0.8	1.7	4.1	6.0	5.7	2.8	3.1	6.9	5.8	18.5	1.7	0.1	0.0	1.8	1.8	0.4	2.6	2.5	1.8	2.7	2.5	1.3	1.5	4.1	0.3	0.0	7.8	4.4	71.2	2.8	4.1	2.3	3.1	3.2	9.5	7.8	1.4	0.0	0.1	5.2	5.1	18.2	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Group enriched"	"Detected in some"	6	"HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	19074133	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	3.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.5	0.1	0.1	54.1	0.4	80.5	1.1	0.3	1.3	8.7	39.3	0.1	0.1	0.1	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;Hep G2: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"T-reg: 12.8"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.8"														"Secreted - unknown location"						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0.0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3.0	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1.0	1.2	0.4	19.6	0.5	0.0	2.0	0.3	0.3	0.0	0.0	0.1	0.1	0.6	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.0	2.0	0.0	0.0	0.8	2.7	0.1	0.6	0.1	0.0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3.0	0.6	0.5	1.3	0.4
LNPEP	"CAP, IRAP, P-LAP, PLAP"	ENSG00000113441	"Leucyl and cystinyl aminopeptidase"	Q9UIQ6	5	96935394-97037515	"Enzymes, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 104.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043642	Approved				"Intracellular and membrane"		390000			"HPA043642: AB_10964137"	"unprognostic (1.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	9.8	4.7	5.6	12.0	7.3	13.2	7.7	23.3	12.9	6.3	7.6	6.9	7.8	4.2	8.2	4.4	10.2	6.6	4.3	10.1	5.2	5.6	7.6	4.3	6.9	15.9	7.7	8.8	8.2	5.9	13.8	9.7	104.4	9.1	7.9	6.8	3.9	7.8	7.7	13.2	14.0	9.0	6.6	7.5	10.0	8.5	3.3	7.7	23.6	7.2	2.9	15.8	8.9	7.7	4.1	3.5	5.0	12.8	11.2	7.9	4.3	5.3	6.2	2.8	3.0	17.1	8.2	3.3	5.5	7.3	6.5	9.9	5.2	8.7	26.5	10.4	7.4	7.1	3.6	10.4	6.8	9.4	2.0	6.6	4.5	3.6	4.4	7.6	9.2	6.3	6.5	9.4	6.9	6.8	2.8	17.6	7.4	4.8	9.0	5.3	0.6	3.3	6.6	10.6	4.0	23.2	11.1	5.5	1.4	6.7	5.9	3.3	18.1	10.1	13.5	9.5	5.3	7.5	8.3	3.8	8.8	24.2	8.4	7.3	4.3	5.0	3.3	4.4	7.9	5.5	6.8	3.1	5.9	6.1	3.5	4.1	5.9	6.4	4.1	11.2	12.8	3.3	5.1	4.3	5.6	7.3	23.3	12.9	5.2	5.6	7.7	8.8	9.1	7.7
LRRC36	FLJ11004	ENSG00000159708	"Leucine rich repeat containing 36"	Q1X8D7	16	67326798-67385203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 11.7;placenta: 9.3;testis: 31.9"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.6;hTEC/SVTERT24-B: 5.0;TIME: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 11.7"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058479	Enhanced									"HPA058479: "	"unprognostic (4.59e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-5)"	"unprognostic (5.27e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-2)"	0.2	0.1	0.3	0.0	1.5	0.0	0.2	0.5	0.4	0.3	0.1	0.0	0.0	0.0	0.4	2.3	0.1	2.6	0.3	0.1	1.2	0.4	0.3	0.1	4.3	0.2	0.2	0.0	0.3	2.0	0.0	1.2	9.3	2.5	0.1	0.4	0.5	0.2	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.4	31.9	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	11.7	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.6	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	1.5	0.5	0.4	1.2	0.4	0.2	0.0	2.5	0.2
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111831	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 344.8"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"		59000000000			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	44.8	25.3	0.8	15.1	0.7	0.0	19.7	0.7	0.7	56.7	26.9	0.7	28.1	5.1	64.8	77.8	28.1	12.2	76.6	48.8	0.8	0.7	26.9	6.4	77.1	32.0	0.9	0.6	73.0	9.1	0.7	2.7	344.8	2.8	77.4	13.3	1.4	5.6	9.9	9.1	8.3	24.0	48.7	4.0	1.3	8.2	30.9	0.3	1.7	18.1	32.3	11.5	65.3	20.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	22.5	11.1	0.0	36.9	182.3	1.5	2.3	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	17.6	0.0	0.0	15.2	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.4	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.7	0.7	0.8	0.7	0.9	0.6	2.8	0.3
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43795929-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 39.6;skin 1: 39.8;tongue: 34.7"	"Cell line enhanced"	"Detected in some"		"A-431: 5.8;BEWO: 9.0;HaCaT: 9.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: "	"unprognostic (4.27e-3)"	"prognostic favourable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.5	1.2	3.4	2.1	7.9	0.7	4.2	2.4	8.8	5.7	1.4	3.5	0.5	1.2	1.3	2.4	7.8	1.6	1.9	1.3	3.9	4.8	0.9	1.0	3.4	1.4	4.5	4.0	0.8	0.9	1.1	1.4	39.6	9.3	1.3	1.5	0.7	2.1	1.5	0.7	39.8	1.1	1.9	3.3	5.9	1.3	7.4	2.7	0.6	1.4	34.7	3.4	2.4	5.4	0.4	0.0	0.5	3.8	0.0	1.2	0.5	5.8	0.0	0.3	0.0	0.1	0.0	9.0	0.4	0.0	0.8	1.0	0.6	2.0	0.3	1.1	0.7	9.3	0.0	1.0	0.5	1.0	0.0	0.2	0.6	0.0	2.5	0.1	0.1	2.8	2.6	0.4	1.1	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.6	1.9	0.0	0.1	0.1	0.6	0.9	0.7	0.2	1.2	1.4	0.0	0.6	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	1.2	0.0	0.0	3.8	0.3	0.0	0.8	0.1	0.0	0.4	0.4	1.2	0.5	0.0	1.4	0.0	0.0	0.5	3.4	7.9	2.4	8.8	3.9	4.8	4.5	4.0	9.3	2.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"			1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: "	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favourable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.1	6.2	10.6	9.1	14.0	16.9	34.1	11.8	18.5	5.3	5.0	4.7	8.2	10.6	21.9	15.1	8.5	4.9	10.0	12.1	13.3	7.4	6.3	8.7	5.2	8.5	9.9	14.5	11.3	10.8	8.1	7.1	15.8	10.1	16.4	11.1	27.6	6.0	3.1	5.4	6.5	5.4	23.1	7.2	7.3	19.4	5.8	8.5	11.7	12.6	9.3	6.2	6.3	15.0	12.1	9.9	8.5	12.0	11.2	7.6	7.2	15.9	7.9	28.5	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Cell line enhanced"	"Detected in many"		"AF22: 93.1;HAP1: 120.8;Hep G2: 93.1;SCLC-21H: 59.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: , HPA051038: "	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.1	93.1	39.3	1.9	3.5	5.4	7.1	4.2	5.1	7.0	21.8	4.3	0.2	0.2	8.2	0.8	120.8	5.0	7.2	0.3	12.7	0.0	15.0	93.1	1.4	14.8	0.0	7.8	1.6	12.7	8.9	3.0	0.0	29.1	10.0	0.6	0.0	0.0	42.6	8.4	5.6	29.8	7.8	23.4	9.7	59.1	3.4	0.0	2.0	7.0	12.6	0.0	0.0	4.1	0.2	0.5	5.4	7.8	5.2	11.6	9.3	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"			36000000	"Plasma membrane"		"CAB002759: , HPA031345: , HPA058494: "	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (3.65e-8)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.6	15.3	12.7	3.2	1.5	0.5	44.2	7.0	15.2	8.6	12.8	71.8	29.7	4.0	21.0	2.1	9.9	2.8	16.3	3.8	2.4	2.6	6.6	8.9	49.0	4.4	3.6	1.9	1.8	12.6	5.4	5.9	1.4	14.8	0.9	3.9	18.9	1.6	2.5	8.1	3.9	1.6	4.1	5.6	7.9	5.2	6.7	4.7	8.2	26.0	3.0	1.1	4.6	3.2	7.9	5.7	1.4	15.8	0.7	1.5	2.4	15.6	2.5	6.4	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5
SLC52A1	"FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1"	ENSG00000132517	"Solute carrier family 52 member 1"	Q9NWF4	17	5032600-5052009	"Disease related genes, Predicted membrane proteins"	Transport	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 25.6;placenta: 34.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.3;BEWO: 3.7;EFO-21: 3.5;HMC-1: 8.8;SK-BR-3: 5.0;T-47d: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (8.81e-3)"	"prognostic favourable (9.54e-4)"	"unprognostic (9.34e-2)"	"unprognostic (7.30e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.19e-2)"	"unprognostic (5.17e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.60e-2)"	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.3	0.6	1.0	20.0	0.2	0.6	24.4	0.5	0.1	1.5	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.2	0.1	1.0	0.1	34.6	0.3	1.4	0.1	0.1	0.5	0.3	0.1	7.4	25.6	0.1	0.1	0.6	0.0	0.7	0.1	0.6	0.2	0.4	0.7	2.5	1.0	1.4	0.6	3.7	0.6	1.4	1.2	0.3	0.2	4.3	0.1	0.2	0.1	0.2	3.7	0.0	0.0	0.6	0.6	0.1	0.2	0.3	3.5	0.1	0.4	0.0	0.3	0.1	0.1	0.2	0.0	0.7	0.3	0.1	0.1	8.8	0.1	0.1	0.2	0.1	0.2	0.1	1.2	0.0	0.3	0.4	0.4	0.4	0.2	0.1	0.0	0.3	0.1	1.4	0.1	0.3	0.8	5.0	0.0	3.0	1.3	0.6	0.3	1.1	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.5	2.6	0.6	0.9	0.7	0.4	0.6	0.6	0.9	1.2	0.2	1.4	1.1	0.8	3.7	1.4	0.4	0.6	0.5	0.3	0.1	0.2	0.3	0.6	0.1	0.1	0.1	0.1	0.3	0.1
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;U-266/70: 3.9;U-266/84: 1.8"									"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"											"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1										
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228007051-228061260	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"lung: 7.4;placenta: 19.9"	"Group enriched"	"Detected in some"	9	"HEK 293: 2.7;U-2 OS: 9.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA066281: "	"unprognostic (9.84e-3)"	"prognostic favourable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	7.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	19.9	0.1	2.4	0.0	0.1	1.7	0.1	0.1	3.0	0.1	0.1	0.6	0.1	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
AC064853.3		ENSG00000284631			2	227616998-227618655	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.9;epididymis: 4.4;placenta: 8.4"	"Cell line enriched"	"Detected in single"	18	"U-2197: 15.4"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.0	0.0		0.9		1.4	0.0		0.5	0.0	0.0			0.0	0.1	4.4	0.0	0.0	0.0	0.0			0.0	1.1	0.0	0.0			0.0	0.3	0.0		8.4		0.0	0.0		0.0	0.3	0.0	0.8	0.0	0.0		0.0	0.0	0.4			0.1		0.0	0.0		1.2	1.3	2.9	0.8	0.6	0.8	0.4	0.1	0.4	0.3	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.6	0.6	0.0	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.1	0.2	0.7	0.1	0.0	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.7	0.3	0.1	15.4	0.3	0.2	0.1	0.4	0.1	0.1	0.4	2.9	0.8	0.4	0.6	0.4	0.2	0.7	0.4	0.4	0.2	1.2	0.7	0.8	2.1	0.6	0.4	1.3	0.4	0.4										
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035392: , HPA035393: "	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 20.5;MOLT-4: 19.8;RPMI-8226: 30.5;U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced									"HPA041014: , HPA043228: "	"unprognostic (6.87e-2)"	"prognostic favourable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favourable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	6.1	4.8	22.8	8.6	26.6	16.3	9.1	17.1	19.6	9.0	14.0	21.8	9.7	28.1	8.5	12.3	7.5	10.8	12.4	32.4	26.3	9.2	19.5	5.5	10.8	13.4	15.1	20.4	12.3	28.8	9.3	5.7	66.4	21.3	14.8	12.5	9.9	21.8	10.2	19.5	9.3	25.9	8.0	11.1	16.1	26.9	21.6	22.9	11.9	14.9	4.8	12.2	8.7	7.1	7.2	4.4	8.7	6.3	12.6	5.5	2.7	0.0	4.9	1.4	0.0	4.7	1.8	0.1	0.5	2.1	2.1	1.4	4.9	0.7	8.5	0.8	2.0	2.5	7.2	1.1	0.4	0.0	0.7	14.7	0.1	20.5	4.8	3.5	0.2	3.0	3.7	0.2	0.0	4.6	0.7	16.5	0.2	0.5	19.8	5.9	0.1	7.9	15.5	0.5	30.5	3.1	3.9	3.5	0.1	0.9	1.9	13.7	9.5	7.8	0.7	0.0	0.0	0.0	0.2	11.5	0.7	0.0	0.2	21.2	5.5	6.3	3.7	8.7	5.5	6.3	4.5	5.2	3.7	4.8	4.4	7.2	3.2	4.9	0.8	12.6	4.1	2.8	3.2	2.7	22.8	26.6	17.1	19.6	26.3	9.2	15.1	20.4	21.3	22.9
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin, beta like 2"	Q562R1	5	57480016-57482809	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HaCaT: 1.7;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain						2600000000			"HPA041264: , HPA041271: "	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.8	0.0	0.0	1.2	0.1	0.1	3.4	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS14		ENSG00000138316	"ADAM metallopeptidase with thrombospondin type 1 motif 14"	Q8WXS8	10	70672803-70762441	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;gallbladder: 12.3;placenta: 13.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.2;K-562: 11.4;RH-30: 6.2;U-138 MG: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.4"	"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.84e-13)"	"unprognostic (3.90e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.16e-2)"	1.7	0.5	4.6	5.4	10.7	1.1	0.6	1.0	4.7	1.3	3.3	13.4	1.0	4.1	1.4	1.0	1.8	1.1	12.3	2.8	7.2	3.0	0.7	0.5	2.7	2.0	8.1	5.7	0.7	0.5	0.2	0.4	13.5	4.0	1.1	3.6	2.6	1.6	0.4	0.4	2.5	5.7	3.9	4.6	0.8	2.6	0.9	5.9	0.5	0.4	2.3	2.3	6.7	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	4.7	0.0	1.2	3.6	0.3	2.0	0.0	10.2	0.0	0.8	1.8	0.8	0.0	0.0	0.1	3.9	0.0	0.4	0.0	0.3	0.0	0.0	2.7	0.4	0.1	0.9	0.2	0.0	11.4	0.0	1.4	0.0	0.0	1.0	0.4	0.0	0.0	6.2	0.2	0.0	0.0	3.9	0.6	0.0	0.1	0.3	0.0	0.0	0.0	10.3	0.1	0.8	0.5	0.9	0.0	0.0	0.5	1.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	10.7	1.0	4.7	7.2	3.0	8.1	5.7	4.0	5.9
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917912-26966513	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.2;placenta: 20.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.3;ASC TERT1: 9.9;fHDF/TERT166: 9.3;RH-30: 24.7;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"		18000	Nucleoplasm		"CAB025996: , HPA005661: AB_1078101, HPA030906: , HPA030908: "	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.15e-1)"	14.1	0.4	1.0	1.6	0.6	0.0	21.2	2.5	0.9	5.5	2.3	0.4	7.2	0.3	10.7	8.2	1.2	3.3	1.0	6.9	1.0	0.0	1.6	0.8	1.2	0.4	1.1	0.4	14.9	0.4	0.1	0.4	20.9	1.5	2.2	0.8	2.3	1.8	9.7	11.0	3.3	2.4	6.2	1.1	6.4	1.8	2.3	0.4	0.6	5.3	1.5	0.6	2.8	3.1	0.0	0.2	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.3	9.9	0.0	1.2	0.2	1.4	0.5	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	2.0	0.0	0.9	0.0	0.3	0.0	2.4	0.0	0.0	5.4	0.0	0.9	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.0	0.0	24.7	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.3	1.3	0.5	0.0	0.0	0.0	8.9	0.1	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.6	2.5	0.9	1.0	0.0	1.1	0.4	1.5	0.4
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 8.7;HBEC3-KT: 13.9;hTCEpi: 21.6;RT4: 5.4;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria				Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.7	0.0	13.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.6	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0
ADM	AM	ENSG00000148926	Adrenomedullin	P35318	11	10304680-10307397	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 133.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 107.9;fHDF/TERT166: 53.9;HSkMC: 65.9;U-138 MG: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 62.3"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016075	Approved				"Secreted to blood"	31000	46000			"CAB016075: AB_628693"	"unprognostic (1.67e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavourable (7.56e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (9.70e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.62e-2)"	65.2	18.3	6.8	18.3	12.4	21.1	52.1	2.5	15.0	28.3	23.3	5.9	1.6	4.8	11.6	8.0	26.5	7.9	18.7	28.3	4.7	3.5	17.3	26.1	34.3	15.2	8.0	2.0	19.0	16.0	10.8	8.4	133.1	14.2	13.8	7.0	23.5	9.6	2.1	92.3	28.7	8.0	11.8	12.7	14.6	10.7	11.6	9.9	0.3	15.9	13.3	10.1	76.1	32.4	0.1	0.6	62.3	3.2	0.0	0.0	0.4	5.3	4.2	5.1	1.4	107.9	46.3	8.0	40.8	38.2	38.6	26.6	21.4	6.5	0.0	1.8	53.9	7.6	1.4	6.3	32.5	0.1	1.6	0.1	2.0	2.5	13.7	0.2	0.1	65.9	5.1	4.4	7.1	8.7	0.0	0.0	9.6	0.1	0.0	1.2	9.6	1.6	0.1	0.1	7.6	2.3	7.3	0.1	0.4	15.5	3.4	0.0	4.7	0.0	2.5	56.8	0.8	35.5	5.9	0.4	4.3	1.4	17.0	0.0	16.9	0.0	1.7	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	62.3	0.0	3.2	0.0	0.0	0.4	6.8	12.4	2.5	15.0	4.7	3.5	8.0	2.0	14.2	9.9
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114044056-114046908	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.0;placenta: 41.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.0;THP-1: 6.8;TIME: 8.7;U-937: 5.1"	"Cancer enriched"	"Detected in many"	10	"prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 10.0;basal ganglia: 7.3;cerebral cortex: 17.1;hippocampal formation: 11.3;thalamus: 6.9"	"Low region specificity"	"Detected in many"			HPA067972	Enhanced									"HPA067972: "	"unprognostic (1.45e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	4.3	1.0	6.9	1.1	14.0	1.3	5.9	1.0	10.7	0.8	3.1	0.8	0.0	1.8	0.9	0.9	1.9	0.8	0.9	48.0	5.6	2.4	1.7	2.5	18.3	0.9	3.5	4.4	0.8	2.4	0.9	1.2	41.7	2.6	6.5	1.6	4.5	10.7	0.8	3.1	0.9	2.3	0.9	1.3	1.7	1.4	1.0	2.5	0.0	1.0	0.0	1.1	1.1	0.4	1.4	1.9	0.1	1.3	0.0	0.5	0.1	2.0	1.2	0.2	1.3	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.5	1.6	0.3	0.4	0.0	0.4	0.1	0.1	0.3	10.0	0.6	0.4	0.2	0.2	0.0	0.4	0.7	0.0	1.1	0.0	2.0	0.2	0.1	0.1	0.2	1.2	1.6	1.4	0.4	3.9	0.3	0.4	0.1	0.0	1.7	0.2	0.3	0.0	0.8	0.1	0.3	6.8	8.7	0.3	0.1	0.2	0.2	0.0	0.1	0.5	0.0	5.1	0.2	0.0	1.3	0.0	0.5	0.9	0.0	0.6	0.1	0.3	1.9	1.4	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.1	6.9	14.0	1.0	10.7	5.6	2.4	3.5	4.4	2.6	2.5
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 121.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA069947: "	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.7	16.6	8.0	11.8	9.5	19.5	26.5	6.5	12.2	20.2	21.0	10.5	18.9	11.1	27.4	16.6	15.8	18.6	15.3	22.4	10.3	5.3	27.6	15.5	18.4	12.9	9.3	5.5	24.7	19.0	28.6	18.5	121.7	9.5	16.8	14.3	27.0	16.0	25.6	58.8	18.6	16.2	20.3	11.5	13.9	15.0	6.7	10.3	17.0	38.8	21.1	13.9	19.5	26.5	11.3	14.6	21.1	5.4	5.1	8.8	2.8	7.8	7.2	6.0	6.3	9.9	11.8	8.5	7.9	11.6	6.0	9.0	7.6	14.5	8.9	10.8	9.6	3.6	9.4	11.9	8.4	15.1	3.7	18.4	18.7	6.3	7.7	17.6	14.6	9.6	8.6	10.3	9.1	22.1	11.3	25.1	2.5	2.1	15.9	5.1	7.9	2.5	12.6	3.5	11.3	17.7	7.5	13.6	2.5	12.0	7.9	3.8	4.7	14.8	11.0	11.2	10.2	6.8	4.3	21.8	12.1	15.3	9.2	20.4	4.0	3.5	5.4	11.7	6.7	4.1	7.4	8.0	8.8	6.6	6.0	11.3	4.7	4.4	21.1	5.1	2.2	14.6	7.5	2.8	8.0	9.5	6.5	12.2	10.3	5.3	9.3	5.5	9.5	10.3
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500619-149000663	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved									"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	1.9	0.6	4.2	5.3	3.7	13.6	1.1	13.6	5.9	4.8	0.4	0.2	1.2	0.2	0.8	15.1	0.5	0.6	2.9	1.3	10.7	5.2	0.7	0.3	3.6	6.3	2.3	5.9	2.0	0.5	0.2	17.4	17.4	3.9	1.0	0.3	0.2	0.8	2.1	0.4	1.3	0.5	0.3	2.4	0.8	0.4	2.8	0.0	5.5	1.1	0.0	7.3	1.0	0.7	0.1	0.0	4.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	1.7	0.0	4.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	12.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	3.8	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.5	0.0	1.3	0.1	0.1	43.2	0.0	9.2	0.0	1.7	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	4.2	3.7	13.6	5.9	10.7	5.2	2.3	5.9	3.9	0.0
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 29.6;placenta: 44.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 62.9;ASC TERT1: 8.8;BJ hTERT+ SV40 Large T+: 12.0;HBF TERT88: 18.9;HSkMC: 11.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003596	Enhanced		Uncertain	Vesicles				Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	18.8	11.6	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.8	5.5			0.0	0.6	0.5	0.5	2.2	1.6	3.1	0.0	0.1	5.7	29.6	2.6	0.0	0.9		0.8	0.6	0.6	0.8	44.9		1.3	1.0		1.0	1.0	2.9	4.4	0.7	1.1	0.0	2.3	1.7	0.2			4.1		0.0	4.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	62.9	8.8	0.0	0.0	1.3	12.0	6.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	1.1	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.3;hTERT-HME1: 29.5;RT4: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	23.1	12.2	2.5	13.2	3.5	19.8	19.1	1.6	3.5	14.6	14.0	5.7	8.7	8.5	11.9	10.1	14.2	11.2	22.2	14.8	3.2	2.2	7.3	23.9	26.4	20.0	6.5	2.5	21.3	6.8	4.5	3.8	69.6	3.7	21.4	8.9	10.9	11.1	8.5	5.2	16.6	13.7	12.1	4.8	15.6	13.3	6.8	4.0	7.1	12.4	7.9	12.3	26.7	26.6	1.1	9.3	5.6	7.6	3.1	2.9	2.0	3.0	2.5	1.0	0.0	7.7	5.3	0.4	6.3	9.2	2.9	4.3	3.1	6.8	0.0	1.9	9.3	8.5	0.6	5.8	7.8	0.1	1.4	1.8	3.2	2.7	14.5	3.0	4.5	7.2	28.3	11.2	29.5	9.8	0.2	0.0	13.3	1.6	0.0	4.8	0.8	4.0	0.0	0.0	0.1	9.4	24.3	0.9	0.0	4.7	5.2	4.6	3.6	1.0	1.6	1.2	0.0	16.1	0.0	1.3	0.0	0.0	20.6	11.9	20.2	0.7	7.6	5.6	0.7	3.6	1.1	0.8	2.6	1.4	9.3	1.1	1.5	1.1	0.8	3.1	1.3	2.2	2.9	2.0	2.5	3.5	1.6	3.5	3.2	2.2	6.5	2.5	3.7	4.0
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.1;HDLM-2: 12.0;Hep G2: 10.5;SK-BR-3: 5.1;U-87 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: "	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (8.36e-4)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.1	0.1	0.0	0.6	0.5	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	12.0	0.0	0.1	0.1	10.5	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.2	3.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.5	5.1	0.0	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.5	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877004-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.8;prostate: 8.2"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 29.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.1	0.0	0.2	2.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0		3.9	0.0	1.5	0.1	0.0	2.2	0.7	0.0	0.0	0.0	7.8	0.0	8.2	0.0	0.0	1.9	0.0	0.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.6	0.6	2.5	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	2.5	0.3	0.0	0.6	0.2	0.0										
APLN	"apelin, XNPEP2"	ENSG00000171388	Apelin	Q9ULZ1	X	129645259-129654937	"Predicted secreted proteins"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;placenta: 52.0"	"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 104.4"	"Group enriched"	"Detected in all"	6	"glioma: 44.2;renal cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.50e-1)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavourable (9.32e-4)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (4.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.42e-2)"	3.8	9.7	10.0	2.8	8.0	0.7	2.3	2.0	10.9	0.9	1.2	21.8	0.0	1.5	1.4	1.0	1.3	0.9	1.1	8.3	9.7	10.3	5.2	1.0	13.6	0.8	13.9	7.6	12.5	0.9	0.9	4.3	52.0	14.5	1.5	1.0	0.0	1.3	1.2	2.9	1.2	1.0	2.5	19.3	1.1	1.1	1.6	10.7	0.0	1.6	0.2	0.9	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.2	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	1.6	0.0	1.5	0.0	104.4	0.0	0.4	0.5	0.0	0.0	0.1	0.3	5.6	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.1	17.7	0.4	0.0	7.6	0.4	0.1	0.0	0.0	7.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	8.0	2.0	8.1	9.7	10.3	13.9	7.6	14.5	10.7
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445134-74455009	"Cancer-related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 83.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 41.8;HBEC3-KT: 72.5;hTCEpi: 73.7;hTERT-HME1: 157.7;MCF7: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 11.6;NK-cells: 3.3"	"Region enriched"	"Detected in single"	4	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria				Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	19.5	1.1	0.4	9.2	2.1	28.9	20.3	0.3	0.4	5.7	6.7	0.2	0.2	0.7	1.7	1.6	22.3	6.0	34.8	13.6	0.5	0.4	2.5	1.7	14.4	13.3	0.4	0.0	5.8	1.0	0.0	7.8	83.5	1.3	1.9	5.0	1.4	3.9	0.9	9.9	3.4	10.0	1.5	1.0	11.3	5.3	4.6	0.0	1.6	1.2	13.4	13.6	8.7	4.6	0.4	0.8	11.6	0.0	3.3	0.4	0.1	1.7	11.9	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.3	41.8	6.7	0.0	0.9	0.0	1.9	0.0	72.5	0.7	0.0	0.0	0.0	0.3	1.9	22.5	0.2	0.0	0.6	73.7	4.3	157.7	0.0	0.1	0.0	1.6	45.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	4.1	0.3	0.0	0.0	2.4	0.1	0.0	1.3	0.0	0.1	0.0	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.2	0.0	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.4	0.2	0.0	0.1	3.3	0.0	0.1	0.0	0.1	0.4	2.1	0.3	0.4	0.5	0.4	0.4	0.0	1.3	0.0
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	"A6NI28, Q9H2Q1"	11	100687653-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 38.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.8;RH-30: 15.8;RT4: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: "	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	11.1	4.9	6.8	8.9	5.8	0.9	10.4	3.0	7.0	9.8	8.3	4.1	2.3	9.9	11.4	7.7	4.3	5.6	9.5	6.5	8.8	3.8	11.9	12.7	13.7	5.1	6.3	5.3	4.8	2.6	9.1	6.0	38.0	5.9	4.8	8.4	25.5	5.1	3.8	9.0	7.2	12.1	5.8	8.7	8.2	11.7	4.1	6.7	12.7	10.9	7.4	3.8	5.5	7.9	1.5	2.5	0.0	0.0	0.7	0.4	0.3	0.5	3.5	4.6	0.1	2.5	3.4	3.1	0.5	0.9	1.1	2.1	4.4	22.8	0.7	6.4	1.7	7.7	2.3	1.7	1.1	0.0	1.9	11.0	8.9	1.4	4.5	0.1	0.0	3.3	2.1	4.2	0.7	1.7	0.4	0.0	3.4	0.6	1.2	0.0	5.5	5.6	3.4	15.8	0.4	5.3	14.8	2.5	1.6	7.6	0.2	6.0	0.8	1.4	3.0	3.0	3.7	3.5	1.7	3.3	0.0	4.4	3.5	2.7	12.9	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.3	6.8	5.8	3.0	7.0	8.8	3.8	6.3	5.3	5.9	6.7
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 38.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 62.8;CACO-2: 21.2;K-562: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	4.0	2.3	1.7	6.2	2.3	11.5	4.4	4.8	3.8	3.6	5.0	1.6	3.3	4.2	2.9	2.9	4.1	2.7	3.2	2.1	2.2	1.5	4.4	2.6	6.1	7.8	2.8	2.0	1.6	5.5	3.4	4.1	38.3	2.1	2.3	1.8	2.6	2.8	5.6	2.0	3.3	5.0	2.6	2.4	8.3	3.4	17.8	2.5	6.6	2.1	2.1	4.6	4.0	6.9	1.5	9.2	6.4	2.9	1.9	0.5	0.8	1.1	1.4	5.2	1.3	2.2	1.6	62.8	4.9	3.2	2.6	1.8	21.2	0.1	0.4	1.1	1.6	0.4	2.1	1.1	1.1	6.5	1.5	2.1	1.8	19.0	0.9	7.2	5.4	2.4	1.6	1.6	0.4	0.9	27.3	6.1	0.7	1.6	2.8	8.3	5.0	0.3	6.3	1.6	4.0	0.3	1.0	2.5	4.8	1.5	1.3	0.9	2.2	19.5	1.4	1.7	2.4	2.5	0.5	14.3	12.7	3.7	1.1	4.3	1.2	0.8	2.4	1.6	0.5	2.1	0.5	1.5	0.3	0.4	1.5	0.9	0.5	0.2	6.4	1.9	2.9	9.2	0.3	0.8	1.7	2.3	4.8	3.8	2.2	1.5	2.8	2.0	2.1	2.5
ARL14EPL		ENSG00000268223	"ADP ribosylation factor like GTPase 14 effector protein like"	P0DKL9	5	116032324-116060118	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"placenta: 5.9"	"Cell line enriched"	"Detected in some"	30	"HDLM-2: 59.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.9;MAIT T-cell: 2.9;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	8	"monocytes: 1.9;T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"															"unprognostic (1.41e-1)"		"unprognostic (3.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.47e-3)"		"unprognostic (1.60e-2)"		"unprognostic (3.79e-2)"	"unprognostic (4.05e-2)"			"unprognostic (1.40e-1)"		"unprognostic (1.50e-1)"	"unprognostic (7.65e-2)"	0.8	0.2	0.1	1.3	1.0	2.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.5	0.0	0.1	0.2	0.6	0.1	1.4	1.6	1.1	0.0	0.6	0.0	0.0	1.1	5.9	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.5	0.0	0.5	0.8	0.1	1.8	0.8	0.0	0.1	0.0	1.5	2.3	0.0	0.0	0.0	0.3	1.9	0.0	2.9	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	2.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.2	1.1	0.0	1.4	0.8
ARSI	"FLJ16069, SPG66"	ENSG00000183876	"Arylsulfatase family member I"	Q5FYB1	5	150296343-150339307	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 9.3;HaCaT: 18.2;Hep G2: 11.2;hTEC/SVTERT24-B: 18.3;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA038386, HPA038398"	Uncertain		Approved	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"		"HPA038386: AB_10669781, HPA038398: "	"unprognostic (6.08e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.77e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.76e-1)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.39e-7)"	"unprognostic (7.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavourable (1.19e-4)"	2.0	0.5	2.1	4.3	2.0	0.9	0.5	0.7	2.0	4.9	2.1	0.6	0.3	1.0	5.0	1.2	4.2	3.6	2.2	2.4	1.7	1.1	1.4	0.8	6.2	0.4	2.5	1.0	3.3	0.8	0.0	1.8	24.2	2.0	5.5	0.8	6.9	0.8	1.5	1.4	9.2	1.0	5.6	6.6	1.2	1.6	1.1	1.0	0.8	0.6	9.2	1.6	5.2	4.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.6	0.0	0.0	0.5	0.0	4.6	7.0	9.3	6.8	0.6	1.0	0.0	1.8	6.6	18.2	0.1	3.0	3.3	0.0	0.0	0.0	0.2	11.2	0.9	0.0	0.0	0.5	2.0	18.3	0.5	0.1	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.8	0.5	0.7	0.0	0.0	0.0	0.1	6.2	0.2	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	2.0	0.7	2.0	1.7	1.1	2.5	1.0	2.0	1.0
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;HEL: 10.0;Hep G2: 6.0;HUVEC TERT2: 22.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in many"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	6.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0
ASCL2	"ASH2, bHLHa45, HASH2"	ENSG00000183734	"Achaete-scute family bHLH transcription factor 2"	Q99929	11	2268495-2270952	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.8;placenta: 16.0"	"Group enriched"	"Detected in some"	5	"BEWO: 18.7;NB-4: 5.5;SCLC-21H: 15.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 76.1;stomach cancer: 23.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.71e-3)"	"prognostic favourable (5.11e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.22e-2)"	"prognostic favourable (4.73e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.45e-6)"	"unprognostic (8.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.12e-4)"	"unprognostic (1.07e-3)"	0.5	0.3	0.7	2.2	1.3	0.9	1.1	0.0	1.2	2.7	7.3	1.4	21.8	9.2	3.6	1.2	2.5	0.7	0.4	0.8	0.6	0.4	2.5	1.1	0.9	0.9	1.5	0.6	0.4	1.5	0.0	0.1	16.0	1.1	3.3	3.4	0.1	9.7	9.5	0.6	10.0	7.3	0.2	3.7	3.0	2.8	1.6	1.1	1.1	0.7	0.8	2.7	3.6	3.3	0.1	1.0	8.6	2.0	0.0	3.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.4	15.3	0.0	0.0	0.3	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.5	1.4	8.6	3.0	2.0	0.2	0.1	0.7	1.7	1.0	0.0	0.2	1.7	1.2	0.0	1.7	0.0	0.0	0.3	0.7	1.3	0.0	1.2	0.6	0.4	1.5	0.6	1.1	1.1
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA050808: "	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.5	1.0	2.4	1.6	6.8	7.4	0.4	10.5	12.7	5.0	9.1	5.4	9.0	4.7	3.9	16.9	2.7	24.5	8.8	7.8	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.6	8.5	0.0	2.5	13.7	0.5	2.5	0.7	0.8	1.3	2.8	5.3	0.0	9.1	1.8	1.6	2.9	4.9	1.2	3.1	2.2	1.2	12.8	12.5	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	4.0	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3
ATP1A4	ATP1AL2	ENSG00000132681	"ATPase Na+/K+ transporting subunit alpha 4"	Q13733	1	160151570-160186977	"Enzymes, Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 13.1;seminal vesicle: 19.0;testis: 35.8"	"Group enriched"	"Detected in some"	11	"BEWO: 10.5;HDLM-2: 26.2;RT4: 31.7"	"Group enriched"	"Detected in some"	8	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.33e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.09e-2)"	"prognostic favourable (2.20e-4)"	0.4	0.3	0.4	0.8	0.3	0.0	2.2	0.4	0.3	0.3	0.3	0.0	11.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.3	0.2	0.2	0.3	3.8	0.3	0.0	0.2	0.2	0.0	0.3	13.1	0.0	0.6	0.0	0.4	1.2	19.0	3.2	0.3	0.5	1.6	0.3	1.1	0.3	35.8	0.0	0.9	0.2	0.2	1.6	8.9	5.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.0	0.0	0.0
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Group enriched"	"Detected in some"	8	"BEWO: 39.7;SK-BR-3: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria				Mitochondria		"HPA034734: , HPA067305: "	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.2	1.4	0.0	0.0	39.7	0.5	0.0	0.0	0.0	0.7	1.0	1.0	0.8	0.0	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	0.4	1.9	0.0	1.2	0.3	1.5	1.0	0.4	0.8	0.7	3.2	0.0	0.9	1.0	1.3	0.3	14.2	0.4	1.4	2.1	0.2	0.5	1.0	0.5	0.5	3.4	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813082	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.9;intestine: 61.6;placenta: 56.0"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;BEWO: 17.6;CAPAN-2: 47.7;EFO-21: 12.2;RT4: 17.1;SK-BR-3: 16.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"					"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.4	0.2	0.2	8.7	0.3	0.0	1.8	0.2	0.3	3.5	25.3	0.0	12.0	16.6	0.4	1.2	15.1	0.6	69.9	0.5	0.2	0.3	11.4	2.5	1.0	1.2	0.2	0.0	0.3	9.1	0.0	0.3	56.0	0.0	4.4	22.4	0.3	24.4	12.8	0.3	2.0	61.6	1.9	0.2	0.3	21.8	0.3	0.0	0.3	0.4	2.6	18.3	10.2	5.4	0.0	0.0	0.0	0.0	0.0	3.2	0.6	17.8	4.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.2	47.7	0.0	12.2	0.0	1.7	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	7.7	0.0	0.0	0.4	10.6	17.1	0.0	0.0	0.0	16.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavourable (8.41e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic unfavourable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.1	6.5	12.2	0.9	5.3	4.2	10.5	15.6	27.3	12.9	8.0	1.1	11.3	2.4	5.4	24.1	9.4	0.3	20.2	11.3	1.0	0.3	0.0	4.7	2.8	9.5	0.1	0.0	4.9	22.4	13.3	45.4	14.2	0.4	0.0	34.9	2.3	0.2	0.0	3.8	22.5	1.0	17.6	0.3	33.8	19.2	0.4	1.0	7.6	8.1	9.7	9.1	0.6	16.7	19.2	5.0	8.2	20.6	1.3	0.5	0.3	2.8	0.0	7.0	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: , HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Group enriched"	"Detected in some"	11	"AF22: 22.1;U-2 OS: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726797-7881422	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 57.6;Karpas-707: 29.9;SiHa: 25.1;TIME: 26.4"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	8	"basophil: 4.0;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	100000	21000	Mitochondria		"CAB002773: , HPA062683: "	"prognostic favourable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	10.5	1.5	1.7	1.3	2.8	0.0	7.7	0.2	1.1	2.5	2.7			1.9	2.1	0.0	1.5	1.1	1.6	3.8	1.7	1.4	6.6	1.4	5.8	0.7	2.2		5.8	0.1	0.0	2.8	17.4		1.5	2.2		1.1	2.2	1.4	1.7	2.0	2.0	1.9	3.4	3.4	1.5			0.5		1.8	2.9	1.7	0.3	0.4	4.0	0.0	0.0	0.2	2.1	0.3	0.9	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.4	0.1	0.4	0.0	0.0	0.0	2.0	5.5	8.5	0.5	0.3	0.3	5.8	0.0	0.0	0.2	1.0	57.6	0.0	29.9	0.0	0.1	0.0	0.0	0.3	4.1	0.2	0.0	5.2	0.1	0.0	4.3	0.0	25.1	0.0	0.0	0.0	0.0	26.4	0.0	1.6	0.1	0.8	3.8	13.1	0.0	0.9	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.0	2.1										
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 104.4;skeletal muscle: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	10.6	7.2	4.2	7.8	8.5	10.1	13.5	3.4	8.9	7.9	13.6	3.4	22.0	7.7	7.6	7.6	17.9	7.1	6.1	70.8	4.4	2.8	8.4	10.2	8.1	11.4	3.5	5.8	6.4	12.3	1.8	5.7	104.4	2.5	9.8	16.2	13.2	10.1	25.3	89.7	16.8	8.0	16.6	2.8	8.4	15.6	3.5	3.4	14.5	13.6	41.1	11.1	16.8	10.3	17.2	37.3	1.7	20.3	20.1	23.6	16.3	16.8	16.4	27.9	40.2	13.6	24.2	25.0	24.1	31.7	23.9	25.4	39.7	25.7	39.4	28.7	18.7	35.2	32.8	27.5	31.6	5.2	18.9	24.5	18.5	22.3	14.2	33.5	15.4	18.5	14.9	20.8	38.5	34.0	46.9	8.5	19.3	19.8	17.0	38.9	28.4	33.9	20.4	18.2	41.4	22.5	30.8	35.7	21.0	9.5	85.1	12.6	37.5	29.1	19.3	18.9	23.9	27.7	26.5	16.4	17.1	55.5	9.2	42.2	67.6	0.9	17.4	1.7	11.0	20.3	17.9	17.2	16.1	14.9	37.3	15.8	23.6	19.5	0.7	20.1	14.5	14.4	11.9	16.3	4.2	8.5	3.4	8.9	4.4	2.8	3.5	5.8	2.5	3.4
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.7;hTCEpi: 28.8;T-47d: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA049367: "	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.0	4.0	0.1	1.6	1.8	2.0	5.0	1.5	1.9	4.7	1.3	3.1	11.3	0.1	17.1	1.1	17.4	0.7	33.7	2.7	0.0	2.7	0.0	1.8	0.3	5.1	0.3	0.0	4.5	28.8	4.5	19.8	15.3	0.0	0.0	0.1	10.1	0.0	18.4	1.1	11.6	0.5	0.0	1.0	0.0	13.7	3.8	1.0	6.1	3.1	3.1	30.0	5.1	15.6	3.0	7.9	1.3	4.3	4.2	3.0	13.2	0.0	4.3	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5
C18orf54	"LAS2, MGC33382"	ENSG00000166845	"Chromosome 18 open reading frame 54"	Q8IYD9	18	54357917-54385218	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 21.4;testis: 25.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040704			Approved	Nucleoplasm	"Secreted in male reproductive system"			Nucleoplasm		"HPA040704: AB_10959454"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.60e-6)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.06e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.05e-2)"	2.9	1.3	2.8	4.8	7.7	2.0	2.1	4.5	4.3	4.1	2.4	3.8	1.0	1.3	3.6	1.1	2.0	1.9	2.1	2.0	3.3	2.2	1.6	0.9	2.5	4.0	10.0	3.4	2.5	1.1	1.9	1.0	21.4	5.7	1.8	2.3	0.7	1.4	1.6	1.0	1.8	2.0	2.7	5.8	4.3	1.5	25.2	6.7	9.3	1.9	1.2	4.0	2.1	3.2	1.4	0.6	1.9	4.1	0.8	2.1	0.6	5.8	3.4	14.4	6.8	3.6	6.2	4.8	9.6	4.1	9.7	12.4	2.1	3.1	4.3	2.7	3.1	6.2	10.0	5.3	12.7	14.2	3.1	4.2	3.6	3.7	0.8	4.7	4.5	2.1	1.1	13.1	6.1	11.5	4.3	9.3	13.8	1.8	5.2	2.9	7.1	6.6	3.9	10.6	2.9	4.7	4.0	8.0	4.5	3.9	1.7	2.1	2.5	4.1	10.4	18.0	7.9	3.0	5.2	5.6	6.3	6.3	4.7	8.1	12.6	1.9	0.7	0.3	1.3	0.8	1.2	0.9	1.1	0.9	0.6	1.4	1.0	1.2	0.0	0.8	4.1	0.3	2.1	0.6	2.8	7.7	4.5	4.3	3.3	2.2	10.0	3.4	5.7	6.7
C20orf202		ENSG00000215595	"Chromosome 20 open reading frame 202"	A1L168	20	1203454-1208274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 8.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;U-266/70: 3.0"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 2.0"					"Low region specificity"	"Detected in all"			HPA042786	Uncertain									"HPA042786: AB_10795760"	"unprognostic (8.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.82e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.24e-3)"	1.3	0.1	1.3	0.2	1.0	0.0	0.7	2.6	0.8	0.3	0.7			0.6	0.2	0.0	0.6	1.0	1.5	1.1	1.2	1.1	0.9	0.2	3.2	0.3	1.4		0.0	0.7	1.0	0.4	8.2		0.1	0.5		0.8	1.4	1.0	1.1	2.5	0.3	1.7	0.4	0.6	1.4			0.3		0.2	0.8	0.2	0.0	0.0	0.0	0.1	0.0	2.0	0.2	0.2	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	4.0	0.1	0.0	0.2	0.1	0.2	0.1	1.0	0.3	0.3	0.0	0.9	0.1	0.4	0.0	0.2	0.1	0.0	0.4	0.0	1.1	1.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.5	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	0.2	0.3	3.0	1.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.2										
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037490-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 22.5;placenta: 23.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;SH-SY5Y: 2.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	1.0	0.9	6.5	0.9	8.4	0.8	1.6	1.7	10.1	0.8	7.8	9.9	0.0	2.3	0.8	1.1	0.9	0.9	1.8	0.8	7.7	4.7	1.4	22.5	1.2	0.8	5.1	7.9	0.8	6.1	1.7	1.7	23.9	8.2	2.0	2.5	0.8	1.0	0.9	0.8	0.8	2.6	1.0	2.2	0.8	4.2	0.9	5.9	0.0	0.8	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.1	1.5	0.8	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.4	1.7	10.1	7.7	4.7	5.1	7.9	8.2	5.9
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453941-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 37.7;placenta: 38.3"	"Group enriched"	"Detected in some"	5	"RT4: 32.8;SK-BR-3: 13.1;T-47d: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 11.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: "	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favourable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	2.0	0.5	2.6	1.5	2.7	1.6	2.2	2.8	5.4	6.5	14.6	2.5	2.3	10.3	4.2	1.9	2.1	1.7	7.4	0.7	4.4	1.7	11.9	26.2	2.8	0.0	3.1	2.5	0.6	37.7	5.8	6.1	38.3	6.2	1.9	14.0	1.9	22.2	9.8	0.6	1.7	11.0	2.3	3.8	0.6	12.4	1.5	2.2	0.0	1.3	1.0	3.3	5.9	2.9	0.9	2.2	11.4	2.1	1.2	1.2	0.3	0.0	0.0	1.3	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	5.3	2.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.7	0.0	3.2	0.0	5.2	32.8	0.4	0.1	0.2	13.1	0.4	47.0	0.2	0.2	0.1	1.9	0.0	0.6	0.1	0.0	0.2	0.0	2.7	2.3	0.9	2.1	2.5	0.8	0.3	0.5	0.3	0.5	0.5	0.3	0.9	0.8	1.2	11.4	1.2	0.2	2.2	0.9	0.3	2.6	2.7	2.8	5.4	4.4	1.7	3.1	2.5	6.2	2.2
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.5;placenta: 43.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.3;HSkMC: 64.8;hTERT-HME1: 34.7;WM-115: 17.2"	"Cancer enhanced"	"Detected in many"		"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		790000	Cytosol		"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (5.75e-4)"	8.9	5.4	23.3	8.5	41.0	0.9	6.1	88.4	96.5	18.0	8.8	6.9	0.7	3.2	2.2	1.6	7.2	3.2	4.1	4.3	23.2	27.4	1.1	1.1	2.9	7.8	18.5	22.4	1.2	2.0	1.0	7.4	43.1	30.4	1.7	8.9	4.5	2.6	3.6	2.0	7.7	6.4	4.1	9.6	7.6	2.8	2.4	4.6	0.0	4.8	0.7	5.9	10.2	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.3	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	19.3	0.0	0.0	64.8	0.0	0.0	34.7	1.5	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	41.0	88.4	55.6	23.2	27.4	18.5	22.4	30.4	4.6
CCDC102B	"ACY1L, AN, C18orf14, FLJ23594, HsT1731"	ENSG00000150636	"Coiled-coil domain containing 102B"	Q68D86	18	68715209-69055189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 33.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.5;BJ hTERT+: 20.4;fHDF/TERT166: 18.3;HSkMC: 11.3;Karpas-707: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"					"Not detected"	"Not detected"			"HPA040623, HPA048194"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA040623: AB_10805715, HPA048194: "	"unprognostic (3.92e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.50e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.50e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (2.90e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.13e-3)"	8.7	4.2	6.4	4.7	7.1	1.3	4.4	3.2	8.0	4.2	4.8	4.9	2.9	2.3	4.0	6.4	4.7	2.9	16.9	4.7	6.0	5.4	5.9	3.3	16.4	11.5	7.0	5.0	3.3	3.1	3.2	5.0	33.7	8.7	4.0	6.1	4.0	3.2	2.2	2.1	2.9	3.9	6.4	9.3	3.3	4.7	4.3	7.0	1.7	6.8	5.0	2.9	16.9	4.0	0.9	11.5	0.4	0.3	1.3	2.6	0.3	0.0	0.0	2.9	0.2	2.6	10.5	0.1	0.5	20.4	0.2	0.3	0.1	0.2	0.1	0.4	18.3	0.2	0.1	0.2	0.3	0.8	0.2	0.6	0.0	0.9	5.1	0.1	0.3	11.3	0.4	0.3	2.5	0.1	0.0	7.2	1.7	0.0	0.4	0.2	0.6	0.3	0.9	0.2	0.3	0.1	0.0	1.2	1.1	0.1	0.0	0.0	0.2	0.9	2.8	0.4	0.2	0.1	0.2	3.1	0.2	0.5	1.5	1.2	1.8	0.0	0.1	0.4	1.4	0.3	1.3	0.6	0.8	1.1	0.3	0.9	2.6	1.6	0.0	1.3	0.2	11.5	0.3	0.3	6.4	7.1	3.2	8.0	6.0	5.4	7.0	5.0	8.7	7.0
CCDC194		ENSG00000269720	"Coiled-coil domain containing 194"	A0A1B0GVG4	19	17390509-17394158	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"ovary: 2.3;placenta: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.4;PC-3: 2.2;U-266/70: 2.2;U-266/84: 1.6"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.87e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.22e-14)"	"unprognostic (1.04e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.86e-2)"	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.1	0.0	0.4	0.2	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.8	0.7	0.9	0.8	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.6	1.4	0.8	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.4	2.2	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0										
CCL8	"HC14, MCP-2, SCYA8"	ENSG00000108700	"C-C motif chemokine ligand 8"	P80075	17	34319036-34321402	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 19.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;EFO-21: 4.0;HSkMC: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"classical monocyte: 5.8"	"Lineage enriched"	"Detected in single"	8	"monocytes: 5.8"					"Low region specificity"	"Detected in all"								"Secreted to blood"	29810					"unprognostic (7.51e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (1.05e-7)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.41e-2)"	10.6	2.8	1.0	7.2	1.2	0.2	4.4	0.6	1.6	0.8	12.0	1.4	1.1	6.9	3.4	3.8	1.2	2.9	3.7	2.4	0.8	0.7	2.8	2.1	8.4	1.3	0.8	0.9	5.3	0.8	6.0	1.6	19.7	1.1	1.5	8.0	5.0	1.1	2.9	1.5	1.3	13.1	4.1	2.4	3.1	1.9	1.6	0.2	2.1	3.0	4.0	2.7	4.4	0.8	0.7	0.2	0.0	5.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.0	1.9	0.0	1.8	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.2	0.6	1.6	0.8	0.7	0.8	0.9	1.1	0.2
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811898-29824308	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;placenta: 46.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3.0	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1.0	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3.0	1.7	4.6	2.0	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0.0	1.4	0.5	4.0	8.4	6.5	9.2	1.4	1.6	79.9	6.5	1.4	2.9	3.5	8.5	8.2	3.4	15.3	2.8	1.2	7.6	3.3	4.1	10.8	4.7	2.9	8.2	8.9	1.1	11.3	7.7	1.6	1.8	3.9	0.5	3.5	11.6	1.5	4.3	6.0	6.2	3.2	10.8	2.0	9.3	7.6	2.6	2.2	6.5	5.5	4.6	9.3	11.5	1.0	2.5	8.4	2.0	6.7	25.4	4.0	4.3	6.5	4.5	23.4	3.8	1.4	3.6	0.0	0.1	0.0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0.0	1.9	0.0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6
CCSAP	"C1orf96, CSAP, FLJ41471"	ENSG00000154429	"Centriole, cilia and spindle associated protein"	Q6IQ19	1	229321005-229343294	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.6;placenta: 28.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028402, HPA043443"	Enhanced									"HPA028402: AB_10603681, HPA043443: AB_2678485"	"unprognostic (4.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (4.50e-13)"	"unprognostic (9.67e-2)"	"unprognostic (4.93e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.03e-1)"	3.4	3.9	19.3	4.9	20.5	13.3	6.8	29.9	39.6	3.7	3.1	9.8	1.4	3.8	3.7	3.0	4.1	2.3	3.7	3.1	14.1	8.9	2.2	3.8	4.8	4.6	9.8	20.7	6.9	3.0	4.3	5.7	28.7	8.9	4.7	3.7	4.9	4.7	3.8	3.0	13.3	3.4	3.0	10.7	5.3	3.4	2.7	11.3	8.5	2.8	0.4	4.2	3.7	2.8	1.0	1.9	5.8	3.2	0.5	2.0	0.4	6.4	3.5	4.7	8.6	3.2	3.0	38.5	4.7	2.4	5.4	5.2	4.3	4.0	4.1	3.5	4.1	5.1	10.0	3.5	5.5	7.6	9.7	4.3	3.5	3.1	2.0	7.0	8.5	1.1	2.8	4.2	5.4	3.8	5.8	6.3	4.3	2.2	19.7	7.4	4.4	5.2	5.8	12.1	2.7	2.5	4.0	9.6	12.9	8.8	5.3	4.5	4.2	9.8	2.5	4.7	7.2	6.4	7.3	5.8	8.9	3.0	5.6	7.0	5.5	5.8	1.5	3.1	0.9	3.0	2.0	0.5	1.1	1.3	1.3	1.0	1.1	0.9	2.4	0.5	3.2	1.9	1.4	0.4	19.3	20.5	29.9	22.1	14.1	8.9	9.8	20.7	8.9	11.3
CD200	"MOX1, MOX2, MRC, OX-2"	ENSG00000091972	"CD200 molecule"	P41217	3	112332347-112362812	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 63.5"	"Cell line enhanced"	"Detected in some"		"AF22: 31.2;HHSteC: 11.5;NTERA-2: 19.5;REH: 16.7;SK-MEL-30: 11.5;WM-115: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"memory B-cell: 9.9;naive B-cell: 36.4"	"Lineage enriched"	"Detected in many"	25	"B-cells: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031149	Approved									"HPA031149: AB_10600694"	"unprognostic (1.84e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-3)"	"unprognostic (4.97e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.22e-2)"	12.8	9.5	18.1	10.9	34.3	1.8	7.1	20.9	38.3	16.0	4.5	11.0	1.5	2.6	21.4	5.7	7.0	20.3	10.1	5.8	17.3	42.4	4.9	1.0	7.2	17.7	12.7	19.3	9.3	3.8	10.9	27.9	63.5	19.6	9.7	6.5	7.5	5.4	13.0	1.4	2.8	4.3	13.9	8.4	4.4	3.4	2.3	6.7	12.7	12.4	1.6	17.6	13.9	3.9	36.4	1.1	1.2	0.1	0.6	1.4	1.3	0.0	0.0	31.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	3.3	0.1	0.1	0.1	0.3	0.0	0.1	0.2	11.5	0.0	0.0	0.2	0.1	0.6	0.0	4.4	0.0	0.3	0.0	0.0	0.4	0.1	19.5	0.0	16.7	0.0	0.2	0.2	0.0	8.2	9.6	0.0	0.1	11.5	0.0	0.1	0.0	0.1	1.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	34.0	1.2	0.1	0.1	0.1	0.0	1.4	9.9	0.8	0.2	0.5	36.4	0.9	0.5	0.7	0.6	0.1	1.1	0.4	1.3	18.1	34.3	20.9	38.3	17.3	42.4	12.7	19.3	19.6	6.7
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314487-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 66.6;ASC TERT1: 65.7;BJ hTERT+: 43.3;fHDF/TERT166: 58.0;HSkMC: 70.0;U-2197: 104.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 17.8"	"Lineage enriched"	"Detected in single"	122	"T-cells: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			27000000	"Plasma membrane"	Nucleoplasm	"HPA051856: "	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	59.2	3.5	0.8	14.4	2.5	0.0	55.2	0.6	2.2	21.2	7.6	1.9	6.3	2.7	14.1	22.9	14.8	17.7	12.3	18.2	1.2	0.5	5.3	1.7	9.3	16.2	1.3	1.6	15.6	4.9	1.4	2.3	71.0	2.1	10.6	2.7	11.5	4.6	8.0	6.7	13.3	7.5	27.6	1.2	1.9	7.5	8.0	0.7	4.1	9.4	6.6	4.5	19.5	17.6	0.1	0.0	0.0	0.0	0.0	17.8	1.9	0.0	0.0	0.6	0.0	66.6	65.7	0.0	28.8	43.3	2.1	2.0	0.0	0.0	0.0	0.7	58.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	13.2	0.0	0.0	70.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.3	0.0	0.1	2.8	17.8	0.0	0.0	0.0	0.0	0.0	1.9	0.8	2.5	0.6	2.2	1.2	0.5	1.3	1.6	2.1	0.7
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 23.9;placenta: 56.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4;HHSteC: 22.3;U-251 MG: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 8.4;T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB076385	Enhanced									"CAB076385: AB_2687655"	"prognostic favourable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favourable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	3.4	2.1	1.7	10.8	3.2	1.4	2.2	2.5	3.3	2.0	2.3	2.5	2.8	2.6	1.7	2.4	3.0	1.9	4.3	9.5	1.4	3.7	3.0	3.6	23.9	6.4	2.3	0.7	1.7	2.7	3.8	7.4	56.0	3.2	2.9	2.2	3.3	1.7	1.6	4.3	1.3	2.7	2.3	2.4	12.8	1.9	1.2	1.0	11.6	3.7	2.1	5.8	3.1	1.9	0.9	0.0	8.4	0.1	0.4	2.4	0.7	5.8	0.1	0.0	0.2	0.0	0.0	0.0	11.7	9.9	3.0	4.1	0.0	1.9	0.0	0.2	0.3	0.2	0.0	5.0	9.7	33.4	0.0	3.3	0.1	0.0	22.3	0.0	0.0	0.2	0.0	6.1	9.1	5.7	0.0	1.1	9.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.3	0.6	0.1	0.0	0.1	0.1	0.9	0.7	0.0	0.1	10.7	6.3	2.0	0.1	37.0	0.2	0.1	0.1	2.1	0.1	0.0	8.4	0.1	0.3	1.2	0.1	2.1	0.9	2.4	1.8	0.0	0.2	1.3	0.7	5.7	0.4	0.0	0.0	1.1	0.7	1.7	3.2	2.5	3.3	1.4	3.7	2.3	0.7	3.2	1.0
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736491	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 285.5"	"Cell line enhanced"	"Detected in many"		"TIME: 213.3;U-2197: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		98000000	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favourable (1.39e-10)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	96.7	41.0	36.7	26.3	44.3	23.8	76.0	25.9	32.7	44.8	36.9	24.0	57.9	16.5	45.4	132.8	68.4	53.2	67.6	90.5	35.6	38.4	100.0	61.0	86.4	39.8	39.7	25.8	39.3	52.3	60.6	48.0	285.5	68.7	47.4	37.7	51.4	114.8	62.6	70.6	43.4	25.0	52.4	32.9	26.2	54.7	28.1	23.1	16.1	85.9	57.7	40.0	51.2	63.4	13.5	20.5	42.8	4.8	17.7	60.4	11.1	16.5	15.5	4.6	13.5	107.8	84.5	2.7	94.2	105.1	23.6	27.7	7.2	49.8	1.2	16.8	101.4	18.7	8.5	93.9	33.2	26.3	12.9	1.7	54.9	10.8	29.4	9.9	5.7	39.2	23.8	20.0	96.4	144.0	11.6	38.3	148.6	15.1	4.6	4.1	2.5	80.9	1.7	14.4	13.3	71.3	28.3	3.2	4.3	32.8	15.2	17.3	11.6	1.0	213.3	54.3	13.0	176.7	32.6	17.0	33.2	1.6	46.7	0.0	94.3	30.5	4.8	42.8	11.3	1.6	14.4	13.5	24.0	12.7	20.5	10.6	15.7	9.3	28.4	17.7	0.9	10.5	60.4	11.1	36.7	44.3	25.9	32.7	35.6	38.4	39.7	25.8	68.7	23.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404786	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 96.6"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 111.2;TIME: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"			1000000000	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	48.7	5.6	4.0	6.2	5.8	0.6	28.1	2.6	4.8	11.1	6.6	3.4	5.5	3.7	18.7	11.2	8.4	7.2	12.6	21.7	4.5	4.3	7.8	12.7	43.7	9.7	6.5	2.8	7.7	3.6	5.0	3.5	96.6	7.6	9.0	4.8	8.5	5.2	4.4	19.0	7.0	6.8	12.1	5.4	10.8	5.7	6.7	3.3	1.2	16.6	15.7	4.5	11.7	11.3	0.0	0.6	0.4	0.8	0.1	0.1	1.1	0.0	0.0	0.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	95.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	1.1	4.0	5.8	2.6	4.8	4.5	4.3	6.5	2.8	7.6	3.3
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885773	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.3;placenta: 105.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 8.3;HeLa: 8.5;RPMI-8226: 11.2;SH-SY5Y: 22.8;SiHa: 15.9;SK-MEL-30: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 26.1;non-classical monocyte: 60.3"	"Lineage enriched"	"Detected in many"	12	"monocytes: 60.3"									HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	53.6	20.7	3.3	5.4	11.9	3.4	13.0	0.9	9.2	10.6	6.9	18.4	3.9	3.3	8.3	5.2	9.9	8.5	7.7	6.9	8.5	5.4	22.7	3.0	5.1	1.8	28.7	4.9	30.9	7.9	1.5	4.0	105.6	11.5	7.2	1.9	8.3	3.1	5.9	27.6	3.0	7.9	6.3	27.9	7.1	7.4	4.3	14.5	0.3	2.0	7.6	2.1	11.2	9.8	0.0	5.0	1.4	60.3	0.0	0.3	2.5	0.1	0.0	1.1	0.0	0.3	0.3	1.2	0.2	0.4	0.2	0.0	2.2	0.2	0.0	8.3	0.1	0.3	0.2	0.2	0.1	3.7	0.8	0.1	8.5	0.0	2.3	0.0	1.0	1.7	1.1	0.0	0.1	0.2	1.8	0.6	0.3	0.0	0.0	3.9	7.4	2.7	1.4	0.0	11.2	0.4	0.0	2.4	22.8	15.9	0.2	8.7	0.1	1.8	0.3	0.0	1.5	0.0	0.0	4.8	0.0	0.0	0.0	1.2	4.5	1.4	0.2	0.2	0.1	26.1	0.3	0.0	0.1	0.1	5.0	0.0	0.2	0.0	0.3	0.0	60.3	0.0	0.1	2.5	3.3	11.9	0.9	5.6	8.5	5.4	28.7	4.9	11.5	14.5
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115090-31120446	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"placenta: 19.2;skin 1: 109.3;tongue: 29.7"	"Cell line enriched"	"Detected in single"	7	"A-431: 5.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0"	"Low region specificity"	"Detected in some"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"					"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	29.7	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin beta subunit 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.7;placenta: 15.0"	"Cell line enriched"	"Detected in some"	20	"BEWO: 38.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9;testis cancer: 4.2"					"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: , HPA038934: "									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.2	0.0	6.7	15.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	1.9	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0										
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048902	Uncertain				"Secreted - unknown location"					"HPA048902: "	"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.7	3.4	11.7	5.9	6.1	8.2	7.8	6.8	6.0	8.2	8.4	2.9	2.2	6.7	4.0	11.2	7.7	7.7	8.6	9.1	7.4	3.9	13.3	3.9	3.5	7.6	20.1	13.7	7.5	7.3	7.1	6.5	9.7	4.8	68.3	6.2	2.4	2.7	13.8	13.4	2.5	6.2	11.7	9.9	5.7	5.5	2.0	11.0	7.1	3.5	12.3	4.0	24.9	8.1	13.5	7.7	6.3	14.2	12.1	28.0	3.9	10.4	19.1	10.0	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5
CLDN6		ENSG00000184697	"Claudin 6"	P56747	16	3014712-3020071	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 9.5;testis: 4.8"	"Group enriched"	"Detected in some"	6	"BEWO: 88.0;CACO-2: 23.9;NTERA-2: 81.0"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 25.8;ovarian cancer: 73.6;testis cancer: 112.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.59e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (2.42e-6)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.50e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.66e-4)"	"unprognostic (1.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (1.78e-4)"	0.1	0.9	0.5	0.1	3.7	0.5	0.1	2.5	1.0	0.1	0.6	0.1	0.1	0.5	0.4	0.1	0.1	0.4	0.7	0.2	0.7	0.8	0.2	0.1	0.9	0.1	0.7	0.1	0.1	3.3	0.0	1.2	9.5	1.5	0.1	0.4	0.1	0.1	0.1	0.6	0.0	0.4	0.1	0.3	0.2	0.4	4.8	0.1	1.3	0.2	0.1	0.1	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	88.0	0.0	0.0	0.0	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	81.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	3.7	2.5	1.0	0.7	0.8	0.7	0.1	1.5	0.1
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"				"Cell Junctions"	Vesicles	"HPA076613: "	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.5	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	19.1	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.2	0.1	15.0	0.1	0.7	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3
CLEC1A	"CLEC1, MGC34328"	ENSG00000150048	"C-type lectin domain family 1 member A"	Q8NC01	12	10069554-10111627	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.5;HUVEC TERT2: 15.6;U-266/70: 4.3;U-266/84: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.2;intermediate monocyte: 1.3;myeloid DC: 5.2;neutrophil: 2.8"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.2;granulocytes: 2.8;monocytes: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"														"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	27.4	2.1	1.6	4.9	3.0	0.5	14.0	1.2	1.9	9.7	3.1	1.2	2.4	1.4	16.1	6.0	4.3	4.2	4.9	4.8	2.0	1.8	3.6	2.5	19.9	4.5	3.1	0.6	4.9	4.1	1.0	2.6	40.8	3.4	5.2	2.0	2.3	2.0	2.3	4.8	2.9	3.0	7.6	3.5	5.8	2.6	3.3	1.7	20.4	5.6	3.6	3.0	6.4	12.3	0.2	5.2	2.8	2.2	0.2	0.1	0.5	0.0	0.0	0.3	0.2	0.2	0.1	18.5	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	15.6	0.0	1.5	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	4.3	9.3	0.0	0.2	0.0	0.0	0.2	2.2	0.1	0.0	1.3	0.1	0.1	0.0	0.0	5.2	0.2	0.1	0.0	2.8	0.2	0.5	0.2	0.0	0.5	1.6	3.0	1.2	1.9	2.0	1.8	3.1	0.6	3.4	1.7
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994635-136996803	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.5;esophagus: 74.1;placenta: 103.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;MCF7: 30.4;SK-BR-3: 12.7;T-47d: 29.0;TIME: 23.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 163.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 163.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA005963	Enhanced		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (7.74e-4)"	1.9	0.2	0.1	1.6	0.2	1.2	1.1	0.0	0.5	17.6	0.5	0.1	0.0	0.2	1.3	6.8	74.1	0.6	0.8	1.8	0.2	0.1	0.4	0.2	27.3	1.4	0.2	0.2	0.4	0.2	0.1	0.5	103.5	0.8	1.0	0.1	1.3	8.2	0.6	0.2	25.0	0.8	0.3	0.6	2.2	2.9	0.6	0.0	15.7	55.5	53.4	43.1	0.8	28.1	0.2	163.5	0.6	0.1	17.1	15.8	10.2	5.4	0.0	0.0	0.0	0.1	0.3	66.8	0.5	0.2	0.1	0.0	0.3	2.7	0.0	4.4	4.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.1	12.7	0.0	29.0	0.0	23.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	15.8	0.1	6.9	0.1	2.2	9.6	0.6	0.2	0.5	8.6	0.6	17.1	0.1	163.5	0.7	10.2	0.1	0.2	0.0	0.5	0.2	0.1	0.2	0.2	0.8	0.0
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 154.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.8;RPTEC TERT1: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 15.5;naive B-cell: 9.2;plasmacytoid DC: 5.5"	"Group enriched"	"Detected in many"	18	"B-cells: 15.5;dendritic cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"	14.3	35.7	3.3	4.1	4.0	1.1	9.3	1.4	4.0	8.1	7.0	3.3	17.7	4.3	5.3	11.2	16.3	2.9	9.7	3.7	4.1	3.2	35.6	43.4	10.8	4.7	4.5	2.9	7.1	23.4	4.9	8.9	154.2	5.2	11.9	3.1	8.8	8.0	22.6	2.6	8.2	5.8	9.7	3.9	4.6	12.6	3.0	2.6	1.2	7.6	9.6	6.9	13.0	11.1	15.5	5.5	0.0	0.0	0.5	0.0	0.3	4.6	1.1	2.9	0.0	3.3	0.6	5.3	15.8	6.4	2.7	2.6	3.9	2.0	0.4	3.1	1.4	17.0	11.8	9.9	2.8	1.3	4.5	4.4	4.6	15.9	4.8	0.0	0.0	0.8	9.2	0.4	13.0	9.9	0.0	28.8	3.4	5.2	0.1	0.0	1.4	5.3	0.6	11.4	4.7	29.1	16.1	6.5	2.5	6.9	6.7	2.2	5.0	0.0	4.2	5.1	4.3	2.0	3.6	10.8	4.0	1.5	2.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.0	5.5	0.0	0.3	3.3	4.0	1.4	4.0	4.1	3.2	4.5	2.9	5.2	2.6
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 38.3;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.6;HBF TERT88: 16.2;HSkMC: 48.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		270000	"Endoplasmic reticulum"		"HPA058335: "	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.3	0.0	1.5	2.0	0.0	13.5	5.1	7.7	28.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	48.2	0.0	0.3	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	2.7	0.0	0.0	2.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: "	"prognostic favourable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.7	0.0	55.3	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.1	0.0	98.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
COL4A1		ENSG00000187498	"Collagen type IV alpha 1 chain"	P02462	13	110148963-110307149	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 163.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 72.8;EFO-21: 124.5;TIME: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.1"	"Low region specificity"	"Detected in many"							CAB001695	Approved				"Secreted to extracellular matrix"		55000			"CAB001695: "	"unprognostic (3.82e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.47e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-2)"	86.0	10.0	1.6	23.5	3.0	0.2	65.2	1.5	2.0	20.5	27.7	1.6	14.3	4.4	52.3	21.8	20.6	18.8	38.8	29.2	2.5	1.5	21.1	5.7	37.3	28.9	2.6	1.0	20.0	8.5	9.1	3.9	163.4	5.0	24.6	5.9	7.6	5.9	17.3	24.6	6.9	11.6	58.1	4.1	60.5	16.0	8.7	1.1	3.1	16.5	9.0	3.8	47.0	24.5	0.0	0.4	1.1	0.1	0.0	0.0	0.0	5.0	2.0	26.3	0.0	72.8	19.5	37.1	33.2	7.9	18.3	9.0	0.5	0.0	0.0	124.5	6.1	3.5	0.0	7.5	4.1	0.1	3.8	0.0	3.9	0.0	20.5	0.0	0.0	7.1	1.1	18.1	8.2	28.0	0.0	0.0	4.0	0.0	0.0	0.0	3.7	0.4	0.0	7.8	0.0	39.2	0.0	0.1	3.6	0.0	0.0	7.3	0.0	1.7	44.2	5.4	16.4	0.1	12.6	0.0	0.1	0.2	0.0	0.0	39.5	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	3.0	1.5	2.0	2.5	1.5	2.6	1.0	5.0	1.1
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513027	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 125.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 142.4;WM-115: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010751, HPA029118"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"		1900000	Vesicles		"CAB010751: AB_476828, HPA029118: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (9.25e-4)"	87.2	9.5	4.6	26.1	3.3	0.1	50.1	2.0	3.0	37.2	53.1	1.9	30.3	7.6	48.4	25.5	23.0	26.3	52.4	26.6	3.6	1.4	18.4	5.7	35.9	17.5	3.8	1.7	25.7	8.3	7.3	3.8	125.7	5.0	26.9	5.5	12.2	7.6	29.3	26.3	9.2	16.9	84.1	2.8	58.5	23.4	11.0	1.9	4.2	16.0	8.0	5.7	65.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.4	6.5	29.5	0.0	38.5	16.0	46.5	40.1	14.5	23.9	11.2	0.7	0.0	0.0	142.4	9.3	11.2	0.0	12.0	4.6	1.5	6.1	0.0	11.0	0.3	28.4	0.0	0.1	7.2	0.7	16.7	11.5	24.9	0.0	0.0	3.9	0.2	0.0	1.0	4.6	2.3	0.0	12.2	0.0	26.3	0.2	0.9	4.8	0.0	0.1	12.5	0.0	0.5	42.8	13.1	33.4	0.3	21.7	0.0	0.2	0.5	0.3	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	3.3	2.0	3.0	3.6	1.4	3.8	1.7	5.0	1.9
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637888-31645006	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.7"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	11	"B-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favourable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	9.9	0.7	1.6	1.7	1.9	0.1	7.9	0.7	2.5	4.7	2.2	1.5	0.9	1.1	5.9	3.5	7.1	2.6	5.4	15.5	1.7	1.4	2.0	0.5	24.6	4.9	2.4	1.0	1.9	1.9	2.1	1.1	60.7	2.7	5.2	1.6	4.1	2.4	2.8	12.8	2.5	2.7	3.9	1.2	0.8	2.0	1.5	2.1	0.5	8.0	7.5	2.3	3.7	3.7	2.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.7	2.5	1.7	1.4	2.4	1.0	2.7	2.1
CPXM1	"CPX-1, CPX1, CPXM"	ENSG00000088882	"Carboxypeptidase X, M14 family member 1"	Q96SM3	20	2794069-2800637	"Enzymes, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.3"	"Cell line enhanced"	"Detected in some"		"AF22: 45.0;HSkMC: 24.4;NB-4: 39.4;REH: 40.2;SH-SY5Y: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	26	"B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (7.48e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (9.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (4.62e-10)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.27e-2)"	24.0	2.4	0.5	4.6	1.1	5.6	14.9	0.9	3.7	32.2	7.4	1.3	7.6	0.2	43.6	41.4	1.4	13.6	31.1	14.4	0.5	0.2	4.3	0.6	2.7	1.9	2.1	0.6	20.7	1.7	0.6	2.7	60.3	2.4	8.5	0.2	16.2	2.7	5.3	2.2	5.8	1.4	14.5	1.4	0.5	1.0	10.1	0.3	15.2	8.8	0.7	1.5	23.0	15.2	2.3	1.4	0.0	0.0	3.9	0.0	0.7	0.0	0.0	45.0	0.0	0.0	1.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.1	0.2	2.3	5.9	0.0	0.0	0.6	0.0	0.9	24.4	0.0	2.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	39.4	9.5	0.0	40.2	0.0	1.1	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.0	1.1	0.0	0.7	0.5	1.1	0.9	1.1	0.5	0.2	2.1	0.6	2.4	0.3
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002067	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"				"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: "	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	14.9	19.8	4.7	17.1	9.8	10.8	15.7	1.9	6.0	25.4	16.7	11.4	18.7	11.6	28.2	25.5	12.8	16.2	16.2	20.4	5.6	4.3	17.0	11.7	14.6	15.2	11.8	3.7	25.9	16.0	38.4	28.8	81.6	9.8	15.9	9.5	24.9	26.5	23.3	5.0	6.9	17.5	17.7	6.2	12.1	14.1	9.8	9.1	7.0	35.8	10.9	18.1	21.3	15.7	4.6	12.4	7.4	5.6	6.5	11.8	3.2	4.0	6.2	11.8	0.2	20.2	20.1	8.9	20.0	32.5	14.1	14.2	8.5	3.6	0.8	5.4	21.7	2.1	6.9	14.7	27.6	5.8	3.4	25.3	8.5	20.2	13.4	7.6	36.3	8.3	9.4	17.7	20.8	18.5	13.0	11.8	16.4	7.2	2.4	9.4	4.2	4.4	5.3	6.4	6.7	11.0	4.1	3.0	7.1	6.5	16.9	8.9	2.4	5.7	19.7	18.9	2.9	22.7	7.3	14.0	4.8	5.3	22.7	21.5	41.9	7.4	5.6	5.9	8.2	2.9	10.6	4.0	6.0	8.6	5.8	4.6	2.2	3.8	2.1	6.5	1.5	12.4	11.8	3.2	4.7	9.8	1.9	6.0	5.6	4.3	11.8	3.7	9.8	9.1
CRIM1	S52	ENSG00000150938	"Cysteine rich transmembrane BMP regulator 1"	Q9NZV1	2	36355926-36551135	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 116.2"	"Cell line enhanced"	"Detected in many"		"BJ: 67.0;fHDF/TERT166: 66.1;TIME: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000556	Enhanced				"Intracellular and membrane"		120000			"HPA000556: AB_1078567"	"unprognostic (2.15e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (9.51e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.67e-2)"	42.4	6.0	9.1	8.7	11.0	1.1	44.6	6.1	9.0	13.8	13.1	6.4	10.2	5.7	14.9	9.8	12.4	14.2	17.3	32.2	8.6	8.7	28.6	6.2	24.7	13.2	7.6	10.2	15.5	9.2	18.0	4.3	116.2	12.0	14.9	9.4	24.7	13.1	13.8	25.9	13.7	9.0	23.1	10.8	17.5	10.2	8.1	6.2	3.0	18.1	7.9	4.5	16.9	22.3	0.8	5.5	3.4	1.4	1.1	1.6	0.2	14.0	10.7	2.2	2.5	10.4	11.8	18.3	67.0	35.5	37.6	19.8	13.5	4.9	0.0	43.7	66.1	6.1	1.6	10.8	30.8	0.1	1.2	0.4	14.4	7.8	33.5	0.3	0.1	16.5	8.1	15.0	27.1	52.6	0.6	0.1	39.5	1.2	0.0	0.1	1.7	3.2	0.7	2.8	2.1	23.7	5.8	0.2	0.0	11.7	3.8	0.4	10.5	0.2	93.2	47.6	17.1	5.9	32.4	3.7	0.0	0.1	14.0	0.0	14.5	3.4	0.4	1.2	1.6	0.2	1.2	0.6	0.7	0.9	0.3	0.8	0.2	1.0	0.5	1.1	1.4	5.5	0.5	0.2	9.1	11.0	6.1	9.0	8.6	8.7	7.6	10.2	12.0	6.2
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.7;HBEC3-KT: 39.6;hTERT-HME1: 30.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Not detected"	"Not detected"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: , HPA030949: "	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.4	0.0	0.0	0.0	8.8	31.7	3.2	1.5	11.6	3.4	3.2	0.7	3.7	16.4	0.7	7.2	16.9	0.1	39.6	1.6	22.3	0.7	0.0	0.4	5.1	4.2	10.0	0.0	15.8	23.1	6.4	30.7	14.4	0.5	2.3	9.1	1.2	2.8	4.0	0.1	6.9	4.9	0.1	0.1	5.3	24.9	0.7	0.0	6.4	11.0	0.1	5.4	7.6	4.2	3.8	0.5	0.0	10.5	1.8	1.4	17.9	18.1	12.6	8.2	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.9;placenta: 55.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.0;BEWO: 15.1;CACO-2: 24.6;CAPAN-2: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm				Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	8.0	4.4	0.0	0.0	4.9	0.9	0.6	43.9	0.2	2.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	55.0	0.0	0.8	1.4	0.1	5.1	0.0	0.0	13.8	10.4	0.0	0.0	0.0	0.9	1.2	0.0	0.1	0.0	22.0	19.8	4.9	16.1	0.7	0.0	2.4	0.1	0.2	1.7	0.3	7.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	24.6	16.5	0.1	5.0	0.0	6.1	0.0	4.4	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.0	0.0	2.9	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.5	0.7	1.7	0.7	0.0	0.6	0.5	0.5	2.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor alpha subunit"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;placenta: 79.5"	"Group enriched"	"Detected in some"	7	"BEWO: 59.0;HMC-1: 17.7;SK-MEL-30: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5"	"Group enriched"	"Detected in many"	28	"dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0"									CAB016148	Uncertain				"Secreted to blood"		9400000			"CAB016148: AB_626868"	"unprognostic (4.19e-2)"	"prognostic favourable (2.38e-5)"	"unprognostic (5.47e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.88e-2)"	"prognostic favourable (2.81e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.48e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavourable (5.53e-4)"	"unprognostic (3.60e-1)"	"unprognostic (9.44e-2)"	8.7	2.3	11.8	11.1	11.1	8.9	17.7	3.4	9.6	3.1	2.2	0.6	0.6	2.2	4.4	0.6	2.1	2.2	5.7	3.7	15.0	4.7	2.4	1.7	11.2	8.3	18.8	6.5	3.5	1.0	0.2	2.1	79.5	13.2	1.5	3.3	0.6	3.1	1.0	0.6	1.8	3.3	2.9	25.5	12.6	1.7	0.6	16.3	0.6	2.5	0.6	10.4	4.2	1.5	0.3	31.9	60.2	30.0	1.4	0.2	10.1	0.1	3.4	0.2	0.0	0.0	0.0	59.0	0.0	0.1	0.1	0.0	1.2	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.4	0.0	0.0	1.3	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	5.4	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	41.3	2.7	4.9	0.0	0.0	1.7	0.3	0.0	0.1	0.1	0.1	0.0	5.3	0.0	2.4	30.0	36.0	0.0	17.7	0.2	0.3	0.0	0.0	31.9	0.1	0.0	0.0	60.2	1.4	8.4	30.5	0.1	10.1	11.8	11.1	3.4	9.6	15.0	4.7	18.8	6.5	13.2	16.3
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor beta common subunit"	P32927	22	36913628-36940449	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.1;placenta: 73.6"	"Group enriched"	"Detected in some"	6	"HEL: 26.3;HMC-1: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.1;neutrophil: 20.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 53.1"					"Low region specificity"	"Detected in all"			HPA078677			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA078677: "	"unprognostic (1.67e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (7.47e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (5.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.52e-2)"	8.5	1.8	1.5	28.9	1.5	21.7	6.0	0.6	1.0	3.0	5.9	2.0	0.4	4.5	2.2	2.8	4.0	3.6	5.5	4.2	1.4	1.4	2.4	3.5	12.6	34.1	2.9	0.2	2.5	1.9	0.3	1.2	73.6	2.4	3.5	3.8	2.8	9.7	1.0	2.6	3.8	10.2	3.0	2.9	25.2	3.9	2.1	1.9	8.2	3.4	4.8	30.5	8.2	4.3	0.4	3.8	53.1	2.1	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	26.3	0.0	0.0	0.0	0.4	82.6	0.0	0.0	0.0	0.0	4.6	0.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	2.6	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.4	0.2	1.6	0.0	3.8	0.0	53.1	1.9	5.8	0.0	2.1	0.0	0.4	0.0	0.0	1.2	0.3	0.0	0.0	20.1	0.0	1.7	3.8	0.6	1.8	1.5	1.5	0.6	1.0	1.4	1.4	2.9	0.2	2.4	1.9
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87725519-87731393	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 237.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 198.5;HSkMC: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 31.0;non-classical monocyte: 44.3"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.3"									"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		17000000	"Golgi apparatus"	Vesicles	"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavourable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	60.3	21.5	10.4	27.2	24.6	18.4	23.3	6.9	12.3	14.8	23.2	14.1	13.7	9.0	24.1	22.3	11.4	25.7	20.7	37.7	10.7	11.4	65.4	98.0	53.1	80.5	18.9	7.7	25.0	14.3	18.8	18.0	237.0	18.4	19.4	13.0	23.2	22.0	23.5	29.3	9.1	12.0	36.6	16.1	108.1	17.5	14.1	15.7	6.8	19.2	9.4	10.1	41.3	26.5	0.0	1.7	0.1	44.3	0.0	4.3	2.4	6.3	36.8	2.5	4.3	46.3	198.5	15.4	20.5	59.7	17.6	22.1	3.5	5.9	0.0	9.6	26.5	5.4	3.3	6.6	14.5	0.1	3.2	1.1	10.4	8.6	30.0	0.0	4.4	91.8	11.2	28.8	11.2	13.8	11.9	0.0	25.3	10.6	0.0	0.7	4.9	7.0	1.5	1.5	0.0	12.3	3.3	3.7	4.5	4.3	9.6	23.5	1.1	7.3	21.7	15.8	8.6	57.5	8.6	1.6	5.9	0.0	57.8	0.0	5.2	0.1	3.5	0.1	0.0	31.0	0.0	0.0	1.8	0.0	1.7	0.0	4.3	0.3	0.1	0.0	44.3	0.1	0.3	2.4	10.4	24.6	6.9	11.7	10.7	11.4	18.9	7.7	18.4	15.7
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4"	"Cell line enriched"	"Detected in single"	77	"HDLM-2: 43.7"	"Group enriched"	"Detected in many"	6	"melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 37.2"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 37.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046528	Uncertain									"HPA046528: "	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.0	11.4	3.4	3.9	4.2	0.7	1.0	1.6	8.0	0.9	1.0	1.1	25.1	2.1	1.3	1.7	0.7	3.4	1.6	11.5	4.1	3.4	1.8	1.0	1.5	4.4	3.3	1.5	5.4	0.5	0.7	2.3	22.6	3.7	3.4	1.1	2.9	0.7	22.4	0.5	1.3	2.5	0.7	2.3	6.9	1.1	1.0	2.9	1.0	1.1	0.5	1.5	1.0	1.2	0.0	0.9	37.2	3.2	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.0	37.2	0.2	3.2	0.0	0.0	0.4	0.0	0.9	0.0	0.5	0.1	0.1	0.4	2.0	0.0	0.3	0.4	3.4	4.2	1.6	8.0	4.1	3.4	3.3	1.5	3.7	2.9
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.6"	"Cell line enhanced"	"Detected in many"		"WM-115: 35.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (2.63e-5)"	24.0	9.1	10.9	6.6	14.4	6.1	22.0	14.2	17.6	10.4	16.4	7.0	5.7	15.1	13.0	8.1	13.4	12.6	13.9	21.1	11.4	7.2	8.8	3.0	14.0	5.4	9.4	10.7	11.0	6.6	9.4	7.1	66.6	9.4	6.8	6.7	17.8	8.6	8.7	12.3	15.6	18.5	15.2	8.5	7.5	9.2	26.0	6.5	2.9	20.4	10.8	5.0	7.7	16.5	0.6	1.8	0.7	0.4	3.3	5.9	0.4	21.2	5.4	5.1	3.5	24.1	28.5	7.3	12.6	11.0	12.5	11.9	8.3	10.6	2.9	7.7	25.4	20.1	3.5	9.1	8.3	0.2	5.1	0.8	6.4	1.0	11.5	0.8	1.3	20.1	4.2	6.6	9.6	2.1	3.3	0.4	9.1	3.5	0.7	3.8	3.6	7.3	3.8	13.8	1.6	9.6	2.6	3.3	6.4	7.8	27.4	22.1	1.6	6.0	7.8	8.6	22.8	9.2	7.7	1.0	0.3	3.0	2.7	2.3	35.0	0.7	0.4	0.0	2.2	0.2	5.9	0.3	1.0	2.4	0.4	0.6	0.1	1.5	0.3	3.3	0.4	1.8	0.8	0.4	10.9	14.4	14.2	17.6	11.4	7.2	9.4	10.7	9.4	6.5
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HUVEC TERT2: 33.5;NB-4: 81.5;WM-115: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: "	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (7.43e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	33.5	0.0	1.7	0.0	0.0	0.0	81.5	0.1	0.0	1.2	1.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.1	0.0	0.0	11.4	0.0	7.9	0.0	0.0	0.2	0.0	0.0	0.0	1.0	19.7	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4
DAB2	DOC-2	ENSG00000153071	"DAB2, clathrin adaptor protein"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 194.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.2;ASC TERT1: 45.4;fHDF/TERT166: 65.6;TIME: 39.5;U-138 MG: 46.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"plasmacytoid DC: 26.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: "	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	51.6	44.2	2.6	12.2	3.5	0.6	21.8	6.1	2.6	16.6	14.0	4.1	4.5	3.3	16.6	34.8	10.8	9.6	13.3	25.1	2.9	3.0	75.2	6.9	22.4	31.8	4.0	2.1	12.7	11.3	3.2	3.9	194.4	4.7	11.6	14.6	14.6	12.9	5.3	12.7	9.3	10.4	16.0	5.2	21.1	7.2	8.7	2.5	7.3	10.9	8.4	7.4	17.8	14.7	0.1	26.6	2.2	2.5	0.9	1.3	7.0	0.0	1.5	2.4	5.3	42.2	45.4	3.0	27.2	27.9	10.7	17.7	19.9	0.0	0.0	1.7	65.6	0.0	0.3	0.9	15.1	0.0	0.8	3.6	36.2	6.5	10.2	0.0	4.7	28.2	0.0	17.5	3.1	32.2	0.0	0.9	17.7	0.1	0.3	0.0	1.6	3.0	0.9	6.2	0.0	7.1	0.5	0.0	0.0	3.2	1.7	15.2	0.1	0.9	39.5	46.0	5.1	5.3	2.2	0.0	0.0	0.0	16.0	3.4	5.9	2.2	1.2	0.2	1.3	2.5	0.0	0.1	0.2	0.7	3.4	0.1	0.1	1.0	1.8	0.9	0.6	26.6	0.2	7.0	2.6	3.5	6.1	2.6	2.9	3.0	4.0	2.1	4.7	2.5
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 94.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 38.7;HUVEC TERT2: 21.9;RPTEC TERT1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	55	"dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome				Centrosome		"CAB037302: AB_1078622, HPA040472: , HPA048436: "	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11.0	8.1	4.8	16.4	15.0	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0.0	18.2	8.8	6.1	0.2	0.1	14.0	1.2	1.7	7.2	8.1	2.6	0.1	0.1	1.8	0.3	17.0	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.8	0.0	38.7	0.5	2.9	1.3	0.5	21.9	6.6	3.7	6.0	0.5	2.6	0.0	9.9	0.0	0.7	7.8	0.0	20.0	18.2	4.0	4.5	0.0	1.8	7.7	0.0	5.8	0.1	0.0	0.1	0.0	0.0	14.6	3.0	0.0	0.1	2.4	1.2	1.3	5.3	6.9	0.0	11.9	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	1.6	0.1	11.7	5.3	0.0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6;placenta: 71.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: "	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.42e-4)"	"prognostic unfavourable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (3.08e-4)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.6	0.6	0.6	3.7	1.5	7.9	0.6	0.8	1.4	1.2	3.3	0.6	0.1	4.8	0.9	0.5	5.2	0.4	19.0	0.4	0.8	0.8	3.3	0.9	1.0	6.9	2.3	0.7	0.6	0.5	0.0	0.3	71.5	1.4	0.5	4.6	0.4	1.3	0.1	0.2	2.1	5.1	0.5	3.2	3.3	2.0	17.0	1.2	21.6	1.5	2.3	7.6	0.9	2.2	1.0	0.6	3.3	0.3	1.4	6.4	0.9	23.7	8.1	24.7	15.1	0.5	0.8	27.1	6.4	4.4	11.4	14.8	13.4	15.1	13.6	15.9	1.9	8.0	19.8	14.5	15.3	19.3	14.3	16.9	9.3	16.7	0.4	14.2	16.6	0.5	1.5	3.7	5.3	10.5	12.1	18.6	10.0	14.9	23.0	12.4	18.2	13.2	25.6	20.1	11.6	9.2	11.9	13.8	6.3	15.1	5.4	7.1	10.1	11.3	4.8	4.8	14.3	3.9	16.3	9.4	16.5	26.8	6.0	21.0	13.4	3.3	0.3	1.7	0.5	0.0	0.4	1.0	2.2	1.5	0.6	0.1	0.3	0.3	0.0	1.4	0.0	0.1	6.4	0.9	0.6	1.5	0.8	1.4	0.8	0.8	2.3	0.7	1.4	1.2
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 40.9;placenta: 17.6"	"Cell line enriched"	"Detected in single"	39	"AF22: 34.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 8.1"												"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	4.5	0.2	0.2	1.7	1.8	0.0	3.5	0.1	0.8	40.9	1.6	0.1	1.0	0.0	3.4	2.2	1.9	3.5	2.9	1.6	0.7	0.0	0.9	2.7	1.4	7.1	0.1	0.1	9.2	4.1	0.0	0.6	17.6	0.3	1.6	0.4	12.6	0.8	2.5	2.2	1.9	0.7	0.9	0.1	2.5	0.7	1.0	0.1	0.1	3.6	1.1	0.4	6.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.1	0.6	0.7	0.0	0.1	0.1	0.3	0.1
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 14.7;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.9;CACO-2: 13.3;HAP1: 9.1;K-562: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA059933: "	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.4	0.3	0.2	1.2	0.7	0.4	0.7	0.3	0.8	0.8	0.6	0.8	0.2	0.2	0.2	0.6	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.5	0.2	0.2	0.2	0.7	0.1	0.2	14.7	1.4	0.5	0.3	0.5	2.7	0.6	0.2	6.0	1.5	0.2	0.2	0.8	0.3	0.5	0.2	0.2	0.6	3.8	1.2	0.4	0.8	0.1	0.9	0.0	1.3	1.0	0.8	0.3	0.4	1.1	0.0	0.1	0.1	0.0	18.9	0.1	0.1	0.0	0.3	13.3	0.8	0.5	2.7	0.2	1.8	9.1	0.3	0.0	3.6	4.8	0.3	4.5	1.4	0.0	0.7	3.1	0.0	2.3	0.1	0.0	0.0	10.5	0.0	0.0	2.3	0.3	4.7	0.2	0.0	0.0	4.3	0.4	0.1	0.7	1.5	0.0	0.3	1.6	0.8	3.3	3.2	0.0	0.0	0.9	0.2	0.0	0.8	0.1	0.0	0.4	2.5	0.0	0.0	0.3	0.0	0.8	1.3	0.0	0.0	0.0	0.4	0.7	0.1	0.2	0.0	0.0	1.0	1.3	0.9	0.0	0.3	0.2	0.7	0.3	0.8	0.2	0.2	0.2	0.2	1.4	0.2
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020392-97024950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6"	"Group enriched"	"Detected in some"	5	"BEWO: 32.5;HAP1: 16.3"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory region: 36.5"	"Region enhanced"	"Detected in many"		"olfactory region: 24.3"	HPA005670	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.6	2.7	0.5	11.5	0.3	1.5	0.1	3.9	10.0	0.6	0.3	1.4	0.7	17.7	1.7	5.8	2.0	0.8	1.2	2.2	4.5	0.4	0.2	0.4	1.9	0.5	2.5	2.1	0.2	0.4	1.9	44.5	0.0	1.8	0.3	0.1	3.6	3.9	0.6	20.6	0.3	1.4	0.2	0.3	0.3	1.2	3.1	2.5	1.6	6.5	2.7	1.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.7	16.3	0.0	0.0	0.0	2.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.1	3.9	2.2	4.5	0.5	2.5	0.0	3.1
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005548-97011039	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.2;placenta: 11.3;testis: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.5;BEWO: 24.9;HAP1: 11.2;SCLC-21H: 5.5;SH-SY5Y: 8.2"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 23.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 44.2"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: "	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.9	0.4	1.8	0.3	23.2	0.9	0.4	0.3	6.1	5.7	0.6	0.5	0.0	0.4	7.0	2.4	0.3	1.5	0.3	0.5	3.9	2.6	0.4	0.3	0.3	1.0	0.5	2.8	0.9	0.3	0.4	0.4	11.3	0.0	0.7	0.3	0.0	1.7	2.5	0.5	1.6	0.3	0.9	0.3	0.5	0.4	10.4	4.2	0.1	0.7	0.0	0.8	0.9	0.6	0.4	0.6	1.5	0.7	0.5	0.7	0.3	0.0	0.0	0.0	7.5	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.5	0.0	1.4	11.2	0.0	0.0	0.0	2.9	0.0	4.2	5.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	1.6	5.5	8.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.8	0.6	1.1	0.5	0.6	0.2	0.3	0.5	0.4	0.4	0.3	0.3	0.4	0.7	0.6	1.5	0.5	0.7	0.6	0.5	0.3	1.8	23.2	0.3	6.1	3.9	2.6	0.5	2.8	0.0	4.2
DPEP2NB		ENSG00000263201	"DPEP2 neighbor"		16	68013436-68015911	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.6;placenta: 2.8;testis: 5.7"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.0;U-2197: 1.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	29	"eosinophil: 3.6;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.6"	"Not detected"	"Not detected"																							"unprognostic (1.91e-1)"											"unprognostic (3.22e-2)"	0.0	0.0		0.0		1.2	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		2.8		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.7			0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0										
DPRX		ENSG00000204595	"Divergent-paired related homeobox"	A6NFQ7	19	53632056-53637009	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"placenta: 4.9;skeletal muscle: 4.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;HEK 293: 1.0;Hep G2: 1.1"	"Cancer enriched"	"Detected in single"	20	"thyroid cancer: 2.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043682	Uncertain									"HPA043682: AB_10963073"												"unprognostic (2.47e-1)"			"unprognostic (1.89e-1)"			2.0	0.0	0.1	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.1			0.0	0.1	1.8	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	1.6	0.0	0.1		0.0	0.0	0.0	0.0	4.9		0.7	0.0		0.0	0.1	4.2	0.5	0.0	0.1	0.1	0.1	0.0	1.6			0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0										
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.4;LHCN-M2: 29.4;RH-30: 31.1;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.8	0.6	0.1	0.3	0.0	4.8	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	32.4	3.1	0.0	29.4	0.0	0.0	2.1	3.2	0.3	0.0	31.1	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.3	21.2	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.6;ASC diff: 18.7;SK-MEL-30: 22.6;U-266/70: 14.8;WM-115: 47.1"	"Group enriched"	"Detected in all"	7	"glioma: 41.1;melanoma: 127.7;renal cancer: 28.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.0;intermediate monocyte: 2.1"	"Lineage enriched"	"Detected in single"	21	"monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: "	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favourable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	25.4	23.2	22.2	10.3	29.8	0.8	23.1	10.3	30.7	8.1	7.2	13.6	2.3	10.9	7.7	3.6	4.9	6.0	8.5	23.7	16.7	16.4	22.3	26.5	28.4	15.6	24.2	8.1	4.9	6.4	7.7	6.3	67.5	33.2	14.9	7.7	51.0	13.4	4.4	6.7	5.1	11.9	7.4	33.4	16.0	5.8	3.1	12.4	0.0	17.6	2.0	2.9	10.9	8.2	0.0	0.0	0.0	2.1	0.0	0.0	0.4	1.9	0.0	24.6	0.0	18.7	0.7	0.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	22.6	0.0	0.1	0.1	0.2	0.0	0.0	0.1	14.8	8.3	0.0	0.4	0.0	47.1	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.2	29.8	10.3	11.9	16.7	16.4	24.2	8.1	33.2	12.4
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 112.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.1;HUVEC TERT2: 69.2;RPMI-8226: 27.2;TIME: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.6;eosinophil: 4.2;intermediate monocyte: 7.7;non-classical monocyte: 6.2;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 7.1;granulocytes: 4.2;monocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"					"HPA050716: "	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	54.8	11.2	17.7	9.0	23.7	8.7	34.2	8.5	23.6	19.7	10.3	7.2	17.4	9.3	28.9	19.7	9.5	14.6	17.5	31.0	18.0	12.7	24.3	10.6	46.9	12.0	21.5	8.1	7.5	9.7	5.7	10.5	112.4	27.5	13.7	3.5	19.9	21.3	16.1	29.3	14.1	9.9	10.9	10.4	41.1	7.4	11.4	17.6	0.2	20.7	16.2	4.9	10.7	55.3	0.1	7.1	4.2	7.7	0.2	0.3	3.4	0.0	9.4	3.0	11.0	0.2	0.2	7.1	2.6	0.5	1.5	0.5	3.3	8.8	0.0	39.1	0.9	1.3	0.7	1.7	0.0	15.6	2.9	5.8	0.7	0.2	2.4	0.0	8.5	0.3	0.6	0.7	0.0	69.2	20.9	0.0	0.5	16.9	0.1	0.1	4.4	0.5	18.5	1.2	27.2	0.9	0.2	1.9	6.5	1.3	1.2	2.4	3.2	8.9	64.6	0.3	8.0	0.9	0.5	0.0	0.0	0.1	0.0	0.0	8.0	0.0	2.6	4.2	0.1	7.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	1.1	0.2	6.2	7.1	0.0	3.4	17.7	23.7	8.5	23.6	18.0	12.7	21.5	8.1	27.5	17.6
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell line enriched"	"Detected in many"	12	"A-431: 337.7"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"		93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavourable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	337.7	4.3	1.1	1.5	6.9	4.3	1.1	3.3	4.5	2.0	1.6	0.8	3.7	0.2	0.8	2.8	13.5	0.0	14.9	2.5	0.1	0.2	0.0	1.8	0.2	1.8	0.0	0.0	2.1	13.7	5.2	27.9	0.2	0.0	0.0	4.4	0.2	0.0	0.0	0.3	2.2	0.0	0.6	0.0	2.5	3.6	0.0	1.3	2.8	3.4	0.6	0.3	0.7	1.0	1.9	0.5	14.6	3.1	0.0	0.3	0.1	2.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.3;HAP1: 12.0;HBF TERT88: 16.8;Hep G2: 12.8;RH-30: 18.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"prognostic favourable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.5	0.0	0.0	0.0	6.5	0.2	0.6	10.1	17.3	0.0	0.0	0.0	0.0	0.6	0.0	12.0	0.0	16.8	0.0	10.3	0.1	0.2	12.8	0.5	0.2	2.7	0.1	0.0	7.8	0.0	0.0	0.6	0.0	0.2	0.0	6.5	0.1	2.1	9.8	9.1	18.2	0.0	0.0	0.1	4.5	5.2	0.0	0.0	4.1	2.1	5.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0
ENDOU	"P11, PP11, PRSS26"	ENSG00000111405	"Endonuclease, poly(U) specific"	P21128	12	47709734-47725567	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 42.1;placenta: 86.0;tongue: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;SK-BR-3: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012388, HPA067448"	Enhanced				"Secreted in other tissues"					"HPA012388: AB_1854860, HPA067448: AB_2685843"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (6.29e-4)"	"unprognostic (6.50e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	0.6	0.1	1.3	0.2	1.4	0.2	1.2	0.2	1.1	7.5	0.2	0.2	0.2	0.1	0.3	0.8	42.1	0.6	0.4	0.4	0.7	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.9	0.2	0.1	0.2	86.0	0.5	0.2	0.1	0.2	9.3	0.2	0.2	13.5	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.5	0.4	28.8	21.6	0.2	10.9	0.2	0.2	0.8	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	2.4	1.5	0.3	1.9	1.6	1.4	0.2	0.1	4.3	1.0	0.2	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	1.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	9.6	0.1	0.2	0.0	0.3	0.4	0.1	1.2	0.2	2.4	2.3	0.8	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.3	1.4	0.2	0.7	0.7	0.1	0.4	0.3	0.5	0.2
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.7;placenta: 79.0"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;ASC diff: 33.8;ASC TERT1: 72.2;BJ hTERT+: 41.5;fHDF/TERT166: 26.8;HSkMC: 33.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Intracellular and membrane"		1100000000	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: "	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	29.9	15.4	24.0	18.2	42.0	0.7	26.2	4.4	33.3	19.6	8.1	103.7	1.7	20.8	44.8	6.4	2.9	18.7	12.7	3.6	39.8	21.5	24.9	8.9	13.5	31.0	71.5	20.9	5.3	5.2	0.9	4.1	79.0	59.7	8.5	10.6	67.6	3.4	9.2	3.0	5.4	12.1	28.9	102.4	17.3	8.3	9.7	63.9	3.6	3.7	0.8	26.1	13.4	5.7	0.2	3.8	26.8	0.1	0.2	1.8	0.3	0.0	0.0	24.7	0.0	33.8	72.2	0.0	22.7	41.5	9.8	9.4	0.0	0.0	0.0	0.3	26.8	0.0	0.5	0.0	6.9	1.8	0.7	0.0	0.0	0.6	15.1	0.0	0.1	33.1	0.2	20.0	1.0	0.1	0.0	4.0	0.5	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.4	23.9	0.1	0.2	0.0	0.0	16.8	0.1	0.5	26.8	0.1	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.8	0.6	0.3	0.2	0.0	3.8	0.0	0.3	24.0	42.0	4.4	33.3	39.8	21.5	71.5	20.9	59.7	63.9
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.9;placenta: 45.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.1;BEWO: 31.9;SK-BR-3: 9.8;T-47d: 15.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol				Cytosol		"HPA041851: , HPA043545: "	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	1.2	0.0	0.2	2.1	0.3	0.0	1.7	0.3	0.4	7.6	2.1	0.2	1.5	2.0	1.3	1.8	40.9	6.2	6.9	0.2	0.2	0.0	4.1	0.2	1.8	0.2	0.2	0.2	1.6	4.0	1.1	1.1	45.0	0.3	2.9	0.5	0.3	6.6	2.5	0.4	18.7	1.5	0.7	0.2	0.4	23.2	0.9	0.2	1.0	6.2	12.1	16.9	1.9	12.1	0.1	3.5	5.1	0.4	1.7	0.8	0.5	9.1	0.4	0.3	0.2	0.0	0.0	31.9	0.8	0.0	0.0	0.0	2.9	7.6	0.1	1.9	0.0	4.6	0.2	0.5	0.0	0.2	0.9	0.7	0.3	0.2	0.1	1.4	6.4	0.0	1.4	0.0	0.0	0.0	3.4	0.0	0.0	4.2	0.5	1.4	0.5	0.0	0.1	0.0	3.0	0.7	0.7	0.1	2.3	0.6	9.8	0.4	15.5	1.8	0.7	0.0	0.4	0.0	0.0	1.4	1.7	0.9	2.0	0.5	1.2	2.6	0.4	5.1	0.8	0.1	0.7	0.0	0.4	0.8	0.0	0.1	0.1	0.0	0.0	1.7	0.0	3.5	0.7	0.5	0.2	0.3	0.3	0.4	0.2	0.0	0.2	0.2	0.3	0.2
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 93.0"	"Group enriched"	"Detected in some"	13	"HEL: 52.2;HUVEC TERT2: 67.9;TIME: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7;neutrophil: 5.5"	"Group enriched"	"Detected in many"	9	"B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051043, HPA056293"	Uncertain		Approved	Microtubules			64000000	Microtubules		"HPA051043: , HPA056293: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	37.1	6.0	6.6	5.3	9.6	1.3	44.6	3.8	8.2	11.8	6.1	5.4	3.7	4.3	14.5	9.5	10.7	10.3	11.5	20.1	7.5	6.6	15.5	10.2	38.4	6.9	9.1	3.9	8.4	6.4	5.4	5.5	93.0	9.0	10.9	5.0	12.4	5.1	9.8	14.6	5.9	6.4	17.2	7.2	8.2	7.6	5.4	5.9	0.9	44.9	10.9	5.0	11.4	25.4	6.7	0.3	5.5	0.5	0.0	1.8	19.4	0.2	0.4	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	3.4	0.2	0.7	0.0	0.0	0.9	0.0	0.0	0.4	0.3	52.2	0.0	1.8	0.1	0.1	0.9	0.0	0.0	0.0	0.0	67.9	0.0	1.5	0.1	0.4	0.0	0.0	0.1	0.5	0.0	0.2	0.2	0.0	0.5	0.0	0.2	0.0	3.9	0.0	0.8	0.2	34.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.5	0.0	0.1	0.2	0.0	1.4	1.3	0.1	0.3	6.7	1.8	0.6	5.5	0.0	0.0	0.3	0.4	19.4	6.6	9.6	3.8	8.2	7.5	6.6	9.1	3.9	9.0	5.9
ESRRG	NR3B3	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5;parathyroid gland: 37.2;placenta: 40.8"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 15.1;SH-SY5Y: 28.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"pons and medulla: 49.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favourable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.5	5.1	2.8	0.4	3.3	0.2	2.9	6.9	10.3	1.4	0.7	0.7	2.2	4.0	0.5	1.5	1.4	2.1	0.8	8.3	3.2	2.6	22.0	0.8	0.7	0.4	6.8	1.7	0.8	4.4	37.2	9.9	40.8	49.5	2.6	0.4	10.7	11.0	2.4	6.3	1.5	3.7	0.9	2.6	1.0	22.2	1.0	1.5	0.0	4.6	7.2	0.4	1.0	0.7	0.4	0.2	1.5	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	15.1	2.3	1.7	5.4	28.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.0	2.8	3.3	6.9	10.3	3.2	2.6	6.8	1.7	49.5	1.5
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144085-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.1"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;LHCN-M2: 5.7;RH-30: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.6;myeloid DC: 33.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 33.7;monocytes: 27.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"		1400000000			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2.0	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5.0	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0.0	33.7	6.6	27.6	0.0	0.1	63.5	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	28.9	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	27.6	0.2	0.1	4.9	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	6.6	0.0	0.1	2.4	0.0	63.5	2.2	6.5	2.2	1.8	2.0	2.2	5.8	1.4	7.5	2.5
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 26.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	7667000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.5	30.3	24.0	44.0	40.9	24.3	15.1	8.0	24.5	0.0	17.5	49.7	36.9	4.4	32.6	8.0	4.2	4.7	3.7	37.5	8.3	30.7	0.1	10.8	33.2	20.5	40.0	14.1	36.6	7.1	0.2	46.1	26.1	0.2	6.2	5.3	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	35.9	25.6	15.6	16.8	1.2	47.3	25.0	10.9	31.4	36.3	0.4	0.8	0.0	70.5	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2
FAM156B	TMEM29B	ENSG00000179304	"Family with sequence similarity 156 member B"	Q8NDB6	X	52891306-52908560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 34.3"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA056640, HPA056643"	Uncertain									"HPA056640: , HPA056643: "		"unprognostic (2.91e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.66e-1)"			"unprognostic (3.24e-5)"	"unprognostic (2.97e-1)"				6.4	7.4	6.5	10.9	6.9	5.2	7.9	13.7	12.3	4.6	5.0	5.6	13.9	5.0	8.8	9.3	4.6	8.7	5.4	6.4	10.1	5.7	5.9	4.9	5.3	3.8	4.7	11.4	7.7	5.0	3.9	13.9	34.3	5.6	6.2	4.4	7.2	6.1	9.8	5.1	20.6	4.8	7.0	5.5	7.6	4.5	4.6	2.4	3.5	7.0	3.0	4.7	5.9	5.1	1.1	8.0	1.2	7.3	3.1	2.6	3.3	3.6	6.9	4.5	6.5	5.0	4.2	13.4	3.8	6.0	5.8	4.2	3.5	3.7	3.3	2.7	11.4	4.7	7.8	6.1	1.7	1.0	8.7	2.4	13.5	14.0	16.9	2.1	2.1	9.7	6.4	6.7	5.4	5.1	2.5	2.1	7.6	8.4	5.1	12.4	4.9	11.9	3.5	4.8	5.5	7.0	4.8	4.3	5.2	3.3	8.8	4.2	4.9	5.7	4.3	3.1	3.5	6.0	4.2	4.7	6.6	6.2	4.4	9.5	1.9	0.0	4.6	1.2	1.2	7.3	1.8	1.1	0.7	1.2	8.0	1.0	2.6	0.6	1.1	3.1	6.8	4.5	2.4	3.3	6.5	6.9	13.7	12.3	10.1	5.7	4.7	11.4	5.6	2.4
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765723	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.6"	"Cell line enhanced"	"Detected in some"		"BJ: 6.8;BJ hTERT+: 18.6;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;HHSteC: 5.2;HSkMC: 6.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 6.9"	"HPA036112, HPA060342"	Enhanced									"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	11.4	12.5	2.2	1.0	4.0	0.5	11.2	0.5	8.6	13.0	3.8	1.1	4.8	1.1	7.8	7.0	6.5	6.7	4.9	7.7	2.0	1.8	4.3	1.0	14.6	2.4	2.7	5.8	7.7	1.5	2.5	6.1	51.6	1.9	9.7	2.2	6.0	6.5	11.8	7.3	2.5	1.9	3.7	1.3	0.5	3.0	2.9	0.5	0.0	8.7	5.2	1.4	5.7	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	6.8	18.6	3.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.0	0.5	8.6	2.0	1.8	2.7	5.8	1.9	0.5
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.4;HEK 293: 9.6;K-562: 13.4;SCLC-21H: 10.7;SH-SY5Y: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: , HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	4.0	2.8	14.2	3.7	13.7	0.6	6.1	13.9	16.0	2.8	3.0	4.6	0.4	3.8	3.9	3.6	2.6	3.9	2.3	2.4	11.3	10.5	6.7	6.4	15.3	4.9	9.1	10.0	7.1	5.1	14.2	15.4	31.4	11.9	4.0	1.9	2.7	2.9	4.1	1.2	2.3	2.6	3.1	4.6	1.0	1.7	23.2	7.1	0.1	8.5	1.1	5.8	2.1	2.0	0.5	0.0	0.0	0.2	0.3	1.9	0.0	0.1	0.3	16.4	1.6	0.2	0.2	0.0	0.5	0.3	0.5	0.8	2.1	1.3	1.1	0.0	0.2	0.0	5.0	0.0	0.2	1.3	9.6	0.5	1.5	7.2	0.1	0.0	1.5	0.3	0.2	0.1	0.0	0.0	13.4	0.6	0.2	0.3	0.3	0.0	5.5	1.2	0.0	0.0	0.0	0.1	0.1	10.7	7.9	0.5	0.5	1.6	2.2	1.9	0.2	0.8	0.5	0.2	4.1	4.1	4.4	0.3	1.3	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.0	0.0	0.1	1.5	1.2	0.0	0.3	0.0	0.0	1.9	0.0	14.2	13.7	13.9	12.9	11.3	10.5	9.1	10.0	11.9	7.1
FAM46A	"C6orf37, FLJ20037"	ENSG00000112773	"Family with sequence similarity 46 member A"	Q96IP4	6	81491439-81752774	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 106.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.8;fHDF/TERT166: 25.0;HeLa: 24.7;HL-60: 28.3;THP-1: 48.8;U-937: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051067: , HPA067140: "	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	10.0	7.1	1.4	4.9	1.4	64.7	5.6	2.8	0.9	14.4	17.7	1.3	24.2	5.1	12.8	20.0	4.2	8.8	17.1	19.4	1.2	4.4	3.2	11.8	5.8	2.3	1.4	0.9	20.1	3.5	6.5	20.4	106.4	3.5	16.2	5.6	4.9	49.8	45.6	4.5	7.0	32.6	15.3	2.5	5.8	13.2	6.8	1.4	1.2	7.7	6.7	3.7	13.4	31.1	12.0	12.4	22.4	22.2	8.3	6.2	6.1	1.0	1.5	1.0	0.0	21.8	9.6	1.9	8.2	5.9	4.9	7.5	15.4	0.8	0.1	0.3	25.0	0.9	0.7	1.3	3.6	0.0	1.9	0.0	24.7	2.4	6.8	28.3	2.2	4.2	0.7	3.8	0.6	0.6	0.4	0.0	3.2	4.4	0.0	20.1	0.2	1.1	0.0	9.0	0.0	0.6	1.9	1.0	1.4	3.7	1.6	2.4	0.3	48.8	1.3	5.6	1.2	2.4	2.2	0.1	0.1	0.1	8.0	21.9	2.4	16.1	14.9	22.4	6.2	15.1	3.7	8.0	2.4	3.0	12.4	12.0	4.7	4.4	7.3	8.3	22.2	4.3	2.7	6.1	1.4	1.4	2.8	0.9	1.2	4.4	1.4	0.9	3.5	1.4
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 39.6;placenta: 48.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.1;SK-MEL-30: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: , HPA059578: "	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	39.6	12.9	8.0	3.7	8.5	3.9	32.8	3.9	5.4	5.1	3.6	4.9	2.0	1.6	5.7	2.1	3.4	2.7	4.6	4.7	7.9	11.2	8.7	5.7	10.5	6.7	14.0	2.3	4.7	15.0	4.0	4.2	48.3	13.1	4.7	2.4	12.0	3.5	3.9	4.2	14.1	1.8	3.5	10.9	9.6	3.1	2.8	8.3	0.8	3.9	5.0	3.6	4.3	9.7	1.2	0.0	4.3	0.7	0.3	3.0	0.8	0.3	4.7	2.2	4.6	5.4	1.1	51.1	2.6	2.0	1.0	1.8	7.1	4.2	0.0	0.6	1.7	2.8	4.1	0.6	0.8	14.2	10.0	2.2	0.1	0.3	20.7	1.6	12.4	18.0	9.3	0.0	4.7	2.5	17.6	3.0	0.9	1.6	1.0	2.9	3.3	1.5	5.5	7.1	5.3	3.5	5.0	2.0	5.6	0.9	0.4	26.7	0.2	9.9	0.3	8.0	0.0	0.1	4.9	6.4	7.7	3.9	2.3	3.3	15.8	4.3	0.7	0.0	0.6	0.1	1.1	1.2	0.8	1.5	0.0	0.6	1.3	3.0	0.0	0.3	0.2	0.0	0.0	0.8	8.0	8.5	3.9	5.4	7.9	11.2	14.0	2.3	13.1	8.3
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 154.6;ASC TERT1: 68.6;BJ: 82.9;BJ hTERT+: 131.8;HSkMC: 113.1;RT4: 118.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: , HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.3	3.3	10.0	21.0	154.6	68.6	46.0	82.9	131.8	7.4	2.8	14.2	0.4	0.0	3.5	3.0	7.3	6.3	0.2	0.9	0.0	1.7	0.0	18.1	9.5	20.5	0.0	0.0	113.1	1.3	7.3	2.7	0.0	0.0	0.1	5.1	0.1	0.0	0.2	14.1	1.2	0.1	0.0	0.1	3.3	118.6	0.7	13.4	10.2	48.3	0.0	0.3	0.4	0.6	1.4	9.2	38.1	0.0	0.1	0.0	0.1	0.1	0.0	3.5	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.6;ASC TERT1: 79.0;fHDF/TERT166: 67.8;HSkMC: 42.7;U-138 MG: 34.8;U-2197: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"		540000000	Cytosol		"CAB002670: , CAB058696: , CAB068188: , HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (7.44e-5)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.6	79.0	0.0	28.5	10.3	8.5	5.4	0.0	0.0	0.0	1.3	67.8	0.1	0.6	0.1	7.7	3.2	0.2	0.3	14.5	0.0	20.6	0.1	0.0	42.7	0.0	22.5	2.6	9.1	0.0	0.0	9.1	0.0	0.2	0.0	0.6	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.2	17.2	34.8	1.0	50.5	6.0	0.2	0.1	0.0	23.3	0.0	2.2	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Secreted to blood"		270000000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"CAB000099: , HPA046519: , HPA067906: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.2	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.3	2.8	0.1	0.2	0.1	12.6	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	8.1	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	12.0	0.2	12.7	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436172	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 235.4;placenta: 433.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 837.5;HSkMC: 391.7;hTERT-HME1: 230.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"		47000000000			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (3.44e-8)"	"prognostic unfavourable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (3.33e-4)"	20.2	4.5	3.1	13.0	5.2	0.2	13.1	2.2	4.3	21.9	57.1	4.4	235.4	3.5	25.1	27.5	37.4	26.5	20.9	57.3	3.9	2.9	5.8	166.3	81.5	7.9	4.6	5.0	16.9	3.3	1.7	3.5	433.0	6.1	17.1	25.1	5.1	10.4	141.2	9.8	7.0	13.5	114.9	4.6	1.9	21.8	9.0	2.7	9.4	5.4	17.4	2.6	64.7	16.9	0.2	0.8	0.0	0.6	0.0	0.3	0.0	0.2	1.9	2.6	0.5	106.3	837.5	0.1	43.2	28.8	43.7	31.2	26.1	1.0	0.0	0.2	143.6	4.4	0.4	98.4	23.6	0.0	0.1	0.0	0.6	81.5	76.9	0.0	0.1	391.7	0.6	103.4	230.4	50.7	0.1	0.1	87.2	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	1.1	0.3	0.1	0.6	5.1	2.7	28.0	0.4	0.0	97.2	63.4	6.7	69.3	8.0	0.1	0.0	0.0	75.3	0.0	16.4	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	3.1	5.2	2.2	4.3	3.9	2.9	4.6	5.0	6.1	2.7
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71096197-71103535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 98.6"	"Cell line enriched"	"Detected in many"	5	"BEWO: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039560: , HPA040232: "	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	8.5	13.2	21.7	3.8	21.5	9.9	5.1	9.1	15.6	4.8	8.4	9.1	11.9	6.3	6.8	10.2	7.3	7.7	5.8	9.7	21.4	14.5	5.2	3.6	5.5	3.6	22.8	8.4	13.4	6.8	8.7	3.0	98.6	9.2	7.0	4.7	4.9	8.5	11.3	33.8	5.5	6.6	9.4	17.3	6.0	5.2	13.9	13.1	4.4	5.9	7.5	4.2	7.5	11.0	0.9	0.2	3.4	0.6	1.0	1.8	0.9	1.7	0.5	1.4	1.8	3.3	2.3	60.0	1.4	1.6	0.7	1.7	1.2	2.4	2.3	1.8	1.8	0.8	3.6	1.6	0.8	2.3	5.5	3.4	11.2	1.9	1.9	1.9	2.7	1.9	3.8	0.6	0.4	1.8	6.9	4.6	0.3	0.3	3.0	3.1	6.5	2.1	2.1	3.5	3.6	1.2	1.0	1.0	2.9	2.9	0.4	3.1	0.7	1.2	1.7	0.4	0.9	3.1	0.3	3.0	1.6	0.4	1.6	5.2	0.5	0.2	0.6	3.2	0.9	0.6	0.3	0.8	0.5	0.9	0.2	0.9	0.4	1.8	3.4	1.0	0.3	0.0	1.3	0.9	21.7	21.5	9.1	15.6	21.4	14.5	22.8	8.4	9.2	13.1
FOXO6		ENSG00000204060	"Forkhead box O6"	A8MYZ6	1	41361922-41383590	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.2;placenta: 8.4"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.8"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (3.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.35e-2)"	"prognostic unfavourable (7.65e-6)"	"unprognostic (5.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.55e-9)"	"unprognostic (4.35e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.10e-2)"	1.1	0.6	0.7	0.6	3.0	0.7	1.0	0.1	4.5	1.0	0.6	1.9	0.0	1.4	0.6	0.6	0.6	0.6	0.9	0.6	4.9		0.7	0.8	0.9	0.7	0.1	1.9	4.8	2.3	0.6	3.6	8.4	0.7	0.6	0.6	1.3	0.6	0.6	1.3	0.6	0.6	0.6	0.0	1.0	0.6	1.2	1.6	7.2	0.6	3.5	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor epsilon subunit"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 36.4;vagina: 27.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.3;EFO-21: 14.6;HeLa: 6.5;SiHa: 6.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"hypothalamus: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA045918	Uncertain									"HPA045918: AB_10961281"	"unprognostic (1.33e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (4.05e-11)"	"unprognostic (1.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.28e-2)"	14.8	1.0	1.5	2.2	2.8	0.3	16.5	1.0	1.6	8.9	5.8	0.0	2.2	1.4	6.0	4.1	5.0	1.5	4.2	16.3	1.0	21.8	1.1	0.9	2.3	0.7	1.1	0.6	1.6	2.5	0.4	4.1	36.4	4.5	5.9	0.8	3.8	2.0	6.3	0.9	5.6	10.1	2.5	1.1	0.9	1.0	0.9	0.4	0.0	2.5	5.9	3.5	2.9	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.0	1.1	0.5	2.2	0.8	0.0	14.6	3.0	2.3	0.0	0.8	0.7	0.0	0.5	1.6	6.5	0.8	0.2	0.0	0.2	1.0	0.6	1.2	0.3	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	1.0	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	1.0	1.3	1.0	21.8	1.1	0.6	4.5	0.4
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605013-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"placenta: 65.6"	"Group enriched"	"Detected in some"	4	"HDLM-2: 46.7;SCLC-21H: 24.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023606	Approved									"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favourable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	7.0	23.6	4.6	4.4	7.7	8.4	6.7	4.8	5.4	23.3	7.4	2.8	12.0	4.2	21.3	6.5	6.1	6.4	5.9	53.4	4.1	3.8	6.7	48.4	4.6	1.5	5.3	3.7	14.1	28.7	4.9	25.4	65.6	7.4	12.7	1.6	3.0	14.7	10.2	58.0	5.5	6.0	5.5	6.7	1.3	6.5	13.0	3.0	0.8	8.4	26.8	2.6	5.1	6.2	0.0	0.2	8.0	0.3	0.0	0.1	0.1	1.2	0.0	6.7	0.0	0.0	0.0	8.8	0.4	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.9	2.2	0.0	0.0	46.7	0.4	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.1	0.4	6.1	0.1	0.5	1.9	0.4	0.0	0.3	24.6	5.6	0.4	2.6	0.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.1	4.6	7.7	4.8	5.4	4.1	3.8	5.3	3.7	7.4	3.0
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell line enriched"	"Detected in some"	8	"LHCN-M2: 26.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.5	3.2	2.1	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	26.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1
GDPD5	"GDE2, PP1665"	ENSG00000158555	"Glycerophosphodiester phosphodiesterase domain containing 5"	Q8WTR4	11	75434640-75525903	"Predicted membrane proteins"	Neurogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.2;placenta: 41.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 17.0;fHDF/TERT166: 16.2;HDLM-2: 33.2;U-2 OS: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.3;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065257, HPA066762, HPA069281"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA065257: , HPA066762: , HPA069281: "	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.59e-9)"	"unprognostic (8.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.65e-1)"	16.5	6.0	3.3	3.3	4.6	7.8	8.0	23.2	7.9	3.3	3.0	3.3	1.6	2.0	6.4	3.1	1.6	3.2	3.6	2.8	3.0	1.8	2.3	2.7	5.4	4.3	3.0	2.6	2.9	13.4	0.4	7.0	41.7	4.2	3.1	1.3	18.8	15.5	4.1	5.9	2.3	3.2	4.9	3.4	37.2	1.4	11.9	5.5	2.0	2.6	1.4	3.4	3.5	11.5	1.1	1.1	9.3	1.2	0.0	3.1	0.7	1.0	3.8	1.6	1.9	1.1	0.6	5.7	1.2	1.6	0.5	0.4	5.0	2.2	7.1	17.0	16.2	2.3	2.0	1.9	0.3	33.2	1.5	1.3	5.8	10.3	1.7	0.8	5.6	1.3	1.0	0.4	0.8	13.6	2.3	3.2	0.7	2.2	1.9	3.5	2.9	5.4	2.2	0.4	1.9	0.4	1.8	0.9	0.6	2.4	9.3	4.5	1.3	3.1	4.0	3.9	15.8	3.0	1.2	0.8	0.1	1.3	0.9	4.2	0.4	9.3	1.2	0.7	2.0	0.6	2.9	1.1	2.3	1.6	0.3	0.4	1.2	1.5	0.1	0.0	0.0	1.1	3.1	0.7	3.3	4.6	23.2	7.9	3.0	1.8	3.0	2.6	4.2	5.5
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 108.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.6;HBEC3-KT: 60.2;hTCEpi: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced				"Intracellular and membrane"		23000000			"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	55.8	16.1	17.8	15.5	18.8	9.6	15.2	8.1	15.2	20.5	10.3	31.7	6.4	8.4	9.5	17.3	39.5	8.8	12.6	13.8	18.0	12.6	7.5	13.2	24.8	30.2	22.4	13.0	12.2	9.3	11.7	5.6	108.7	18.9	11.9	14.5	14.1	13.3	10.4	3.9	42.8	11.2	10.9	35.9	28.5	8.2	8.9	15.3	21.9	7.1	25.9	39.7	21.0	32.0	15.9	19.0	4.2	19.4	1.9	3.3	8.0	4.5	3.0	3.2	15.0	20.9	10.4	43.6	7.2	15.5	4.0	5.4	6.1	5.3	14.7	7.5	5.5	12.5	3.5	60.2	5.7	8.2	2.1	2.3	3.7	7.6	5.1	3.8	24.7	13.9	60.1	5.1	3.4	5.7	2.3	6.4	6.2	1.9	8.0	3.6	2.1	6.7	3.6	1.5	9.2	3.8	8.9	0.8	2.8	5.9	27.9	11.8	6.3	4.5	5.0	9.8	3.8	8.0	2.1	15.9	18.9	40.3	11.2	6.1	4.0	3.5	19.4	1.1	1.9	6.5	1.4	14.9	2.3	2.0	19.0	15.9	3.3	2.5	4.2	1.9	1.4	13.7	2.4	8.0	17.8	18.8	8.1	13.9	18.0	12.6	22.4	13.0	18.9	15.3
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 19.1"	"Group enriched"	"Detected in some"	4	"HHSteC: 52.5;hTCEpi: 23.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.7;pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	2.3	5.0	0.5	0.6	10.7	0.1	1.7	0.4	1.2	4.1	0.6	4.8	1.6	0.2	1.3	0.7	6.6	1.1	2.7	3.8	1.6	0.5	0.7	0.0	0.5	3.1	0.2	0.3	3.2	0.1	0.0	0.4	19.1	6.6	0.7	0.6	1.1	1.5	0.4	1.5	6.7	0.5	2.3	0.3	0.2	0.2	1.6	1.0	0.0	0.7	2.2	1.2	3.1	7.7	0.5	0.1	1.4	0.2	0.5	0.2	0.6	0.8	0.1	0.7	0.0	0.1	2.9	0.2	5.4	9.3	3.3	2.8	0.0	0.0	0.0	0.3	2.7	0.1	0.2	0.0	1.1	0.0	0.1	0.0	1.8	0.0	52.5	0.0	0.0	2.1	23.7	4.8	7.7	0.0	0.0	0.0	6.7	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.3	1.1	0.0	0.0	0.0	0.0	0.1	4.1	1.8	4.7	0.4	0.0	0.0	0.0	1.4	0.0	0.1	1.3	0.2	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.5	0.2	0.2	1.4	0.5	0.1	0.1	0.2	0.6	0.5	10.7	0.4	1.2	1.6	0.5	0.2	0.3	6.6	1.0
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159807-72197785	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.6;placenta: 49.2"	"Group enriched"	"Detected in some"	12	"BEWO: 58.1;SK-BR-3: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 2.3"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.3"	"Low region specificity"	"Detected in many"							HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (7.01e-4)"	"unprognostic (7.29e-2)"	0.1	0.0	2.0	0.2	4.5	0.0	6.8	1.1	1.0	3.1	0.7	1.2	9.8	0.6	0.4	24.6	1.0	8.2	0.8	0.1	2.9	6.5	1.9	0.1	9.7	0.2	1.1	0.1	1.1	1.0	0.2	0.9	49.2	3.9	1.2	0.5	1.0	1.8	4.0	0.3	1.5	3.6	0.1	1.0	0.1	0.4	0.7	0.9	0.2	7.7	1.3	1.1	0.3	0.6	0.0	2.3	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	26.5	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.5	1.1	1.0	2.9	6.5	1.1	0.1	3.9	0.9
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492432-101669726	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 47.9;seminal vesicle: 42.4"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CACO-2: 11.3;HaCaT: 18.9;hTCEpi: 14.8;MCF7: 13.0;RT4: 27.9;T-47d: 32.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA004820: AB_1857928, HPA062839: "	"prognostic unfavourable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.4	0.3	0.4	3.3	0.4	0.0	11.3	0.3	0.4	6.0	9.9	0.0	34.7	2.1	1.6	16.4	18.7	5.2	10.3	0.4	0.4	0.4	6.4	0.7	11.3	0.0	0.4	0.0	1.5	22.1	7.1	1.5	47.9	0.1	15.2	5.6	0.1	15.0	42.4	0.4	18.0	8.6	1.6	0.4	0.4	5.9	0.6	0.0	1.7	12.7	14.3	12.2	7.4	8.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	15.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	11.3	7.7	0.0	0.0	0.0	18.9	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.5	0.0	0.0	6.2	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.0	0.1	0.0
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.8;K-562: 47.5;T-47d: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036365	Uncertain		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA036365: AB_10601762"	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	15.8	11.1	4.9	18.2	6.6	17.3	21.4	18.0	9.5	13.5	14.9	2.9	14.6	9.7	11.0	11.7	11.6	10.9	16.1	18.7	3.8	5.8	11.1	10.1	23.5	6.5	3.8	5.7	17.8	28.0	34.4	26.9	81.9	3.7	8.7	7.2	18.2	17.7	25.2	22.5	13.3	14.8	8.8	4.2	12.1	13.2	10.4	2.1	59.0	14.9	12.0	17.4	10.2	16.9	3.5	2.5	4.5	6.0	1.9	3.2	1.1	4.4	8.1	5.4	13.5	3.5	3.2	42.8	6.1	4.2	3.4	1.2	6.9	6.2	2.6	7.3	6.9	4.2	8.5	2.3	1.7	4.9	7.2	19.4	7.6	8.5	4.5	8.9	11.1	5.9	5.6	3.6	1.7	0.9	47.5	0.4	1.1	30.2	32.0	7.9	9.4	2.4	21.1	1.8	6.8	3.1	1.7	35.2	24.4	12.0	22.5	1.1	48.9	22.4	1.5	7.0	8.8	1.9	1.6	7.4	4.4	15.6	4.0	5.6	6.1	4.0	1.6	4.5	3.2	2.9	3.1	3.5	1.2	2.0	2.5	3.4	0.6	2.4	1.3	1.9	6.0	0.0	0.0	1.1	4.9	6.6	18.0	9.5	3.8	5.8	3.8	5.7	3.7	2.1
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;BJ hTERT+: 1.1;CACO-2: 1.5;HAP1: 2.8;HEK 293: 1.5;SK-BR-3: 2.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3
GUCY1A2	"GC-SA2, GUC1A2"	ENSG00000152402	"Guanylate cyclase 1 soluble subunit alpha 2"	P33402	11	106674012-107018524	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 23.0;placenta: 23.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 12.2;BJ hTERT+ SV40 Large T+ RasG12V: 14.3;HBF TERT88: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009534	Uncertain									"CAB009534: AB_2279509"	"unprognostic (7.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.70e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.48e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	5.5	3.3	4.6	1.3	10.9	0.6	3.9	4.3	10.7	19.2	1.5	1.2	1.1	0.9	23.0	5.0	1.3	8.4	2.6	3.8	4.6	4.0	3.2	2.8	11.8	1.6	3.7	5.3	3.9	6.2	1.8	1.5	23.6	5.5	3.2	1.3	1.4	1.4	10.1	4.1	1.4	1.2	18.0	2.4	7.9	1.0	2.8	5.4	0.0	2.4	3.0	1.0	2.2	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	4.3	0.0	0.2	2.6	2.3	0.3	12.2	1.6	14.3	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	7.6	0.0	1.2	0.0	0.1	0.0	0.2	0.0	1.7	0.7	0.0	1.9	0.2	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	3.7	0.0	0.8	0.8	0.2	4.7	3.9	3.2	0.8	1.3	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	10.9	4.3	9.9	4.6	4.0	3.7	5.3	5.5	5.4
GULP1	"CED-6, CED6, GULP"	ENSG00000144366	"GULP, engulfment adaptor PTB domain containing 1"	Q9UBP9	2	188291669-188595931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid transport, Phagocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 86.0"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;SH-SY5Y: 24.2;WM-115: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA020587	Enhanced		Approved	Vesicles				Vesicles		"HPA020587: AB_1850452"	"unprognostic (1.95e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.23e-1)"	"prognostic favourable (4.25e-6)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.04e-4)"	8.0	15.0	3.1	7.6	9.8	0.0	9.7	0.7	8.0	22.6	11.8	2.2	14.4	6.5	23.3	40.6	11.5	10.4	8.9	5.1	2.5	4.8	11.4	1.0	9.0	1.2	2.4	4.5	17.9	32.3	23.9	3.7	86.0	14.3	14.3	3.8	19.4	10.7	16.1	5.9	5.0	10.5	15.1	2.8	3.2	11.9	17.0	2.2	0.3	8.0	6.1	3.1	11.3	20.2	0.6	0.4	1.5	1.9	0.6	0.2	0.3	3.7	9.3	32.1	7.1	5.0	4.9	6.0	5.2	8.8	8.5	6.9	5.8	18.5	0.0	3.9	4.2	2.5	6.4	0.4	6.2	0.0	4.3	7.9	6.9	0.0	4.6	0.0	0.0	3.0	1.1	4.0	4.3	3.9	6.6	0.1	5.8	0.5	0.0	0.1	8.1	14.4	0.0	7.6	3.8	17.0	1.6	0.1	24.2	0.0	4.3	11.1	1.4	0.0	1.9	2.6	1.2	8.6	2.9	0.0	0.0	0.0	1.4	0.0	69.9	1.3	1.9	0.4	0.2	1.1	0.1	0.3	0.1	0.1	0.4	0.6	0.2	0.2	1.5	0.6	0.7	0.2	0.1	0.3	3.1	9.8	0.7	8.0	2.5	4.8	2.4	4.5	14.3	2.2
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: "	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.5	2.5	10.7	13.4	6.4	8.5	12.7	7.2	11.1	4.6	6.9	2.3	2.1	2.0	3.2	5.4	2.4	2.7	4.9	9.7	8.2	6.8	7.1	2.3	3.1	6.4	6.1	2.3	5.7	4.5	5.9	5.0	7.5	6.8	2.3	9.0	2.6	4.5	3.6	4.7	2.4	7.2	12.2	0.8	3.7	6.1	5.8	8.7	3.9	4.1	2.1	2.6	8.4	7.9	3.7	3.1	9.9	6.8	3.3	3.6	6.9	3.9	5.8	6.7	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 61.4;placenta: 62.9"	"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 117.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"hippocampal formation: 0.3"	"HPA019591, CAB025576"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB025576: , HPA019591: "	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	4.2	24.2	0.2	10.9	0.2	0.0	4.7	0.4	0.2	34.3	42.7	0.2	7.5	1.9	42.7	7.9	16.6	9.7	61.4	54.1	0.2	0.2	0.2	8.2	0.2	0.1	0.2	0.0	13.4	3.8	0.0	0.3	62.9	0.0	13.1	3.6	5.2	1.1	4.2	0.6	1.7	13.5	37.5	0.2	1.8	19.9	5.4	0.0	0.0	1.5	2.7	2.2	25.7	12.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.7	3.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.8	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	152687-154503	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.9;placenta: 5.0;testis: 9.9"	"Cell line enriched"	"Detected in some"	79	"K-562: 222.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol			160000000	Cytosol	Nucleoplasm	"HPA063268: , HPA064073: , HPA071726: "					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.8	0.0	0.8	0.1	0.5	8.9	0.6	0.6	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.6	3.3	0.7	0.3	0.1	1.1	0.6	0.1	1.1	0.1	0.7	0.1	0.0	0.1	5.0	0.1	1.2	0.0	0.1	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.8	0.1	9.9	0.1	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.5	0.6	0.6	0.7	0.3	1.1	0.1	0.1	0.1
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 71.1;placenta: 20.2;testis: 32.5"	"Cell line enriched"	"Detected in some"	4	"K-562: 75.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.2"	"Group enriched"	"Detected in many"	27	"granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2"					"Region enriched"	"Detected in all"	5	"cerebellum: 55.9"	"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.3	0.2	0.2	0.4	0.2	71.1	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.3	1.0	0.2	0.2	0.3	0.9	5.4	0.5	0.2	0.0	0.6	0.2	0.0	0.3	20.2	1.1	0.2	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.3	2.8	0.2	32.5	0.0	17.1	0.3	0.2	0.5	1.4	4.8	0.0	0.1	2.1	0.1	2.9	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.1	0.8	0.0	2.3	1.1	0.1	0.0	8.2	3.3	1.0	2.9	0.0	0.0	1.2	4.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	0.0
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;placenta: 60.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.7;HaCaT: 19.9;HBEC3-KT: 17.1;hTCEpi: 9.9;TIME: 29.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039462	Uncertain									"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.8	0.0	0.2	0.7	0.2	0.2	0.7	0.2	0.3	6.7	6.0	0.2	0.2	0.1	0.4	0.4	22.6	2.5	0.2	0.2	0.2	0.0	1.0	0.4	3.8	0.2	0.2	0.2	0.5	0.2	0.2	0.4	60.9	0.3	1.2	4.6	0.5	2.9	0.6	0.2	14.5	0.9	0.2	0.2	0.2	0.0	1.8	0.2	0.7	0.2	8.6	6.0	0.3	11.9	0.6	0.6	4.9	0.4	0.5	0.6	0.2	0.9	0.3	0.0	0.1	0.2	0.0	10.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.9	0.1	19.9	0.5	17.1	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.0	9.9	0.0	0.4	5.2	0.1	0.2	0.0	1.5	0.0	0.8	0.0	7.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	1.0	5.6	0.2	0.7	0.3	29.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.6	0.5	0.3	0.3	0.4	0.5	0.4	0.1	0.6	0.4	0.6	3.9	0.5	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 112.8;BJ hTERT+: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	21.1	16.7	5.8	19.2	112.8	34.8	19.0	26.0	84.4	25.4	55.2	19.5	27.7	0.0	20.7	21.3	17.0	6.2	26.5	33.6	11.8	11.2	2.8	16.2	14.7	33.1	2.3	22.9	30.7	15.6	26.7	17.9	29.1	7.8	34.7	27.8	21.5	2.7	5.3	5.4	7.5	6.4	8.5	27.6	17.5	19.4	3.8	4.7	20.2	13.7	25.1	14.5	15.7	17.2	16.8	4.2	30.8	24.0	16.1	27.6	0.1	38.2	20.8	30.4	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HHLA1	PLA2L	ENSG00000132297	"HERV-H LTR-associating 1"	C9JL84	8	132061486-132111159	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"placenta: 1.3"	"Cell line enriched"	"Detected in single"	51	"NTERA-2: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"											"unprognostic (5.15e-2)"								"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6		0.0	0.0	0.0	0.1	1.3		0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850480	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 61.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	6.4	0.7	12.4	0.7	18.2	0.6	3.2	4.5	9.7	5.7	1.9	3.6	0.4	1.5	6.4	7.6	2.5	3.1	7.1	11.0	12.4	10.1	2.6	0.6	21.6	1.7	15.8	6.8	2.0	2.0	2.5	0.3	61.8	8.7	3.6	1.0	0.7	1.3	4.4	7.9	1.3	1.3	7.3	6.2	0.4	1.5	1.2	8.9	0.1	3.4	1.8	1.1	3.0	1.6	1.1	3.3	4.6	2.9	1.9	3.5	1.1	0.5	1.7	0.0	2.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.9	0.6	1.7	0.5	0.0	0.7	0.0	0.0	0.0	1.4	1.9	0.4	2.1	1.3	0.0	2.6	3.7	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.7	1.9	1.9	1.3	1.0	2.2	1.2	2.5	0.0	1.3	2.1	1.0	0.6	0.0	0.3	0.8	1.0	0.0	1.8	0.6	1.2	1.4	1.3	3.8	2.0	1.5	3.1	2.2	4.6	1.9	0.7	3.5	2.9	1.3	0.7	2.3	2.6	3.3	1.1	2.5	2.3	0.0	1.9	0.3	0.9	2.0	1.1	12.4	18.2	4.5	9.7	12.4	10.1	15.8	6.8	8.7	8.9
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 107.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062583: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.1	16.5	52.0	27.0	2.2	6.5	64.7	16.3	10.8	19.0	9.9	13.0	15.4	26.0	52.6	12.5	17.9	47.3	107.0	21.4	17.7	13.8	22.6	15.9	20.4	3.2	34.0	11.5	5.1	25.3	7.7	19.6	24.5	11.7	15.5	22.5	28.5	37.5	26.2	30.8	20.2	46.0	42.3	14.7	13.9	17.8	37.5	24.5	24.2	26.2	8.1	23.1	22.6	18.4	7.9	18.7	25.1	35.9	14.1	17.5	96.4	9.4	17.4	16.0	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.8;skin 1: 154.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.1;HUVEC TERT2: 29.0;RT4: 21.6;TIME: 32.8;U-266/70: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 68.6;NK-cell: 90.9"	"Group enriched"	"Detected in many"	14	"NK-cells: 90.9;T-cells: 68.6"									"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	1.7	5.0	24.1	5.2	13.0	2.0	23.1	4.0	28.2	26.4	3.1	3.6	3.0	3.4	2.5	106.2	90.3	2.3	6.7	5.7	20.0	8.2	2.3	0.7	112.4	3.4	12.1	12.9	1.4	1.1	2.3	1.2	128.8	15.0	4.5	1.6	1.0	19.0	12.9	3.4	154.6	3.4	20.9	11.2	2.3	3.2	9.6	1.9	1.8	65.9	93.2	66.3	6.8	37.8	5.6	0.4	1.5	0.5	90.9	68.6	38.2	0.0	0.0	0.0	0.0	2.2	7.1	2.6	0.0	0.0	0.6	0.4	0.0	0.0	5.3	0.3	0.1	0.9	0.6	0.0	0.8	13.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.3	1.6	0.0	29.0	0.0	0.2	1.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	21.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.1	0.2	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.6	0.1	0.2	68.6	0.4	37.4	5.6	17.1	30.1	0.3	4.3	3.1	21.0	1.5	90.9	0.5	0.4	1.0	38.2	24.1	13.0	4.0	28.2	20.0	8.2	12.1	12.9	15.0	1.9
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell line enhanced"	"Detected in some"		"A549: 27.3;ASC diff: 16.9;HEL: 59.7;RT4: 92.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favourable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.3	0.0	0.0	16.9	1.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	59.7	2.0	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	2.8	0.0	0.2	5.6	92.8	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in some"	8	"HEL: 31.6;HMC-1: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol			170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	2.4	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.7;Hep G2: 18.8;hTERT-HME1: 11.3;RT4: 38.9;TIME: 21.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: "	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	23.7	0.0	0.0	4.3	0.7	0.0	4.7	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.1	18.8	0.1	0.1	0.1	0.0	1.2	0.0	11.3	0.3	0.0	0.2	3.5	0.1	0.0	0.4	0.1	8.6	0.0	0.0	0.5	0.4	38.9	0.2	0.6	0.0	1.1	0.1	0.0	0.0	21.8	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 40.8;TIME: 18.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA028808: "	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.0	40.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6
HTR1F	"5-HT1F, HTR1EL"	ENSG00000179097	"5-hydroxytryptamine receptor 1F"	P30939	3	87990696-87993835	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 5.7"	"Group enriched"	"Detected in some"	6	"A549: 1.2;K-562: 4.4;LHCN-M2: 4.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	16	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005555	Uncertain									"HPA005555: AB_1856708"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.67e-6)"	"unprognostic (1.25e-4)"	"unprognostic (1.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.31e-2)"	2.8	0.5	0.7	0.0	0.6	1.5	1.6	0.0	1.8	1.4	0.0			0.0	1.2	0.3	0.1	0.4	0.1	0.3	0.6	0.4	0.6	0.0	0.9	0.1	0.8		0.4	0.7	0.3	1.4	5.7		0.4	0.0		0.1	1.0	0.6	0.4	0.0	1.3	0.3	1.7	0.0	0.3			1.5		0.5	0.6	0.7	0.1	0.2	3.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125118	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 26.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 6.8;HSkMC: 13.0;SK-MEL-30: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 3.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	29	"granulocytes: 3.8;T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA012867: AB_1856710, HPA063658: "	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	2.3	17.9	0.2	5.8	0.3	0.7	4.1	0.3	0.6	17.8	7.3	0.2	1.7	1.0	14.9	9.5	5.7	1.9	0.8	4.6	0.3	0.3	5.6	2.5	1.8	0.5	0.3	0.4	4.3	0.3	0.3	0.4	26.0	0.9	2.6	1.5	1.8	0.5	1.0	0.2	0.2	6.3	12.8	0.3	0.4	5.2	3.3	0.3	2.4	6.8	1.0	0.4	4.9	0.8	0.0	0.1	3.8	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.1	0.4	3.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	0.1	0.2	13.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	23.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	2.9	0.0	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.4	0.9	0.3
HYAL4		ENSG00000106302	"Hyaluronoglucosaminidase 4"	Q2M3T9	7	123828983-123877478	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.1;skeletal muscle: 8.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;CAPAN-2: 7.1;RT4: 16.6"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"					"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA029453	Uncertain									"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.5	0.0	0.1			0.0	0.1	0.4	0.4	0.2	0.0	0.4	0.0	0.0	0.6	0.1	0.4	0.0	0.0		0.1	0.6	0.0	0.1	7.1		0.2	0.0		1.2	0.0	8.3	1.4	0.2	0.0	0.1	1.0	0.2	3.4			0.4		1.5	1.0	0.1	1.3	0.6	3.3	0.6	1.0	0.9	0.1	0.3	0.6	0.1	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.1	0.3	0.3	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	16.6	0.2	0.1	0.0	0.9	0.0	0.4	0.2	2.4	0.1	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.6	0.5	0.5	0.4	0.5	0.5	0.2	1.3	0.7	0.9	3.3	1.0	0.6	0.6	0.3	0.1										
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666061-27672218	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 225.6"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 131.9;BJ hTERT+ SV40 Large T+ RasG12V: 154.2;EFO-21: 53.0;SK-MEL-30: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria				Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	32.3	27.5	24.9	13.5	28.2	37.3	10.9	14.2	36.1	11.4	13.8	22.9	6.5	16.5	26.8	68.0	8.6	11.9	113.9	19.3	23.0	42.3	44.8	23.5	31.6	5.8	20.0	17.0	14.1	21.3	5.9	60.1	225.6	34.3	13.9	10.1	31.6	111.4	10.1	7.4	5.4	12.5	17.0	26.0	27.3	35.4	15.4	6.8	24.8	35.2	7.9	9.7	7.8	7.6	9.7	19.4	84.9	58.6	15.8	27.5	16.8	1.4	0.4	2.2	1.3	7.1	3.9	8.8	4.6	21.3	131.9	154.2	0.7	5.6	0.5	53.0	2.1	0.5	0.5	1.0	4.3	10.8	1.7	3.4	1.1	0.4	1.9	1.1	4.4	4.2	0.1	7.9	0.1	1.2	0.2	9.3	1.4	0.4	4.0	14.2	0.4	4.5	2.7	1.2	1.3	1.1	0.0	3.1	2.8	5.7	1.3	93.6	0.6	4.4	2.0	1.2	1.9	0.9	0.8	11.1	6.3	0.3	2.4	9.9	3.4	29.3	44.4	39.4	22.7	58.6	22.4	9.7	23.0	20.7	19.4	8.0	24.3	23.6	84.9	15.8	38.8	2.0	27.5	16.8	24.9	28.2	14.2	36.1	23.0	42.3	20.0	17.0	34.3	6.8
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;parathyroid gland: 16.6;placenta: 12.2"	"Group enriched"	"Detected in some"	5	"AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015713			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.2	0.6	3.5	0.4	2.1	0.2	1.7	10.8	4.6	1.0	0.5	3.3	0.0	0.3	1.6	0.4	0.2	1.4	0.4	0.4	3.2	2.6	0.6	0.2	0.3	0.2	2.5	1.7	1.7	0.3	16.6	2.9	12.2	2.6	0.5	0.3	0.6	0.2	0.5	0.5	0.4	0.3	0.6	2.2	0.3	0.4	4.7	2.7	3.7	1.7	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.1	10.8	4.6	3.2	2.6	2.5	1.7	2.6	2.7
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB017126: , HPA035145: "	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.2	2.4	27.6	5.2	15.1	23.9	16.9	14.9	21.1	23.2	27.9	20.3	8.0	0.0	22.2	12.6	12.9	12.9	21.7	37.7	0.0	13.4	8.0	0.1	14.0	32.3	0.2	0.0	17.5	11.5	15.4	60.0	21.3	7.8	0.0	17.0	0.2	0.0	6.8	20.2	10.2	2.9	11.0	8.4	15.0	0.1	1.7	0.2	1.1	0.0	26.6	2.2	18.9	32.3	8.1	17.6	10.1	17.1	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 320.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 412.2;U-2197: 171.0;U-87 MG: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	3247666667	5600000000	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	47.4	1.6	4.4	10.6	2.7	0.0	52.1	2.7	4.1	44.3	21.3	1.7	3.2	6.9	58.4	8.1	11.7	14.9	5.4	41.6	4.4	2.6	11.1	80.4	11.7	12.7	3.7	1.9	49.2	2.2	0.6	19.2	320.7	4.1	22.5	6.1	9.1	6.4	9.3	13.9	23.9	10.2	22.9	3.8	18.7	8.3	12.1	3.1	2.2	5.6	8.6	8.3	32.0	26.3	0.0	28.9	0.0	0.0	0.0	6.0	1.7	9.3	2.8	5.5	0.0	4.2	1.7	0.0	41.2	7.5	3.5	1.9	0.0	7.6	0.0	13.1	412.2	22.6	0.0	0.1	1.4	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	14.4	0.6	0.7	2.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.5	0.0	0.0	3.8	2.6	20.4	0.6	1.6	14.2	0.5	0.7	0.0	0.0	0.0	40.7	0.0	171.0	2.3	0.5	0.0	0.0	88.5	0.0	13.7	0.0	0.0	0.0	5.2	0.0	4.3	0.0	6.0	5.6	0.0	0.0	2.8	4.7	0.0	0.0	0.0	28.9	0.3	1.7	4.4	2.7	2.7	4.1	4.4	2.6	3.7	1.9	4.1	3.1
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;WM-115: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036305: , HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favourable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.3	9.1	7.0	1.7	1.6	3.4	18.9	0.0	0.2	0.7	0.2	5.2	3.0	0.0	2.8	0.0	14.9	3.1	7.3	0.3	61.2	2.3	2.9	3.5	0.1	0.0	0.2	5.5	0.4	5.8	0.0	1.3	0.0	0.8	0.0	0.1	18.7	0.2	0.1	4.4	0.2	2.1	8.6	0.0	5.4	6.7	4.1	12.5	2.2	21.0	13.5	7.0	0.3	0.0	1.2	4.2	0.0	5.5	0.0	0.3	0.0	0.5	0.1	59.0	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125838-37175054	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 104.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 14.7;NK-cell: 51.6"	"Group enriched"	"Detected in many"	32	"NK-cells: 51.6;T-cells: 14.7"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Low region specificity"	"Detected in all"			HPA062657	Enhanced									"HPA062657: "	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favourable (6.76e-4)"	"prognostic favourable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	2.2	1.0	0.8	20.5	0.8	12.3	1.6	0.6	0.7	1.3	5.5	0.6	1.4	1.8	4.3	2.8	2.6	1.8	5.8	3.7	0.7	0.8	1.9	6.0	7.4	20.8	0.8	0.2	1.5	1.0	0.0	1.1	58.5	0.7	3.5	1.8	2.9	3.7	2.1	0.9	4.0	7.3	0.6	1.1	35.0	2.3	1.1	0.2	21.0	2.1	1.8	28.7	4.0	1.5	0.3	0.0	1.0	0.1	51.6	14.7	7.9	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	104.1	0.1	0.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.1	7.5	12.8	0.0	0.1	0.0	0.1	1.0	0.0	0.1	14.7	0.1	8.1	0.1	3.3	8.2	0.0	0.3	1.1	4.3	0.3	51.6	0.1	0.0	6.8	7.9	0.8	0.8	0.6	0.7	0.7	0.8	0.8	0.2	0.7	0.2
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain family member 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"placenta: 58.6"	"Cell line enriched"	"Detected in some"	6	"WM-115: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"			"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	42.6	2.4	3.7	15.2	5.0	0.0	33.7	2.9	5.1	8.1	9.4	3.6	4.4	4.1	12.0	8.6	6.9	3.4	18.8	4.8	4.4	4.0	5.3	2.3	6.9	3.2	4.4	4.3	7.2	4.4	1.4	3.1	58.6	4.6	11.0	5.3	12.7	3.4	16.2	4.7	4.1	5.7	37.5	3.9	2.2	5.6	4.0	2.2	0.0	6.4	5.2	5.5	24.0	11.7	0.8	0.4	1.4	0.5	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	47.1	1.4	0.3	0.3	0.4	0.4	0.5	0.4	0.6	0.4	0.2	0.8	0.6	0.5	1.0	0.5	0.5	0.4	0.5	0.1	3.7	5.0	2.9	5.1	4.4	4.0	4.4	4.3	4.6	2.2
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639272-25717562	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.7"	"Cell line enhanced"	"Detected in some"		"AF22: 18.9;BJ hTERT+: 12.0;HDLM-2: 11.8;U-138 MG: 13.6;U-87 MG: 10.0"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"			17000	"Plasma membrane"	Nucleoplasm	"HPA028789: , HPA077346: "	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	16.6	17.2	13.8	8.4	18.9	1.5	14.6	9.9	23.4	18.1	14.7	14.5	8.0	7.5	20.5	13.5	13.3	12.0	14.4	21.9	13.5	12.5	6.5	3.5	17.1	4.6	17.6	13.5	18.9	3.9	5.8	7.7	66.7	18.5	12.0	9.7	11.1	5.5	18.0	8.4	6.9	9.2	21.8	23.0	2.8	9.7	25.8	12.2	0.6	9.5	10.1	6.3	13.5	15.1	3.1	1.9	1.9	0.7	2.8	1.1	0.4	0.0	0.0	18.9	0.1	0.7	0.2	0.4	0.5	12.0	1.5	5.7	0.0	0.0	0.1	0.0	0.2	0.1	1.6	0.0	3.5	11.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.3	0.0	0.0	0.0	0.2	5.8	0.1	0.3	0.1	6.0	0.0	2.2	3.9	0.1	0.0	0.0	0.3	2.8	0.1	0.2	0.0	0.7	0.1	0.0	13.6	1.3	0.1	1.9	1.5	0.0	0.0	10.0	0.1	0.5	1.4	0.7	0.3	0.4	0.5	0.6	0.3	0.4	0.9	0.4	3.1	0.7	1.1	1.9	2.8	0.6	1.9	0.2	0.4	13.8	18.9	9.9	20.5	13.5	12.5	17.6	13.5	18.5	12.2
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol				Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	26.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	10.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 75.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"				"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: "	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	13.2	7.9	16.2	14.0	22.6	9.1	22.7	16.7	26.0	11.7	12.2	10.7	10.5	9.6	13.5	12.5	28.8	10.9	10.2	9.0	11.2	9.0	9.1	10.9	20.2	10.7	13.8	10.3	10.9	14.3	8.7	10.4	75.0	15.0	11.9	13.6	8.9	10.5	9.0	7.4	19.7	9.4	16.1	17.8	12.0	11.0	11.0	12.8	7.5	8.3	8.6	12.3	10.2	19.1	9.1	10.2	46.0	6.8	4.3	8.9	4.5	17.9	15.7	25.1	16.8	20.3	20.4	18.7	24.4	14.9	19.6	19.6	8.9	10.0	8.8	16.1	15.8	23.7	12.2	14.0	23.2	18.0	6.6	15.5	16.6	10.5	14.2	16.2	16.8	12.1	20.7	13.3	26.2	35.0	16.5	18.4	26.6	8.7	10.1	13.3	18.4	12.5	15.7	15.3	8.2	18.1	24.2	14.2	12.7	15.0	11.0	7.2	13.6	19.4	20.0	26.7	13.7	23.6	19.3	11.5	15.4	18.0	23.9	17.7	19.8	16.5	6.8	10.3	7.0	6.3	8.9	8.5	7.7	7.2	7.4	9.1	8.6	7.6	46.0	4.3	4.0	10.2	6.3	4.5	16.2	22.6	16.7	26.0	11.2	9.0	13.8	10.3	15.0	12.8
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 45.7;salivary gland: 82.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.8;SK-BR-3: 27.5;WM-115: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 2.3"	"Low region specificity"	"Detected in some"			"HPA053841, HPA059622"	Approved									"HPA053841: , HPA059622: "	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavourable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavourable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.75e-4)"	3.0	0.1	0.5	12.2	2.5	6.5	5.6	0.4	0.5	8.0	5.7	0.7	6.4	2.0	0.9	2.9	2.6	2.6	8.8	0.6	1.4	0.5	0.8	0.3	2.6	5.7	1.7	0.6	1.3	0.3	0.0	0.3	45.7	1.5	11.0	3.8	0.8	82.3	6.8	0.7	10.8	10.0	2.0	1.1	8.4	13.6	0.9	1.0	9.1	0.7	3.6	17.3	10.3	2.4	18.7	14.4	1.9	15.8	0.0	6.9	5.2	5.1	9.5	0.0	0.0	0.0	0.8	13.5	0.2	0.7	0.5	0.1	0.1	27.8	1.4	2.2	0.2	4.1	0.0	9.8	1.4	9.3	0.0	6.8	12.5	0.2	0.0	0.0	0.1	0.0	1.2	0.6	4.4	0.0	1.5	0.8	0.1	5.0	1.4	5.2	0.0	10.3	4.6	0.1	5.1	8.5	14.4	0.0	0.0	13.8	27.5	8.1	0.0	5.5	0.3	3.8	19.7	0.1	11.1	0.0	0.3	0.6	13.1	1.2	70.6	1.9	10.2	0.0	0.3	15.8	0.4	18.7	5.1	2.6	14.4	9.4	3.4	3.2	0.5	0.0	8.6	0.4	6.9	5.2	0.5	2.5	0.4	0.5	1.4	0.5	1.7	0.6	1.5	1.0
KDELC2	MGC33424	ENSG00000178202	"KDEL motif containing 2"	Q7Z4H8	11	108472105-108498432	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"			Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: "	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (6.27e-5)"	20.8	7.8	4.2	12.7	4.7	2.7	19.7	3.6	3.2	27.2	11.1	4.8	9.7	4.1	21.8	21.1	16.1	17.6	18.0	13.3	4.1	4.2	11.4	13.5	12.5	10.0	4.6	2.7	25.6	9.5	19.8	5.1	65.0	4.6	20.6	8.0	13.4	13.0	14.5	8.1	6.9	7.3	24.4	5.0	9.9	8.9	9.5	4.4	10.0	9.2	8.7	6.5	19.5	20.0	0.9	2.0	0.2	1.5	4.5	4.6	1.0	3.1	3.6	14.1	14.4	23.8	27.7	13.5	14.0	13.1	20.1	21.9	17.2	23.4	0.0	8.8	18.2	2.3	10.6	0.3	21.3	5.6	8.2	5.3	4.0	7.9	9.6	13.7	0.0	15.9	4.4	10.6	0.3	16.9	11.8	0.1	30.4	2.3	8.8	7.9	6.1	10.4	0.4	22.0	0.0	3.7	8.8	2.9	9.0	26.5	1.8	3.8	12.7	5.3	16.8	39.0	7.7	3.3	14.5	0.1	0.0	0.0	10.0	14.5	30.9	0.1	0.3	0.0	4.6	1.5	3.9	0.5	2.3	3.8	1.1	0.9	2.4	3.6	0.2	4.5	0.7	2.0	1.9	1.0	4.2	4.7	3.6	3.2	4.1	4.2	4.6	2.7	4.6	4.4
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887199	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0"	"Group enriched"	"Detected in some"	28	"HEL: 22.6;K-562: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.5	0.0	0.3	30.6	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	1.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.2	9.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	7.0	0.0	0.1	0.0	0.0	0.8	1.2	0.0	0.6	0.0	0.3	0.5	0.5	4.7	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.6	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.2	4.7	0.0	0.3	0.0	0.1	0.5	0.1	0.1	0.2	0.5	0.0	2.9	0.0	0.0	1.6	0.5	0.3	0.1	0.4	0.2	0.1	0.2	0.0	0.3	0.0
KLF14	BTEB5	ENSG00000266265	"Kruppel like factor 14"		7	130731235-130734061	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;pancreas: 1.8;placenta: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;BJ hTERT+: 3.9;RH-30: 4.3;SK-MEL-30: 1.7"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044729	Uncertain									"HPA044729: AB_10960356"	"unprognostic (4.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.92e-1)"		"unprognostic (9.90e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	2.3	1.7		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.4	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.2	1.8	0.0		2.9		0.0	0.0		0.0	0.0	1.6	0.3	0.0	0.5		0.5	0.0	1.1			0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	2.9	0.8	3.9	1.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.7	0.5	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;liver: 58.6;placenta: 26.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;RPMI-8226: 7.6;RPTEC TERT1: 19.6;SK-BR-3: 10.1;U-698: 8.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	79	"classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	97	"B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7"	"Region enriched"	"Detected in single"	4	"thalamus: 1.3"	"Low region specificity"	"Detected in single"			"HPA031115, HPA056942"	Enhanced									"HPA031115: AB_10601924, HPA056942: "	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	3.7	0.6	0.5	3.3	0.6	0.3	2.4	0.2	0.9	0.3	0.4	0.2	0.0	0.0	2.7	0.1	0.3	0.4	0.5	0.4	0.8	0.4	14.2	58.6	6.5	3.2	0.3	0.3	0.4	0.3	0.0	0.4	26.0	0.3	0.4	0.3	0.3	0.5	0.0	0.2	0.3	1.0	0.1	0.5	8.0	0.4	0.6	0.1	0.7	0.4	0.1	4.5	1.4	0.3	20.3	11.1	0.1	14.7	0.0	0.0	2.8	0.1	1.6	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.4	0.0	0.2	5.2	0.4	0.0	2.1	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.8	0.0	0.2	0.0	2.2	0.9	0.4	1.4	0.1	7.6	19.6	4.0	0.2	0.1	0.0	10.1	0.0	3.9	1.6	0.0	0.0	0.1	0.0	1.3	0.3	0.5	8.1	0.2	1.9	1.6	0.0	5.2	0.1	0.0	14.7	0.0	16.1	0.0	0.0	5.3	20.3	0.0	0.0	0.1	0.0	14.7	11.1	0.0	2.8	0.5	0.6	0.2	0.9	0.8	0.4	0.3	0.3	0.3	0.1
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 268.7"	"Cell line enhanced"	"Detected in many"		"A549: 225.8;BEWO: 142.5;CACO-2: 248.3;CAPAN-2: 180.4;MCF7: 330.6;SK-BR-3: 182.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 10.0"	"Cell type enriched"	"Detected in many"	5	"basophil: 28.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol			140000000	Cytosol		"CAB000008: , CAB000030: , HPA001605: "	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	23.3	4.8	1.0	31.0	1.1	0.0	24.1	2.9	1.2	28.6	45.4	1.3	66.3	35.0	6.6	55.3	22.4	21.7	147.4	6.8	1.1	2.5	61.9	181.0	39.6	2.8	1.2	1.0	13.7	162.9	8.2	39.8	268.7	10.0	29.3	57.0	14.1	121.1	49.9	1.3	6.5	83.6	3.9	1.4	4.4	36.0	9.5	0.8	4.2	83.4	10.8	20.9	21.5	10.8	4.1	1.0	28.6	0.1	1.0	5.9	1.6	75.7	225.8	0.0	0.3	0.0	0.0	142.5	11.5	14.0	14.9	4.2	248.3	180.4	0.0	32.1	12.5	18.5	3.1	87.6	9.0	0.0	5.3	0.7	36.9	68.3	38.6	0.0	0.0	0.5	8.2	13.0	18.0	15.9	18.2	0.0	0.0	330.6	0.1	1.3	18.4	17.1	0.1	0.0	8.6	72.7	45.7	2.6	0.1	18.7	182.8	0.7	96.5	0.2	5.0	0.2	17.4	0.2	2.5	0.0	0.2	0.1	0.0	0.0	1.4	28.6	0.1	1.1	0.2	0.1	1.1	2.1	2.3	0.6	1.0	4.1	5.9	2.1	1.5	1.0	0.0	0.0	0.2	1.6	1.0	1.1	2.9	1.2	1.1	2.5	1.2	1.0	10.0	0.8
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 205.3;intestine: 184.9;placenta: 179.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 100.7;HBEC3-KT: 151.7;MCF7: 111.9;RT4: 161.1;SK-BR-3: 284.6;T-47d: 191.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.7"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"			330000000	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	9.8	1.6	0.7	22.8	0.9	0.0	50.1	2.9	0.8	37.4	126.7	1.0	38.0	37.8	9.9	53.0	102.1	19.5	205.3	2.3	0.8	0.2	35.0	2.1	50.6	0.7	0.8	0.8	16.7	7.5	1.2	2.6	179.4	1.3	39.2	40.1	1.8	103.0	46.3	0.7	15.8	184.9	11.7	0.6	0.6	69.1	6.4	0.7	33.3	4.9	21.2	89.2	77.0	35.4	0.0	0.0	0.0	0.0	2.7	0.6	0.2	0.1	17.6	0.0	0.3	0.0	0.0	61.6	21.2	0.0	0.6	0.1	50.6	100.7	0.0	20.8	10.1	53.9	0.0	151.7	0.1	0.0	0.5	0.0	11.4	34.6	1.6	0.0	4.3	0.0	27.6	0.4	0.0	1.3	7.3	0.1	0.0	111.9	0.2	0.1	0.9	25.6	0.1	0.0	0.3	69.5	161.1	2.1	0.0	0.1	284.6	0.0	191.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.7	0.9	2.9	0.8	0.8	0.2	0.8	0.8	1.3	0.7
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922696-40937634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.3;salivary gland: 99.8;skin 1: 48.2"	"Group enriched"	"Detected in some"	9	"HBEC3-KT: 20.7;Hep G2: 12.8;T-47d: 35.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	12	"neutrophil: 30.1"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"			170000	"Intermediate filaments"	Cytosol	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (8.26e-4)"	0.3	0.0	0.2	0.5	0.2	0.5	10.0	0.3	0.3	9.8	0.2	0.2	2.1	0.0	1.1	1.2	2.5	1.5	4.5	0.2	0.2	0.0	0.3	0.6	1.1	0.6	0.2	0.2	0.6	1.2	0.0	0.9	128.3	0.2	6.9	0.0	0.3	99.8	2.8	0.3	48.2	0.2	0.3	0.2	1.0	0.0	9.1	0.2	2.0	0.3	11.7	9.5	2.3	3.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.3	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2	0.2
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 117.7;HBEC3-KT: 262.1;RT4: 312.5;SiHa: 246.4;SK-BR-3: 143.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments"			350000000	"Intermediate filaments"		"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (9.42e-5)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	99.7	0.0	0.0	0.1	0.0	117.7	21.4	0.0	11.2	1.0	0.3	71.2	0.0	0.0	7.3	78.5	0.0	262.1	0.5	0.1	0.0	0.0	53.5	0.3	2.5	0.0	0.0	0.0	16.3	0.0	105.7	11.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.2	1.5	64.7	312.5	0.1	0.1	246.4	143.9	0.0	5.5	0.0	85.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA031686: "	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	40.1	0.1	0.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.7	0.5	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	44.8	27.2	0.5	0.1	0.2	3.9	3.2	23.5	0.1	0.0	0.1	0.2	0.3	20.5	0.0	2.4	0.1	0.1	0.0	0.2	0.1	0.6	20.7	0.1	0.0	22.2	3.3	0.2	11.1	5.7	0.3	1.3	0.1	19.6	0.0	0.1	0.0	0.0	70.2	4.6	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194831-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.2;placenta: 34.0"	"Cell line enriched"	"Detected in some"	25	"NTERA-2: 75.0"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 8.1"	"Lineage enriched"	"Detected in single"	17	"monocytes: 8.1"																				"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.6	0.8	0.2	18.2	0.4	0.0	0.7	0.4	0.2	1.6	6.9	0.0	0.3	0.1	0.3	0.4	0.4	0.4	0.3	0.3	0.2	0.2	0.4	0.2	3.1	1.6	0.2	0.1	1.3	0.3	0.0	0.4	34.0	0.7	2.4	1.6	1.5	0.7	0.1	0.6	0.3	0.6	0.5	0.2	2.9	0.4	8.5	0.0	0.4	2.4	0.1	0.1	1.6	1.3	0.4	0.3	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.7	0.0
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883141-129516569	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.7;placenta: 71.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 65.2;ASC TERT1: 47.5;HHSteC: 14.2;HSkMC: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 2.2;T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"		38000000			"CAB040310: , CAB078182: "	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (3.65e-5)"	35.3	7.4	1.7	3.5	8.1	0.9	38.9	6.4	3.8	22.0	10.4	1.7	6.3	2.0	13.3	12.8	17.1	17.7	13.6	65.7	2.1	1.5	3.6	3.8	17.1	8.8	4.7	3.3	33.0	5.4	2.1	7.0	71.2	6.2	8.2	4.2	3.5	9.4	7.5	26.1	8.2	7.2	26.8	6.9	7.3	10.2	16.7	5.4	0.0	9.6	9.2	1.4	18.5	22.1	0.1	0.1	0.0	0.0	2.2	2.2	0.1	0.0	0.0	0.7	0.0	65.2	47.5	0.0	6.4	2.3	0.1	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	39.9	0.0	3.3	0.0	0.0	0.0	0.2	10.8	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.2	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.0	2.2	0.0	0.0	0.5	0.1	1.7	8.1	6.4	3.8	2.1	1.5	4.7	3.3	6.2	5.4
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 150.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	16.9	2.1	0.0	0.0	0.9	0.1	0.0	0.3	0.2	0.1	0.2	0.7	19.6	0.0	2.2	0.2	31.0	0.0	150.6	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.1	16.9	0.1	17.8	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.0	0.3	0.0	0.0	6.6	1.9	0.0	0.3	0.7	0.2	0.0	0.5	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009082-131094473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.8;testis: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;EFO-21: 20.1;Hep G2: 7.3;SiHa: 7.4;U-2 OS: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022814	Enhanced				"Secreted to extracellular matrix"		240000			"HPA022814: "	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.3	9.5	1.0	0.9	2.0	0.6	1.6	0.8	3.0	23.5	1.3	2.4	2.2	1.0	6.0	5.1	1.2	1.2	9.1	0.9	1.4	1.0	8.8	3.7	15.6	0.6	1.7	2.1	1.3	3.3	0.9	8.8	50.8	3.6	7.0	0.7	7.5	1.8	4.9	0.7	6.2	0.6	10.7	1.9	17.0	1.0	32.5	0.8	0.0	1.1	2.4	0.5	13.8	12.4	0.7	0.2	1.7	0.3	0.3	0.8	0.1	0.0	0.7	5.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.1	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.7	7.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	2.8	0.5	0.0	0.0	0.2	0.0	0.0	0.5	0.1	7.4	0.0	3.2	0.0	0.6	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.2	0.3	0.3	0.2	0.0	0.2	0.7	0.5	0.1	0.2	0.4	0.8	0.5	1.7	0.3	0.1	0.2	0.5	0.1	1.0	2.0	0.8	3.0	1.4	1.0	1.7	2.1	3.6	0.8
LARGE2	"FLJ35207, GYLTL1B, PP5656"	ENSG00000165905	"LARGE xylosyl- and glucuronyltransferase 2"	Q8N3Y3	11	45921621-45929096	"Predicted intracellular proteins"		"Glycosyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 38.9;placenta: 29.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.4;NTERA-2: 16.3;SK-BR-3: 11.7;T-47d: 35.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 2.1"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5;naive B-cell: 5.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA056621	Approved				"Intracellular and membrane"					"HPA056621: "	"unprognostic (9.82e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.94e-2)"	"prognostic favourable (3.04e-12)"	"unprognostic (2.31e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	0.2	1.4	0.2	2.8	0.2	0.1	2.8	0.2	0.4	3.5	0.8	0.8	16.0	0.6	1.6	8.3	10.5	2.5	0.4	0.4	0.4	0.1	12.2	1.7	2.5	2.8	0.2	0.2	1.8	38.9	9.5	6.6	29.6	2.1	5.8	0.2	14.8	20.7	12.7	0.2	11.1	2.3	0.7	0.2	1.6	5.2	1.2	0.2	2.0	8.1	3.9	8.1	1.3	3.7	5.8	0.0	0.1	0.0	0.8	1.1	0.2	0.6	0.7	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	4.1	0.3	0.0	0.4	0.0	4.0	0.0	7.4	0.0	0.0	2.3	0.0	0.5	4.5	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.7	0.0	0.0	1.3	0.1	0.0	16.3	0.5	0.4	0.0	1.5	0.2	0.3	4.8	0.5	0.1	11.7	0.0	35.6	0.0	0.0	0.1	5.4	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	3.5	0.3	0.9	0.0	5.8	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.2	2.1	0.2
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439770-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 15.8;SH-SY5Y: 46.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.1"	"Region enriched"	"Detected in some"	8	"olfactory region: 41.8"	"Low region specificity"	"Detected in many"			HPA012530	Approved									"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favourable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	2.3	2.2	3.5	0.8	18.1	0.4	2.1	0.9	9.5	2.2	4.2	24.5	0.0	6.1	4.9	1.7	0.6	19.9	0.8	0.8	5.0	3.4	0.9	1.4	1.4	0.4	32.3	5.1	1.5	0.6	1.0	2.0	21.6	10.8	1.8	4.6	0.9	3.1	9.0	26.6	4.0	6.5	0.7	15.0	0.6	2.9	0.7	25.7	0.0	0.9	0.9	2.1	0.7	1.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.4	15.8	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	6.3	0.1	46.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	18.1	0.9	9.5	5.0	3.4	32.3	5.1	10.8	25.7
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 30.7;HaCaT: 47.1;RPTEC TERT1: 31.3;TIME: 61.1"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in all"			HPA016966	Uncertain				"Secreted to blood"	656750000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.5	30.7	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.3	4.8	0.0	7.5	0.0	47.1	2.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	10.8	4.8	9.4	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.7	31.3	3.6	0.2	0.0	0.2	0.3	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474148	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 17.7;placenta: 22.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.3;fHDF/TERT166: 23.4;HBF TERT88: 12.9;LHCN-M2: 23.2;RT4: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.72e-4)"	2.6	1.0	8.7	1.8	7.9	0.4	14.6	3.3	8.2	2.0	4.4	4.3	1.1	2.8	4.0	1.0	1.2	2.9	17.7	1.4	6.2	11.5	3.4	0.8	1.3	0.8	6.2	5.3	1.4	3.2	2.6	0.9	22.7	7.2	2.5	4.1	2.8	0.8	2.6	0.7	1.4	5.6	4.7	5.1	1.3	6.2	4.5	2.6	0.0	0.6	0.0	2.3	4.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.4	18.3	0.0	0.0	0.2	7.4	3.2	9.5	6.0	0.1	1.5	0.0	0.4	23.4	1.9	2.6	0.0	12.9	0.0	0.8	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.7	0.1	0.0	0.0	23.2	2.9	0.0	1.7	2.6	2.1	0.0	10.1	0.0	1.1	19.1	0.7	3.3	5.0	5.7	0.6	0.7	0.3	0.0	0.2	2.9	0.2	4.0	0.0	0.0	0.0	1.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.7	7.9	3.3	8.2	6.2	11.5	6.2	5.3	7.2	2.6
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216511	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 114.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 30.7;SK-MEL-30: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.9;NK-cells: 14.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: "	"prognostic favourable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	45.8	15.4	5.0	10.7	10.7	18.8	32.9	4.1	10.4	16.5	14.7	5.1	6.4	5.1	17.1	4.9	21.5	18.3	27.2	17.2	5.2	5.4	8.6	16.5	31.5	2.9	9.8	1.5	24.5	12.4	3.5	6.2	114.6	12.6	20.1	6.9	5.9	8.8	34.0	60.7	14.3	8.6	15.0	6.5	4.2	13.9	6.9	8.4	0.9	11.3	10.3	8.2	28.6	34.4	0.6	0.9	16.9	2.2	14.1	2.2	1.2	7.3	1.2	1.7	2.6	2.7	8.5	7.7	15.0	20.8	7.7	8.3	2.2	6.1	0.2	1.4	6.4	5.0	0.4	6.0	13.0	1.4	0.2	0.8	0.7	1.9	7.1	0.5	2.7	3.7	10.0	30.7	17.1	16.1	1.4	7.2	5.9	1.7	0.3	1.9	1.2	6.1	0.5	1.4	1.5	7.7	11.4	0.9	1.3	2.2	6.0	36.5	1.3	0.5	20.9	9.7	7.2	7.1	5.0	2.7	2.8	0.3	14.7	0.6	6.1	16.9	0.3	0.2	2.2	0.5	2.1	0.6	1.2	1.5	0.9	0.4	1.6	1.2	5.9	14.1	2.2	0.1	0.5	1.2	5.0	10.7	4.1	10.4	5.2	5.4	9.8	1.5	12.6	8.4
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530714-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 62.4"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB026820: , HPA060841: "	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	15.7	14.3	12.6	12.4	20.1	16.3	13.0	4.2	12.5	9.3	18.0	13.5	6.7	18.2	14.7	5.0	10.1	10.2	12.7	30.9	13.2	11.8	10.5	10.9	18.7	8.7	19.7	11.0	7.2	34.9	6.0	8.7	62.4	14.5	16.1	5.1	6.7	11.0	12.0	26.8	12.8	16.8	26.1	12.1	11.3	13.2	4.1	13.1	22.8	9.1	9.7	7.5	13.7	19.0	1.9	5.1	3.6	1.7	1.5	2.6	1.4	20.0	14.4	0.5	2.1	1.6	2.0	11.0	13.3	7.6	3.3	2.3	10.3	5.6	4.7	4.9	3.3	15.6	1.2	3.8	1.4	7.2	10.5	2.7	18.4	7.5	3.7	6.4	8.7	2.0	5.0	5.4	4.1	2.9	7.0	2.6	1.5	13.2	7.2	23.1	4.6	14.6	10.9	0.5	7.9	3.0	8.3	6.2	2.3	8.0	23.8	5.8	9.2	8.6	6.9	5.0	34.8	25.0	7.3	5.0	1.5	7.8	6.6	9.0	7.1	1.7	1.6	3.6	2.1	0.8	2.3	1.4	1.2	2.5	0.7	1.9	2.6	2.0	2.2	1.5	1.7	5.1	2.2	1.4	12.6	20.1	4.2	12.5	13.2	11.8	19.7	11.0	14.5	13.1
MAP1LC3C	ATG8J	ENSG00000197769	"Microtubule associated protein 1 light chain 3 gamma"	Q9BXW4	1	241995490-241999073	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;ASC TERT1: 8.6;BEWO: 5.8;EFO-21: 5.1;LHCN-M2: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA072670			Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA072670: "	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.44e-3)"	"prognostic unfavourable (1.34e-7)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.73e-2)"	12.2	0.8	0.5	1.4	0.7	0.1	13.4	0.5	0.9	0.3	4.4	0.2	0.7	0.4	0.5	1.9	8.9	3.5	1.5	1.8	0.3	0.1	0.7	0.4	9.0	5.4	0.5	0.3	4.4	0.4	0.5	2.0	17.9	0.6	0.7	0.5	4.7	7.8	0.2	5.7	5.5	2.6	0.9	0.9	1.4	4.3	1.2	0.5	0.1	2.3	7.1	5.0	6.5	3.5	1.0	0.8	2.6	2.5	0.4	0.5	0.1	0.2	0.1	9.0	0.1	0.3	8.6	5.8	0.1	0.0	0.3	0.4	0.8	0.0	0.1	5.1	2.4	0.0	0.2	0.2	0.3	0.0	1.7	0.4	0.4	0.3	0.0	0.1	0.2	2.3	0.0	0.1	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.3	2.8	0.1	0.0	2.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	2.3	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	2.6	0.6	0.4	0.4	1.2	0.3	0.6	0.3	0.5	0.2	1.0	0.2	0.4	1.2	0.4	2.5	0.8	0.1	0.1	0.5	0.7	0.5	0.9	0.3	0.1	0.5	0.3	0.6	0.5
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992111-20012694	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.5;placenta: 16.6"	"Cell line enriched"	"Detected in many"	6	"Hep G2: 55.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.9;hypothalamus: 3.2"	HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"			"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: "	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.4	1.3	6.6	1.0	5.1	0.3	3.4	1.8	7.9	4.1	1.0	2.4	2.6	0.9	2.7	1.8	1.4	2.6	3.4	0.9	6.2	4.9	4.1	0.4	19.5	0.7	8.6	3.7	1.1	1.3	0.4	0.3	16.6	7.4	2.7	1.0	1.9	0.8	7.2	0.5	0.9	0.8	2.8	7.9	0.7	2.8	1.6	6.0	0.0	1.7	0.0	0.7	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	1.9	6.4	0.0	1.8	4.0	0.4	0.7	0.4	2.6	3.3	1.8	1.0	0.0	0.3	0.6	0.4	0.1	4.9	3.7	0.0	0.1	0.0	0.4	55.1	0.4	0.0	0.0	8.7	0.3	2.8	0.6	3.4	0.0	0.0	5.4	0.9	0.0	0.0	1.9	0.9	0.0	0.0	0.0	7.8	1.7	0.0	0.8	4.1	0.7	2.4	7.6	0.0	1.9	3.8	4.7	0.1	0.4	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.1	1.8	7.9	6.2	4.9	8.6	3.7	7.4	6.0
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192918161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 34.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 6.6;T-reg: 5.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Uncertain		Approved	Cytosol				Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	5.7	6.0	4.4	4.4	6.9	1.6	5.1	11.1	10.9	5.8	6.9	5.6	2.7	12.0	7.3	2.9	3.2	5.3	10.1	7.6	3.9	5.0	5.8	2.3	5.9	3.1	4.4	3.5	6.5	2.8	5.6	8.6	34.9	4.6	4.9	4.3	4.0	3.1	3.9	4.9	8.6	15.7	7.8	3.5	3.0	5.1	11.4	3.3	1.2	3.3	2.5	2.5	8.7	5.0	0.3	0.6	0.0	0.6	0.0	6.6	1.8	9.6	1.4	2.4	7.2	1.5	2.3	4.3	7.0	6.6	12.7	7.6	6.2	1.5	0.0	4.2	17.2	4.3	5.4	1.8	13.9	42.1	3.0	1.2	0.7	0.7	2.9	0.1	0.6	2.9	2.8	3.5	2.2	2.4	0.0	0.6	2.2	7.2	0.1	0.0	5.0	17.4	0.2	4.0	2.0	2.9	5.5	3.7	1.9	1.5	4.8	0.7	7.5	0.1	0.8	2.4	7.2	4.2	13.4	18.7	14.7	0.0	1.7	1.4	3.2	0.0	0.3	0.0	0.3	0.6	2.9	0.3	6.6	1.7	0.6	0.0	4.2	1.2	0.0	0.0	0.0	0.0	5.5	1.8	4.4	6.9	11.1	10.9	3.9	5.0	4.4	3.5	4.6	3.3
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 38.9;Hep G2: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.6	10.4	1.8	14.7	1.9	5.1	7.5	0.9	1.6	3.8	5.9	2.8	10.8	4.0	4.8	25.8	9.6	4.6	4.6	14.2	1.6	1.9	5.6	23.5	12.0	16.2	3.0	1.1	5.5	10.4	2.4	6.3	67.0	1.8	5.4	4.7	2.8	5.5	6.1	1.6	5.5	9.7	6.7	3.5	15.2	5.2	23.8	1.9	18.6	3.5	7.9	10.8	8.3	8.3	18.1	12.3	7.2	14.0	13.4	12.5	6.2	2.2	0.0	2.8	0.4	0.5	1.2	5.1	0.1	1.0	0.3	0.0	38.9	7.2	10.2	0.2	0.4	2.5	6.3	2.6	0.2	1.0	2.4	9.1	8.4	53.4	0.5	10.1	3.3	0.5	2.3	0.0	1.1	0.3	0.8	2.9	0.5	6.0	17.2	3.8	0.4	0.5	16.5	3.4	5.8	1.8	5.9	1.0	3.4	4.7	2.7	1.4	1.0	2.6	1.2	2.0	0.4	2.6	2.1	5.9	3.9	15.0	0.4	6.8	6.4	7.2	5.9	3.7	12.5	6.9	11.1	15.0	7.7	8.6	6.2	18.1	7.8	8.7	0.9	13.4	14.0	12.3	1.5	6.2	1.8	1.9	0.9	1.6	1.6	1.9	3.0	1.1	1.8	1.9
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.8;placenta: 193.5"	"Cell line enriched"	"Detected in many"	6	"AN3-CA: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	44.9	26.0	7.8	4.7	12.9	3.4	63.8	2.6	22.7	2.4	7.5	3.4	1.1	7.9	7.3	4.6	2.6	5.2	6.6	3.7	7.9	8.0	6.7	13.7	18.8	4.1	3.3	9.0	7.8	13.0	2.5	15.4	193.5	15.5	4.1	6.1	8.4	7.0	2.5	2.2	2.1	7.2	5.3	3.2	22.4	3.0	10.1	3.3	2.0	4.3	2.5	1.9	4.5	3.7	3.1	6.7	8.6	2.0	2.7	18.8	5.3	3.1	1.7	8.3	513.1	0.1	0.0	0.0	3.5	1.6	3.6	1.7	9.8	4.8	1.5	1.1	0.1	0.4	0.1	0.0	1.4	0.0	0.0	2.7	2.6	1.6	14.1	0.1	0.0	0.2	0.1	2.7	0.0	1.3	3.0	0.0	6.9	4.4	0.3	3.4	5.2	0.8	0.0	92.3	1.0	3.9	2.9	29.2	0.0	3.0	10.0	0.0	0.3	2.3	1.3	1.2	0.0	11.5	0.2	0.1	0.3	0.0	4.4	0.0	0.4	8.6	1.9	6.2	0.7	2.0	1.7	3.1	2.0	1.4	6.7	2.8	7.6	18.8	1.1	2.7	1.2	0.3	0.1	5.3	7.8	12.9	2.6	22.7	7.9	8.0	3.3	9.0	15.5	3.3
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.1;ASC TERT1: 49.6;HUVEC TERT2: 50.7;SH-SY5Y: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA007354	Enhanced				"Secreted to extracellular matrix"					"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	13.1	1.6	0.2	6.0	0.4	0.0	20.8	0.4	0.8	24.8	5.0	0.5	6.7	1.6	28.7	14.0	5.7	6.6	29.7	29.6	0.6	0.3	3.4	0.8	12.5	1.2	0.3	1.0	23.6	33.9	0.0	4.7	51.7	1.8	16.9	1.7	15.4	6.9	5.0	4.6	10.9	4.3	18.3	2.9	1.3	3.5	10.4	0.3	0.7	3.8	7.4	3.3	10.3	13.2	0.3	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.0	18.7	0.0	48.1	49.6	1.2	4.7	19.7	7.4	14.5	4.3	0.2	0.0	16.4	16.5	0.0	1.3	1.5	3.0	0.0	14.6	0.0	6.9	0.4	4.5	0.0	0.0	20.3	3.7	20.9	8.3	50.7	0.0	3.1	3.6	2.2	0.0	0.0	21.9	0.1	0.2	0.0	0.6	0.2	0.0	1.0	42.6	1.6	7.1	1.8	2.4	2.5	14.1	13.0	27.1	10.4	0.5	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.8	0.6	0.3	0.3	1.0	1.8	0.3
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 52.2;BJ: 18.9;EFO-21: 45.8;HeLa: 17.3;LHCN-M2: 15.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010553	Enhanced				"Secreted to extracellular matrix"		3800000			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (5.81e-4)"	44.3	3.2	0.6	3.3	0.7	0.3	21.8	0.5	0.5	71.5	11.2	0.5	18.2	1.4	78.4	34.0	31.3	9.0	6.8	16.5	0.7	0.6	1.9	3.0	3.3	3.3	0.6	0.4	4.7	1.4	0.2	1.7	128.1	0.7	7.6	11.0	0.9	6.0	13.5	19.6	13.0	9.0	37.0	3.4	1.0	7.9	12.3	0.3	1.0	13.1	35.0	4.5	46.3	21.1	1.1	1.2	5.3	2.4	0.6	1.2	0.8	0.4	1.6	0.4	0.8	9.0	3.8	52.2	18.9	0.3	0.2	0.3	0.6	0.3	0.1	45.8	5.8	2.7	0.1	3.9	0.0	0.1	0.1	0.4	17.3	0.5	0.1	0.3	0.2	2.6	1.3	2.2	0.0	0.0	0.7	1.1	15.8	0.2	0.5	0.2	0.9	0.8	0.3	0.4	1.8	1.9	0.7	0.2	0.2	0.5	0.2	0.3	7.2	0.2	0.6	3.3	6.6	13.8	0.8	0.6	0.5	0.6	1.8	0.2	0.0	5.3	2.4	2.0	0.7	1.9	1.2	0.4	0.4	0.4	1.2	1.1	1.2	0.5	3.1	0.6	1.4	1.0	0.1	0.8	0.6	0.7	0.5	0.5	0.7	0.6	0.6	0.4	0.7	0.3
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.5;THP-1: 58.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.4	6.6	3.1	0.6	0.0	2.0	3.9	4.5	5.4	0.2	1.1	13.0	1.2	1.0	5.2	4.3	7.5	3.5	1.6	2.1	1.5	0.0	0.0	10.5	2.3	7.7	3.5	4.7	18.5	7.6	1.1	0.0	3.3	2.0	0.2	3.5	3.5	3.5	1.6	2.5	6.5	3.0	0.7	6.1	1.6	2.4	1.5	11.1	1.1	0.5	58.2	0.7	1.0	1.9	3.3	8.5	0.6	1.1	2.9	10.4	8.8	3.2	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3
MFSD2B		ENSG00000205639	"Major facilitator superfamily domain containing 2B"	A6NFX1	2	24010081-24063321	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.4;brain: 7.5;placenta: 7.5"	"Group enriched"	"Detected in some"	14	"HEL: 12.8;K-562: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 7.5"	"Cell type enriched"	"Detected in some"	4	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044145	Enhanced									"HPA044145: "	"unprognostic (5.67e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.84e-1)"	"unprognostic (5.35e-5)"	"unprognostic (2.82e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.87e-6)"	"unprognostic (7.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-1)"	0.2	0.1	0.1	0.6	7.5	17.4	0.2	0.1	0.3	0.3	0.4	0.0	1.1	0.3	0.5	0.3	0.1	0.2	0.2	0.5	0.1	0.4	0.1	0.4	3.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	7.5	0.3	1.2	0.2	0.2	1.0	0.1	0.5	0.2	0.2	0.1	0.3	2.3	0.2	2.0	0.0	0.1	0.1	0.0	0.4	0.8	1.8	0.0	0.2	5.5	0.0	0.2	0.0	3.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	5.5	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.0	3.4	0.1	7.5	0.1	0.3	0.1	0.4	0.3	0.0	0.3	0.0
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 34.3;PC-3: 43.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"			Vesicles	Cytosol	"HPA055174: "																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724533-174730893	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7;urinary bladder: 18.2"	"Cell line enriched"	"Detected in some"	6	"BEWO: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 6.9"	"Low region specificity"	"Detected in single"			HPA005652	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.0	0.4	0.3	0.4	0.5	0.0	7.6	6.3	1.6	2.6	0.9	2.0	0.0	0.3	6.2	0.2	0.9	1.1	1.5	1.7	2.5	0.5	0.3	0.1	0.9	0.1	1.5	1.2	0.4	0.6	9.4	0.5	44.7	7.2	6.3	0.1	6.6	0.9	0.8	2.1	6.4	0.9	10.4	6.6	1.1	2.6	5.2	1.3	0.0	0.8	0.2	0.3	18.2	2.4	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	1.0	0.2	0.8	0.0	0.0	83.8	0.5	0.9	0.2	0.0	14.2	5.8	0.0	2.2	0.0	1.5	4.5	1.6	0.0	0.0	2.7	0.0	0.3	0.0	0.6	0.0	0.7	0.9	1.1	0.8	0.9	0.0	0.0	0.0	1.2	6.9	0.0	0.1	0.6	2.2	0.0	2.2	0.0	1.0	8.9	0.0	0.6	0.0	11.0	0.7	6.6	0.0	0.0	0.2	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	6.3	1.6	2.5	0.5	1.5	1.2	7.2	1.3
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969720-92985066	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0"	"Group enriched"	"Detected in some"	8	"AF22: 1.1;U-138 MG: 1.4;WM-115: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"midbrain: 0.8;pons and medulla: 1.2"	HPA074024	Supported									"HPA074024: "					"unprognostic (3.61e-1)"												"unprognostic (1.43e-1)"	0.1	0.0	0.3	0.0	3.0	0.0	0.0	0.1	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1		0.0	0.0	0.0	0.0	4.5		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0			0.0		1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559033-26572233	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;K-562: 9.8;SK-BR-3: 16.7;U-266/70: 6.6;U-266/84: 17.6"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 1.3;thalamus: 1.5"	"Low region specificity"	"Detected in all"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"					"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.9	0.0	0.0	9.3	0.0	0.1	265.1	11.0	1.0	0.1	0.1	0.0	0.0	5.2	0.1	4.8	0.1	0.0	0.0	0.1	1.8	0.0	2.1	56.8	0.0	0.8	0.0	0.0	14.4	1.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	1.1	77.8	8.1	1.7	3.0	6.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.6	0.0	16.7	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	6.6	17.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940564-15947007	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 16.8"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;BEWO: 68.9;HMC-1: 16.6;NTERA-2: 26.1;RH-30: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA057420: "	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0.0	3.0	1.9	0.8	1.3	1.4	2.6	2.3	7.0	4.7	6.0	1.5	1.6	2.9	6.0	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1.0	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4.0	5.7	5.1	2.3	3.5	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	68.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	26.1	0.0	0.0	18.2	3.5	0.0	0.8	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	1.4	7.0	7.0	4.7	6.0	2.2	6.8	4.0
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129125-16148248	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 84.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favourable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (4.11e-5)"	23.4	12.5	7.3	10.3	10.6	44.2	19.5	5.4	11.4	28.5	14.4	18.9	16.4	7.5	31.8	16.1	12.1	22.2	19.1	9.0	8.6	6.1	13.1	3.5	19.0	19.4	12.9	8.8	22.3	10.5	9.8	6.1	84.0	7.4	20.1	9.7	20.2	16.2	20.9	20.6	16.7	15.7	18.0	7.0	23.5	14.8	15.2	12.2	8.8	39.1	10.9	15.7	19.0	33.7	4.9	1.4	14.2	2.3	3.2	8.4	1.5	1.9	4.0	1.6	2.0	17.1	4.6	4.4	1.4	3.4	3.4	7.5	11.4	2.1	9.1	7.3	2.2	5.1	8.0	2.5	2.9	3.3	8.3	6.1	4.3	2.1	2.5	4.2	6.1	7.3	3.3	1.7	1.4	7.9	17.6	10.8	1.3	7.6	0.1	20.6	4.8	3.7	2.0	7.8	33.5	3.7	24.3	8.5	3.6	1.7	18.6	9.4	3.4	10.3	2.3	1.6	3.9	1.2	3.5	10.0	4.4	4.8	1.0	12.1	5.4	8.5	2.3	11.1	8.4	2.2	7.3	4.9	5.3	5.9	1.4	4.9	5.9	5.4	14.2	3.2	2.0	0.7	3.2	1.5	7.3	10.6	5.4	11.4	8.6	6.1	12.9	8.8	7.4	12.2
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;MCF7: 10.6;RH-30: 10.7;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	7.9	0.0	0.0	0.0	0.0	1.6	0.5	0.7	1.0	0.0	2.4	0.2	0.0	0.0	1.2	0.4	2.0	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	6.3	1.3	0.5	0.0	10.6	0.1	0.1	5.9	0.0	5.9	10.7	2.7	0.6	1.2	0.9	0.4	0.3	37.9	2.5	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.1	6.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3
NCMAP	"C1orf130, FLJ42528, MP11"	ENSG00000184454	"Non-compact myelin associated protein"	Q5T1S8	1	24556111-24609328	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 28.8;placenta: 21.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.0;RPTEC TERT1: 3.3;T-47d: 7.9;U-266/70: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013656	Uncertain									"HPA013656: AB_2275006"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.79e-1)"	"prognostic favourable (2.83e-6)"	"unprognostic (3.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.27e-3)"	0.6	0.2	0.6	0.5	0.7	0.6	4.6	0.2	0.7	1.3	7.0	1.3	0.0	6.3	0.5	1.8	0.5	1.1	15.0	0.5	0.8	0.6	2.2	5.8	4.7	0.2	1.0	0.1	0.2	28.8	0.0	9.1	21.2	0.8	2.1	0.2	1.3	13.4	0.0	0.6	0.6	7.5	0.2	2.2	0.3	5.7	0.2	1.1	0.2	5.3	0.7	1.4	0.9	0.3	1.4	1.0	2.7	0.9	0.7	0.8	0.1	0.2	4.0	0.1	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	1.7	0.4	1.0	0.0	0.3	0.6	0.0	0.0	0.2	0.1	0.4	0.3	1.9	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.5	0.0	0.4	0.2	0.4	0.2	0.0	0.4	0.1	1.1	3.3	1.0	0.4	0.3	0.2	0.3	0.0	7.9	0.2	0.5	0.2	0.3	0.5	0.2	6.3	0.8	0.1	0.1	0.2	0.3	2.7	0.9	0.6	0.5	0.3	0.4	0.8	0.5	0.4	0.2	1.4	0.7	0.8	2.0	0.7	0.4	1.0	0.3	0.1	0.6	0.7	0.2	0.7	0.8	0.6	1.0	0.1	0.8	1.1
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 94.2"	"Cell line enhanced"	"Detected in many"		"TIME: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Approved	"Centriolar satellite"			20000000	"Centriolar satellite"		"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (3.76e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.04e-2)"	"prognostic favourable (9.82e-7)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.05e-1)"	5.6	4.0	5.4	4.4	6.0	0.0	4.5	1.3	8.9	4.6	12.6	6.5	2.8	17.8	5.0	2.2	3.5	5.4	4.4	4.8	6.3	5.0	6.9	16.4	5.6	1.9	6.0	4.1	9.2	4.7	1.9	1.9	94.2	5.5	6.9	12.6	10.7	3.4	4.8	2.3	1.8	18.9	7.2	8.9	1.8	13.2	27.6	4.5	0.4	24.1	2.0	1.4	5.4	7.7	0.1	0.0	0.3	0.0	0.2	1.7	0.7	0.0	9.9	32.9	2.1	13.3	24.7	2.0	21.6	22.9	13.4	11.5	9.1	4.6	0.0	7.2	30.6	0.1	9.2	3.1	24.7	0.2	2.4	0.0	3.5	0.6	22.5	1.5	0.3	12.5	1.3	8.9	8.6	11.2	0.0	8.7	28.9	0.0	2.1	0.0	9.2	3.6	0.0	16.3	0.0	8.4	5.2	0.8	6.0	0.4	0.0	4.5	0.3	0.1	46.6	17.0	7.1	3.1	12.9	4.8	0.0	0.0	10.7	0.0	15.7	0.0	0.0	0.3	0.1	0.0	1.2	0.0	1.7	1.0	0.0	0.1	0.3	0.4	0.0	0.2	0.0	0.0	0.1	0.7	5.4	6.0	1.3	8.9	6.3	5.0	6.0	4.1	5.5	4.5
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.9;HaCaT: 18.0;MCF7: 11.2;SK-BR-3: 23.4;T-47d: 15.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"		11000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	18.0	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.2	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.1	23.4	0.0	15.2	0.0	0.0	0.0	1.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.8"	"Cell line enhanced"	"Detected in many"		"A-431: 10.9;CAPAN-2: 9.8;HaCaT: 12.9;HBEC3-KT: 9.3;RT4: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036765	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.5	0.4	0.4	5.4	1.4	0.0	2.2	0.8	0.7	3.6	9.1	0.1	0.0	3.3	0.4	6.3	18.5	1.1	1.8	0.6	0.7	0.7	4.6	10.7	0.5	0.0	0.4	0.2	0.8	6.6	2.9	5.5	30.8	0.7	3.0	8.9	1.2	5.3	0.6	0.7	17.1	12.6	1.0	0.6	0.4	4.3	0.8	0.3	0.2	2.0	9.8	11.2	4.2	5.3	1.0	1.4	1.4	0.8	0.6	0.9	0.0	10.9	0.2	0.0	0.0	0.0	0.0	1.8	2.1	2.0	1.5	2.8	6.5	9.8	0.0	1.5	0.0	12.9	1.9	9.3	4.1	0.1	2.4	0.0	0.1	0.4	0.0	0.1	0.1	0.1	3.5	0.1	2.3	0.5	0.1	0.0	2.2	4.1	0.1	0.1	1.6	2.9	0.0	0.0	0.0	5.5	14.9	1.0	0.3	1.0	3.6	1.6	2.3	0.0	4.1	0.1	3.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	4.1	0.9	0.8	0.5	0.8	0.4	0.6	0.4	0.5	0.3	0.1	1.0	0.7	0.9	1.4	0.6	0.5	1.4	0.3	0.0	0.4	1.4	0.8	0.7	0.7	0.7	0.4	0.2	0.7	0.3
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	"Disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8;placenta: 37.1;retina: 18.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 49.8;LHCN-M2: 15.1;NB-4: 11.0;PC-3: 15.1;U-2 OS: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1"	"Lineage enriched"	"Detected in single"	81	"T-cells: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"					"HPA061318: "	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favourable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.9	0.3	4.9	2.0	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1.0	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0.0	1.1	0.9	3.1	0.0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.4	0.5	0.5	0.1	0.4	0.0	49.8	0.6	0.2	0.8	0.1	1.3	0.0	0.9	0.0	1.9	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	15.1	0.0	0.4	11.0	1.0	15.1	6.5	4.6	0.0	1.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.2	0.3	0.9	15.5	0.1	1.0	0.0	0.0	0.1	0.0	1.2	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	1.9	0.2	0.0	0.0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	7.3	0.0	19.9	0.4	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0
OC90	PLA2L	ENSG00000253117	"Otoconin 90"	Q02509	8	132024220-132059380	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9"	"Cell line enriched"	"Detected in single"	46	"SK-MEL-30: 4.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"														"unprognostic (1.92e-1)"						"unprognostic (2.93e-1)"			0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.2	0.7	1.5	0.0	0.0	0.0
OLIG3	"Bhlhb7, bHLHe20"	ENSG00000177468	"Oligodendrocyte transcription factor 3"	Q7RTU3	6	137492202-137494250	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.7;esophagus: 1.4;placenta: 1.8"	"Group enriched"	"Detected in some"	4	"AF22: 2.9;NTERA-2: 4.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA018303, CAB024865"	Uncertain									"CAB024865: , HPA018303: AB_1854796"				"unprognostic (1.07e-3)"							"unprognostic (1.44e-1)"	"unprognostic (2.77e-1)"			"unprognostic (2.03e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	1.8	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.0
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lung: 46.8;placenta: 53.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5"					"Low region specificity"	"Detected in all"			HPA050798			Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	2.0	1.9	6.0	14.1	10.3	10.6	2.0	1.3	10.2	1.9	0.5	21.3	0.0	0.8	1.0	0.9	0.5	1.2	3.9	1.1	8.5	6.7	6.9	1.8	46.8	0.5	16.4	4.4	0.4	1.6	2.8	1.9	53.4	12.3	1.4	0.7	0.2	2.0	0.7	0.4	0.5	0.8	1.2	28.5	0.6	1.4	2.8	10.5	0.0	1.5	0.0	0.6	4.3	0.4	0.5	5.9	3.3	1.5	0.3	0.3	1.1	1.8	0.1	0.0	0.1	0.0	0.0	4.4	3.1	0.5	1.9	0.7	32.0	0.0	0.3	0.0	4.1	16.8	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	33.8	0.0	0.0	0.2	15.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	64.4	25.6	0.0	7.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	1.5	2.7	0.2	0.2	0.3	0.3	0.3	0.2	5.9	0.5	0.3	0.3	3.3	0.3	0.4	0.8	0.2	1.1	6.0	10.3	1.3	7.4	8.5	6.7	16.4	4.4	12.3	10.5
OR10J3	OR10J3P	ENSG00000196266	"Olfactory receptor family 10 subfamily J member 3"	Q5JRS4	1	159313670-159314659	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"placenta: 3.3"	"Cell line enriched"	"Detected in single"	8	"LHCN-M2: 5.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042963	Uncertain									"HPA042963: AB_10961176"																		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	3.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR10Q1		ENSG00000180475	"Olfactory receptor family 10 subfamily Q member 1"	Q8NGQ4	11	58227882-58228918	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 1.3;placenta: 1.4"	"Cell line enhanced"	"Detected in single"		"HHSteC: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046968	Uncertain									"HPA046968: "											"unprognostic (4.82e-1)"		"unprognostic (6.34e-2)"	"unprognostic (4.37e-1)"				0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1			0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0		0.0	1.3	0.0	0.0	1.4		0.0	0.3		0.6	0.0	0.7	0.2	0.5	0.4	0.0	0.1	0.0	0.3			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR1E1	"HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P"	ENSG00000180016	"Olfactory receptor family 1 subfamily E member 1"	P30953	17	3397104-3398410	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.7;placenta: 1.5;testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"																								"unprognostic (1.12e-1)"										"unprognostic (1.33e-1)"			0.4	0.1	0.2	0.0	0.4	0.0	0.6	0.0	0.1	0.2	0.1			0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.3	0.3	0.3		0.0	0.0	0.0	0.0	1.5		0.0	0.0		0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	1.4			0.0		0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0										
OR51E1	"GPR136, GPR164, OR51E1P, OR52A3P"	ENSG00000180785	"Olfactory receptor family 51 subfamily E member 1"	Q8TCB6	11	4643420-4655488	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 10.0;prostate: 12.1"	"Cell line enriched"	"Detected in single"	114	"SCLC-21H: 14.1"	"Cancer enriched"	"Detected in many"	21	"prostate cancer: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB019995, HPA051439"	Approved									"CAB019995: AB_10283600, HPA051439: "	"unprognostic (6.67e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.71e-2)"	"unprognostic (4.87e-5)"	"unprognostic (3.55e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.36e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.23e-6)"	"unprognostic (2.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	7.6	0.0	0.6	1.9	0.8	0.0	5.1	0.1	0.6	0.9	2.6	0.1	0.1	0.4	2.5	0.3	0.8	0.8	0.7	4.8	0.1	0.2	1.6	0.1	0.1	1.9	0.6	0.1	1.0	0.1	0.2	1.0	10.0	0.6	12.1	1.1	0.8	4.4	0.8	2.4	0.3	2.1	1.3	1.8	0.1	0.9	0.3	0.1	0.1	0.9	0.9	0.4	1.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.1	0.6	0.1	0.2	0.6	0.1	0.6	0.1
OR5H14		ENSG00000236032	"Olfactory receptor family 5 subfamily H member 14"	A6NHG9	3	98147479-98156614	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;placenta: 2.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"																																					0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.4	0.1			0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.2	0.1		0.2	0.1	0.0	0.1	2.1		0.1	0.0		0.3	0.0	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5			0.1		0.0	0.2	0.1	0.4	0.4	2.1	0.4	0.4	0.4	0.0	0.6	0.6	0.6	0.6	0.3	0.1	0.5	0.8	0.5	0.1	0.0	0.9	0.5	0.3	0.4	0.0	0.9	0.1	0.3	0.0	0.5	0.6	0.6	1.0	0.7	0.2	0.4	0.5	0.1	0.7	0.2	0.0	0.0	0.3	1.4	0.0	1.0	0.4	0.7	0.7	1.1	0.7	0.2	0.4	0.1	1.0	0.3	0.5	0.4	0.4	0.5	0.6	0.3	0.1	0.7	1.1	0.9	0.4	0.8	0.9	0.7	0.5	0.3	0.5	2.1	0.4	0.4	0.4	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.4	0.2	0.4	0.3	0.0										
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152834693-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;placenta: 24.7"	"Cell line enriched"	"Detected in some"	5	"HEL: 29.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 29.1"	"Group enriched"	"Detected in some"	5	"basophil: 7.0;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.0;monocytes: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced									"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	2.9	1.7	4.7	5.9	29.1	4.8	2.0	3.1	6.3	6.7	8.7	4.9	0.6	3.3	8.5	0.8	19.4	2.3	2.2	2.9	8.4	2.3	1.1	1.6	10.4	2.1	1.8	6.1	9.6	3.6	0.5	2.3	24.7	2.4	8.0	6.9	2.6	5.6	2.6	7.1	8.8	6.1	4.8	3.8	2.4	1.7	1.3	3.3	3.0	1.5	9.9	3.5	3.0	9.5	0.0	0.9	7.0	4.1	0.0	0.0	0.2	0.0	0.5	4.7	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	5.8	0.0	0.0	0.5	0.0	1.0	2.6	0.8	0.2	0.0	2.3	29.6	0.0	0.0	0.0	3.4	2.7	0.4	5.8	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.1	4.3	3.6	0.0	0.1	0.8	0.0	2.0	0.7	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.5	1.2	0.0	2.5	0.0	0.0	0.0	3.0	0.0	3.4	7.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.2	4.7	29.1	3.1	6.3	8.4	2.3	1.8	6.1	2.4	3.3
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149315-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0;placenta: 31.1;seminal vesicle: 23.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: "	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	1.9	7.6	17.9	1.5	35.5	1.2	1.3	1.7	48.0	3.3	1.5	23.2	4.5	1.3	3.1	1.9	1.6	2.6	1.9	1.8	17.5	12.6	3.7	1.3	2.0	1.2	13.2	16.3	4.1	1.4	1.2	1.7	31.1	13.6	14.7	1.5	1.3	1.8	23.6	1.2	1.3	1.7	2.0	6.8	1.2	1.3	2.9	19.2	0.9	1.5	0.0	1.2	3.6	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	5.1	0.0	0.1	0.0	0.0	4.9	2.7	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.2	0.0	2.4	0.0	13.2	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	31.4	8.5	0.0	0.0	7.2	0.0	0.0	0.0	0.5	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.9	35.5	1.7	27.7	17.5	12.6	13.2	16.3	13.6	19.2
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943585-141969741	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 13.8;Karpas-707: 34.3"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.0"	"Lineage enriched"	"Detected in single"	35	"monocytes: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"		720000			"HPA051242: "	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	7.9	2.9	0.5	0.7	0.6	0.0	3.1	2.2	0.6	1.3	0.8			0.7	1.3	0.0	0.7	1.2	1.8	4.6	0.5	0.4	3.7	2.1	9.0	0.7	0.4		0.9	0.6	1.4	2.5	17.9		1.1	0.4		0.6	1.0	1.6	0.5	1.0	2.6	0.3	11.3	1.0	0.1			4.8		0.1	2.1	1.1	0.1	0.2	0.0	7.0	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	13.8	0.0	34.3	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.1	1.5	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.0	0.9	0.9	0.2	0.0	0.4	0.0	0.2	0.1	0.0	0.2	5.5	1.2	0.0	0.4	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.1	0.2										
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.8"	"Cell line enhanced"	"Detected in some"		"AF22: 29.8;EFO-21: 71.6;HAP1: 49.7;HHSteC: 44.1;NTERA-2: 23.0;TIME: 47.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"									"HPA007534, CAB008376, HPA073453"	Enhanced		Approved	Vesicles				Vesicles		"CAB008376: AB_592530, HPA007534: AB_1857718, HPA073453: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	27.7	2.0	6.3	29.8	10.9	0.5	30.3	5.0	6.7	21.4	12.8	11.0	4.1	2.5	16.8	15.3	8.9	19.8	23.7	18.6	5.7	6.5	1.9	0.8	17.8	10.4	10.0	2.4	18.4	3.9	0.7	2.3	71.8	13.5	11.3	6.4	26.6	6.0	8.6	21.9	10.0	7.6	18.6	17.5	0.7	15.1	9.7	7.9	3.2	5.7	9.7	9.9	27.3	28.9	0.4	0.2	3.1	0.4	0.3	0.4	0.1	0.0	0.0	29.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	71.6	1.7	0.1	49.7	8.8	0.0	0.1	9.1	0.0	0.0	0.0	44.1	0.0	0.0	6.0	16.5	3.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.6	8.4	7.2	0.1	0.0	0.0	0.0	0.1	17.9	0.0	0.0	1.0	0.4	0.6	0.2	0.2	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.3	3.1	0.3	0.2	0.2	0.2	0.1	6.3	10.9	5.0	4.8	5.7	6.5	10.0	2.4	13.5	7.9
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"		17	64319415-64413776	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"adipose tissue: 77.7;blood: 88.4;placenta: 65.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 118.2;TIME: 81.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 88.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004690	Enhanced									"HPA004690: AB_1078462"	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavourable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	77.7	2.5	2.2	10.2	3.3	3.8	26.5	1.2	3.6	14.2	9.2	1.6	3.7	3.5	15.2	7.6	12.3	4.7	12.2	13.8	2.2		13.4	3.5	50.2	10.7	3.0	0.3	7.4	2.3	2.7	1.2	65.7	3.7	10.2	4.9	4.6	2.9	3.0	21.2	2.0	4.8	11.6	2.8	13.9	3.4	6.4	2.0	7.8	15.7	10.0	7.8	15.2	16.2	5.0	21.0	53.3	88.4	5.2	10.0	24.2	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	118.2	0.3	8.9	0.0	0.0	4.8	1.2	0.0	1.2	0.2	2.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.2	81.3	0.1	0.0	0.1	0.0	0.5	0.9	1.0	0.2	1.0	0.0	6.2	34.8	28.9	2.8	57.2	2.7	3.6	0.3	6.7	21.0	5.0	5.4	10.0	53.3	5.2	88.4	12.0	0.2	24.2										
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810083-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.0;ovary: 106.4;placenta: 49.8"	"Group enriched"	"Detected in some"	5	"BEWO: 31.4;Hep G2: 63.9;RH-30: 21.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Low region specificity"	"Detected in all"							HPA026070	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (6.68e-3)"	2.0	29.8	10.1	1.0	51.0	0.5	4.5	9.8	22.4	4.1	2.4	5.9	0.0	0.7	9.1	2.6	1.7	5.8	1.2	2.3	9.7	9.6	1.8	2.1	1.7	0.7	3.5	16.0	106.4	1.9	7.3	24.6	49.8	21.3	1.8	1.2	0.4	2.3	2.5	1.7	1.8	1.7	4.1	4.8	1.6	2.0	12.3	7.3	0.0	2.7	0.0	2.7	2.6	2.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	21.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	10.1	51.0	9.8	22.4	9.7	9.6	3.5	16.0	21.3	7.3
PHACTR2	"C6orf56, KIAA0680"	ENSG00000112419	"Phosphatase and actin regulator 2"	O75167	6	143536845-143831185	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 60.1"	"Cell line enhanced"	"Detected in many"		"TIME: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031719, HPA031720, HPA031725"	Approved									"HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279"	"unprognostic (3.25e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.80e-1)"	"prognostic favourable (1.99e-4)"	"unprognostic (3.60e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	14.6	28.1	6.6	10.8	4.1	5.4	13.3	2.8	5.2	10.9	10.2	4.6	12.0	5.8	12.3	7.9	16.7	6.6	11.0	17.6	6.3	3.8	6.2	13.0	16.1	10.0	4.4	5.3	8.6	4.2	11.0	8.0	60.1	13.0	10.6	6.8	18.7	9.7	8.9	9.8	4.4	10.7	8.4	3.8	11.9	9.1	7.2	2.7	2.6	12.0	8.9	8.8	8.6	10.5	0.5	3.6	6.9	3.9	3.6	14.3	1.8	9.2	5.8	1.6	11.6	1.6	3.6	6.7	7.7	11.8	3.4	4.3	10.1	4.1	0.5	21.0	22.1	2.8	0.8	7.7	4.1	7.6	3.7	15.0	6.5	5.9	2.7	3.8	4.6	5.0	4.3	3.4	11.1	20.4	4.2	0.0	5.4	10.1	0.5	0.8	11.7	1.6	1.4	11.6	0.0	4.1	8.2	2.3	2.3	8.6	11.4	0.1	4.3	5.6	35.3	15.5	8.1	6.6	5.0	0.1	0.0	0.1	3.8	4.0	1.3	4.5	3.9	6.9	3.9	2.8	14.3	0.5	4.7	5.1	3.6	0.2	2.9	2.0	2.0	3.6	2.8	3.6	5.7	1.8	6.6	4.1	2.8	5.2	6.3	3.8	4.4	5.3	13.0	2.7
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 104.0"	"Cell line enhanced"	"Detected in many"		"A-431: 31.9;HaCaT: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: "	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favourable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	15.5	3.8	1.3	13.2	1.9	0.4	9.9	1.6	2.9	13.9	22.8	1.4	8.4	2.8	17.4	10.1	10.7	10.7	9.1	21.7	1.3	1.2	36.6	24.6	14.4	2.2	2.1	1.9	8.5	6.4	0.9	5.3	104.0	7.1	16.7	4.4	6.9	7.0	14.3	6.0	5.8	6.5	49.3	2.4	7.9	11.4	4.3	0.4	1.7	5.9	6.8	2.3	33.8	17.8	1.0	1.0	0.4	0.1	1.7	5.6	1.3	31.9	3.5	20.1	0.0	6.5	10.8	8.2	18.5	9.1	12.3	14.6	10.0	2.3	0.0	19.5	7.1	33.3	0.3	11.9	22.5	0.4	0.4	0.0	8.6	3.3	7.1	0.0	0.1	12.6	7.1	8.4	15.8	19.7	0.0	0.1	3.7	0.0	1.3	0.0	8.1	6.2	2.8	25.9	0.0	7.3	7.7	0.5	1.5	18.3	0.3	1.9	0.6	0.1	17.2	3.3	28.2	8.8	4.5	1.7	0.0	0.0	3.4	0.0	6.3	0.2	0.0	0.0	5.2	0.0	3.7	0.4	3.6	5.6	0.1	1.0	0.0	2.3	0.4	1.7	0.1	1.0	0.8	1.3	1.3	1.9	1.6	2.9	1.3	1.2	2.1	1.9	7.1	0.4
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 17.7;HEK 293: 7.8;LHCN-M2: 18.2;RH-30: 15.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA050074: , HPA062728: "	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.8	0.0	0.7	1.8	1.5	2.9	0.6	0.3	2.0	1.5	17.7	0.0	0.0	3.8	3.6	0.3	0.1	0.0	1.1	0.0	7.8	0.0	1.4	0.0	6.6	0.0	3.7	2.0	0.1	0.3	0.0	0.0	0.4	0.0	18.2	0.5	1.9	0.0	0.3	0.3	0.0	15.3	0.0	0.3	2.4	0.0	0.0	1.4	2.4	0.2	0.1	0.0	0.0	2.4	5.8	0.0	2.9	0.0	0.1	0.7	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 91.6;placenta: 140.9"	"Cell line enhanced"	"Detected in some"		"AF22: 19.9;BEWO: 17.4;MCF7: 22.5;PC-3: 31.7;RPTEC TERT1: 51.7;SCLC-21H: 44.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 91.6"	"Cell type enriched"	"Detected in some"	11	"myeloid DC: 22.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 22.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 92.0;olfactory region: 58.4"	HPA030156	Approved									"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favourable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	0.8	2.0	3.3	7.3	3.7	0.0	8.8	91.6	2.3	1.8	33.0	1.0	1.0	5.4	0.9	1.2	1.6	1.8	2.3	0.5	2.8	4.5	0.9	2.6	2.0	0.9	6.1	2.2	0.5	2.3	18.9	22.3	140.9	17.7	2.0	23.6	5.6	2.8	1.2	0.5	3.1	12.0	1.2	2.8	0.8	12.2	1.2	0.7	1.6	1.0	1.3	2.5	1.8	0.7	0.1	22.3	0.0	1.9	1.4	0.5	0.5	0.0	0.7	19.9	0.1	0.1	0.0	17.4	0.0	0.2	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	1.0	0.3	1.1	0.4	0.0	0.0	3.4	0.1	0.3	0.3	4.3	0.1	5.8	0.1	0.0	22.5	0.0	0.1	8.2	31.7	0.1	3.0	0.1	51.7	2.8	44.1	0.0	0.0	4.7	0.5	3.3	0.4	1.7	0.0	13.4	0.0	1.6	0.0	0.0	0.0	13.1	0.4	0.1	0.0	0.4	0.0	0.0	1.9	0.5	0.0	0.0	0.0	22.3	0.1	0.3	0.1	0.0	1.4	0.1	0.3	0.2	0.5	3.3	3.7	91.6	2.3	2.8	4.5	6.1	2.2	17.7	0.7
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 95.0"	"Cell line enhanced"	"Detected in many"		"AF22: 35.0;RH-30: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"				"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: "	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (4.94e-6)"	"prognostic unfavourable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	14.6	28.5	2.3	14.8	4.3	7.7	12.3	2.0	7.6	12.9	8.9	4.6	10.0	3.9	19.5	16.3	12.4	7.7	13.0	9.0	5.1	1.5	6.8	1.5	12.1	8.2	2.6	2.2	16.0	11.2	5.2	45.6	95.0	3.6	12.6	8.6	19.3	11.7	7.3	4.5	23.1	7.9	16.8	3.8	6.8	10.9	6.8	2.0	3.9	5.6	24.2	12.0	14.2	18.4	4.1	10.3	16.4	8.1	1.7	1.4	2.3	0.0	1.5	35.0	0.0	13.9	28.6	0.1	12.0	7.7	6.0	12.5	0.1	1.9	0.8	5.9	10.4	0.0	0.2	4.2	11.8	0.9	1.6	14.9	17.5	0.2	4.6	13.3	3.0	21.5	1.5	5.2	4.6	11.8	1.4	0.2	7.1	2.0	5.5	6.2	5.8	1.1	6.7	35.6	0.0	11.2	0.3	3.1	3.4	17.3	0.0	0.0	0.0	16.5	6.8	0.0	12.8	27.7	12.9	3.1	3.0	0.1	9.2	5.5	0.6	3.4	8.1	16.4	1.0	6.2	1.0	2.7	0.9	1.4	10.3	4.1	0.7	1.2	14.8	1.7	1.9	4.6	1.3	2.3	2.3	4.3	2.0	7.6	5.1	1.5	2.6	2.2	3.6	2.0
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917497	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 48.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.9;LHCN-M2: 66.5;RPTEC TERT1: 252.9;U-251 MG: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 4.5;granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008719	Approved				"Secreted to blood"	647333	58000			"HPA008719: AB_1858635"	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	26.7	2.4	1.0	15.5	2.1	11.3	9.7	1.6	1.5	6.9	5.8	2.9	4.9	3.8	10.7	21.2	9.1	6.5	10.7	14.3	1.3	1.0	23.3	2.3	23.4	5.5	1.6	1.5	6.8	3.7	3.6	1.8	48.4	3.1	7.5	6.7	4.5	10.6	5.0	12.2	9.0	8.1	8.4	2.5	23.8	7.8	5.8	1.3	4.8	10.9	11.6	8.2	16.3	9.3	0.1	4.5	4.5	0.4	0.0	0.0	0.3	13.0	7.0	3.0	0.1	0.2	5.0	0.1	7.9	37.2	3.2	5.1	0.1	68.9	0.0	14.7	1.1	9.0	0.0	13.3	3.7	0.7	0.0	0.0	0.3	0.1	6.1	1.1	2.6	13.3	1.6	22.2	8.6	9.2	0.0	0.0	66.5	0.0	0.0	1.7	0.8	18.3	0.0	9.0	0.0	252.9	10.3	0.0	0.0	0.0	0.3	0.2	0.0	1.8	23.3	0.2	1.6	1.7	67.9	0.0	0.1	0.1	17.9	1.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.3	1.0	2.1	1.6	1.5	1.3	1.0	1.6	1.5	3.1	1.3
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 16.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055947	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA055947: "	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favourable (2.99e-4)"	1.5	1.0	1.9	3.4	5.8	9.6	1.2	5.8	10.9	1.6	2.8	0.4	0.0	6.1	1.0	0.6	1.8	1.2	1.9	1.5	3.6	2.5	2.5	4.1	2.0	5.9	2.9	6.8	1.1	2.3	0.4	4.1	16.0	10.3	1.5	3.6	4.1	2.0	0.7	1.2	1.5	5.9	0.9	2.9	3.5	2.1	4.2	1.1	3.1	3.2	0.5	4.8	1.9	1.6	0.9	7.2	0.6	0.0	2.1	3.6	0.6	3.0	2.7	2.6	1.2	0.1	0.1	0.8	5.2	2.5	4.9	4.3	1.9	1.5	2.1	2.7	0.2	7.3	1.1	5.0	9.6	0.6	1.3	0.5	4.9	1.7	0.4	0.7	2.6	0.0	1.0	1.6	2.9	2.7	0.1	5.3	0.5	0.3	1.5	0.5	0.9	6.7	1.4	3.7	2.0	2.3	3.1	0.6	4.6	1.1	0.7	1.0	0.4	0.2	2.6	1.1	6.6	0.5	1.0	6.3	0.9	0.4	0.5	0.4	0.3	0.6	0.0	0.0	3.6	0.0	3.5	0.5	1.9	3.5	0.3	0.9	0.9	2.0	0.2	2.1	0.0	7.2	1.7	0.6	1.9	5.8	5.8	10.9	3.6	2.5	2.9	6.8	10.3	1.1
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"				"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: "	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	55.6	0.1	0.0	0.1	0.1	17.6	9.7	0.1	0.1	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	0.3	0.0	0.0	0.1	0.0	18.7	0.1	0.0	0.4	8.3	0.1	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.2;HHSteC: 7.9;HSkMC: 18.8;SiHa: 15.0;U-2 OS: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042807	Approved				"Secreted - unknown location"					"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (4.49e-4)"	2.4	1.6	2.2	3.5	4.1	2.2	4.5	7.9	3.2	6.7	2.3	3.0	2.2	1.9	1.7	2.5	8.7	1.7	5.9	4.4	2.0	7.5	1.4	1.0	3.8	1.3	4.2	2.3	3.1	2.5	0.7	4.7	24.5	5.0	6.1	1.5	11.1	4.2	4.1	3.7	12.7	2.7	2.6	3.8	1.3	3.0	7.6	2.1	0.8	2.4	14.9	3.9	4.8	9.9	0.9	3.4	1.3	1.7	1.0	0.8	0.6	0.5	0.6	0.6	0.3	1.0	2.4	0.2	6.4	3.9	1.2	2.6	0.5	0.7	0.3	0.5	10.2	2.4	0.2	0.2	0.7	2.3	1.0	1.2	0.4	0.1	7.9	0.3	0.8	18.8	1.1	1.7	0.2	0.0	0.6	0.4	2.6	4.1	0.3	0.4	0.2	0.6	0.2	0.2	0.0	0.5	0.1	1.2	0.7	15.0	0.2	0.5	0.1	0.8	1.1	3.2	11.0	0.9	0.4	0.5	0.1	0.1	1.2	1.4	0.3	0.7	1.7	0.7	0.8	1.4	0.3	0.9	0.6	0.3	3.4	0.5	0.4	0.3	1.3	1.0	0.2	0.5	0.2	0.6	2.2	4.1	7.9	3.2	2.0	7.5	4.2	2.3	5.0	2.1
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.5	4.8	1.7	8.9	0.0	0.0	23.5	0.5	0.2	5.6	0.3	12.1	16.4	0.0	14.9	1.9	13.2	10.1	12.5	4.0	0.5	11.2	0.0	7.7	16.1	1.6	0.0	5.8	0.3	7.5	0.0	4.3	0.0	3.3	0.1	0.1	9.2	0.4	0.0	3.4	11.7	0.0	0.0	2.6	9.6	7.9	12.3	9.9	6.1	13.7	2.6	9.6	2.0	0.0	0.0	7.1	0.1	0.0	3.5	0.6	0.1	0.6	0.1	8.5	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5
PRLR		ENSG00000113494	"Prolactin receptor"	P16471	5	35048756-35230589	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3;placenta: 45.7;seminal vesicle: 42.7"	"Cell line enriched"	"Detected in some"	18	"T-47d: 91.5"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 20.6"	"Region enriched"	"Detected in many"	7	"pons and medulla: 54.3"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 2.8"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.8"					"Low region specificity"	"Detected in some"								"Intracellular and membrane"						"unprognostic (3.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.84e-4)"	"unprognostic (2.50e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.84e-5)"	"unprognostic (1.24e-1)"	0.5	13.3	1.8	0.2	5.6	0.3	13.3	0.4	1.4	23.5	5.3	10.7	36.6	3.5	25.1	10.0	1.1	2.1	2.0	0.6	7.6	2.4	17.8	5.9	0.6	0.0	0.6	0.2	3.2	4.3	11.5	15.7	45.7	54.3	3.2	3.0	0.5	1.8	42.7	0.4	2.6	10.1	6.4	0.7	0.4	3.3	2.0	0.4	0.1	0.5	0.5	0.0	1.4	6.2	0.0	0.2	0.1	2.8	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.7	0.1	0.4	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	91.5	0.7	0.0	0.5	0.5	0.1	0.3	0.0	0.0	0.0	0.9	0.0	0.2	0.1	2.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	5.6	0.4	1.4	7.6	2.4	0.6	0.2	54.3	0.4
PROCR	"CCD41, CD201, EPCR"	ENSG00000101000	"Protein C receptor"	Q9UNN8	20	35172073-35216240	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 77.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.9;HUVEC TERT2: 101.2;TIME: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039461	Enhanced						1600000000			"HPA039461: AB_10673359"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (7.62e-6)"	"unprognostic (3.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.19e-2)"	51.0	11.9	2.3	10.1	3.2	4.4	24.6	2.9	2.3	16.8	25.0	3.1	14.1	8.7	27.7	44.5	19.4	17.3	13.4	27.4	2.7	2.4	11.7	3.8	10.6	30.3	3.1	2.1	19.3	11.5	2.7	4.7	77.8	7.4	15.5	12.3	16.4	4.2	14.0	17.7	10.4	14.0	20.0	5.8	22.1	10.4	9.1	2.0	0.6	12.1	13.0	3.9	25.8	14.9	1.6	7.3	4.1	1.7	3.4	14.6	2.0	2.4	14.5	0.0	1.5	16.0	13.1	3.4	3.4	14.9	5.6	11.0	18.7	12.7	0.4	10.7	3.4	8.0	3.3	21.7	4.7	0.1	4.5	5.3	3.5	0.7	3.9	0.2	64.9	11.1	8.1	26.6	22.2	101.2	1.8	0.7	5.8	0.8	0.1	0.2	2.0	15.0	0.1	2.8	0.0	9.6	0.9	0.4	0.2	1.8	3.9	3.0	1.3	0.8	59.8	14.6	7.4	5.5	5.7	0.0	0.1	0.1	16.8	5.4	3.0	4.1	1.5	0.9	8.3	1.7	14.6	1.0	2.6	5.2	7.3	1.6	0.7	6.3	4.1	3.4	1.4	1.2	2.0	2.0	2.3	3.2	2.9	2.3	2.7	2.4	3.1	2.1	7.4	2.0
PRR5-ARHGAP8		ENSG00000248405	"PRR5-ARHGAP8 readthrough"		22	44702233-44862706	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.5;placenta: 17.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;CACO-2: 3.2;HEK 293: 5.3;MCF7: 3.5;U-266/70: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"																				"unprognostic (1.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.28e-8)"	"unprognostic (8.64e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.45e-1)"	1.5	0.5	0.8	2.0	0.8	0.9	3.9	0.6	0.9	4.8	3.1	0.0	1.4	2.3	2.6	7.7	3.7	2.8	2.5	0.5	0.7	0.8	5.7	0.9	1.9	10.6	0.6	0.0	2.6	3.1	3.6	4.2	17.9	0.6	3.4	1.5	4.0	4.9	4.1	0.5	1.6	4.9	0.7	0.6	17.5	1.6	4.3	0.2	3.8	5.6	4.3	7.5	1.8	6.2	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	4.9	0.0	2.1	0.0	0.0	3.2	0.5	0.0	0.2	0.0	1.1	0.7	2.3	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	1.8	0.0	0.0	0.0	0.8	0.2	1.2	0.4	0.0	0.0	1.4	0.0	2.0	0.0	0.0	0.0	0.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4	0.0	0.8	0.8	0.6	0.7	0.7	0.8	0.6	0.0	0.6	0.2
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 194.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042127, HPA056243"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"		3200000000	"Golgi apparatus"	Vesicles	"HPA042127: , HPA056243: "	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	41.5	5.9	1.4	17.7	18.1	37.5	70.5	44.2	44.7	37.8	26.7	0.6	13.4	0.6	27.5	35.3	9.0	1.7	11.9	18.5	2.4	2.7	1.3	3.5	1.8	194.6	4.5	12.8	20.0	5.4	40.3	48.4	55.6	1.8	6.5	24.9	7.2	0.9	8.4	4.8	17.0	1.8	3.2	1.0	6.2	11.9	5.1	5.2	12.9	17.6	8.5	3.2	21.5	65.4	47.4	18.6	31.7	37.3	4.8	7.8	1.1	18.0	14.6	14.2	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990764	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;placenta: 37.6;prostate: 20.0"	"Cell line enhanced"	"Detected in many"		"BJ: 43.7;BJ hTERT+: 16.9;fHDF/TERT166: 15.8;TIME: 33.9"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.4	5.8	16.6	1.4	8.5	0.8	1.8	2.0	13.8	0.4	3.1	0.9	0.0	1.6	0.5	0.8	0.5	0.7	2.7	0.4	9.9	15.8	1.4	1.3	0.5	0.5	4.5	9.3	3.2	2.1	0.4	13.7	37.6	18.2	20.0	4.4	0.1	0.8	0.6	1.0	3.7	1.9	0.9	1.4	0.5	2.7	0.8	1.3	0.0	0.5	0.0	0.6	0.6	0.4	1.1	0.8	2.1	0.5	0.5	0.4	0.0	0.6	2.9	0.4	0.4	0.1	0.8	0.0	43.7	16.9	8.8	4.3	3.5	1.3	0.2	0.7	15.8	0.0	5.4	4.5	15.0	0.0	0.4	0.0	0.2	1.1	0.7	0.0	0.0	0.4	0.1	14.6	3.3	2.7	0.1	0.1	9.7	0.1	0.0	0.0	7.0	0.4	0.1	0.0	0.0	1.4	0.2	1.5	0.4	0.0	0.1	0.0	0.0	0.1	33.9	8.6	3.2	0.1	14.2	0.0	0.2	0.1	7.8	0.0	0.3	1.1	0.5	0.3	0.4	0.3	0.3	0.6	0.3	0.4	0.1	1.1	0.4	0.4	2.1	0.5	0.5	0.8	0.2	0.0	16.6	8.5	2.0	13.8	9.9	15.8	4.5	9.3	18.2	1.3
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656237-34832627	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"				Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavourable (9.75e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	5.6	4.5	3.9	8.3	5.9	0.5	5.1	4.4	3.2	23.3	9.1	5.5	14.1	2.5	29.2	8.2	8.8	6.8	8.8	3.6	4.4	3.5	7.7	11.2	10.4	5.1	6.9	1.5	9.5	4.8	6.4	2.7	64.4	5.6	10.4	4.0	8.2	8.4	10.8	2.0	7.6	3.6	34.7	17.0	21.2	6.0	26.6	5.7	2.1	6.7	2.7	3.8	22.5	14.9	0.8	0.6	2.5	0.8	2.5	3.3	0.3	2.7	10.8	12.4	8.3	6.6	23.4	15.9	32.5	26.2	18.8	18.9	8.1	3.5	0.6	13.0	15.9	1.8	14.1	24.0	40.8	0.0	6.7	4.4	10.1	4.9	20.7	0.1	0.4	21.8	7.5	33.7	26.9	59.5	6.2	0.2	24.4	2.1	0.4	0.1	9.7	10.4	3.9	19.0	0.1	21.8	15.5	3.3	1.8	19.2	2.8	8.7	3.3	0.5	38.3	30.6	16.4	7.5	14.1	0.7	0.0	0.0	25.9	0.0	11.9	2.5	0.8	0.3	3.3	0.3	0.4	0.5	1.0	0.2	0.2	0.8	0.3	0.6	1.6	2.5	0.1	0.6	0.1	0.3	3.9	5.9	4.4	3.2	4.4	3.5	6.9	1.5	5.6	5.7
RGPD1	RGP1	ENSG00000187627	"RANBP2-like and GRIP domain containing 1"	P0DJD0	2	86907953-87013976	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.4;placenta: 8.0;testis: 17.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.0;MOLT-4: 13.5;NTERA-2: 4.1;RPMI-8226: 3.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA049497: , HPA051675: , HPA067564: "	"unprognostic (8.24e-2)"	"unprognostic (6.05e-2)"		"unprognostic (6.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.06e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.80e-1)"		"unprognostic (2.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.88e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.99e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	10.4	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.1	0.2		0.2	1.7	1.1	4.8	8.0		0.0	0.0		0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.3	0.3	17.7			0.2		0.5	0.0	0.1	1.3	0.0	0.1	0.0	1.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	13.5	0.2	4.1	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.7	0.0	0.2	0.1	0.8	0.0	1.1	0.0	0.0	0.1	0.1										
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.9;skeletal muscle: 63.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;NK-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040205: , HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.6	9.8	2.7	2.0	5.8	0.5	4.5	0.8	5.0	8.8	4.7	7.2	16.5	3.4	10.2	4.9	1.9	6.8	6.3	6.6	3.7	2.5	20.5	3.4	5.4	1.4	6.7	2.3	6.9	6.0	7.4	2.2	50.9	4.6	4.9	2.6	13.3	1.4	20.3	63.5	1.9	3.5	7.7	3.8	7.4	11.7	8.5	5.7	0.6	2.3	5.2	0.9	5.0	5.2	0.5	1.6	0.7	0.6	1.3	0.0	1.3	0.1	6.1	9.3	0.0	4.4	3.9	0.0	2.7	2.5	2.2	3.4	0.3	0.1	0.0	11.5	14.3	0.1	2.7	0.8	2.7	0.0	2.5	0.5	4.5	33.9	4.9	0.6	0.2	5.7	1.5	1.4	1.4	10.7	5.0	0.0	9.9	0.2	2.5	0.0	4.0	4.0	2.2	13.1	3.2	7.4	0.3	2.6	10.0	3.2	3.6	3.5	0.7	1.2	9.5	4.4	11.5	0.1	2.9	0.0	0.0	0.0	2.1	2.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.7	1.3	0.6	0.0	0.0	1.3	2.7	5.8	0.8	5.0	3.7	2.5	6.7	2.3	4.6	5.7
RHOBTB3	KIAA0878	ENSG00000164292	"Rho related BTB domain containing 3"	O94955	5	95713522-95824383	"Predicted intracellular proteins"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 86.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 51.2;HaCaT: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.1;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000265			Uncertain	Vesicles				Vesicles		"HPA000265: "	"unprognostic (1.68e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.39e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.00e-3)"	"unprognostic (9.29e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.01e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.23e-1)"	"unprognostic (8.21e-2)"	38.7	21.4	27.0	6.4	25.8	4.0	12.8	11.8	23.1	16.4	12.0	26.9	11.8	8.2	7.5	15.5	9.8	7.8	11.0	17.6	26.2	12.8	16.4	11.5	9.5	3.6	20.1	21.3	46.6	59.2	24.1	11.0	86.0	13.0	16.4	11.7	21.7	21.0	12.2	15.3	7.4	9.0	11.2	18.2	6.0	12.1	12.4	21.3	1.8	11.1	4.1	1.6	10.9	12.8	0.8	1.2	10.1	1.5	0.5	2.9	0.9	10.3	4.2	10.3	11.0	38.9	22.6	0.1	18.0	17.2	7.0	11.0	20.0	1.9	0.0	51.2	9.2	65.0	5.5	1.3	12.1	0.4	7.1	3.6	39.6	5.7	30.7	0.8	5.1	36.5	1.0	10.5	0.1	5.4	14.1	2.7	27.8	2.9	1.1	2.8	3.9	6.5	1.5	20.3	1.2	5.9	7.4	18.3	23.7	14.2	6.2	16.7	4.7	5.2	8.6	9.4	40.6	6.3	6.8	2.7	5.3	0.4	2.9	0.2	15.4	0.1	0.9	10.1	2.9	0.5	1.2	0.8	2.1	2.5	0.2	0.2	2.9	0.6	0.7	0.5	1.5	1.2	1.1	0.9	27.0	25.8	11.8	18.6	26.2	12.8	20.1	21.3	13.0	21.3
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083648	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.0;placenta: 20.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.5;HEL: 3.3;NTERA-2: 2.0;U-138 MG: 3.5;U-266/70: 10.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	17	"monocytes: 1.6"	"Group enriched"	"Detected in some"	7	"amygdala: 8.2;cerebral cortex: 18.2;hippocampal formation: 23.2"	"Group enriched"	"Detected in many"	5	"amygdala: 23.3;cerebral cortex: 18.0;hippocampal formation: 24.1;midbrain: 33.2"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"					"CAB025900: , HPA024764: AB_10603236, HPA053068: "	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	3.9	1.4	6.3	0.5	0.2	1.9	27.0	3.6	12.0	4.2	3.6	5.1	0.3	3.6	8.9	0.2	4.8	0.5	5.8	10.5	0.2	1.1	9.3	0.2	15.7	5.4	1.1	0.2	0.2	2.8	20.1	2.0	11.6	10.1	15.5	0.2	3.4	0.3	0.3	5.8	0.7	1.3	0.2	8.3	2.0	1.7	0.0	0.2	0.0	0.2	2.2	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.2	0.1	0.0	10.4	0.0	0.0	1.0	0.4	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.3	1.9	27.0	5.8	10.5	15.7	5.4	2.0	1.7
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin/insulin like family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;placenta: 12.2"	"Group enriched"	"Detected in some"	4	"EFO-21: 23.6;HEL: 7.8;RPTEC TERT1: 10.9"	"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	6	"basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA027067	Approved									"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.5	6.5	2.1	0.5	10.4	0.2	0.4	0.4	19.7	4.0	0.5	0.0	1.1	0.3	9.0	1.6	0.5	1.3	1.2	0.4	2.0	1.7	2.9	2.1	5.1	0.7	0.8	12.4	0.8	0.6	0.2	0.6	12.2	0.0	1.0	0.3	0.6	0.4	4.2	0.4	0.4	0.9	1.3	0.4	0.6	0.6	0.6	0.0	0.0	2.4	0.0	0.6	0.5	2.2	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.1	10.4	0.4	18.5	2.0	1.7	0.8	12.4	0.0	0.0
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 173.1;liver: 93.7;placenta: 65.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.9;monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	Vesicles				Vesicles		"CAB070124: AB_10107658, HPA066285: , HPA072449: "	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavourable (1.83e-5)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	21.2	173.1	7.9	3.5	21.4	1.8	25.0	4.3	10.1	4.7	28.6	13.4	1.1	8.8	4.3	3.5	2.8	4.7	8.0	3.2	7.4	5.1	2.2	93.7	5.8	5.3	6.3	5.1	14.3	2.9	3.3	4.4	65.9	9.4	4.3	4.9	10.7	8.6	2.3	3.0	6.3	21.3	4.4	5.7	5.0	2.7	7.7	11.4	0.5	4.0	1.1	5.6	3.6	10.0	3.1	24.9	1.2	6.5	0.2	0.4	2.5	9.1	22.2	7.2	28.5	4.8	10.3	0.0	6.4	7.4	8.0	5.1	26.5	29.3	26.5	18.7	4.4	14.0	18.4	43.4	3.8	12.6	18.6	7.4	21.9	42.7	16.3	12.7	6.5	17.6	8.8	15.3	10.9	21.9	14.1	11.4	1.4	18.2	3.9	17.1	6.6	23.0	16.6	5.8	53.0	0.7	12.8	13.6	5.3	35.2	47.5	32.9	26.6	14.5	2.1	1.3	8.7	6.5	10.0	2.7	1.1	4.4	5.2	15.5	12.5	0.0	6.5	0.0	0.2	3.7	0.2	3.1	0.1	0.4	8.2	1.7	0.1	0.1	1.2	0.2	0.5	24.9	0.0	2.5	7.9	21.4	4.3	10.1	7.4	5.1	6.3	5.1	9.4	11.4
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 37.7;SK-BR-3: 40.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.1	8.3	0.2	0.2	0.1	0.6	0.1	1.3	0.1	0.2	0.0	37.7	1.4	1.7	0.0	0.4	40.9	0.0	4.3	0.3	0.0	0.1	0.3	0.8	0.0	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845769-38950561	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;placenta: 5.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.7;HDLM-2: 4.9;SCLC-21H: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"amygdala: 0.9;basal ganglia: 0.4;cerebral cortex: 0.6;hippocampal formation: 0.8"	"HPA036746, HPA036747"	Uncertain									"HPA036746: AB_10696785, HPA036747: "	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.9	0.2	0.8	0.5	0.8	0.0	0.6	0.1	0.3	0.0	1.1			0.4	0.0	1.4	0.0	0.1	0.1	0.0	0.4	0.5	0.4	0.3	0.0	0.2	0.4		0.0	0.1	0.0	0.4	5.2		0.1	1.3		0.0	0.0	0.1	0.8	1.0	0.5	0.6	7.5	0.0	2.6			0.1		0.1	3.4	0.1	0.2	0.4	0.9	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.1	4.9	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.5	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.9	0.1	0.1	0.4	0.0	0.0										
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.9;hTCEpi: 56.3;U-251 MG: 58.0;U-266/70: 60.1;U-266/84: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Supported	"Focal adhesion sites"	"Secreted to blood"	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavourable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	30.8	17.3	5.5	13.8	1.5	0.2	17.3	8.6	8.3	8.1	6.8	3.6	18.8	0.0	3.2	6.1	30.4	2.4	60.9	5.4	0.1	1.6	0.0	1.6	18.5	1.3	1.3	0.1	0.8	56.3	7.2	17.3	0.8	0.7	12.1	4.3	18.4	0.0	0.3	4.9	33.5	0.6	2.0	23.3	10.3	46.3	1.6	12.8	6.5	43.9	1.9	4.3	0.3	1.3	32.1	10.3	1.1	58.0	60.1	126.7	0.1	9.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.8;placenta: 36.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.9;SCLC-21H: 12.3;SH-SY5Y: 11.4;U-266/70: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		480000	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.3	1.9	10.3	3.7	16.7	0.8	5.3	5.4	17.1	5.3	14.7	15.3	4.3	18.9	2.1	2.9	2.0	5.2	4.0	8.3	10.3	11.2	14.2	3.0	8.2	2.2	14.0	13.6	25.0	14.8	16.2	6.1	36.7	15.9	4.8	12.0	10.0	4.4	8.5	15.6	3.1	40.8	3.4	12.7	2.5	3.4	2.6	11.0	0.2	6.3	1.5	1.1	3.1	9.6	0.5	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	2.3	0.0	1.3	1.1	0.2	0.5	13.9	0.3	0.0	0.3	0.1	1.9	0.0	3.5	7.2	2.9	0.9	0.1	0.9	1.7	0.0	4.2	0.0	3.7	0.0	0.1	1.0	7.6	0.0	0.5	0.9	0.1	3.0	0.4	0.7	2.3	0.6	4.4	0.0	1.4	0.1	2.1	1.0	0.9	12.3	11.4	0.1	0.9	3.8	0.4	0.0	0.0	6.4	0.3	0.2	0.0	9.1	0.0	2.1	1.7	0.2	1.6	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	10.3	16.7	5.4	17.1	10.3	11.2	14.0	13.6	15.9	11.0
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 8.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles			29000000	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.2	1.9	5.4	10.4	13.8	12.8	1.4	22.9	27.3	1.3	1.8	19.9	1.4	2.7	4.3	1.8	3.2	1.2	3.3	1.4	10.8	5.7	1.4	1.5	4.4	19.0	28.5	5.7	5.9	0.9	6.4	1.9	54.0	28.6	1.4	1.8	7.8	1.7	3.5	1.4	4.7	6.0	2.0	36.4	34.7	3.7	23.6	15.4	9.0	1.1	0.4	19.7	4.6	1.7	1.4	1.8	8.9	0.0	0.8	0.2	0.0	5.7	0.0	1.7	0.5	2.2	7.4	14.3	26.5	10.7	5.6	8.6	2.2	9.4	0.0	1.5	12.0	1.7	0.5	1.7	5.8	0.4	0.3	10.3	0.0	2.8	0.5	0.3	99.7	5.2	0.0	39.1	2.2	0.0	5.9	3.6	18.1	0.4	1.4	3.4	1.8	4.0	0.2	1.1	1.5	2.3	2.4	0.1	0.1	0.2	4.8	2.1	0.3	2.1	1.0	10.5	7.0	5.0	57.5	0.6	0.4	0.1	33.6	1.2	0.5	3.9	0.0	8.9	0.2	0.0	0.2	1.4	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.8	0.0	1.8	0.0	0.0	5.4	13.8	22.9	27.3	10.8	5.7	28.5	5.7	28.6	15.4
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903890	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.6;placenta: 222.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 79.8;U-138 MG: 95.5;U-2197: 145.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 16.3;eosinophil: 7.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.3"	"Region enriched"	"Detected in single"	14	"cerebellum: 2.9"	"Low region specificity"	"Detected in all"			HPA015480	Supported				"Intracellular and membrane"		110000			"HPA015480: AB_1855456"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (1.55e-5)"	6.0	0.0	0.1	2.9	0.2	8.7	2.6	0.2	0.1	6.4	0.8	0.1	0.1	0.0	0.7	0.4	70.6	3.1	0.1	0.4	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.6	0.3	0.0	0.1	222.1	0.2	0.3	0.0	0.1	11.3	0.2	0.3	25.7	0.2	0.3	0.1	0.3	0.1	0.2	0.1	0.9	0.2	49.0	37.7	1.1	13.8	0.0	0.2	16.3	3.9	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.4	20.6	0.7	1.5	0.1	0.0	0.0	0.0	0.6	79.8	0.0	16.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	9.5	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.5	95.5	0.0	145.1	0.0	0.0	0.0	0.0	2.5	0.2	11.1	16.3	3.9	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell line enhanced"	"Detected in many"		"BJ: 140.2;HUVEC TERT2: 162.7;LHCN-M2: 157.1;TIME: 402.3;U-138 MG: 191.5;U-251 MG: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"		14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: "	"unprognostic (5.02e-2)"	"prognostic unfavourable (5.01e-4)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (5.88e-8)"	"prognostic unfavourable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.5	0.0	0.2	32.1	64.0	3.6	140.2	26.5	70.7	61.8	0.3	0.2	0.1	33.6	44.6	0.7	0.0	10.8	73.1	0.1	0.0	0.0	0.2	2.4	64.6	0.0	0.1	25.0	4.3	108.5	57.1	162.7	0.2	0.1	157.1	0.0	0.0	0.0	0.7	1.6	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.5	3.1	0.3	0.1	0.3	402.3	191.5	8.4	65.2	168.3	0.0	0.1	0.1	47.8	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684214-63728039	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.4;U-698: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA053149: , HPA064908: "	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	10.5	12.1	12.1	15.7	11.6	4.3	7.6	14.3	12.9	9.2	9.6	15.1	3.9	6.2	8.4	10.3	5.7	5.9	8.9	5.5	13.1	12.6	24.7	29.4	10.3	18.5	13.0	7.0	7.4	14.1	15.5	6.4	49.4	11.1	9.0	8.7	6.7	5.7	7.0	4.4	4.8	8.9	7.9	19.6	16.5	5.8	8.2	9.8	15.4	7.8	3.7	19.1	8.6	7.3	3.2	0.5	8.8	3.3	0.5	2.0	0.5	10.3	3.3	1.6	4.7	6.0	5.6	19.9	8.5	5.9	5.3	6.0	1.4	5.9	23.4	2.5	4.3	11.0	2.6	5.0	8.6	9.1	3.1	2.1	2.0	2.3	7.4	3.8	6.7	4.1	8.1	4.6	7.3	2.5	1.2	0.6	7.7	3.8	4.4	0.0	1.1	7.2	1.1	4.6	1.8	8.4	5.2	1.0	2.7	5.9	5.6	4.4	7.3	1.4	2.8	7.4	5.1	5.2	4.2	5.6	3.4	30.5	5.4	0.0	3.1	8.8	0.3	2.8	1.0	2.3	1.0	3.2	1.0	0.7	0.5	0.8	1.5	1.1	0.4	0.5	3.3	0.3	2.0	0.5	12.1	11.6	14.3	12.9	13.1	12.6	13.0	7.0	11.1	9.8
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.4	7.6	16.6	14.9	14.3	12.5	17.0	7.9	10.8	11.8	5.8	5.8	11.1	11.0	8.8	10.0	9.9	11.4	11.6	14.6	4.4	9.2	5.9	6.0	15.1	20.0	5.8	9.1	15.0	20.9	6.9	16.1	9.9	9.5	10.5	9.6	5.8	15.6	11.9	20.2	11.8	18.2	25.0	11.6	11.0	10.7	18.9	16.8	23.6	11.8	20.3	7.5	13.4	10.5	12.7	11.4	6.8	8.4	13.7	5.7	20.2	9.4	7.2	11.4	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36184319	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.1"	"Cell line enhanced"	"Detected in all"		"BEWO: 73.6;RH-30: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.72e-7)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	6.5	6.9	7.8	8.0	7.5	12.9	6.5	11.5	9.0	7.5	7.7	10.3	3.7	10.2	9.9	6.3	13.5	8.1	4.9	4.1	7.3	5.1	4.2	14.0	5.8	9.4	8.8	7.4	7.7	6.1	3.9	12.5	49.1	6.5	7.2	9.5	6.1	6.3	5.4	3.4	7.6	7.7	6.4	7.4	9.4	5.3	3.9	7.4	19.5	5.0	7.5	11.7	7.9	8.4	6.5	16.0	14.7	7.9	7.7	8.5	5.0	7.4	3.7	15.8	17.6	3.9	6.2	73.6	9.7	7.3	24.8	18.8	20.6	5.9	10.8	2.6	7.8	7.8	17.7	12.3	26.7	4.8	10.1	6.3	13.8	9.7	1.9	13.9	2.9	5.7	3.2	4.5	3.1	6.8	10.8	2.5	8.9	3.6	16.1	8.0	14.4	5.7	16.0	92.3	6.9	1.8	7.9	13.6	16.3	30.4	6.6	4.3	6.7	7.9	3.1	9.3	10.8	3.5	6.7	3.1	3.0	13.4	4.2	17.1	6.7	10.3	7.9	14.7	5.4	7.2	8.5	5.6	5.7	5.8	16.0	6.5	7.9	6.0	1.5	7.7	4.1	4.3	5.3	5.0	7.8	7.5	11.5	9.0	7.3	5.1	8.8	7.4	6.5	7.4
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.6;BJ hTERT+: 12.7;CAPAN-2: 18.8;HHSteC: 12.6;SK-MEL-30: 19.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"				"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: , HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	6.0	1.3	1.9	4.3	8.5	12.6	3.3	12.7	1.1	3.2	1.8	18.8	0.3	3.5	10.3	0.3	0.1	1.2	1.2	0.3	1.5	0.3	1.3	1.9	12.6	0.4	0.3	6.3	0.2	1.9	0.1	2.6	0.3	0.6	2.1	0.6	0.2	0.3	0.4	0.2	0.1	0.9	0.1	2.2	0.3	0.7	0.4	0.3	6.1	19.3	0.3	0.0	0.3	0.7	0.5	0.2	0.9	0.3	0.1	0.9	0.6	0.3	3.5	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.1	0.4	7.2	0.1	0.2	0.3	0.6	18.4	0.5	0.4	0.2	0.1	0.5	0.5	0.5	0.8	0.1	1.2	0.1	0.9	0.7	1.7	0.2	0.2	3.2	0.4	0.1	0.9	0.0	0.2	0.8	0.0	1.8	0.1	0.6	3.2	0.3	0.3	0.2	0.2	0.2	0.3	1.0	0.1	0.5	2.0	0.5	0.3	0.2	0.5	0.5	0.5	4.1	0.3	0.2	0.1	0.6	1.4	0.3	0.4	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295343	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"		"HPA051720: "	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favourable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (1.91e-5)"	6.8	8.2	4.0	10.2	8.3	7.4	8.1	2.6	6.0	13.0	7.2	11.1	18.2	8.3	14.1	11.6	5.3	8.6	7.5	4.4	8.2	3.7	14.4	4.4	7.2	8.2	8.9	5.2	3.4	9.6	6.6	12.9	44.4	9.2	8.2	7.9	11.3	6.2	24.9	3.4	4.2	7.2	6.0	9.7	9.4	9.8	20.2	7.2	9.0	9.1	4.1	7.1	7.2	4.6	3.8	7.2	9.0	11.1	3.2	5.6	2.9	4.4	12.3	2.1	9.2	7.1	2.8	5.1	2.9	2.6	3.2	3.6	1.4	11.5	5.1	3.0	3.4	10.0	2.6	3.5	1.7	2.7	3.2	4.3	9.1	1.7	2.6	0.5	11.7	5.8	2.0	6.1	1.1	5.1	1.2	1.8	2.6	2.4	4.6	2.4	0.7	4.1	5.0	1.5	2.2	2.5	11.4	1.1	2.7	8.5	5.1	3.6	11.4	3.3	6.6	2.2	1.7	5.2	2.5	3.9	2.3	1.7	5.6	7.6	5.6	4.5	7.3	9.0	5.5	11.1	4.3	2.6	4.8	5.6	7.2	3.8	1.7	3.5	1.4	3.2	7.8	3.6	4.9	2.9	4.0	8.3	2.6	6.0	8.2	3.7	8.9	5.2	9.2	7.2
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Group enriched"	"Detected in some"	5	"BEWO: 4.6;RPTEC TERT1: 10.4;WM-115: 6.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in some"			HPA017979			Approved	Vesicles				Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	0.9	0.3	0.1	4.6	0.4	0.1	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.8	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.0	0.6	1.4	0.0	0.7	0.5	0.9	0.7	0.2	0.3	0.7	0.6	10.4	0.4	0.9	0.5	0.6	1.1	0.4	0.7	0.5	0.5	0.7	1.1	0.6	0.3	1.0	0.5	0.7	0.5	0.6	6.3	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.2"	"Cell line enhanced"	"Detected in all"		"BEWO: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles				Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavourable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	7.2	6.3	8.2	6.9	8.0	5.2	6.8	9.9	9.7	6.4	7.5	9.2	6.7	6.6	7.5	5.9	9.0	5.8	7.1	3.9	6.2	6.4	6.7	13.5	6.4	8.4	9.4	6.4	6.9	18.2	10.1	11.8	44.2	8.6	5.9	8.5	6.7	7.6	5.3	5.2	6.2	7.1	7.2	8.8	8.9	7.7	15.8	8.5	13.3	7.1	5.7	11.4	8.7	6.9	10.8	10.8	7.4	11.8	8.9	10.0	6.4	7.9	8.1	6.8	9.1	9.5	9.8	49.1	6.7	9.5	8.1	13.5	13.1	11.0	13.1	11.4	5.5	9.9	9.1	7.9	10.7	7.0	8.6	4.1	8.7	8.7	15.1	7.4	5.0	11.8	9.5	9.0	10.6	9.1	9.0	8.7	7.6	6.8	9.3	7.1	12.6	7.4	7.1	11.4	13.2	11.0	6.4	3.8	6.0	6.9	4.3	11.4	9.3	15.0	12.4	1.7	5.5	12.0	7.0	9.4	19.3	7.9	4.2	7.6	4.7	4.8	11.8	7.4	7.8	10.2	10.0	10.8	6.3	9.0	10.8	6.2	9.2	7.7	2.9	8.9	7.5	10.8	8.1	6.4	8.2	8.0	9.9	9.7	6.2	6.4	9.4	6.4	8.6	8.5
SLC43A2	MGC34680	ENSG00000167703	"Solute carrier family 43 member 2"	Q8N370	17	1569267-1628886	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 92.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021564	Enhanced									"HPA021564: AB_1857169"	"unprognostic (5.95e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (1.05e-6)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.40e-5)"	"unprognostic (1.84e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-1)"	5.5	2.7	5.4	13.7	5.7	12.2	3.6	14.8	11.9	2.6	2.6	5.0	2.1	7.0	2.1	4.1	1.4	5.9	3.9	1.6	5.6	7.2	15.8	3.0	6.8	8.3	5.1	3.8	2.3	1.6	1.5	6.2	92.7	5.8	2.8	2.4	4.9	4.0	3.5	23.2	1.3	11.6	4.7	3.5	8.9	2.8	1.5	1.3	5.0	5.8	2.2	3.5	5.0	1.3	1.3	3.1	15.0	5.4	0.5	0.3	2.0	0.9	2.5	0.8	7.5	1.5	1.3	10.2	0.5	0.2	1.8	0.8	15.2	1.7	4.4	5.1	0.7	1.8	4.6	0.9	0.3	0.0	0.4	0.8	2.3	3.8	1.8	0.1	1.4	1.6	1.4	1.1	0.5	7.2	1.9	0.0	0.3	3.6	9.1	0.8	0.8	0.3	2.5	0.0	5.2	3.4	8.7	3.1	1.6	2.3	6.2	0.2	6.1	5.3	9.3	0.2	1.1	2.0	0.6	0.5	9.2	2.2	0.4	0.9	0.2	2.5	5.4	5.3	0.3	4.6	0.1	1.3	0.2	0.2	3.1	1.2	0.2	0.2	15.0	0.5	4.5	1.7	0.2	2.0	5.4	5.7	14.8	11.9	5.6	7.2	5.1	3.8	5.8	1.3
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248385-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.7;placenta: 32.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 0.4"	"Low region specificity"	"Detected in all"			"HPA015584, CAB034438, HPA063911"	Enhanced						160000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: "	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0.0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0.0	1.0	8.4	0.1	0.3	0.0	0.7	1.9	0.0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.4	1.4	1.7	0.6	0.7	1.0	0.2	0.4	0.3	0.8	1.3	3.2	0.7	0.6	0.3	1.4	0.5	0.5	1.0	1.3	1.3	1.6	1.5	2.2	0.0	0.8	2.3	0.8	0.5	0.8	0.8	0.2	4.7	3.4	0.4	0.6	0.9	3.5	0.9	0.5	2.5	0.7	1.8	0.3	0.8	2.2	1.0	1.3	1.4	0.5	2.5	1.8	1.0	2.3	2.0	1.4	1.4	1.0	2.3	1.1	1.6	2.1	1.1	6.1	1.0	2.0	1.1	0.9	1.0	1.1	1.0	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0.0
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 68.0;SK-BR-3: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Cell Junctions"				"Cell Junctions"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.4	17.0	10.9	14.3	10.1	3.7	68.0	6.0	4.1	9.1	6.3	25.1	5.9	11.4	9.1	3.2	9.2	23.3	6.9	6.4	8.8	13.7	20.2	7.3	38.4	12.0	25.9	10.6	12.7	5.9	11.2	8.7	8.2	29.5	4.7	5.8	33.8	8.8	12.6	31.4	6.2	14.8	12.8	16.5	5.2	15.8	9.2	13.6	6.5	73.1	8.6	16.2	5.6	3.7	10.1	13.8	6.1	16.0	7.9	18.0	18.1	5.5	18.2	14.1	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 104.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"CAB078195: , HPA004057: AB_1080012, HPA076311: "	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.8	104.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2
SLC7A4	"CAT-4, HCAT3, VH"	ENSG00000099960	"Solute carrier family 7 member 4"	O43246	22	21028718-21032840	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 19.6;testis: 29.1"	"Cell line enriched"	"Detected in some"	21	"BEWO: 55.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.4;naive CD8 T-cell: 2.4"	"Group enriched"	"Detected in many"	18	"NK-cells: 1.0;T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA031023	Enhanced									"HPA031023: AB_10669669"	"unprognostic (1.02e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	2.7	3.5	2.2	0.4	3.8	0.1	2.6	6.0	5.9	2.8	1.8	0.4	1.4	1.7	1.5	0.7	8.5	1.6	4.1	1.2	2.7	7.1	0.2	0.3	1.4	1.2	2.4	4.3	0.3	0.4	0.1	5.1	19.6	2.4	4.1	1.4	3.3	4.3	5.3	0.6	1.9	2.0	0.6	0.6	0.9	2.4	29.1	0.4	0.2	0.1	1.3	2.1	2.4	0.7	0.0	0.0	0.0	0.0	1.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.4	0.0	0.2	1.2	0.0	0.0	0.1	2.4	0.0	1.0	0.0	0.0	0.0	0.8	2.2	3.8	6.0	5.9	2.7	7.1	2.4	4.3	2.4	0.4
SOX14	SOX28	ENSG00000168875	"SRY-box 14"	O95416	3	137764284-137766338	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4;placenta: 15.1;prostate: 3.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.8"	"Group enriched"	"Detected in many"	15	"hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.1;midbrain: 5.9"	"Group enriched"	"Detected in some"	7	"midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5"														"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"								"unprognostic (1.88e-2)"		"unprognostic (2.49e-3)"	"unprognostic (5.08e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	15.1	4.4	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	5.4	1.6	0.0	4.4	3.3
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
SPIRE2	"KIAA1832, spir-2"	ENSG00000204991	"Spire type actin nucleation factor 2"	Q8WWL2	16	89818179-89871319	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.5;T-47d: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041413, HPA049415"	Uncertain		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"				Nucleoplasm	"Vesicles, Intermediate filaments"	"HPA041413: , HPA049415: "	"unprognostic (2.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.07e-3)"	"unprognostic (6.96e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavourable (9.77e-5)"	"unprognostic (2.10e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.95e-3)"	"unprognostic (7.21e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.59e-2)"	1.5	2.1	7.2	3.9	9.3	2.2	1.7	19.5	11.2	2.1	14.8	2.1	5.9	10.9	2.5	3.2	2.5	9.1	7.6	0.8	6.2	7.8	1.9	4.0	3.2	1.0	5.5	6.1	1.6	3.0	8.4	18.4	40.6	7.4	3.5	11.7	2.7	2.2	5.0	1.2	2.0	12.6	1.9	2.5	1.5	20.2	3.8	1.4	0.0	5.0	0.9	1.3	6.4	4.9	2.1	1.6	5.5	1.4	1.7	1.2	0.6	0.3	6.8	4.3	3.6	1.2	0.8	14.5	2.3	1.3	3.2	1.3	2.6	7.2	4.5	1.0	0.6	7.2	1.9	0.2	1.0	1.8	8.3	0.9	5.6	6.9	1.1	0.3	1.5	1.5	1.7	1.0	0.8	0.1	6.9	1.3	0.9	10.1	0.1	1.5	4.7	4.2	3.4	1.5	1.0	1.6	6.9	11.3	5.8	9.4	4.1	4.1	15.5	2.4	0.3	1.9	4.1	2.6	1.9	0.6	2.9	0.4	2.9	1.6	3.9	4.6	1.4	0.9	1.1	0.7	0.8	1.2	0.9	0.7	0.3	2.1	1.2	1.2	5.5	1.7	1.3	1.6	0.5	0.6	7.2	9.3	19.5	11.2	6.2	7.8	5.5	6.1	7.4	1.4
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 213.7;Hep G2: 105.2;RPTEC TERT1: 466.7"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"CAB002212, HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	180200000	54000000	"Golgi apparatus"		"CAB002212: AB_564074, HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavourable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	213.7	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	105.2	0.0	0.2	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	9.9	0.0	0.1	0.0	50.1	466.7	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	19.5	0.0	19.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 74.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 44.7;WM-115: 101.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 29.6;granulocytes: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049827	Approved				"Intracellular and membrane"					"HPA049827: "	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	7.8	38.0	6.2	6.5	12.2	7.8	12.9	4.0	13.6	8.3	27.0	26.4	5.1	2.0	6.0	42.1	25.5	6.0	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9.0	18.7	9.0	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8.0	1.9	5.6	3.8	11.0	23.0	17.0	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.8	4.0	3.2	2.7	9.4	7.8	7.9	5.6	10.9	5.1	3.5	2.3	8.4	1.4	4.3	8.9	7.6	6.6	3.7	4.0	5.2	1.9	12.4	10.1	2.7	6.1	14.8	25.4	6.2	5.9	7.7	12.2	6.8	7.7	3.7	6.3	20.0	4.7	15.2	2.0	26.5	4.8	9.8	0.6	1.1	14.0	6.0	3.8	6.2	37.7	44.7	13.1	9.8	2.5	12.3	2.8	8.7	10.6	0.3	0.8	0.7	5.6	22.8	101.5	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0.0	0.1	0.8	22.8	1.2	1.2	29.6	0.0	1.8	6.2	12.2	4.0	13.6	8.6	6.2	18.7	9.0	13.8	12.4
STH	MAPTIT	ENSG00000256762	Saitohin	Q8IWL8	17	45999250-45999694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.2;breast: 1.9;placenta: 1.6;skeletal muscle: 2.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;HDLM-2: 3.1;PC-3: 1.0;RT4: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.24e-1)"				"unprognostic (3.22e-1)"													0.0	0.0	0.8	0.0	1.3	0.0	1.9	4.1	4.2	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.9	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.3	1.6		0.2	0.0		0.5	0.0	2.5	0.7	0.0	0.0	0.6	0.0	0.0	0.4			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.9	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SYDE1	"7h3, FLJ13511, SYD1"	ENSG00000105137	"Synapse defective Rho GTPase homolog 1"	Q6ZW31	19	15107403-15114988	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013328	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA013328: AB_1848705"	"unprognostic (9.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.65e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (5.63e-7)"	"unprognostic (1.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.27e-4)"	15.6	7.7	3.5	5.9	4.3	0.1	19.9	2.0	3.5	19.5	13.9	4.4	3.8	4.3	18.6	6.8	10.7	12.2	10.5	9.3	4.0	1.8	9.6	3.3	9.4	4.9	3.1	2.4	17.9	4.6	2.3	3.8	60.0	5.0	11.8	2.9	22.0	3.3	13.6	5.9	4.4	5.7	14.2	2.5	7.6	7.9	7.4	4.3	0.9	8.2	5.8	2.8	12.9	12.8	0.2	0.3	0.0	0.0	0.0	0.5	0.0	4.0	6.3	3.4	8.8	7.7	7.2	2.7	17.2	12.7	17.0	14.4	1.4	2.4	0.0	11.4	17.3	2.6	2.6	3.0	9.5	0.1	3.0	0.6	11.7	2.7	14.7	0.0	0.0	12.5	2.2	10.1	4.6	3.1	0.0	0.0	12.6	2.0	0.0	0.0	5.6	6.5	0.0	8.5	0.0	4.2	0.5	0.1	6.8	9.6	5.9	11.5	0.7	0.4	6.5	40.8	12.4	18.6	18.5	0.0	0.1	0.0	11.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	2.0	3.5	4.0	1.8	3.1	2.4	5.0	4.3
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006582-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;MCF7: 6.3;SK-MEL-30: 16.4;U-2 OS: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.5	6.0	10.5	3.4	11.0	0.0	2.9	0.5	2.5	7.0	7.3	0.5	0.5	2.3	2.6	1.0	12.2	0.2	2.9	0.9	9.2	8.9	1.0	6.1	2.4	0.5	2.4	0.5	0.5	6.4	0.0	1.1	17.0	0.5	2.0	3.5	1.5	7.1	1.7	0.5	0.0	14.3	3.9	1.3	0.8	13.8	0.7	0.5	0.7	0.9	1.2	5.9	1.3	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.2	0.3	6.3	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.4	3.6	0.1	0.3	1.4	16.4	0.0	0.0	0.0	0.2	5.5	0.0	3.6	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	11.0	0.5	2.5	9.2	8.9	2.4	0.5	0.5	0.5
TBX5	HOS	ENSG00000089225	"T-box 5"	Q99593	12	114353931-114408442	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.5;lung: 14.0;placenta: 19.7"	"Cell line enhanced"	"Detected in some"		"BJ: 12.8;BJ hTERT+: 28.6;BJ hTERT+ SV40 Large T+: 6.6;BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HAP1: 11.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA008786: AB_10601720, HPA064683: "	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	2.2	0.1	0.1	0.0	0.1	0.0	3.8	0.8	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	6.4	0.1	0.0	44.5	2.2	0.1	0.1	0.1	14.0	1.6	0.1	0.1	0.1	0.1	0.0	0.1	19.7	0.5	5.4	0.0	1.4	0.1	0.0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	6.5	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.8	28.6	6.6	8.1	0.0	0.0	0.0	0.0	0.7	0.0	11.2	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0.0
TCL1B	TML1	ENSG00000213231	"T cell leukemia/lymphoma 1B"	O95988	14	95686417-95692643	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3"	"Cell line enriched"	"Detected in some"	7	"U-698: 102.4"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"naive B-cell: 13.0;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	23	"B-cells: 13.0;dendritic cells: 5.9"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol				Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.2	0.1	0.9	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	1.4	0.4	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	5.3	0.1	0.0	0.2	0.1	0.0	0.1	12.7	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	1.8	0.1	7.3	0.0	0.0	0.1	0.0	5.4	0.1	0.1	13.0	5.9	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	102.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.3	0.4	0.0	5.9	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489792-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 41.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;HBEC3-KT: 14.2;hTCEpi: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA008462	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	5.7	9.0	7.7	6.1	13.1	0.5	11.0	10.4	9.2	8.5	4.9	3.6	8.4	2.3	9.4	9.8	5.7	12.9	9.9	3.7	7.4	10.3	14.3	9.4	9.6	3.9	6.3	3.6	13.0	13.7	15.2	11.1	41.9	8.4	12.5	2.8	17.7	6.2	12.3	2.3	3.3	2.8	5.0	4.6	2.6	3.6	8.1	3.2	3.0	22.7	3.2	6.3	9.9	12.8	0.4	0.0	0.0	0.1	0.0	0.2	1.1	4.9	5.0	8.8	0.0	0.0	0.0	29.5	2.9	1.8	2.7	2.5	0.0	0.0	0.0	1.2	0.9	1.1	0.0	14.2	3.5	0.0	0.4	0.0	0.0	7.4	3.4	0.0	2.1	3.4	11.3	0.0	5.3	0.4	0.6	0.0	2.9	0.0	0.0	0.0	10.4	1.0	0.0	0.0	0.0	9.1	7.4	2.6	4.2	0.0	8.9	2.1	2.9	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	7.7	13.1	10.4	7.5	7.4	10.3	6.3	3.6	8.4	3.2
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 130.5;retina: 48.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.3;HDLM-2: 31.6;hTCEpi: 30.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Region enhanced"	"Detected in single"		"cerebellum: 4.3"	"Region enhanced"	"Detected in single"		"cerebellum: 8.6"	"CAB000326, HPA028850, HPA056871"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000326: AB_667767, HPA028850: AB_10600730, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.4	0.3	0.3	0.0	0.3	0.0	19.0	2.2	0.5	4.4	0.8	0.0	18.7	0.2	0.5	17.8	18.3	0.4	1.7	0.7	0.3	0.2	6.4	0.2	0.5	0.1	0.2	0.2	0.3	0.3	0.0	0.4	130.5	0.6	5.8	0.2	48.1	19.4	26.7	0.2	36.0	0.4	0.1	0.4	0.2	0.7	1.6	0.0	0.1	0.4	16.6	9.9	2.4	9.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	16.5	6.4	0.0	28.3	0.1	0.0	6.1	12.2	9.4	10.0	9.9	0.6	6.2	0.9	1.6	3.5	17.6	1.5	20.9	9.6	31.6	15.9	0.1	14.9	0.0	0.0	0.4	0.4	0.0	30.5	0.0	22.2	0.0	0.9	0.0	0.1	3.6	0.0	5.1	0.1	7.9	1.8	1.5	0.6	5.7	6.7	4.1	0.1	15.0	26.4	24.0	17.5	0.5	0.0	3.1	0.8	2.1	7.7	0.0	1.5	0.2	1.6	0.5	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.3	0.3	0.2	0.2	0.2	0.6	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629302-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 53.9;skin 1: 32.5"	"Group enriched"	"Detected in many"	4	"BEWO: 44.7;MCF7: 37.9;SK-BR-3: 72.1;T-47d: 20.1;WM-115: 26.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory region: 2.9"	"Low region specificity"	"Detected in single"			"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2686902, HPA057076: "	"unprognostic (1.74e-2)"	"prognostic favourable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.1	0.3	0.7	0.2	0.4	0.0	16.1	0.4	0.9	17.3	2.4	0.2	7.7	0.0	3.7	3.4	19.6	1.6	2.0	0.4	1.4	0.2	0.7	0.1	2.8	0.0	0.2	0.5	0.3	1.6	0.0	0.6	53.9	0.4	5.7	0.7	1.9	19.7	7.9	1.0	32.5	0.3	0.6	0.4	0.1	0.3	0.7	0.2	0.3	4.2	21.0	10.1	2.1	11.1	0.1	0.2	0.8	0.1	0.2	0.2	0.0	2.8	3.6	0.0	0.0	0.0	0.0	44.7	4.6	8.4	5.8	1.0	0.7	0.0	0.0	0.3	3.0	9.8	6.3	1.2	4.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	5.0	1.7	1.7	0.0	0.0	0.7	0.0	37.9	4.6	0.2	2.2	4.8	0.0	0.0	1.5	0.0	2.3	1.2	0.0	3.1	72.1	4.7	20.1	1.0	0.0	3.8	0.1	2.0	3.4	0.0	0.0	0.0	0.9	0.0	26.5	0.4	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.1	0.0	0.7	0.4	0.4	0.9	1.4	0.2	0.2	0.5	0.4	0.2
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.2;placenta: 192.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.5;plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005575, CAB020842"	Supported		Approved	"Intermediate filaments,Cytosol"	"Secreted to blood"		95000000	Cytosol	"Intermediate filaments"	"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	52.8	5.0	1.3	5.2	2.2	1.6	18.5	1.9	2.4	22.8	32.1	0.3	7.2	12.8	13.3	14.8	25.9	12.5	15.0	14.0	1.2	1.1	35.6	98.2	89.7	40.2	2.4	1.0	17.3	7.7	0.9	4.9	192.3	2.3	18.2	6.9	3.8	6.0	3.8	15.8	6.6	37.0	13.6	5.4	16.5	7.7	13.7	1.6	3.4	22.6	10.4	4.0	30.0	14.7	1.5	5.1	5.5	0.6	1.0	0.6	4.9	5.0	3.5	4.1	0.1	32.1	38.5	0.0	9.1	21.7	5.9	9.2	3.2	27.0	0.0	3.6	7.1	0.3	1.2	0.4	15.5	0.2	1.0	1.6	10.9	27.4	55.2	0.1	0.0	17.6	0.7	32.1	8.6	103.8	4.0	0.1	63.6	4.7	0.6	0.1	2.5	8.8	0.0	5.7	0.0	10.1	0.2	0.0	0.0	7.4	0.2	0.4	0.1	0.0	62.1	4.3	4.0	8.5	1.7	0.0	0.1	0.0	34.6	0.0	4.9	5.5	0.6	0.5	0.5	0.3	0.2	0.9	0.4	0.2	0.5	1.5	0.5	0.6	2.6	1.0	0.3	5.1	0.2	4.9	1.3	2.2	1.9	2.4	1.2	1.1	2.4	1.0	2.3	1.6
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	21.9	20.0	9.2	18.6	20.4	11.8	57.5	31.4	23.9	22.1	36.7	48.7	20.2	22.5	59.6	11.6	33.9	31.5	10.4	27.1	107.6	10.7	85.3	17.0	22.6	16.1	69.9	17.3	13.3	10.3	19.0	17.2	7.3	35.5	21.6	17.2	20.3	22.9	14.8	28.0	41.0	12.2	13.7	27.0	19.8	55.6	21.0	8.7	30.3	79.7	7.1	77.4	14.6	9.4	26.3	21.4	23.0	47.0	6.1	47.5	35.2	30.8	19.0	15.9	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 160.1;EFO-21: 53.8;HUVEC TERT2: 72.7;TIME: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"			1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.5	4.9	0.0	0.1	5.1	0.5	2.5	9.9	4.8	0.0	0.1	8.0	160.1	0.0	53.8	0.1	0.1	0.0	23.2	0.3	0.0	0.0	1.0	0.2	3.5	20.9	0.0	0.0	0.5	0.0	4.2	0.0	72.7	2.1	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.0	0.0	0.1	23.2	0.0	0.8	0.2	0.0	94.8	0.1	6.0	0.7	4.7	0.0	0.0	0.0	6.5	0.0	1.9	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370357-11832198	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.5"	"Cell line enhanced"	"Detected in some"		"A549: 9.5;HUVEC TERT2: 6.3;REH: 6.5;SH-SY5Y: 9.7;THP-1: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	76	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"		3000000			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favourable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	9.6	2.2	4.7	2.1	5.7	0.6	5.2	2.0	7.2	8.4	2.7	1.0	0.9	1.2	8.3	2.7	1.7	4.8	6.2	2.1	3.8	4.7	17.7	2.0	3.0	1.2	4.6	3.6	6.4	1.4	2.6	9.4	22.5	3.5	8.4	2.1	4.4	1.7	5.5	0.9	1.7	1.5	5.9	4.3	2.3	1.7	2.2	1.9	0.0	4.9	2.5	1.1	4.5	6.8	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	9.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	6.5	0.0	0.0	0.3	0.1	0.7	9.7	0.0	0.3	0.0	0.1	17.5	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.7	2.0	7.2	3.8	4.7	4.6	3.6	3.5	1.9
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 269.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.8;ASC TERT1: 153.5;BJ hTERT+: 87.2;fHDF/TERT166: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.3;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"		83000000			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	75.2	35.1	30.9	17.7	18.9	3.4	45.6	4.6	25.8	95.8	40.5	36.8	28.2	12.9	87.9	41.5	37.4	39.8	72.3	38.5	23.2	29.6	21.1	12.2	38.4	15.4	25.3	23.2	182.4	14.4	15.8	17.2	269.8	34.0	44.6	20.3	49.7	16.9	51.6	24.5	38.4	22.0	70.7	32.6	37.9	24.2	51.7	26.1	28.4	25.3	24.0	11.3	60.2	58.1	0.2	2.1	13.3	5.0	0.2	0.3	0.8	14.8	7.5	8.5	16.2	124.8	153.5	4.6	52.6	87.2	25.8	20.5	2.7	26.0	0.0	18.6	95.6	2.9	2.6	2.2	27.1	0.3	1.5	0.0	15.2	4.2	37.0	0.2	0.1	60.3	1.1	25.4	4.1	34.1	0.0	0.0	26.5	1.7	15.3	2.6	1.5	11.1	10.3	19.5	6.3	16.4	0.2	4.3	26.8	32.9	15.6	67.1	7.9	3.7	40.4	69.2	13.3	40.1	9.0	7.7	6.4	0.1	15.8	2.8	33.3	0.0	5.0	6.8	0.0	3.3	0.0	0.1	0.1	0.0	2.1	0.2	0.3	0.3	13.3	0.2	3.8	1.4	0.1	0.8	30.9	18.9	4.6	25.8	23.2	29.6	25.3	23.2	34.0	26.1
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801701-32863043	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 392.5;retina: 247.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;BJ: 125.0;BJ hTERT+: 55.2;fHDF/TERT166: 113.6;WM-115: 95.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	130.4	44.6	8.7	15.8	10.1	0.1	103.3	5.1	12.1	68.3	25.4	13.5	27.8	4.5	65.1	47.4	40.2	51.9	39.9	75.0	10.2	8.5	54.0	14.1	115.4	31.3	11.4	8.7	25.3	11.8	15.6	21.6	392.5	19.1	44.2	12.6	247.1	24.3	55.0	22.7	22.9	16.2	58.3	7.2	35.1	22.9	43.2	7.1	1.2	48.9	29.4	10.1	37.5	38.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	1.8	0.2	55.9	31.5	0.1	125.0	55.2	10.2	12.2	2.1	0.0	0.0	3.0	113.6	1.9	0.3	5.1	14.8	0.0	1.5	15.4	2.6	5.4	22.0	0.0	6.5	5.2	13.1	18.1	1.0	0.0	0.0	0.1	4.7	0.1	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.2	10.2	1.3	1.8	2.5	0.0	32.8	0.0	0.1	0.0	0.8	2.8	26.6	2.0	0.0	0.0	0.0	25.5	0.0	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.7	10.1	5.1	12.1	10.2	8.5	11.4	8.7	19.1	7.1
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 57.5;CAPAN-2: 31.4;EFO-21: 72.5;HaCaT: 31.5;HBEC3-KT: 37.1;HUVEC TERT2: 30.7;TIME: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048695	Approved				"Secreted to extracellular matrix"		170000			"HPA048695: "	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favourable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favourable (9.64e-4)"	"unprognostic (3.43e-2)"	43.0	8.4	2.2	11.6	3.4	0.8	60.0	0.8	4.4	30.2	22.0	2.9	14.2	12.0	25.7	23.4	23.7	17.0	36.1	52.6	3.4	2.3	53.3	14.7	24.4	12.8	3.9	3.3	15.5	7.4	3.2	5.6	128.4	5.0	19.4	7.9	12.0	24.2	20.0	19.6	7.6	15.9	22.5	2.7	34.3	16.3	10.3	2.1	0.8	30.7	11.0	6.4	39.8	20.0	1.1	0.6	4.8	0.5	1.5	0.8	0.0	16.4	0.0	0.0	0.1	0.1	0.0	57.5	2.6	0.3	0.1	0.0	7.7	31.4	0.0	72.5	2.3	31.5	0.0	37.1	0.0	0.1	0.0	0.0	1.3	1.9	0.8	0.0	0.1	0.0	6.7	0.0	1.3	30.7	0.4	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.0	0.0	10.0	12.7	0.0	0.1	6.6	22.2	0.7	1.3	0.0	65.6	0.0	16.6	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.5	4.8	0.5	0.5	0.8	0.3	0.5	0.4	0.6	0.5	0.1	1.1	0.8	0.8	2.7	1.5	0.5	0.6	0.5	0.0	2.2	3.4	0.8	4.4	3.4	2.3	3.9	3.3	5.0	2.1
TLE6	"FLJ14009, GRG6"	ENSG00000104953	"Transducin like enhancer of split 6"	Q9H808	19	2977446-2995184	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.1;SK-BR-3: 11.3;U-266/70: 12.0;U-698: 12.6;U-937: 9.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"hypothalamus: 3.1"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.1"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.32e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.63e-5)"	"unprognostic (4.05e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-4)"	"unprognostic (3.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-3)"	1.8	1.4	0.6	1.2	0.4	0.0	4.8	0.4	0.7	1.4	1.6	0.4	7.7	0.9	2.1	7.1	1.0	1.2	1.1	3.4	0.4	3.1	3.3	5.3	3.4	1.0	0.6	0.4	0.4	2.2	3.9	2.3	18.8	0.7	1.6	1.9	2.7	7.5	5.3	0.8	0.7	1.2	1.2	1.4	1.5	1.6	4.0	0.4	0.9	10.2	0.4	1.5	1.8	0.7	2.3	0.7	0.0	0.4	3.1	1.2	0.6	3.7	4.9	0.1	2.0	0.0	0.0	14.1	0.0	0.0	0.2	0.8	0.0	1.1	6.5	1.0	0.4	0.0	1.9	1.0	0.2	5.4	0.9	0.0	0.1	0.6	0.6	0.1	1.2	0.8	0.7	0.0	0.1	0.9	1.1	0.0	0.4	2.5	0.0	0.3	0.0	1.0	4.0	0.3	5.4	1.2	1.0	0.3	1.3	0.3	11.3	4.5	3.2	0.6	0.8	0.4	0.7	0.3	0.3	12.0	7.8	12.6	2.8	9.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	1.6	0.6	0.6	0.7	2.3	0.0	0.5	0.0	3.1	0.4	0.0	1.2	0.6	0.6	0.4	0.4	0.7	0.4	3.1	0.6	0.4	0.7	0.4
TLR3	CD283	ENSG00000164342	"Toll like receptor 3"	O15455	4	186069152-186088069	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Receptor, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 48.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.4;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 17.7;CAPAN-2: 27.6;HSkMC: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 7.6;memory CD8 T-cell: 8.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.5;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025658	Enhanced				"Intracellular and membrane"					"CAB025658: "	"unprognostic (2.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.83e-1)"	11.9	10.7	3.1	6.8	5.0	0.0	11.1	1.7	3.5	9.9	20.1	3.0	6.8	13.4	5.6	7.3	12.9	7.8	8.6	7.7	3.5	2.6	12.4	11.2	12.2	1.0	3.3	1.9	8.9	8.2	4.8	2.7	48.1	3.0	11.3	9.5	5.0	8.5	10.2	2.3	3.8	34.9	6.5	8.0	7.0	8.2	5.8	4.2	1.2	11.8	7.6	3.0	10.3	14.6	0.0	2.5	0.5	0.0	0.7	8.0	1.1	1.9	0.5	0.3	0.0	11.4	12.0	0.9	0.1	8.2	5.1	17.7	0.0	27.6	0.0	1.1	1.2	2.8	0.0	5.8	0.9	10.6	0.1	1.7	0.5	0.0	5.1	1.7	0.7	11.7	2.2	6.8	0.3	2.4	0.0	0.0	2.8	0.0	2.0	0.0	0.8	1.0	2.5	0.0	0.1	4.8	2.7	0.0	0.1	1.4	1.2	2.2	0.3	0.0	1.7	0.9	0.6	0.0	1.2	0.0	0.0	0.0	2.3	1.1	1.9	0.5	0.0	0.0	7.6	0.0	4.3	0.0	1.8	8.0	2.5	0.0	1.2	3.9	0.3	0.7	0.0	0.0	0.2	1.1	3.1	5.0	1.7	3.5	3.5	2.6	3.3	1.9	3.0	4.2
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.5	0.7	0.1	0.0	0.0	0.0	6.4	0.1	0.0	0.0	0.0	2.2	17.9	0.1	12.6	0.0	8.1	0.0	4.1	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.4	0.0	0.7	0.1	0.1	0.0	31.5	2.4	0.1	0.0	0.4	11.1	0.0	30.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1
TMEM2		ENSG00000135048	"Transmembrane protein 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.6"	"Cell line enhanced"	"Detected in many"		"AF22: 37.7;BEWO: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044889	Approved		Supported	"Vesicles,Plasma membrane"			130000	"Plasma membrane"	Vesicles	"HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	23.3	3.9	6.0	10.5	4.4	12.4	13.6	8.9	6.0	3.0	18.6	1.9	10.1	12.2	4.5	5.2	4.4	4.9	19.2	9.5	8.6	3.6	9.3	24.9	35.7	14.0	4.0	4.1	3.1	9.2	24.0	9.5	67.6	4.3	5.5	13.1	7.9	9.5	10.2	5.5	6.4	20.0	5.5	5.1	15.6	14.5	3.7	2.4	6.4	8.0	4.6	8.8	11.4	6.8	6.3	0.9	5.5	2.1	0.5	4.1	1.4	5.9	28.8	37.7	1.7	3.9	7.1	35.0	20.3	13.0	14.1	10.4	8.1	8.2	0.1	6.1	5.2	9.0	12.2	2.8	19.2	0.7	3.7	10.3	6.1	21.4	6.1	0.0	2.8	7.3	3.1	10.9	2.4	18.5	1.4	3.0	7.6	5.0	1.2	0.1	7.8	2.8	0.9	11.2	0.8	8.9	19.4	1.9	0.2	5.3	3.7	5.4	2.6	0.4	8.1	9.6	10.8	5.3	10.1	0.6	8.7	0.3	1.8	0.9	12.1	0.2	2.1	5.5	2.7	1.9	0.8	0.7	2.9	2.6	0.9	6.3	4.1	2.0	4.5	0.5	1.8	0.2	3.9	1.4	6.0	4.4	8.9	6.0	8.6	3.6	4.0	4.1	4.3	2.4
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 72.0;hTCEpi: 16.2;hTERT-HME1: 20.5;RT4: 10.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044165	Enhanced		Approved	Cytosol			7000000	Cytosol		"HPA044165: AB_10961279"	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.2	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	2.1	0.0	72.0	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.0	20.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.1	0.0	0.0	0.0	9.0	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMPRSS13	"MSPL, TMPRSS11"	ENSG00000137747	"Transmembrane serine protease 13"	Q9BYE2	11	117900643-117929459	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.1;salivary gland: 16.6;skin 1: 26.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;BEWO: 17.5;MCF7: 14.7;SK-BR-3: 25.3;T-47d: 25.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.16e-6)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.44e-1)"	0.2	0.3	0.2	0.6	0.2	0.3	6.2	0.2	0.2	5.8	0.2	0.2	0.2	0.2	0.9	0.7	14.8	0.1	0.2	0.2	0.4	0.0	0.7	0.2	4.0	0.7	0.2	0.2	0.3	5.7	0.0	0.5	22.1	0.2	0.9	0.2	0.6	16.6	0.2	0.2	26.0	0.5	0.2	0.2	1.0	0.1	0.3	0.2	0.4	9.5	13.7	10.6	0.3	5.6	1.0	2.6	1.0	0.7	1.9	1.2	0.8	7.3	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	5.6	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.4	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.2	0.0	0.0	25.3	0.3	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.6	0.0	0.9	0.7	0.0	1.0	0.1	1.2	1.8	0.5	0.4	0.1	0.0	1.9	0.5	2.6	0.7	0.8	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 25.0"	"Group enriched"	"Detected in many"	8	"eosinophil: 38.1;neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA007853	Approved		Approved	"Plasma membrane,Cytosol"			170000	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	10.8	14.2	2.4	11.3	5.1	2.7	21.2	0.9	3.0	8.0	18.9	3.2	4.1	14.5	11.6	10.2	10.7	6.4	28.1	27.0	5.0	2.6	50.4	36.2	23.0	2.6	4.8	0.5	6.4	47.0	51.1	20.0	81.3	25.0	11.1	1.9	2.8	17.3	6.9	23.3	5.0	31.0	16.8	4.3	3.9	13.2	5.3	3.3	1.2	11.5	11.5	4.7	14.8	5.2	0.0	4.1	38.1	3.5	2.0	2.4	1.1	24.3	19.8	2.2	4.1	4.0	9.2	13.1	51.3	37.2	44.0	28.3	8.5	43.5	0.1	68.0	34.1	27.0	0.5	37.5	16.9	0.9	1.3	0.1	6.6	7.2	27.8	0.4	1.8	8.5	26.0	46.2	55.4	12.7	2.7	0.3	46.3	46.0	0.0	3.2	10.7	43.4	0.2	24.7	1.0	44.5	4.8	2.5	0.8	36.6	17.0	30.3	8.9	0.7	22.3	79.3	36.6	52.4	84.2	0.8	0.3	0.3	24.7	2.2	62.3	3.5	3.5	38.1	1.8	2.0	2.4	0.0	0.8	1.5	4.1	0.0	0.4	0.8	29.9	2.0	1.3	0.1	1.0	1.1	2.4	5.1	0.9	3.0	5.0	2.6	4.8	0.5	25.0	3.3
TNS4	CTEN	ENSG00000131746	"Tensin 4"	Q8IZW8	17	40475828-40501597	"Predicted intracellular proteins"	Apoptosis	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 76.9;salivary gland: 58.8;skin 1: 60.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 23.2;HBEC3-KT: 103.4;hTCEpi: 77.0;hTERT-HME1: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (4.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.68e-4)"	"unprognostic (7.88e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.08e-2)"	0.4	0.2	0.2	0.5	0.2	0.0	10.4	0.2	0.2	12.5	1.7	0.0	18.2	0.3	1.2	10.8	35.3	0.6	2.4	0.2	0.2	0.2	2.6	0.2	1.3	0.0	0.2	0.0	0.2	0.2	0.0	1.0	76.9	0.0	17.5	3.5	0.0	58.8	38.2	0.2	60.1	0.4	2.1	0.2	0.2	0.9	1.2	0.0	0.0	8.1	28.4	27.6	7.4	23.1	0.0	0.0	0.0	0.0	0.2	1.4	0.1	1.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.1	0.0	0.6	0.0	23.2	0.0	103.4	0.0	0.0	0.0	0.0	9.2	1.5	0.0	0.0	0.0	0.0	77.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	13.3	2.5	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TP53TG3	"P53TG3, TP53TG3A"	ENSG00000183632	"TP53 target 3"	Q9ULZ0	16	32673528-32676732	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.9;placenta: 1.4;testis: 4.3"	"Cell line enhanced"	"Detected in some"		"HEL: 3.3;HMC-1: 1.5;SK-MEL-30: 1.2;U-2 OS: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0			0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.4		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
TP53TG3E		ENSG00000275034	"TP53 target 3 family member E"	Q9ULZ0	16	33303739-33306935	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;placenta: 1.6;salivary gland: 1.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;AN3-CA: 3.1;SH-SY5Y: 1.3;U-266/70: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.3"																																					0.0	0.0		0.6		0.2	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.1	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		1.6		0.0	0.0		1.0	0.0	0.0	0.3	0.0	0.0		0.0	0.1	0.0			0.0		0.0	0.0		0.0	0.1	1.3	0.0	0.0	0.0	1.2	0.0	1.5	0.0	3.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2										
TRAPPC3L	"bA259P20.2, BET3L, FLJ11180"	ENSG00000173626	"Trafficking protein particle complex 3 like"	Q5T215	6	116494989-116545610	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.9;placenta: 9.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"														"unprognostic (1.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.09e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.47e-3)"	1.1	0.9	0.8	0.5	0.9	4.3	1.0	0.6	1.3	0.7	0.8	0.7	0.4	0.7	1.1	2.2	0.9	0.8	1.3	2.6	1.5	1.6	1.3	5.2	3.4	5.0	1.4	0.4	1.1	0.5	1.5	0.8	9.7	0.8	1.8	0.1	3.4	1.1	0.5	1.8	2.6	1.9	1.6	2.3	10.9	0.9	1.9	0.4	0.4	2.1	0.4	0.4	0.9	0.7	0.4	0.7	2.1	0.5	0.4	0.6	7.0	1.6	0.9	2.1	3.1	0.6	2.3	2.2	1.2	1.0	0.8	1.0	1.0	1.4	2.6	1.4	0.5	1.9	0.7	1.4	1.2	1.4	1.1	2.6	3.2	1.2	1.2	1.8	1.4	1.4	0.9	0.6	1.0	1.5	1.6	12.4	0.8	2.8	1.6	2.1	2.1	1.1	1.6	1.5	3.9	1.4	2.6	2.1	1.6	1.6	1.0	1.1	1.6	1.6	2.3	2.3	2.0	2.5	1.2	2.4	1.4	1.7	1.8	1.7	1.5	1.1	0.4	0.6	0.5	0.4	0.3	0.3	0.4	0.4	0.3	0.4	0.6	0.4	2.1	0.4	0.5	0.7	0.3	7.0	0.8	0.9	0.6	1.3	1.5	1.6	1.4	0.4	0.8	0.4
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41190277-41201194	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.8;bone marrow: 13.6;placenta: 54.3"	"Cell line enhanced"	"Detected in some"		"HEL: 24.4;HL-60: 5.7;U-698: 6.9;U-937: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.1;neutrophil: 20.8"	"Group enriched"	"Detected in many"	15	"B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8"					"Low region specificity"	"Detected in some"										2300000				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.2	0.2	6.3	0.2	13.6	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.9	0.3	0.5	0.2	0.2	0.3	0.4	1.5	9.2	0.2	0.1	0.2	0.2	0.0	0.2	54.3	0.3	0.2	0.0	0.1	1.5	0.1	0.2	0.2	1.9	0.1	0.3	12.3	0.4	5.9	0.2	4.9	0.3	0.1	7.5	0.8	0.2	16.1	5.5	20.8	0.8	0.4	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.3	1.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	4.5	0.0	1.4	0.3	7.7	0.2	0.7	0.3	3.6	0.6	0.1	1.3	16.1	0.9	0.2	20.8	0.4	0.8	5.5	0.4	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.2
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151945-30160934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8"	"Cell line enriched"	"Detected in single"	11	"EFO-21: 1.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hippocampal formation: 4.0"	HPA043325	Uncertain									"HPA043325: "		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	3.0	0.0	0.0	1.4	0.1	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.9;HEL: 21.0;K-562: 11.6;PC-3: 20.2;U-2 OS: 16.5;WM-115: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain						310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	7.9	0.0	0.0	0.0	0.8	21.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.1	1.3	20.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	16.5	0.0	0.0	3.5	0.0	0.0	0.0	5.9	21.3	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1
TRIM75P	TRIM75	ENSG00000250374	"Tripartite motif containing 75, pseudogene"	A6NK02	4	165059148-165060554	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"placenta: 1.8;testis: 1.2"	"Cell line enriched"	"Detected in single"	15	"BEWO: 6.8"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (8.51e-2)"					"unprognostic (2.81e-2)"			"unprognostic (1.94e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.78e-2)"			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2			0.4	0.0	0.0		1.8		0.0	0.0		0.0	0.0	0.2	0.2	0.0	0.0		0.0	0.0	1.2			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC diff: 8.6;BJ hTERT+: 4.6;HEL: 4.3;RPTEC TERT1: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved						140000			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.6	0.2	0.0	8.6	2.1	0.0	3.0	4.6	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;HaCaT: 10.2;RT4: 18.3;SK-BR-3: 13.5;T-47d: 30.1"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA062864	Approved									"HPA062864: "	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.1	0.0	0.0	13.5	0.3	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3
TUSC3	"MGC13453, MRT7, N33, OST3A"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved									"HPA049851: , HPA049974: "	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.86e-4)"	"unprognostic (1.55e-1)"	10.5	35.3	10.5	4.0	23.0	0.1	19.7	21.5	19.8	12.1	6.2	5.4	5.1	4.5	16.0	50.5	6.1	27.0	8.1	16.1	10.4	21.4	11.6	3.2	8.5	3.3	6.0	15.6	35.5	15.8	24.8	50.6	127.8	13.4	23.9	7.1	11.6	5.7	14.1	2.8	3.8	4.1	14.4	4.3	3.6	5.2	10.2	3.3	2.9	4.7	3.6	2.4	15.0	9.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	13.1	9.5	26.4	24.5	30.8	35.7	0.0	18.7	40.2	20.7	34.7	0.0	0.0	0.1	6.6	24.9	10.1	9.2	18.0	30.1	0.0	12.6	0.0	7.8	1.5	13.3	0.0	1.3	28.3	5.7	29.0	10.8	1.7	17.4	4.0	31.4	9.5	4.8	0.1	13.1	8.3	5.9	21.9	0.1	28.6	32.8	10.5	20.2	0.0	10.7	14.6	12.5	0.0	8.1	19.1	18.9	7.9	9.3	0.0	2.3	0.0	0.3	0.0	26.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	23.0	21.5	19.8	10.4	21.4	6.0	15.6	13.4	3.3
TWIST1	"ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST"	ENSG00000122691	"Twist family bHLH transcription factor 1"	Q15672	7	19020991-19117672	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 50.0;placenta: 45.6"	"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 74.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"														"unprognostic (4.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.29e-9)"	"unprognostic (8.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.97e-2)"	19.9	5.1	0.6	2.6	0.6	0.1	50.0	0.4	1.2	4.6	3.3	0.5	1.4	0.2	19.6	4.0	7.0	2.2	7.5	3.3	0.6	0.4	0.7	0.3	0.4	2.8	0.7	1.1	6.2	0.4	0.2	5.3	45.6	1.6	7.6	0.6	2.2	6.4	1.0	3.5	12.0	0.4	11.3	1.0	0.1	4.5	3.6	0.5	0.0	2.8	8.6	5.3	12.6	11.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.4	0.5	2.5	0.0	12.8	5.3	0.0	10.4	4.9	8.1	10.6	0.0	0.0	0.0	1.1	8.6	0.0	1.0	0.8	5.3	2.2	2.8	0.0	1.1	0.0	7.6	2.6	0.0	12.8	2.7	1.6	4.4	0.0	0.0	0.0	8.5	0.0	0.0	0.1	1.0	4.3	0.0	0.0	0.0	0.0	0.0	4.4	74.0	1.7	0.0	2.1	0.2	3.3	0.0	10.0	0.0	7.8	1.7	0.0	0.0	0.0	5.4	0.0	12.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	0.4	1.2	0.6	0.4	0.7	1.1	1.6	0.5
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.7;HMC-1: 11.0;U-266/70: 5.4;U-266/84: 6.7;WM-115: 24.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 43.5"	"Group enriched"	"Detected in many"	26	"NK-cells: 43.5;T-cells: 17.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles				Vesicles		"HPA062482: "	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4.0	49.1	0.5	0.5	0.5	1.0	0.4	1.3	28.4	0.6	0.9	1.0	1.0	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1.0	1.7	0.2	14.0	1.9	0.2	19.3	2.4	1.4	0.0	0.1	1.1	0.0	43.5	17.5	10.6	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.7	0.0	1.4	0.0	0.2	0.0	0.0	0.4	0.2	0.1	2.3	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.0	0.0	2.0	0.0	0.8	0.3	0.0	0.0	1.3	1.2	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.0	0.3	0.1	5.4	6.7	0.4	0.0	0.4	24.8	1.1	0.0	0.3	13.2	0.0	17.4	0.0	6.8	6.4	0.0	0.0	17.5	11.9	0.8	43.5	0.0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827531-165911618	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm				Nucleoplasm		"HPA057128: "	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavourable (9.22e-8)"	"prognostic unfavourable (4.98e-4)"	"prognostic unfavourable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.5	7.1	6.5	11.1	8.6	11.6	17.5	16.9	9.6	9.3	18.4	8.9	11.0	15.3	10.1	15.3	20.5	8.8	9.0	9.6	6.4	6.6	6.6	14.6	11.1	10.3	10.5	6.6	7.5	17.6	7.9	9.4	65.8	11.2	8.1	19.9	5.0	16.1	9.9	20.9	15.0	24.8	10.0	8.2	7.7	13.2	7.2	7.9	13.1	6.4	12.4	12.3	9.0	11.1	3.4	14.7	0.8	5.6	3.4	3.9	2.0	25.2	26.3	14.2	12.7	7.3	12.2	23.1	27.9	20.6	29.8	34.0	25.0	27.8	12.5	19.9	17.3	20.8	26.6	32.8	26.7	22.9	22.5	14.5	22.6	25.6	18.2	28.3	11.1	11.5	16.9	56.2	35.1	19.6	38.3	18.0	26.7	18.3	25.1	18.2	38.9	25.5	11.5	15.6	42.5	13.8	16.5	21.4	25.3	19.9	39.4	19.3	24.3	27.0	20.4	16.7	23.3	18.9	29.5	24.2	36.0	46.3	14.4	18.8	12.7	0.8	5.6	0.1	1.8	3.7	3.9	3.4	1.7	2.4	14.7	3.4	0.0	1.4	0.2	3.4	3.2	14.0	2.2	2.0	6.5	8.6	16.9	9.6	6.4	6.6	10.5	6.6	11.2	7.9
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell line enhanced"	"Detected in many"		"HEL: 55.1;HMC-1: 57.1;SK-BR-3: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol			14000000	Cytosol	Vesicles	"HPA067117: , HPA073525: "	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.3	3.2	0.0	0.0	0.1	0.2	10.4	0.0	0.0	0.0	0.0	8.0	18.8	0.7	10.0	0.0	2.9	0.0	0.5	0.0	0.1	0.1	55.1	24.4	5.1	0.9	20.9	57.1	0.1	0.4	0.1	0.5	3.7	19.0	0.2	0.0	14.2	22.1	10.5	0.2	0.4	7.1	0.2	0.3	0.3	3.3	0.0	15.3	3.6	39.1	0.2	10.5	11.9	10.4	0.1	14.8	0.1	0.0	0.3	1.3	0.8	0.1	6.7	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205153	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.4;urinary bladder: 41.9"	"Group enriched"	"Detected in some"	4	"CACO-2: 15.0;RPTEC TERT1: 14.0;RT4: 54.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 147.3"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031799, HPA031800"	Enhanced									"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favourable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	6.1	0.2	0.2	0.2	1.2	0.0	0.2	0.2	0.3	3.6	0.7	0.0	0.0	0.0	1.5	0.3	2.4	5.1	12.9	1.8	0.2	0.2	6.6	0.6	1.4	0.0	0.2	0.1	0.8	11.6	0.0	0.4	56.4	1.1	15.4	0.0	0.0	0.4	0.0	0.2	0.6	0.2	4.3	1.8	0.2	22.9	0.7	0.0	1.4	0.2	1.4	12.9	41.9	1.1	0.7	1.1	2.5	0.5	0.6	1.9	0.5	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.0	0.0	0.0	2.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.5	0.3	0.3	0.2	0.4	0.2	0.3	0.5	0.7	1.9	0.3	1.8	0.6	0.4	1.1	0.2	0.5	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.1	1.1	0.0
USP43	FLJ30626	ENSG00000154914	"Ubiquitin specific peptidase 43"	Q70EL4	17	9644698-9729691	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.3;SK-BR-3: 8.5;T-47d: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA023389, HPA027762"	Uncertain									"HPA023389: AB_1858691, HPA027762: AB_10603001"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.49e-2)"	"unprognostic (5.95e-2)"	"prognostic favourable (5.39e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.28e-1)"	0.2	0.2	4.2	1.2	3.4	0.9	3.0	0.7	6.0	4.9	10.0	0.6	15.7	6.2	2.9	1.7	6.7	6.3	5.1	0.2	4.1	3.8	3.7	8.7	3.4	0.2	1.7	3.1	1.0	7.7	1.7	3.7	61.6	0.7	10.8	5.0	0.3	11.3	12.4	0.2	2.4	12.5	0.3	1.0	0.2	2.6	2.9	0.2	0.4	1.7	4.2	2.7	1.3	2.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	5.6	1.4	0.0	0.6	0.0	0.0	12.3	0.1	0.2	0.6	1.7	2.8	4.6	0.0	1.9	0.2	6.9	0.6	5.4	0.6	3.6	1.9	0.3	2.9	1.0	0.1	0.5	0.0	0.0	7.1	0.3	3.0	0.0	0.0	0.0	0.0	2.6	0.9	4.6	0.7	0.3	3.7	0.0	0.8	4.3	3.1	0.7	0.0	2.4	8.5	1.0	10.2	1.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	4.2	3.4	0.7	6.0	4.1	3.8	1.7	3.1	0.7	0.2
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571160-107965144	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.5;placenta: 54.4"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;RH-30: 23.0;RPTEC TERT1: 32.3;T-47d: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB002012	Uncertain									"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	2.3	1.2	1.8	12.2	2.4	7.1	15.2	2.7	3.0	11.4	17.5	0.8	6.4	3.8	3.3	4.8	32.6	1.6	1.7	2.0	1.2	1.9	47.5	1.1	7.1	8.6	3.8	0.8	1.0	7.3	0.5	2.0	54.4	3.1	6.2	22.2	6.9	6.3	5.3	0.8	27.1	7.6	2.1	1.0	13.1	3.7	2.5	0.4	8.9	4.2	17.6	17.6	7.3	11.5	4.4	4.8	6.8	1.1	3.8	4.6	1.1	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	1.6	6.2	2.2	3.6	0.0	5.7	2.4	0.0	13.6	0.0	0.4	0.0	0.0	4.9	0.0	2.0	11.9	1.5	1.8	0.4	18.7	23.0	0.1	32.3	10.6	1.0	0.9	5.9	2.7	0.1	39.5	10.6	0.4	0.2	0.0	0.0	0.2	3.0	1.1	0.2	4.9	9.4	0.4	6.8	1.1	1.4	4.1	1.0	2.3	2.9	1.2	2.0	4.8	4.4	0.3	2.9	3.3	3.8	0.4	3.1	4.6	1.1	1.8	2.4	2.7	3.0	1.2	1.9	3.8	0.8	3.1	0.4
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850531	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 9.9;placenta: 10.7"	"Cell line enhanced"	"Detected in some"		"A-431: 1.8;HaCaT: 2.5;PC-3: 10.5;SH-SY5Y: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: "	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.5	0.6	3.1	0.4	2.9	0.1	1.1	2.2	8.2	2.8	3.0	0.4	0.6	0.5	0.9	3.2	0.5	0.5	1.5	0.8	3.2	9.9	2.1	0.1	0.3	0.2	4.7	3.5	0.3	1.3	0.1	1.2	10.7	4.9	1.6	4.4	0.3	1.4	1.3	0.2	0.3	1.3	1.9	1.3	0.1	4.9	0.4	0.0	0.0	0.4	0.0	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.9	0.2	1.1	0.0	0.0	0.2	2.5	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.3	0.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	2.2	8.2	3.2	9.9	4.7	3.5	4.9	0.0
WNT1	INT1	ENSG00000125084	"Wnt family member 1"	P04628	12	48978453-48981676	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.7;brain: 6.5;placenta: 17.5"	"Cell line enhanced"	"Detected in single"		"CACO-2: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	8	"gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	24	"T-cells: 7.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1"						"Secreted to extracellular matrix"						"unprognostic (2.02e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.76e-2)"	0.3	0.1	0.4	1.5	6.5	2.3	0.3	0.3	2.9	0.3	0.3	0.3	0.3	1.5	0.3	0.3	0.5	0.1	0.7	0.3	0.6	0.5	0.3	0.3	0.7	2.9	0.3	0.3	0.3	0.3	0.0	0.3	17.5	0.3	0.3	0.0	0.3	1.2	0.3	0.3	0.0	1.8	0.3	0.3	1.9	1.2	1.4	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.0	7.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.7	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	7.7	0.3	3.0	4.8	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.4	0.8	0.4	6.5	0.3	1.8	0.6	0.5	0.3	0.3	0.3	0.3
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA020920: AB_1858850"	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0
WNT7A		ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880121	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;gallbladder: 8.7;placenta: 19.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 24.7;EFO-21: 23.2;PC-3: 8.1;RPTEC TERT1: 41.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.4	0.4	7.8	0.6	6.1	0.7	0.4	1.2	11.5	1.1	0.4	2.1	0.0	0.4	3.4	1.0	1.6	0.7	8.7	0.4	3.3	2.8	0.7	0.5	5.7	1.4	3.1	3.2	0.4	0.8	0.4	0.2	19.4	3.9	0.5	0.4	0.0	0.5	1.4	0.4	2.8	0.4	0.5	4.4	3.1	0.4	2.3	2.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.5	3.4	0.0	0.3	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	3.1	0.0	23.2	0.0	4.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.6	41.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	7.8	6.1	1.2	7.2	3.3	2.8	3.1	3.2	3.9	2.3
XG	PBDX	ENSG00000124343	"Xg blood group"	P55808	X	2752048-2816500	"Blood group antigen proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8"	"Group enriched"	"Detected in some"	6	"ASC diff: 33.7;ASC TERT1: 25.0;fHDF/TERT166: 15.7;hTCEpi: 23.4;T-47d: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 2.1;naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.1"					"Low region specificity"	"Detected in all"														"prognostic unfavourable (4.25e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-6)"	"unprognostic (3.96e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.77e-3)"	8.9	0.0	0.3	0.3	0.6	0.8	9.1	0.5	0.6	22.8	0.3	0.3	0.3	0.0	2.6	0.3	7.1	0.6	3.0	1.2	1.4	0.0	1.3	0.3	0.3	0.3	0.6	0.3	1.1	0.3	0.0	0.3	18.4	1.9	0.5	0.0	0.3	4.1	0.4	1.4	25.8	0.3	0.3	4.2	0.3	0.1	0.3	0.3	0.3	0.9	0.3	2.4	1.2	7.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	25.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	23.4	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	1.7	12.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	1.4	0.0	0.6	0.3	1.9	0.3
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related, X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	44	"B-cells: 5.0;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.18e-1)"	0.1	1.0	0.2	2.1	0.3	0.1	1.1	0.1	0.1	1.2	7.2	0.2	8.3	0.4	0.2	1.9	3.5	1.1	0.5	0.1	0.2	0.4	0.3	0.1	3.3	2.4	0.2	0.0	0.3	0.2	0.0	12.0	12.2	0.2	0.5	1.3	0.0	1.0	1.8	0.2	12.9	6.8	0.0	0.2	0.6	0.5	0.4	0.0	0.8	11.0	1.9	5.4	0.5	2.4	5.0	0.0	0.0	0.0	0.0	3.7	0.6	0.3	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	13.0	1.6	1.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.0	0.0	0.0	2.5	0.1	2.0	0.3	1.1	0.2	1.1	0.0	0.4	0.0	2.3	0.0	0.3	0.0	0.0	1.9	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	5.0	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.0
ZFAT	"KIAA1485, ZFAT1, ZNF406"	ENSG00000066827	"Zinc finger and AT-hook domain containing"	Q9P243	8	134477788-134713049	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 68.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020989, HPA063592"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA020989: , HPA063592: "	"unprognostic (2.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-3)"	"unprognostic (5.91e-3)"	"unprognostic (2.45e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (6.27e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.33e-1)"	4.5	2.9	4.2	3.5	4.2	1.7	5.0	6.8	4.5	3.0	7.8	2.6	2.8	3.2	5.0	3.1	4.2	3.3	2.4	3.8	3.0	1.7	12.4	2.8	4.1	4.5	2.5	2.8	3.3	3.3	3.7	4.6	68.8	2.9	3.9	2.6	4.3	3.7	4.2	8.5	3.4	3.8	3.9	2.0	4.4	3.6	3.5	3.0	4.8	3.3	2.8	4.0	6.0	5.3	0.6	22.1	0.8	0.5	0.0	0.5	0.5	5.7	9.0	3.3	4.1	6.4	6.4	2.8	6.2	5.5	5.7	5.7	6.1	7.2	6.4	5.4	6.4	4.4	6.5	7.8	7.4	5.3	8.7	12.0	9.1	4.6	5.0	6.6	5.9	5.4	4.0	6.3	8.2	6.9	4.5	12.0	4.8	7.4	6.9	0.8	4.5	5.9	4.3	4.3	2.7	5.4	8.5	3.7	3.1	6.3	4.9	5.2	4.0	6.3	7.6	3.3	5.0	4.7	7.0	4.3	5.8	6.4	4.3	4.9	6.4	0.7	0.3	0.8	0.3	0.5	0.3	0.6	0.2	0.5	0.3	0.6	0.4	0.2	0.7	0.0	0.3	22.1	0.1	0.5	4.2	4.2	6.8	4.5	3.0	1.7	2.5	2.8	2.9	3.0
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005050	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.7;placenta: 6.6;testis: 7.1"	"Cell line enriched"	"Detected in some"	15	"BEWO: 50.7"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain									"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.5	0.2	0.2	0.3	0.2	1.3	0.2	0.2	0.3	0.3	0.9	0.2	0.2	0.6	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.3	0.4	0.2	1.1	0.8	0.3	0.2	0.2	0.2	0.0	0.2	6.6	1.3	0.2	0.3	0.2	0.4	0.2	1.9	1.8	0.2	0.2	0.2	1.1	0.5	7.1	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.9	1.2	4.7	1.0	2.3	2.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	50.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	3.3	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	4.3	1.0	1.2	2.0	0.8	1.5	1.7	1.6	1.3	0.4	1.9	1.7	1.7	4.7	2.3	0.9	1.2	1.5	0.4	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.3	0.2
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567065-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051857	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA051857: "	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	9.9	3.0	3.6	9.3	2.9	10.9	15.0	2.2	3.1	7.6	6.7	3.1	6.1	4.5	6.2	2.9	10.0	5.7	5.7	5.4	3.4	1.6	6.3	10.3	8.8	20.9	3.0	2.3	6.1	7.1	8.3	3.9	65.5	4.8	7.1	6.8	5.7	11.0	8.6	5.2	11.9	8.9	6.6	3.4	16.8	6.7	9.9	2.4	16.7	6.9	4.9	9.5	10.6	8.6	4.3	4.1	19.4	11.5	5.8	3.6	2.2	9.1	10.8	9.1	13.2	8.5	9.8	20.0	10.1	10.4	11.6	5.7	6.9	10.2	8.8	11.0	12.4	8.9	7.3	10.7	13.5	6.3	2.0	2.8	4.7	12.0	6.6	4.5	12.2	5.3	10.4	6.2	17.3	6.6	6.2	41.9	8.7	36.1	15.6	10.1	9.6	10.8	12.4	7.6	10.2	6.7	20.3	0.9	2.5	9.4	49.0	9.9	14.6	19.3	4.6	23.4	8.7	11.9	12.4	17.4	19.3	7.5	8.5	5.1	7.4	5.9	4.9	8.4	2.8	6.3	3.6	4.3	3.0	3.5	3.9	3.9	3.4	3.3	19.4	5.8	11.5	4.1	2.9	2.2	3.6	2.9	2.2	3.1	3.4	1.6	3.0	2.3	4.8	2.4
ZNF28	"DKFZp781D0275, KOX24"	ENSG00000198538	"Zinc finger protein 28"	P17035	19	52797409-52857600	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 64.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"prognostic unfavourable (9.29e-4)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.91e-3)"	"unprognostic (5.38e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.68e-2)"	7.3	7.8	7.5	4.8	6.4	1.0	7.6	10.2	5.7	6.8	7.5	4.5	11.6	6.8	5.7	5.9	7.3	8.1	8.1	4.6	5.7	3.9	8.9	3.9	5.2	9.0	5.0	3.1	5.9	8.3	7.2	7.0	64.1	5.9	7.3	9.3	3.2	6.5	5.8	2.2	4.7	11.0	6.0	4.7	6.1	6.8	6.1	5.7	12.7	11.7	2.8	6.9	8.8	6.5	5.4	6.1	15.4	4.7	19.4	8.0	5.5	7.4	0.8	4.4	8.3	7.1	5.7	15.6	6.6	5.2	6.6	9.1	6.2	7.2	12.7	7.8	5.0	5.7	7.2	4.2	9.2	0.1	7.5	10.0	4.3	1.7	7.2	0.1	10.3	4.7	6.7	8.6	8.6	6.5	11.6	0.1	7.7	2.3	10.0	4.2	5.5	6.4	6.6	11.3	7.3	7.0	25.6	7.3	5.5	14.1	6.6	5.1	9.8	9.3	5.5	3.4	6.7	2.9	6.7	2.6	11.1	13.7	0.2	1.5	13.1	15.4	4.7	7.3	8.0	3.5	6.9	5.0	5.6	6.6	6.1	5.4	6.5	7.6	2.5	19.4	3.8	3.2	4.4	5.5	7.5	6.4	10.2	5.7	5.7	3.9	5.0	3.1	5.9	5.7
ZNF468		ENSG00000204604	"Zinc finger protein 468"	"A2RRD8, Q5VIY5"	19	52838008-52890375	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Cell line enhanced"	"Detected in many"		"RT4: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: "	"prognostic unfavourable (6.87e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.25e-2)"	"prognostic favourable (3.94e-7)"	"unprognostic (1.04e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.59e-2)"	6.6	7.6	6.6	3.5	5.1	5.2	6.9	8.4	5.1	6.2	6.2	4.3	11.0	3.2	4.7	6.4	6.3	6.3	8.0	4.6	4.2	2.9	8.2	3.4	4.9	9.8	4.2	2.8	4.8	10.0	8.8	5.5	65.5	5.2	7.9	7.2	3.1	7.0	5.8	3.7	4.6	10.8	6.2	3.9	5.1	7.1	3.4	3.3	12.0	10.4	1.9	5.5	8.0	5.4	8.8	7.0	11.5	10.3	19.1	12.5	8.6	6.1	0.8	5.6	9.8	6.0	4.5	16.4	4.9	6.2	6.4	9.5	6.0	3.8	9.4	5.0	5.2	3.2	3.9	5.0	8.4	0.0	5.7	7.2	6.2	2.6	12.1	0.4	9.2	7.0	6.0	7.9	6.5	5.3	7.1	0.4	5.6	1.4	9.0	5.8	6.9	6.0	5.4	8.1	6.3	8.6	46.1	5.8	8.5	6.2	5.6	1.5	7.4	5.6	4.3	2.1	5.6	2.9	7.2	3.8	13.6	8.4	0.5	0.8	7.9	8.3	6.1	11.5	12.3	10.3	12.5	8.1	8.0	9.8	7.0	8.8	10.0	9.2	6.3	19.1	8.0	5.3	9.3	8.6	6.6	5.1	8.4	5.1	4.2	2.9	4.2	2.8	5.2	3.3
ZNF595	FLJ31740	ENSG00000272602	"Zinc finger protein 595"		4	53285-88211	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"placenta: 35.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.5;K-562: 63.1;SH-SY5Y: 43.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.63e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.46e-2)"	5.4	5.0	3.5	3.8	5.3	4.5	5.8	15.9	5.7	6.7	3.6	3.7	3.0	2.3	6.0	3.5	2.5	4.4	2.8	2.5	3.9		3.1	3.5	4.0	5.3	4.5	4.2	10.1	4.2	3.5	10.3	35.9	7.0	4.6	3.5	3.1	2.9	2.5	5.1	3.9	1.8	6.4	5.5	5.1	2.7	4.7	4.7	9.5	7.4	1.9	5.7	4.2	3.2	12.5	11.6	11.0	2.4	16.7	6.7	3.4	1.0	3.6	2.3	2.2	13.8	17.2	18.4	1.2	1.1	1.4	1.8	1.7	1.5	27.5	2.1	1.0	0.8	13.3	1.2	2.1	2.1	1.9	0.1	0.0	0.0	0.9	0.0	7.2	1.8	1.6	1.4	1.5	1.1	63.1	0.3	1.1	7.8	0.0	7.6	4.2	1.6	0.0	0.5	0.0	2.0	1.1	1.9	43.2	1.5	1.8	0.7	13.4	4.4	7.7	1.4	10.7	0.8	1.5	0.1	13.3	3.3	0.0	0.0	4.7	3.4	2.1	11.0	6.7	2.4	3.1	12.5	3.6	4.3	3.1	12.4	5.0	5.0	3.7	16.7	2.2	11.6	2.7	3.4										
ZNF850	ZNF850P	ENSG00000267041	"Zinc finger protein 850"	A8MQ14	19	36714383-36772825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 17.9"	"Cell line enhanced"	"Detected in many"		"HEL: 14.7;NTERA-2: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA029299	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA029299: "	"unprognostic (1.35e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.37e-3)"	4.0	3.4	2.6	3.0	4.2	11.5	3.3	8.7	3.1	5.1	2.4	3.4	1.6	1.9	5.6	2.6	2.8	2.9	3.2	4.6	2.5	1.7	2.0	2.8	3.0	4.0	5.9	0.7	5.9	4.1	3.2	6.4	17.9	3.2	3.4	2.9	3.0	2.3	2.2	1.9	3.2	2.9	2.3	3.5	3.6	2.7	6.7	3.8	7.0	2.6	1.0	2.9	5.0	4.4	6.8	3.5	6.0	3.8	3.8	6.0	5.1	0.3	1.7	3.7	5.8	0.8	0.3	7.1	2.4	1.3	1.4	2.1	1.3	0.4	1.2	5.1	0.4	0.8	2.6	0.5	2.7	0.6	2.1	14.7	0.2	1.1	1.0	1.8	8.3	1.1	0.1	2.4	0.0	1.3	3.8	0.8	3.7	0.8	2.6	1.8	10.8	1.0	1.6	7.3	0.9	0.6	7.3	2.5	4.0	3.8	0.2	0.6	1.5	3.3	2.9	3.7	5.8	2.1	3.6	1.5	2.6	3.2	0.0	0.8	5.7	4.2	3.4	2.4	3.9	3.6	5.0	6.8	4.8	3.2	3.2	5.4	5.7	6.0	6.0	3.8	3.8	3.5	3.2	5.1	2.6	4.2	8.7	3.1	2.5	1.7	5.9	0.7	3.2	3.8
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA008547	Supported				"Secreted in female reproductive system"					"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	1.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
